<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="fd7f9ff1-7e34-4b03-8c1f-0cabbca023c6" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;issue:issue:pii\:S0092867421X00207;website:website:cell-site;ctype:string:Journal Content;article:article:pii\:S0092867422009953;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="A general chemical principle for creating closure-stabilizing integrin inhibitors">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(22)00995-3">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/ff61a929-0ad7-45aa-83d2-5767275e0bc8/fx1.jpg">
    


        <meta property="og:description" content="A design principle for integrin inhibitors.">
    











        <meta name="twitter:title" content="A general chemical principle for creating closure-stabilizing integrin inhibitors">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/ff61a929-0ad7-45aa-83d2-5767275e0bc8/fx1.jpg">
    


        <meta name="twitter:description" content="A design principle for integrin inhibitors.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(22)00995-3">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>A general chemical principle for creating closure-stabilizing integrin inhibitors: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="A general chemical principle for creating closure-stabilizing integrin inhibitors"> <meta name="citation_date" content="2022/09/15"> <meta name="citation_volume" content="185"> <meta name="citation_issue" content="19"> <meta name="citation_firstpage" content="3533"> <meta name="citation_lastpage" content="3550.e27"> <meta name="citation_pmid" content="36113427"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867422009953"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867422009953"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867422009953"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2022.08.008"> <meta name="citation_pmid" content="36113427"> <meta name="citation_author" content="Fu-Yang Lin"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Jing Li"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Yonghua Xie"><meta name="citation_author_institution" content="School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, PRC"><meta name="citation_author" content="Jianghai Zhu"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author" content="Thi Thu Huong Nguyen"><meta name="citation_author_institution" content="Blood Research Institute, Versiti, Milwaukee, WI 53226, USA"><meta name="citation_author_institution" content="Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA"><meta name="citation_author" content="Yonghui Zhang"><meta name="citation_author_email" content="zhangyonghui@tsinghua.edu.cn"><meta name="citation_author_institution" content="School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, PRC"><meta name="citation_author" content="Jieqing Zhu"><meta name="citation_author_email" content="jieqing.zhu@versiti.org"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_author_institution" content="Blood Research Institute, Versiti, Milwaukee, WI 53226, USA"><meta name="citation_author_institution" content="Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA"><meta name="citation_author" content="Timothy A. Springer"><meta name="citation_author_email" content="springer@crystal.harvard.edu"><meta name="citation_author_orcid" content="0000-0001-6627-2904"><meta name="citation_author_institution" content="Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA"><meta name="citation_keywords" content="integrins; drug discovery; conformational change; thrombosis; autoimmune disease; membrane receptors; integrin inhibitors; conformations; agonism; αIIbβ3; α4β1; hydrogen bonds; conformation specificity"><meta name="citation_reference" content="citation_title=Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis; citation_author=B.D. Adair; citation_author=J.L. Alonso; citation_author=J. van Agthoven; citation_author=V. Hayes; citation_author=H.S. Ahn; citation_author=I.S. Yu; citation_author=S.W. Lin; citation_author=J.P. Xiong; citation_author=M. Poncz; citation_author=M.A. Arnaout; citation_journal_title=Nat. Commun.; citation_volume=11; citation_firstpage=398; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Phenix: a comprehensive Python-based system for macromolecular structure solution; citation_author=P.D. Adams; citation_author=P.V. Afonine; citation_author=G. Bunkóczi; citation_author=V.B. Chen; citation_author=I.W. Davis; citation_author=N. Echols; citation_author=J.J. Headd; citation_author=L.W. Hung; citation_author=G.J. Kapral; citation_author=R.W. Grosse-Kunstleve; citation_author=et al.; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=213; citation_lastpage=221; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=UR-3216: a new generation oral platelet GPIIb/IIIa antagonist; citation_author=Y. Aga; citation_author=K. Baba; citation_author=S. Tam; citation_author=T. Nakanishi; citation_author=K. Yoneda; citation_author=J. Kita; citation_author=H. Ueno; citation_journal_title=Curr. Pharm. Des.; citation_volume=10; citation_firstpage=1597; citation_lastpage=1601; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization; citation_author=S.K. Akiyama; citation_author=S.S. Yamada; citation_author=W.T. Chen; citation_author=K.M. Yamada; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=109; citation_firstpage=863; citation_lastpage=875; citation_publication_date=1989; "><meta name="citation_reference" content="citation_title=Regulation of integrin α5β1 conformational states and intrinsic affinities by metal ions and the ADMIDAS; citation_author=J.M. Anderson; citation_author=J. Li; citation_author=T.A. Springer; citation_journal_title=Mol. Biol. Cell; citation_volume=33; citation_firstpage=ar56; citation_publication_date=2022; "><meta name="citation_reference" content="citation_title=Structural mechanism of laminin recognition by integrin; citation_author=T. Arimori; citation_author=N. Miyazaki; citation_author=E. Mihara; citation_author=M. Takizawa; citation_author=Y. Taniguchi; citation_author=C. Cabañas; citation_author=K. Sekiguchi; citation_author=J. Takagi; citation_journal_title=Nat. Commun.; citation_volume=12; citation_firstpage=4012; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in myocardial infarction; citation_author=K.A. Ault; citation_author=C.P. Cannon; citation_author=J. Mitchell; citation_author=J. McCahan; citation_author=R.P. Tracy; citation_author=W.F. Novotny; citation_author=J.D. Reimann; citation_author=E. Braunwald; citation_journal_title=J.&nbsp;Am. Coll. Cardiol.; citation_volume=33; citation_firstpage=634; citation_lastpage=639; citation_publication_date=1999; "><meta name="citation_reference" content="citation_title=UR-3216: a manageable oral GPIIb/IIIa antagonist; citation_author=K. Baba; citation_author=Y. Aga; citation_author=T. Nakanishi; citation_author=T. Motoyama; citation_author=H. Ueno; citation_journal_title=Cardiovasc. Drug Rev.; citation_volume=19; citation_firstpage=25; citation_lastpage=40; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Delayed tirofiban-induced thrombocytopenia: two case reports; citation_author=A. Bosco; citation_author=G. Kidson-Gerber; citation_author=S. Dunkley; citation_journal_title=J.&nbsp;Thromb. Haemost.; citation_volume=3; citation_firstpage=1109; citation_lastpage=1110; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin; citation_author=D.W. Bougie; citation_author=M. Rasmussen; citation_author=J. Zhu; citation_author=R.H. Aster; citation_journal_title=Blood; citation_volume=119; citation_firstpage=6317; citation_lastpage=6325; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes; citation_author=L. Breth; citation_author=J. Kochie; citation_author=A. Combs; citation_author=S. Wang; citation_author=J. Smallheer; citation_author=J. Billheimer; citation_author=D. Seiffert; citation_author=G. Hollis; citation_author=K. O'Neil; citation_journal_title=J.&nbsp;Immunol. Methods; citation_volume=301; citation_firstpage=11; citation_lastpage=20; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Anti-integrin monoclonal antibodies; citation_author=A. Byron; citation_author=J.D. Humphries; citation_author=J.A. Askari; citation_author=S.E. Craig; citation_author=A.P. Mould; citation_author=M.J. Humphries; citation_journal_title=J.&nbsp;Cell Sci.; citation_volume=122; citation_firstpage=4009; citation_lastpage=4011; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Cryo-EM reveals integrin-mediated TGF-β activation without release from latent TGF-β; citation_author=M.G. Campbell; citation_author=A. Cormier; citation_author=S. Ito; citation_author=R.I. Seed; citation_author=A.J. Bondesson; citation_author=J. Lou; citation_author=J.D. Marks; citation_author=J.L. Baron; citation_author=Y. Cheng; citation_author=S.L. Nishimura; citation_journal_title=Cell; citation_volume=180; citation_firstpage=490; citation_lastpage=501; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials; citation_author=D.P. Chew; citation_author=D.L. Bhatt; citation_author=S. Sapp; citation_author=E.J. Topol; citation_journal_title=Circulation; citation_volume=103; citation_firstpage=201; citation_lastpage=206; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist; citation_author=J. Chiba; citation_author=N. Machinaga; citation_author=T. Takashi; citation_author=A. Ejima; citation_author=G. Takayama; citation_author=M. Yokoyama; citation_author=A. Nakayama; citation_author=J.J. Baldwin; citation_author=E. McDonald; citation_author=K.J. Moriarty; citation_author=et al.; citation_journal_title=Bioorg. Med. Chem. Lett.; citation_volume=15; citation_firstpage=41; citation_lastpage=45; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist; citation_author=D. Cox; citation_author=T. Aoki; citation_author=J. Seki; citation_author=Y. Motoyama; citation_author=K. Yoshida; citation_journal_title=Thromb. Haemost.; citation_volume=75; citation_firstpage=503; citation_lastpage=509; citation_publication_date=1996; "><meta name="citation_reference" content="citation_title=Integrins as therapeutic targets: lessons and opportunities; citation_author=D. Cox; citation_author=M. Brennan; citation_author=N. Moran; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=9; citation_firstpage=804; citation_lastpage=820; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes; citation_author=D. Cox; citation_author=R. Smith; citation_author=M. Quinn; citation_author=P. Theroux; citation_author=P. Crean; citation_author=D.J. Fitzgerald; citation_journal_title=J.&nbsp;Am. Coll. Cardiol.; citation_volume=36; citation_firstpage=1514; citation_lastpage=1519; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Platelet activation and atherothrombosis; citation_author=G. Davì; citation_author=C. Patrono; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=357; citation_firstpage=2482; citation_lastpage=2494; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists; citation_author=T. Dickfeld; citation_author=A. Ruf; citation_author=G. Pogatsa-Murray; citation_author=I. Müller; citation_author=B. Engelmann; citation_author=W. Taubitz; citation_author=J. Fischer; citation_author=O. Meier; citation_author=M. Gawaz; citation_journal_title=Thromb. Res.; citation_volume=101; citation_firstpage=53; citation_lastpage=64; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Structural determinants of integrin β-subunit specificity for latent TGF-β; citation_author=X. Dong; citation_author=N.E. Hudson; citation_author=C. Lu; citation_author=T.A. Springer; citation_journal_title=Nat. Struct. Mol. Biol.; citation_volume=21; citation_firstpage=1091; citation_lastpage=1096; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent; citation_author=C.D. Eldred; citation_author=B. Evans; citation_author=S. Hindley; citation_author=B.D. Judkins; citation_author=H.A. Kelly; citation_author=J. Kitchin; citation_author=P. Lumley; citation_author=B. Porter; citation_author=B.C. Ross; citation_author=K.J. Smith; citation_author=et al.; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=37; citation_firstpage=3882; citation_lastpage=3885; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Features and development of coot; citation_author=P. Emsley; citation_author=B. Lohkamp; citation_author=W.G. Scott; citation_author=K. Cowtan; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=486; citation_lastpage=501; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Intact αIIbβ3 extends after activation measured by solution X-ray scattering and electron microscopy; citation_author=E.T. Eng; citation_author=B.J. Smagghe; citation_author=T. Walz; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=286; citation_firstpage=35218; citation_lastpage=35226; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Platelet activation in unstable coronary disease; citation_author=D.J. Fitzgerald; citation_author=L. Roy; citation_author=F. Catella; citation_author=G.A. FitzGerald; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=315; citation_firstpage=983; citation_lastpage=989; citation_publication_date=1986; "><meta name="citation_reference" content="citation_title=Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers; citation_author=A.L. Frelinger; citation_author=I. Cohen; citation_author=E.F. Plow; citation_author=M.A. Smith; citation_author=J. Roberts; citation_author=S.C.T. Lam; citation_author=M.H. Ginsberg; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=265; citation_firstpage=6346; citation_lastpage=6352; citation_publication_date=1990; "><meta name="citation_reference" content="citation_title=Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion; citation_author=A.L. Frelinger; citation_author=S.C.T. Lam; citation_author=E.F. Plow; citation_author=M.A. Smith; citation_author=J.C. Loftus; citation_author=M.H. Ginsberg; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=263; citation_firstpage=12397; citation_lastpage=12402; citation_publication_date=1988; "><meta name="citation_reference" content="citation_title=New peptidomimetics in the chemistry of fibrinogen receptor antagonists; citation_author=J. Gante; citation_author=H. Juraszyk; citation_author=P. Raddatz; citation_author=H. Wurziger; citation_author=S. Bernotat-Danielowski; citation_author=G. Melzer; citation_author=F. Rippmann; citation_journal_title=Lett. Pept. Sci.; citation_volume=2; citation_firstpage=135; citation_lastpage=140; citation_publication_date=1995; "><meta name="citation_reference" content="citation_title=New antithrombotic RGD-mimetics with high bioavailability; citation_author=J. Gante; citation_author=H. Juraszyk; citation_author=P. Raddatz; citation_author=H. Wurziger; citation_author=S. Bernotat-Danielowski; citation_author=G. Melzer; citation_author=F. Rippmann; citation_journal_title=Bioorg. Med. Chem. Lett.; citation_volume=6; citation_firstpage=2425; citation_lastpage=2430; citation_publication_date=1996; "><meta name="citation_reference" content="Himmelsbach, F., Volkhard, A., Pieper, H., Linz, G., Weisenberger, J., and Mueller, T. (1996). Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds. US patent US5576444 published Nov. 19 1996."><meta name="citation_reference" content="citation_title=Clot retraction: cellular mechanisms and inhibitors, measuring methods, and clinical implications; citation_author=E.E. Jansen; citation_author=M. Hartmann; citation_journal_title=Biomedicines; citation_volume=9; citation_firstpage=1064; citation_publication_date=2021; "><meta name="citation_reference" content="citation_author=W. Kabsch; citation_journal_title=XDS. Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=125; citation_lastpage=132; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa; citation_author=R. Kekomaki; citation_author=B. Dawson; citation_author=J. McFarland; citation_author=T.J. Kunicki; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=88; citation_firstpage=847; citation_lastpage=854; citation_publication_date=1991; "><meta name="citation_reference" content="citation_title=First human use of RUC-4: A nonactivating second-generation small-molecule platelet glycoprotein IIb/IIIa (integrin αiibβ3) inhibitor designed for subcutaneous point-of-care treatment of ST-segment-elevation myocardial infarction; citation_author=D.J. Kereiakes; citation_author=T.D. Henry; citation_author=A.N. DeMaria; citation_author=O. Bentur; citation_author=M. Carlson; citation_author=C. Seng Yue; citation_author=L.H. Martin; citation_author=J. Midkiff; citation_author=M. Mueller; citation_author=T. Meek; citation_author=et al.; citation_journal_title=J.&nbsp;Am. Heart Assoc.; citation_volume=9; citation_firstpage=e016552; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=A monoclonal antibody against an activation epitope on mouse integrin chain β1 blocks adhesion of lymphocytes to the endothelial integrin α6β1; citation_author=M. Lenter; citation_author=H. Uhlig; citation_author=A. Hamann; citation_author=P. Jenö; citation_author=B. Imhof; citation_author=D. Vestweber; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=90; citation_firstpage=9051; citation_lastpage=9055; citation_publication_date=1993; "><meta name="citation_reference" content="citation_title=Integrin-based therapeutics: biological basis, clinical use and new drugs; citation_author=K. Ley; citation_author=J. Rivera-Nieves; citation_author=W.J. Sandborn; citation_author=S. Shattil; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=15; citation_firstpage=173; citation_lastpage=183; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Novel pure αVβ3 integrin antagonists that do not induce receptor extension, prime the receptor, or enhance angiogenesis at low concentrations; citation_author=J. Li; citation_author=Y. Fukase; citation_author=Y. Shang; citation_author=W. Zou; citation_author=J.M. Muñoz-Félix; citation_author=L. Buitrago; citation_author=J. van Agthoven; citation_author=Y. Zhang; citation_author=R. Hara; citation_author=Y. Tanaka; citation_author=et al.; citation_journal_title=ACS Pharmacol. Transl. Sci.; citation_volume=2; citation_firstpage=387; citation_lastpage=401; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Integrin extension enables ultrasensitive regulation by cytoskeletal force; citation_author=J. Li; citation_author=T.A. Springer; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=114; citation_firstpage=4685; citation_lastpage=4690; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Energy landscape differences among integrins establish the framework for understanding activation; citation_author=J. Li; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=217; citation_firstpage=397; citation_lastpage=412; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Conformational equilibria and intrinsic affinities define integrin activation; citation_author=J. Li; citation_author=Y. Su; citation_author=W. Xia; citation_author=Y. Qin; citation_author=M.J. Humphries; citation_author=D. Vestweber; citation_author=C. Cabañas; citation_author=C. Lu; citation_author=T.A. Springer; citation_journal_title=EMBO J; citation_volume=36; citation_firstpage=629; citation_lastpage=645; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction; citation_author=J. Li; citation_author=S. Vootukuri; citation_author=Y. Shang; citation_author=A. Negri; citation_author=J.K. Jiang; citation_author=M. Nedelman; citation_author=T.G. Diacovo; citation_author=M. Filizola; citation_author=C.J. Thomas; citation_author=B.S. Coller; citation_journal_title=Arterioscler. Thromb. Vasc. Biol.; citation_volume=34; citation_firstpage=2321; citation_lastpage=2329; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand; citation_author=B.H. Luo; citation_author=T.A. Springer; citation_author=J. Takagi; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=100; citation_firstpage=2403; citation_lastpage=2408; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=A specific interface between integrin transmembrane helices and affinity for ligand; citation_author=B.H. Luo; citation_author=T.A. Springer; citation_author=J. Takagi; citation_journal_title=PLoS Biol; citation_volume=2; citation_firstpage=e153; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common β1 chain; citation_author=A. Luque; citation_author=M. Gómez; citation_author=W. Puzon; citation_author=Y. Takada; citation_author=F. Sánchez-Madrid; citation_author=C. Cabañas; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=271; citation_firstpage=11067; citation_lastpage=11075; citation_publication_date=1996; "><meta name="citation_reference" content="citation_title=CuI-catalyzed coupling reaction of beta-amino acids or esters with aryl halides at temperature lower than that employed in the normal Ullmann reaction. Facile synthesis of SB-214857; citation_author=D. Ma; citation_author=C. Xia; citation_journal_title=Org. Lett.; citation_volume=3; citation_firstpage=2583; citation_lastpage=2586; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster; citation_author=H. Matsuno; citation_author=O. Kozawa; citation_author=M. Niwa; citation_author=T. Ito; citation_author=K. Tanabe; citation_author=M. Nishida; citation_author=H. Hayashi; citation_author=T. Uematsu; citation_journal_title=J.&nbsp;Cardiovasc. Pharmacol.; citation_volume=32; citation_firstpage=191; citation_lastpage=197; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster; citation_author=H. Matsuno; citation_author=O. Kozawa; citation_author=M. Niwa; citation_author=T. Kaida; citation_author=H. Hayashi; citation_author=T. Uematsu; citation_journal_title=Br. J. Pharmacol.; citation_volume=122; citation_firstpage=1099; citation_lastpage=1104; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial; citation_author=D.H. Miller; citation_author=T. Weber; citation_author=R. Grove; citation_author=C. Wardell; citation_author=J. Horrigan; citation_author=O. Graff; citation_author=G. Atkinson; citation_author=P. Dua; citation_author=T. Yousry; citation_author=D. Macmanus; citation_author=et al.; citation_journal_title=Lancet Neurol; citation_volume=11; citation_firstpage=131; citation_lastpage=139; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=An anti-α v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice; citation_author=F. Mitjans; citation_author=D. Sander; citation_author=J. Adán; citation_author=A. Sutter; citation_author=J.M. Martinez; citation_author=C.S. Jäggle; citation_author=J.M. Moyano; citation_author=H.G. Kreysch; citation_author=J. Piulats; citation_author=S.L. Goodman; citation_journal_title=J.&nbsp;Cell Sci.; citation_volume=108; citation_firstpage=2825; citation_lastpage=2838; citation_publication_date=1995; "><meta name="citation_reference" content="citation_title=Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture; citation_author=K. Miyake; citation_author=Y. Hasunuma; citation_author=H. Yagita; citation_author=M. Kimoto; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=119; citation_firstpage=653; citation_lastpage=662; citation_publication_date=1992; "><meta name="citation_reference" content="citation_title=Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit; citation_author=A.P. Mould; citation_author=A.N. Garratt; citation_author=J.A. Askari; citation_author=S.K. Akiyama; citation_author=M.J. Humphries; citation_journal_title=FEBS Lett; citation_volume=363; citation_firstpage=118; citation_lastpage=122; citation_publication_date=1995; "><meta name="citation_reference" content="citation_title=A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients; citation_author=D. Mould; citation_author=M. Chapelsky; citation_author=J. Aluri; citation_author=J. Swagzdis; citation_author=R. Samuels; citation_author=J. Granett; citation_journal_title=Clin. Pharmacol. Ther.; citation_volume=69; citation_firstpage=210; citation_lastpage=222; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men; citation_author=T.H. Müller; citation_author=H. Weisenberger; citation_author=R. Brickl; citation_author=H. Narjes; citation_author=F. Himmelsbach; citation_author=J. Krause; citation_journal_title=Circulation; citation_volume=96; citation_firstpage=1130; citation_lastpage=1138; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=Discovery of trans-4-[1-[[2, 5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist; citation_author=F. Muro; citation_author=S. Iimura; citation_author=Y. Sugimoto; citation_author=Y. Yoneda; citation_author=J. Chiba; citation_author=T. Watanabe; citation_author=M. Setoguchi; citation_author=Y. Iigou; citation_author=K. Matsumoto; citation_author=A. Satoh; citation_author=et al.; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=52; citation_firstpage=7974; citation_lastpage=7992; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in&nbsp;vivo; citation_author=N.P. Murphy; citation_author=D. Pratico; citation_author=D.J. Fitzgerald; citation_journal_title=J.&nbsp;Pharmacol. Exp. Ther.; citation_volume=286; citation_firstpage=945; citation_lastpage=951; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor; citation_author=M. Nagae; citation_author=S. Re; citation_author=E. Mihara; citation_author=T. Nogi; citation_author=Y. Sugita; citation_author=J. Takagi; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=197; citation_firstpage=131; citation_lastpage=140; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3; citation_author=P.J. Newman; citation_author=R.W. Allen; citation_author=R.A. Kahn; citation_author=T.J. Kunicki; citation_journal_title=Blood; citation_volume=65; citation_firstpage=227; citation_lastpage=232; citation_publication_date=1985; "><meta name="citation_reference" content="citation_title=Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in&nbsp;vitro intestinal parameters; citation_author=M. Nomoto; citation_author=T. Tatebayashi; citation_author=J. Morita; citation_author=H. Suzuki; citation_author=K. Aizawa; citation_author=T. Kurosawa; citation_author=I. Komiya; citation_journal_title=J.&nbsp;Pharm. Sci.; citation_volume=98; citation_firstpage=1532; citation_lastpage=1544; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Delayed profound thrombocytopenia associated with eptifibatide; citation_author=A.A. Onitilo; citation_journal_title=Am. J. Hematol.; citation_volume=81; citation_firstpage=984; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Intrinsic activating properties of GP IIb/IIIa blockers; citation_author=K. Peter; citation_author=M. Schwarz; citation_author=T. Nordt; citation_author=C. Bode; citation_journal_title=Thromb. Res.; citation_volume=103; citation_firstpage=S21; citation_lastpage=S27; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of Roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers; citation_author=H.J. Pieniaszek; citation_author=S.K. Sy; citation_author=W. Ebling; citation_author=M.J. Fossler; citation_author=V.A. Cain; citation_author=J.T. Mondick; citation_author=S. Ma; citation_author=D.M. Kornhauser; citation_journal_title=J.&nbsp;Clin. Pharmacol.; citation_volume=42; citation_firstpage=738; citation_lastpage=753; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Genome engineering using the CRISPR-Cas9 system; citation_author=F.A. Ran; citation_author=P.D. Hsu; citation_author=J. Wright; citation_author=V. Agarwala; citation_author=D.A. Scott; citation_author=F. Zhang; citation_journal_title=Nat. Protoc.; citation_volume=8; citation_firstpage=2281; citation_lastpage=2308; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors; citation_author=A.R. Reynolds; citation_author=I.R. Hart; citation_author=A.R. Watson; citation_author=J.C. Welti; citation_author=R.G. Silva; citation_author=S.D. Robinson; citation_author=G. Da Violante; citation_author=M. Gourlaouen; citation_author=M. Salih; citation_author=M.C. Jones; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=15; citation_firstpage=392; citation_lastpage=400; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents; citation_author=R.M. Scarborough; citation_author=D.D. Gretler; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=43; citation_firstpage=3453; citation_lastpage=3473; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Structural insights into integrin α5β1 opening by fibronectin ligand; citation_author=S. Schumacher; citation_author=D. Dedden; citation_author=R.V. Nunez; citation_author=K. Matoba; citation_author=J. Takagi; citation_author=C. Biertümpfel; citation_author=N. Mizuno; citation_journal_title=Sci. Adv.; citation_volume=7; citation_firstpage=eabe9716; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2; citation_author=M. Sen; citation_author=K. Yuki; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=203; citation_firstpage=629; citation_lastpage=642; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Therapeutic antagonists and the conformational regulation of integrin structure and function; citation_author=M. Shimaoka; citation_author=T.A. Springer; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=2; citation_firstpage=703; citation_lastpage=716; citation_publication_date=2003; "><meta name="citation_reference" content="Smallheer, J.M., Wang, S., and Jadhav, P.K. (2001). Isoxazoline fibrinogen receptor antagonists. US patent US6303609 B1. published October 16, 2001."><meta name="citation_reference" content="citation_title=Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling; citation_author=J. Takagi; citation_author=B.M. Petre; citation_author=T. Walz; citation_author=T.A. Springer; citation_journal_title=Cell; citation_volume=110; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction; citation_author=P. Théroux; citation_author=F. Catella-Lawson; citation_author=P. Armstrong; citation_author=J. DeCani; citation_author=J. Hirsh; citation_author=C. Pepine; citation_author=T.J. Ryan; citation_author=G. Pelletier; citation_author=R. Davies; citation_author=M. Flather; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=338; citation_firstpage=1488; citation_lastpage=1497; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists; citation_author=J.W. Tilley; citation_author=A. Sidduri; citation_author=J. Lou; citation_author=G. Kaplan; citation_author=N. Tare; citation_author=G. Cavallo; citation_author=K. Frank; citation_author=A. Pamidimukkala; citation_author=D.S. Choi; citation_author=L. Gerber; citation_author=et al.; citation_journal_title=Bioorg. Med. Chem. Lett.; citation_volume=23; citation_firstpage=1036; citation_lastpage=1040; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Platelet GPIIb-IIIa blockers; citation_author=E.J. Topol; citation_author=T.V. Byzova; citation_author=E.F. Plow; citation_journal_title=Lancet; citation_volume=353; citation_firstpage=227; citation_lastpage=231; citation_publication_date=1999; "><meta name="citation_reference" content="citation_title=Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease; citation_author=E.J. Topol; citation_author=D. Easton; citation_author=R.A. Harrington; citation_author=P. Amarenco; citation_author=R.M. Califf; citation_author=C. Graffagnino; citation_author=S. Davis; citation_author=H.C. Diener; citation_author=J. Ferguson; citation_author=D. Fitzgerald; citation_author=et al.; citation_journal_title=Circulation; citation_volume=108; citation_firstpage=399; citation_lastpage=406; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Platelet hyperreactivity and prognosis in survivors of myocardial infarction; citation_author=M.D. Trip; citation_author=V.M. Cats; citation_author=F.J. van Capelle; citation_author=J. Vreeken; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=322; citation_firstpage=1549; citation_lastpage=1554; citation_publication_date=1990; "><meta name="citation_reference" content="citation_title=General structural features that regulate integrin affinity revealed by atypical αVβ8; citation_author=J. Wang; citation_author=Y. Su; citation_author=R.E. Iacob; citation_author=J.R. Engen; citation_author=T.A. Springer; citation_journal_title=Nat. Commun.; citation_volume=10; citation_firstpage=5481; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines; citation_author=T. Weller; citation_author=L. Alig; citation_author=M. Beresini; citation_author=B. Blackburn; citation_author=S. Bunting; citation_author=P. Hadváry; citation_author=M.H. Müller; citation_author=D. Knopp; citation_author=B. Levet-Trafit; citation_author=M.T. Lipari; citation_author=et al.; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=39; citation_firstpage=3139; citation_lastpage=3147; citation_publication_date=1996; "><meta name="citation_reference" content="citation_title=Pharmacokinetics and pharmacodynamics of RO 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers; citation_author=B. Wittke; citation_author=I.J. Mackie; citation_author=S.J. Machin; citation_author=U. Timm; citation_author=M. Zell; citation_author=T. Goggin; citation_journal_title=Br. J. Clin. Pharmacol.; citation_volume=47; citation_firstpage=521; citation_lastpage=530; citation_publication_date=1999; "><meta name="citation_reference" content="citation_title=&quot;Panning&quot; for lymphocytes: A method for cell selection; citation_author=L.J. Wysocki; citation_author=V.L. Sato; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=75; citation_firstpage=2844; citation_lastpage=2848; citation_publication_date=1978; "><meta name="citation_reference" content="citation_title=Metal ion and ligand binding of integrin α5β1; citation_author=W. Xia; citation_author=T.A. Springer; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=111; citation_firstpage=17863; citation_lastpage=17868; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics; citation_author=T. Xiao; citation_author=J. Takagi; citation_author=B.S. Coller; citation_author=J.H. Wang; citation_author=T.A. Springer; citation_journal_title=Nature; citation_volume=432; citation_firstpage=59; citation_lastpage=67; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand; citation_author=J.P. Xiong; citation_author=T. Stehle; citation_author=R. Zhang; citation_author=A. Joachimiak; citation_author=M. Frech; citation_author=S.L. Goodman; citation_author=M.A. Arnaout; citation_journal_title=Science; citation_volume=296; citation_firstpage=151; citation_lastpage=155; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=How natalizumab binds and antagonizes α4 integrins; citation_author=Y. Yu; citation_author=T. Schürpf; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=288; citation_firstpage=32314; citation_lastpage=32325; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Structural specializations of α4β7 an integrin that mediates rolling adhesion; citation_author=Y. Yu; citation_author=J. Zhu; citation_author=L.Z. Mi; citation_author=T. Walz; citation_author=H. Sun; citation_author=J.-F. Chen; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=196; citation_firstpage=131; citation_lastpage=146; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=The enantiospecific synthesis of an isoxazoline. A RGD mimic platelet GPIIb/IIIa antagonist; citation_author=Lh Zhang; citation_author=J.C. Chung; citation_author=T.D. Costello; citation_author=I. Valvis; citation_author=P. Ma; citation_author=S. Kauffman; citation_author=R. Ward; citation_journal_title=J.&nbsp;Org. Chem.; citation_volume=62; citation_firstpage=2466; citation_lastpage=2470; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=Modulation of integrin activation and signaling by α1/α1'-helix unbending at the junction; citation_author=C. Zhang; citation_author=J. Liu; citation_author=X. Jiang; citation_author=N. Haydar; citation_author=C. Zhang; citation_author=H. Shan; citation_author=J. Zhu; citation_journal_title=J.&nbsp;Cell Sci.; citation_volume=126; citation_firstpage=5735; citation_lastpage=5747; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Structure-guided design of a high affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg2+ binding to the MIDAS; citation_author=J. Zhu; citation_author=W.-S. Choi; citation_author=J.G. McCoy; citation_author=A. Negri; citation_author=J. Zhu; citation_author=S. Naini; citation_author=J. Li; citation_author=M. Shen; citation_author=W. Huang; citation_author=D. Bougie; citation_author=et al.; citation_journal_title=Sci. Transl. Med.; citation_volume=4; citation_firstpage=125; citation_lastpage=132; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Complete integrin headpiece opening in eight steps; citation_author=J. Zhu; citation_author=J. Zhu; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=201; citation_firstpage=1053; citation_lastpage=1068; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening; citation_author=J. Zhu; citation_author=J. Zhu; citation_author=A. Negri; citation_author=D. Provasi; citation_author=M. Filizola; citation_author=B.S. Coller; citation_author=T.A. Springer; citation_journal_title=Blood; citation_volume=116; citation_firstpage=5050; citation_lastpage=5059; citation_publication_date=2010; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Integrins are validated drug targets with six approved therapeutics. However, small-molecule inhibitors to three integrins failed in late-stage clinical trials for chronic indications. Such unfavorable outcomes may in part be caused by partial agonism, i.e., the stabilization of the high-affinity, extended-open integrin conformation. Here, we show that the failed, small-molecule inhibitors of integrins αIIbβ3 and α4β1 stabilize the high-affinity conformation. Furthermore, we discovered a simple chemical feature present in multiple αIIbβ3 antagonists that stabilizes integrins in their bent-closed conformation. Closing inhibitors contain a polar nitrogen atom that stabilizes, via hydrogen bonds, a water molecule that intervenes between a serine residue and the metal in the metal-ion-dependent adhesion site (MIDAS). Expulsion of this water is a requisite for transition to the open conformation. This change in metal coordination is general to integrins, suggesting broad applicability of the drug-design principle to the integrin family, as validated with a distantly related integrin, α4β1.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=12807&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(22)00995-3&amp;be=3158&amp;fe=10402&amp;dc=9662&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749594462938,%22n%22:0,%22f%22:2517,%22dn%22:2518,%22dne%22:2518,%22c%22:2518,%22s%22:2518,%22ce%22:2518,%22rq%22:2518,%22rp%22:3143,%22rpe%22:3913,%22dl%22:3148,%22di%22:4443,%22ds%22:9662,%22de%22:9910,%22dc%22:10402,%22l%22:10402,%22le%22:10514%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><script type="text/javascript" src="https://www.cell.com/products/marlin/cell/releasedAssets/public/mathjax-511ffcc670c4d93d695bf67802ba7aad/tex-mml-chtml.js" async=""></script><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"><style type="text/css">.CtxtMenu_InfoClose {  top:.2em; right:.2em;}
.CtxtMenu_InfoContent {  overflow:auto; text-align:left; font-size:80%;  padding:.4em .6em; border:1px inset; margin:1em 0px;  max-height:20em; max-width:30em; background-color:#EEEEEE;  white-space:normal;}
.CtxtMenu_Info.CtxtMenu_MousePost {outline:none;}
.CtxtMenu_Info {  position:fixed; left:50%; width:auto; text-align:center;  border:3px outset; padding:1em 2em; background-color:#DDDDDD;  color:black;  cursor:default; font-family:message-box; font-size:120%;  font-style:normal; text-indent:0; text-transform:none;  line-height:normal; letter-spacing:normal; word-spacing:normal;  word-wrap:normal; white-space:nowrap; float:none; z-index:201;  border-radius: 15px;                     /* Opera 10.5 and IE9 */  -webkit-border-radius:15px;               /* Safari and Chrome */  -moz-border-radius:15px;                  /* Firefox */  -khtml-border-radius:15px;                /* Konqueror */  box-shadow:0px 10px 20px #808080;         /* Opera 10.5 and IE9 */  -webkit-box-shadow:0px 10px 20px #808080; /* Safari 3 & Chrome */  -moz-box-shadow:0px 10px 20px #808080;    /* Forefox 3.5 */  -khtml-box-shadow:0px 10px 20px #808080;  /* Konqueror */  filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color="gray", Positive="true"); /* IE */}
</style><style type="text/css">.CtxtMenu_MenuClose {  position:absolute;  cursor:pointer;  display:inline-block;  border:2px solid #AAA;  border-radius:18px;  -webkit-border-radius: 18px;             /* Safari and Chrome */  -moz-border-radius: 18px;                /* Firefox */  -khtml-border-radius: 18px;              /* Konqueror */  font-family: "Courier New", Courier;  font-size:24px;  color:#F0F0F0}
.CtxtMenu_MenuClose span {  display:block; background-color:#AAA; border:1.5px solid;  border-radius:18px;  -webkit-border-radius: 18px;             /* Safari and Chrome */  -moz-border-radius: 18px;                /* Firefox */  -khtml-border-radius: 18px;              /* Konqueror */  line-height:0;  padding:8px 0 6px     /* may need to be browser-specific */}
.CtxtMenu_MenuClose:hover {  color:white!important;  border:2px solid #CCC!important}
.CtxtMenu_MenuClose:hover span {  background-color:#CCC!important}
.CtxtMenu_MenuClose:hover:focus {  outline:none}
</style><style type="text/css">.CtxtMenu_Menu {  position:absolute;  background-color:white;  color:black;  width:auto; padding:5px 0px;  border:1px solid #CCCCCC; margin:0; cursor:default;  font: menu; text-align:left; text-indent:0; text-transform:none;  line-height:normal; letter-spacing:normal; word-spacing:normal;  word-wrap:normal; white-space:nowrap; float:none; z-index:201;  border-radius: 5px;                     /* Opera 10.5 and IE9 */  -webkit-border-radius: 5px;             /* Safari and Chrome */  -moz-border-radius: 5px;                /* Firefox */  -khtml-border-radius: 5px;              /* Konqueror */  box-shadow:0px 10px 20px #808080;         /* Opera 10.5 and IE9 */  -webkit-box-shadow:0px 10px 20px #808080; /* Safari 3 & Chrome */  -moz-box-shadow:0px 10px 20px #808080;    /* Forefox 3.5 */  -khtml-box-shadow:0px 10px 20px #808080;  /* Konqueror */}
.CtxtMenu_MenuItem {  padding: 1px 2em;  background:transparent;}
.CtxtMenu_MenuArrow {  position:absolute; right:.5em; padding-top:.25em; color:#666666;  font-family: null; font-size: .75em}
.CtxtMenu_MenuActive .CtxtMenu_MenuArrow {color:white}
.CtxtMenu_MenuArrow.CtxtMenu_RTL {left:.5em; right:auto}
.CtxtMenu_MenuCheck {  position:absolute; left:.7em;  font-family: null}
.CtxtMenu_MenuCheck.CtxtMenu_RTL { right:.7em; left:auto }
.CtxtMenu_MenuRadioCheck {  position:absolute; left: .7em;}
.CtxtMenu_MenuRadioCheck.CtxtMenu_RTL {  right: .7em; left:auto}
.CtxtMenu_MenuInputBox {  padding-left: 1em; right:.5em; color:#666666;  font-family: null;}
.CtxtMenu_MenuInputBox.CtxtMenu_RTL {  left: .1em;}
.CtxtMenu_MenuComboBox {  left:.1em; padding-bottom:.5em;}
.CtxtMenu_MenuSlider {  left: .1em;}
.CtxtMenu_SliderValue {  position:absolute; right:.1em; padding-top:.25em; color:#333333;  font-size: .75em}
.CtxtMenu_SliderBar {  outline: none; background: #d3d3d3}
.CtxtMenu_MenuLabel {  padding: 1px 2em 3px 1.33em;  font-style:italic}
.CtxtMenu_MenuRule {  border-top: 1px solid #DDDDDD;  margin: 4px 3px;}
.CtxtMenu_MenuDisabled {  color:GrayText}
.CtxtMenu_MenuActive {  background-color: #606872;  color: white;}
.CtxtMenu_MenuDisabled:focus {  background-color: #E8E8E8}
.CtxtMenu_MenuLabel:focus {  background-color: #E8E8E8}
.CtxtMenu_ContextMenu:focus {  outline:none}
.CtxtMenu_ContextMenu .CtxtMenu_MenuItem:focus {  outline:none}
.CtxtMenu_SelectionMenu {  position:relative; float:left;  border-bottom: none; -webkit-box-shadow:none; -webkit-border-radius:0px; }
.CtxtMenu_SelectionItem {  padding-right: 1em;}
.CtxtMenu_Selection {  right: 40%; width:50%; }
.CtxtMenu_SelectionBox {  padding: 0em; max-height:20em; max-width: none;  background-color:#FFFFFF;}
.CtxtMenu_SelectionDivider {  clear: both; border-top: 2px solid #000000;}
.CtxtMenu_Menu .CtxtMenu_MenuClose {  top:-10px; left:-10px}
</style><style id="MJX-CHTML-styles">
mjx-container[overflow="scroll"][display] {
  overflow-x: auto;
  min-width: initial !important;
}

mjx-container[overflow="truncate"][display] {
  overflow-x: hidden;
  min-width: initial !important;
}

mjx-container[jax="CHTML"] {
  white-space: nowrap;
}

mjx-container [space="1"] {
  margin-left: .111em;
}

mjx-container [space="2"] {
  margin-left: .167em;
}

mjx-container [space="3"] {
  margin-left: .222em;
}

mjx-container [space="4"] {
  margin-left: .278em;
}

mjx-container [space="5"] {
  margin-left: .333em;
}

mjx-container [rspace="1"] {
  margin-right: .111em;
}

mjx-container [rspace="2"] {
  margin-right: .167em;
}

mjx-container [rspace="3"] {
  margin-right: .222em;
}

mjx-container [rspace="4"] {
  margin-right: .278em;
}

mjx-container [rspace="5"] {
  margin-right: .333em;
}

mjx-container [size="s"] {
  font-size: 70.7%;
}

mjx-container [size="ss"] {
  font-size: 50%;
}

mjx-container [size="Tn"] {
  font-size: 60%;
}

mjx-container [size="sm"] {
  font-size: 85%;
}

mjx-container [size="lg"] {
  font-size: 120%;
}

mjx-container [size="Lg"] {
  font-size: 144%;
}

mjx-container [size="LG"] {
  font-size: 173%;
}

mjx-container [size="hg"] {
  font-size: 207%;
}

mjx-container [size="HG"] {
  font-size: 249%;
}

mjx-container [width="full"] {
  width: 100%;
}

mjx-box {
  display: inline-block;
}

mjx-block {
  display: block;
}

mjx-itable {
  display: inline-table;
}

mjx-row {
  display: table-row;
}

mjx-row > * {
  display: table-cell;
}

mjx-container [inline-breaks] {
  display: inline;
}

mjx-mtext {
  display: inline-block;
}

mjx-mstyle {
  display: inline-block;
}

mjx-merror {
  display: inline-block;
  color: red;
  background-color: yellow;
}

mjx-mphantom {
  visibility: hidden;
}

mjx-math {
  display: inline-block;
  text-align: left;
  line-height: 0;
  text-indent: 0;
  font-style: normal;
  font-weight: normal;
  font-size: 100%;
  font-size-adjust: none;
  letter-spacing: normal;
  word-wrap: normal;
  word-spacing: normal;
  direction: ltr;
  padding: 1px 0;
}

mjx-container[jax="CHTML"][display="true"] {
  display: block;
  text-align: center;
  justify-content: center;
  margin: 1em 0;
}

mjx-container[jax="CHTML"][display="true"][width="full"] {
  display: flex;
}

mjx-container[jax="CHTML"][display="true"] mjx-math {
  padding: 0;
}

mjx-container[jax="CHTML"][justify="left"] {
  text-align: left;
  justify-content: left;
}

mjx-container[jax="CHTML"][justify="right"] {
  text-align: right;
  justify-content: right;
}

mjx-container[jax="CHTML"] mjx-break::after {
  content: " ";
  white-space: normal;
  font-family: MJX-BRK;
}

mjx-break[size="0"] {
  letter-spacing: -0.999em;
}

mjx-break[size="1"] {
  letter-spacing: -0.889em;
}

mjx-break[size="2"] {
  letter-spacing: -0.833em;
}

mjx-break[size="3"] {
  letter-spacing: -0.778em;
}

mjx-break[size="4"] {
  letter-spacing: -0.722em;
}

mjx-break[size="5"] {
  letter-spacing: -0.667em;
}

mjx-math[breakable] {
  display: inline;
}

mjx-mrow {
  display: inline-block;
  text-align: left;
}

mjx-linestack, mjx-mrow[break-top] {
  display: inline-table;
  width: 100%;
}

mjx-linestack[break-align="bottom"], mjx-mrow[break-top][break-align="bottom"] {
  display: inline-block;
}

mjx-linestack[break-align="middle"], mjx-mrow[break-top][break-align="middle"] {
  vertical-align: middle;
}

mjx-linestack[break-align="center"], mjx-mrow[break-top][break-align="center"] {
  vertical-align: middle;
}

mjx-linestack[breakable] {
  display: inline;
}

mjx-linestack[breakable] > mjx-linebox {
  display: inline;
}

mjx-linestack[breakable] > mjx-linebox::before {
  white-space: pre;
  content: "\A";
}

mjx-linestack[breakable] > mjx-linebox::after {
  white-space: normal;
  content: " ";
  letter-spacing: -.999em;
  font-family: MJX-BRK;
}

mjx-linestack[breakable] > mjx-linebox:first-of-type::before {
  display: none;
}

mjx-linestack[breakable] > mjx-linebox:last-of-type::after {
  display: none;
}

mjx-linebox {
  display: block;
}

mjx-linebox[align="left"] {
  text-align: left;
}

mjx-linebox[align="center"] {
  text-align: center;
}

mjx-linebox[align="right"] {
  text-align: right;
}

mjx-linestrut {
  display: inline-block;
  height: 1em;
  vertical-align: -.25em;
}

mjx-msubsup {
  display: inline-block;
  text-align: left;
}

mjx-script {
  display: inline-block;
  padding-right: .05em;
  padding-left: .033em;
}

mjx-script > mjx-spacer {
  display: block;
}

mjx-mi {
  display: inline-block;
  text-align: left;
}

mjx-c {
  display: inline-block;
  width: 0;
  text-align: right;
}

mjx-utext {
  display: inline-block;
  padding: .75em 0 .2em 0;
}

mjx-mo {
  display: inline-block;
  text-align: left;
}

mjx-stretchy-h {
  display: inline-block;
}

mjx-stretchy-h > * {
  display: inline-block;
  width: 0;
}

mjx-stretchy-h > mjx-ext {
  /* IE */ overflow: hidden;
  /* others */ overflow: clip visible;
  width: 100%;
  border: 0px solid transparent;
  box-sizing: border-box;
  text-align: center;
}

mjx-stretchy-h > mjx-ext > mjx-c {
  transform: scalex(500);
  width: 0;
}

mjx-stretchy-v {
  display: inline-block;
  text-align: center;
}

mjx-stretchy-v > * {
  display: block;
  height: 0;
}

mjx-stretchy-v > mjx-ext {
  /* IE */ overflow: hidden;
  /* others */ overflow: visible clip;
  height: 100%;
  border: 0px solid transparent;
  box-sizing: border-box;
}

mjx-mark {
  display: inline-block;
  height: 0;
}

mjx-msub {
  display: inline-block;
  text-align: left;
}

mjx-mn {
  display: inline-block;
  text-align: left;
}

mjx-mfrac {
  display: inline-block;
  text-align: left;
}

mjx-frac {
  display: inline-block;
  vertical-align: 0.17em;
  padding: 0 .22em;
}

mjx-frac[type="d"] {
  vertical-align: .04em;
}

mjx-frac[delims] {
  padding: 0 .1em;
}

mjx-frac[atop] {
  padding: 0 .12em;
}

mjx-frac[atop][delims] {
  padding: 0;
}

mjx-dtable {
  display: inline-table;
  width: 100%;
}

mjx-dtable > * {
  font-size: 2000%;
}

mjx-dbox {
  display: block;
  font-size: 5%;
}

mjx-num {
  display: block;
  text-align: center;
}

mjx-den {
  display: block;
  text-align: center;
}

mjx-mfrac[bevelled] > mjx-num {
  display: inline-block;
}

mjx-mfrac[bevelled] > mjx-den {
  display: inline-block;
}

mjx-den[align="right"], mjx-num[align="right"] {
  text-align: right;
}

mjx-den[align="left"], mjx-num[align="left"] {
  text-align: left;
}

mjx-nstrut {
  display: inline-block;
  height: .054em;
  width: 0;
  vertical-align: -.054em;
}

mjx-nstrut[type="d"] {
  height: .217em;
  vertical-align: -.217em;
}

mjx-dstrut {
  display: inline-block;
  height: .505em;
  width: 0;
}

mjx-dstrut[type="d"] {
  height: .726em;
}

mjx-line {
  display: block;
  box-sizing: border-box;
  min-height: 1px;
  height: .06em;
  border-top: .075em solid;
  margin: .06em -.1em;
  overflow: hidden;
}

mjx-line[type="d"] {
  margin: .18em -.1em;
}

mjx-mspace {
  display: inline-block;
  text-align: left;
}

.MM-N {
  font-family: MJX-MM-ZERO, MJX-MM-N;
}

.MM-B {
  font-family: MJX-MM-ZERO, MJX-MM-B;
}

.MM-I {
  font-family: MJX-MM-ZERO, MJX-MM-I;
}

.MM-BI {
  font-family: MJX-MM-ZERO, MJX-MM-BI;
}

.MM-DS {
  font-family: MJX-MM-ZERO, MJX-MM-DS;
}

.MM-F {
  font-family: MJX-MM-ZERO, MJX-MM-F;
}

.MM-FB {
  font-family: MJX-MM-ZERO, MJX-MM-FB;
}

.MM-S {
  font-family: MJX-MM-ZERO, MJX-MM-S;
}

.MM-SB {
  font-family: MJX-MM-ZERO, MJX-MM-SB;
}

.MM-SS {
  font-family: MJX-MM-ZERO, MJX-MM-SS;
}

.MM-SSB {
  font-family: MJX-MM-ZERO, MJX-MM-SSB;
}

.MM-SSI {
  font-family: MJX-MM-ZERO, MJX-MM-SSI;
}

.MM-SSBI {
  font-family: MJX-MM-ZERO, MJX-MM-SSBI;
}

.MM-M {
  font-family: MJX-MM-ZERO, MJX-MM-M;
}

.MM-SO {
  font-family: MJX-MM-ZERO, MJX-MM-SO;
}

.MM-LO {
  font-family: MJX-MM-ZERO, MJX-MM-LO;
}

.MM-S3 {
  font-family: MJX-MM-ZERO, MJX-MM-S3;
}

.MM-S4 {
  font-family: MJX-MM-ZERO, MJX-MM-S4;
}

.MM-S5 {
  font-family: MJX-MM-ZERO, MJX-MM-S5;
}

.MM-S6 {
  font-family: MJX-MM-ZERO, MJX-MM-S6;
}

.MM-S7 {
  font-family: MJX-MM-ZERO, MJX-MM-S7;
}

.MM-MI {
  font-family: MJX-MM-ZERO, MJX-MM-MI;
}

.MM-C {
  font-family: MJX-MM-ZERO, MJX-MM-C;
}

.MM-CB {
  font-family: MJX-MM-ZERO, MJX-MM-CB;
}

.MM-OS {
  font-family: MJX-MM-ZERO, MJX-MM-OS;
}

.MM-OB {
  font-family: MJX-MM-ZERO, MJX-MM-OB;
}

.MM-V {
  font-family: MJX-MM-ZERO, MJX-MM-V;
}

.MM-LT {
  font-family: MJX-MM-ZERO, MJX-MM-LT;
}

.MM-RB {
  font-family: MJX-MM-ZERO, MJX-MM-RB;
}

.MM-EM {
  font-family: MJX-MM-ZERO, MJX-MM-EM;
}

@font-face /* MJX-MM-ZERO */ {
  font-family: MJX-MM-ZERO;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-zero.woff") format("woff");
}

@font-face /* MJX-BRK */ {
  font-family: MJX-BRK;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-brk.woff") format("woff");
}

@font-face /* MJX-MM-N */ {
  font-family: MJX-MM-N;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-n.woff") format("woff");
}

@font-face /* MJX-MM-B */ {
  font-family: MJX-MM-B;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-b.woff") format("woff");
}

@font-face /* MJX-MM-I */ {
  font-family: MJX-MM-I;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-i.woff") format("woff");
}

@font-face /* MJX-MM-BI */ {
  font-family: MJX-MM-BI;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-bi.woff") format("woff");
}

@font-face /* MJX-MM-DS */ {
  font-family: MJX-MM-DS;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-ds.woff") format("woff");
}

@font-face /* MJX-MM-F */ {
  font-family: MJX-MM-F;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-f.woff") format("woff");
}

@font-face /* MJX-MM-FB */ {
  font-family: MJX-MM-FB;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-fb.woff") format("woff");
}

@font-face /* MJX-MM-S */ {
  font-family: MJX-MM-S;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-s.woff") format("woff");
}

@font-face /* MJX-MM-SB */ {
  font-family: MJX-MM-SB;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-sb.woff") format("woff");
}

@font-face /* MJX-MM-SS */ {
  font-family: MJX-MM-SS;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-ss.woff") format("woff");
}

@font-face /* MJX-MM-SSB */ {
  font-family: MJX-MM-SSB;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-ssb.woff") format("woff");
}

@font-face /* MJX-MM-SSI */ {
  font-family: MJX-MM-SSI;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-ssi.woff") format("woff");
}

@font-face /* MJX-MM-SSBI */ {
  font-family: MJX-MM-SSBI;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-ssbi.woff") format("woff");
}

@font-face /* MJX-MM-M */ {
  font-family: MJX-MM-M;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-m.woff") format("woff");
}

@font-face /* MJX-MM-SO */ {
  font-family: MJX-MM-SO;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-so.woff") format("woff");
}

@font-face /* MJX-MM-LO */ {
  font-family: MJX-MM-LO;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-lo.woff") format("woff");
}

@font-face /* MJX-MM-S3 */ {
  font-family: MJX-MM-S3;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-s3.woff") format("woff");
}

@font-face /* MJX-MM-S4 */ {
  font-family: MJX-MM-S4;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-s4.woff") format("woff");
}

@font-face /* MJX-MM-S5 */ {
  font-family: MJX-MM-S5;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-s5.woff") format("woff");
}

@font-face /* MJX-MM-S6 */ {
  font-family: MJX-MM-S6;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-s6.woff") format("woff");
}

@font-face /* MJX-MM-S7 */ {
  font-family: MJX-MM-S7;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-s7.woff") format("woff");
}

@font-face /* MJX-MM-MI */ {
  font-family: MJX-MM-MI;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-mi.woff") format("woff");
}

@font-face /* MJX-MM-C */ {
  font-family: MJX-MM-C;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-c.woff") format("woff");
}

@font-face /* MJX-MM-CB */ {
  font-family: MJX-MM-CB;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-cb.woff") format("woff");
}

@font-face /* MJX-MM-OS */ {
  font-family: MJX-MM-OS;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-os.woff") format("woff");
}

@font-face /* MJX-MM-OB */ {
  font-family: MJX-MM-OB;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-ob.woff") format("woff");
}

@font-face /* MJX-MM-V */ {
  font-family: MJX-MM-V;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-v.woff") format("woff");
}

@font-face /* MJX-MM-LT */ {
  font-family: MJX-MM-LT;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-lt.woff") format("woff");
}

@font-face /* MJX-MM-RB */ {
  font-family: MJX-MM-RB;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-rb.woff") format("woff");
}

@font-face /* MJX-MM-EM */ {
  font-family: MJX-MM-EM;
  src: url("https://cdn.jsdelivr.net/npm/mathjax-modern-font/chtml/woff/mjx-mm-em.woff") format("woff");
}

mjx-c.mjx-c1D43E {
  padding: 0.683em 0.889em 0 0;
}

mjx-c.mjx-c1D436 {
  padding: 0.705em 0.76em 0.022em 0;
}

mjx-c.mjx-c1D451 {
  padding: 0.694em 0.52em 0.011em 0;
}

mjx-c.mjx-c2F {
  padding: 0.75em 0.5em 0.25em 0;
}

mjx-c.mjx-c1D438 {
  padding: 0.68em 0.764em 0 0;
}

mjx-c.mjx-c2062 {
  padding: 0 0 0 0;
}

mjx-c.mjx-c1D442 {
  padding: 0.705em 0.763em 0.022em 0;
}

mjx-c.mjx-c1D456 {
  padding: 0.661em 0.345em 0.011em 0;
}

mjx-c.mjx-c1D45B {
  padding: 0.442em 0.6em 0.011em 0;
}

mjx-c.mjx-c210E {
  padding: 0.694em 0.576em 0.011em 0;
}

mjx-c.mjx-c1D44F {
  padding: 0.694em 0.429em 0.011em 0;
}

mjx-c.mjx-c1D461 {
  padding: 0.626em 0.361em 0.011em 0;
}

mjx-c.mjx-c1D45C {
  padding: 0.442em 0.485em 0.011em 0;
}

mjx-c.mjx-c1D45F {
  padding: 0.442em 0.451em 0.011em 0;
}

mjx-c.mjx-c1D43F {
  padding: 0.683em 0.681em 0 0;
}

mjx-c.mjx-c1D437 {
  padding: 0.683em 0.828em 0 0;
}

mjx-c.mjx-c1D449 {
  padding: 0.683em 0.769em 0.022em 0;
}

mjx-c.mjx-c1D443 {
  padding: 0.683em 0.754em 0 0;
}

mjx-c.mjx-c1D440 {
  padding: 0.683em 1.044em 0 0;
}

mjx-c.mjx-c1D439 {
  padding: 0.68em 0.749em 0 0;
}

mjx-c.mjx-c1D43C {
  padding: 0.683em 0.497em 0 0;
}

mjx-c.mjx-c1D460 {
  padding: 0.442em 0.469em 0.011em 0;
}

mjx-c.mjx-c3D {
  padding: 0.367em 0.778em 0 0;
}

mjx-c.mjx-c30 {
  padding: 0.666em 0.5em 0.022em 0;
}

mjx-c.mjx-c2212 {
  padding: 0.583em 0.778em 0.083em 0;
}

mjx-c.mjx-c1D44E {
  padding: 0.442em 0.529em 0.011em 0;
}

mjx-c.mjx-c31 {
  padding: 0.666em 0.5em 0 0;
}

mjx-c.mjx-c2B {
  padding: 0.583em 0.778em 0.083em 0;
}

mjx-c.mjx-c35 {
  padding: 0.666em 0.5em 0.022em 0;
}

mjx-c.mjx-c28.MM-SO {
  padding: 0.797em 0.422em 0.297em 0;
}

mjx-c.mjx-c29.MM-SO {
  padding: 0.797em 0.422em 0.297em 0;
}

mjx-c.mjx-c1D452 {
  padding: 0.442em 0.466em 0.011em 0;
}

mjx-c.mjx-c1D450 {
  padding: 0.442em 0.433em 0.011em 0;
}

mjx-c.mjx-c2061 {
  padding: 0 0 0 0;
}

mjx-c.mjx-c2C {
  padding: 0.106em 0.278em 0.193em 0;
}

mjx-c.mjx-c1D454 {
  padding: 0.442em 0.477em 0.205em 0;
}

mjx-c.mjx-c1D462 {
  padding: 0.442em 0.572em 0.011em 0;
}

mjx-c.mjx-cD7 {
  padding: 0.491em 0.778em 0 0;
}

mjx-c.mjx-c22C5 {
  padding: 0.303em 0.278em 0 0;
}

mjx-c.mjx-c28 {
  padding: 0.748em 0.389em 0.248em 0;
}

mjx-c.mjx-c29 {
  padding: 0.748em 0.389em 0.248em 0;
}
</style></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(22)00995-3"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(22)00995-3"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-311642" aria-expanded="false" aria-controls="login-links-311642" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-311642" id="login-links--311642" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-311642" data-opens="#links-dialog-311642" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-311642" aria-modal="true"><button data-closes="#links-dialog-311642" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2022.08.008">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(22)00995-3" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(21)X0020-7"><span>Volume 185</span>, <span>Issue 19</span></a></span><span class="meta-panel__pages"><span>p3533-3550.e27</span></span><span class="meta-panel__onlineDate">September 15, 2022</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=185&amp;issue=19&amp;pii=S0092-8674%2821%29X0020-7" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">A general chemical principle for creating closure-stabilizing integrin inhibitors</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Fu-Yang</span> <span property="familyName">Lin</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Fu-Yang</span> <span property="familyName">Lin</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">5</div><div id="fn1"><div id="ntpara0010" role="paragraph">Present address: Morphic Therapeutic, 35 Gatehouse Dr, Waltham, MA 02451, USA</div></div></div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn3"><div id="ntpara0020" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Lin/Fu-Yang" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">5</a>,<a role="doc-noteref">7</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Jing</span> <span property="familyName">Li</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jing</span> <span property="familyName">Li</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn3"><div id="ntpara0020" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Li/Jing" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">7</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Yonghua</span> <span property="familyName">Xie</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yonghua</span> <span property="familyName">Xie</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn3"><div id="ntpara0020" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, PRC</span></div></div><div class="core-author-link"><a href="/authored-by/Xie/Yonghua" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a role="doc-noteref">7</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Jianghai</span> <span property="familyName">Zhu</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jianghai</span> <span property="familyName">Zhu</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn2"><div id="ntpara0015" role="paragraph">Present address: Research Technologies Development Section, National Institute of Allergy and Infectious Diseases, 5625 Fishers LN, Rockville, MD 20852, USA</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zhu/Jianghai" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Thi Thu</span> <span property="familyName">Huong Nguyen</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Thi Thu</span> <span property="familyName">Huong Nguyen</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Blood Research Institute, Versiti, Milwaukee, WI 53226, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Huong+Nguyen/Thi+Thu" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Yonghui</span> <span property="familyName">Zhang</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yonghui</span> <span property="familyName">Zhang</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:zhangyonghui@tsinghua.edu.cn" property="email" title="Send email to Yonghui Zhang">zhangyonghui@tsinghua.edu.cn</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, PRC</span></div></div><div class="core-author-link"><a href="/authored-by/Zhang/Yonghui" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup> <a id="eadd0010" href="mailto:zhangyonghui@tsinghua.edu.cn" property="email" title="Send email to Yonghui Zhang">zhangyonghui@tsinghua.edu.cn</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Jieqing</span> <span property="familyName">Zhu</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jieqing</span> <span property="familyName">Zhu</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:jieqing.zhu@versiti.org" property="email" title="Send email to Jieqing Zhu">jieqing.zhu@versiti.org</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Blood Research Institute, Versiti, Milwaukee, WI 53226, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zhu/Jieqing" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup> <a id="eadd0015" href="mailto:jieqing.zhu@versiti.org" property="email" title="Send email to Jieqing Zhu">jieqing.zhu@versiti.org</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Timothy A.</span> <span property="familyName">Springer</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Timothy A.</span> <span property="familyName">Springer</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6627-2904" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6627-2904</a></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0020" href="mailto:springer@crystal.harvard.edu" property="email" title="Send email to Timothy A. Springer">springer@crystal.harvard.edu</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn3"><div id="ntpara0020" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">8</div><div id="fn4"><div id="ntpara0025" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Springer/Timothy+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">7</a>,<a role="doc-noteref">8</a></sup> <a id="eadd0020" href="mailto:springer@crystal.harvard.edu" property="email" title="Send email to Timothy A. Springer">springer@crystal.harvard.edu</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Department of Biological Chemistry and Molecular Pharmacology, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, PRC</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Blood Research Institute, Versiti, Milwaukee, WI 53226, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">5</div><div id="fn1"><div id="ntpara0010" role="paragraph">Present address: Morphic Therapeutic, 35 Gatehouse Dr, Waltham, MA 02451, USA</div></div></div><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn2"><div id="ntpara0015" role="paragraph">Present address: Research Technologies Development Section, National Institute of Allergy and Infectious Diseases, 5625 Fishers LN, Rockville, MD 20852, USA</div></div></div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn3"><div id="ntpara0020" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">8</div><div id="fn4"><div id="ntpara0025" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received April 19, 2022</span>; <span>Revised July 7, 2022</span>; <span>Accepted August 4, 2022</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2022.08.008" property="sameAs" target="_blank">10.1016/j.cell.2022.08.008 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867422009953" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2022 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2022.08.008" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(21)X0020-7"><img src="/cms/asset/fa11a010-9223-4062-83b2-1de023b46670/cov200h.gif" alt="Cover Image - Cell, Volume 185, Issue 19"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2822%2900995-3" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (2)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2822%2900995-3" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2022.08.008">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2822%2900995-3" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2022.08.008&amp;pii=S0092-8674%2822%2900995-3" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2822%2900995-3" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2022.08.008">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2022.08.008" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867422009953&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867422009953&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=185&amp;issue=19&amp;pii=S0092-8674%2821%29X0020-7" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(22)00922-9" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(22)01061-3" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (2)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Integrin inhibitors in failed clinical trials stabilized the open conformation</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">Inhibitor designs that stabilize the closed integrin conformation were discovered</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Inhibitor design principles were transferrable from integrin αIIbβ3 to α4β1</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Closing inhibitors may lack the partial agonism seen with opening inhibitors</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Integrins are validated drug targets with six approved therapeutics. However, small-molecule inhibitors to three integrins failed in late-stage clinical trials for chronic indications. Such unfavorable outcomes may in part be caused by partial agonism, i.e., the stabilization of the high-affinity, extended-open integrin conformation. Here, we show that the failed, small-molecule inhibitors of integrins αIIbβ3 and α4β1 stabilize the high-affinity conformation. Furthermore, we discovered a simple chemical feature present in multiple αIIbβ3 antagonists that stabilizes integrins in their bent-closed conformation. Closing inhibitors contain a polar nitrogen atom that stabilizes, via hydrogen bonds, a water molecule that intervenes between a serine residue and the metal in the metal-ion-dependent adhesion site (MIDAS). Expulsion of this water is a requisite for transition to the open conformation. This change in metal coordination is general to integrins, suggesting broad applicability of the drug-design principle to the integrin family, as validated with a distantly related integrin, α4β1.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/6a53dbb2-ea41-4833-96ab-b0ea792f0949/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2022.08.008/asset/ff61a929-0ad7-45aa-83d2-5767275e0bc8/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/6a53dbb2-ea41-4833-96ab-b0ea792f0949/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;integrins&quot;" alt="Search on this keyword" rel="nofollow">integrins</a></li><li><a href="/action/doSearch?AllField=&quot;drug+discovery&quot;" alt="Search on this keyword" rel="nofollow">drug discovery</a></li><li><a href="/action/doSearch?AllField=&quot;conformational+change&quot;" alt="Search on this keyword" rel="nofollow">conformational change</a></li><li><a href="/action/doSearch?AllField=&quot;thrombosis&quot;" alt="Search on this keyword" rel="nofollow">thrombosis</a></li><li><a href="/action/doSearch?AllField=&quot;autoimmune+disease&quot;" alt="Search on this keyword" rel="nofollow">autoimmune disease</a></li><li><a href="/action/doSearch?AllField=&quot;membrane+receptors&quot;" alt="Search on this keyword" rel="nofollow">membrane receptors</a></li><li><a href="/action/doSearch?AllField=&quot;integrin+inhibitors&quot;" alt="Search on this keyword" rel="nofollow">integrin inhibitors</a></li><li><a href="/action/doSearch?AllField=&quot;conformations&quot;" alt="Search on this keyword" rel="nofollow">conformations</a></li><li><a href="/action/doSearch?AllField=&quot;agonism&quot;" alt="Search on this keyword" rel="nofollow">agonism</a></li><li><a href="/action/doSearch?AllField=&quot;%CE%B1IIb%CE%B23&quot;" alt="Search on this keyword" rel="nofollow">αIIbβ3</a></li><li><a href="/action/doSearch?AllField=&quot;%CE%B14%CE%B21&quot;" alt="Search on this keyword" rel="nofollow">α4β1</a></li><li><a href="/action/doSearch?AllField=&quot;hydrogen+bonds&quot;" alt="Search on this keyword" rel="nofollow">hydrogen bonds</a></li><li><a href="/action/doSearch?AllField=&quot;conformation+specificity&quot;" alt="Search on this keyword" rel="nofollow">conformation specificity</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0055" role="paragraph"><blockquote><div id="dspara0010" role="paragraph">In time and with water, everything changes.</div><div class="figure__source">—Leonardo da Vinci</div></blockquote>Integrins are attractive therapeutic targets with central functions in multiple diseases (<span class="dropBlock reference-citations"><a id="body-ref-sref17-1" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-1" aria-controls="sref17-1">Cox et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Cox, D. ∙ Brennan, M. ∙ Moran, N.</div><div><strong>Integrins as therapeutic targets: lessons and opportunities</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2010; <strong>9</strong>:804-820</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd3266" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-77957363101" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20885411/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd3266&amp;pmid=20885411" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36-1" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-1" aria-controls="sref36-1">Ley et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref36-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Ley, K. ∙ Rivera-Nieves, J. ∙ Sandborn, W.J. ...</div><div><strong>Integrin-based therapeutics: biological basis, clinical use and new drugs</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2016; <strong>15</strong>:173-183</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd.2015.10" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84959369497" target="_blank" aria-label="Open Scopus in new tab">Scopus (321)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26822833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd.2015.10&amp;pmid=26822833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Shimaoka and Springer, 2003</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Shimaoka, M. ∙ Springer, T.A.</div><div><strong>Therapeutic antagonists and the conformational regulation of integrin structure and function</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2003; <strong>2</strong>:703-716</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd1174" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0142026204" target="_blank" aria-label="Open Scopus in new tab">Scopus (311)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12951577/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd1174&amp;pmid=12951577" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The 24 integrin αβ heterodimers have evolved highly specialized functions. Antibodies to integrin α4β7/α4β1 and specific for α4β7 are approved for multiple sclerosis and ulcerative colitis, respectively. Integrin ligand-binding pockets are unusually good binding sites for small molecules. Small molecules to the leukocyte integrin LFA-1 (αLβ2) and the fibrinogen receptor on platelets, integrin αIIbβ3, are approved topically for dry eye disease and acutely to prevent thrombosis, respectively. However, despite emergence of new targets, including integrins αVβ6 and αVβ8 in fibrosis and immuno-oncology, there are no approved chronic (oral) small-molecule integrin antagonists.</div><div id="p0060" role="paragraph">An intense pharmaceutical effort to develop oral antagonists of αIIbβ3 following the success of parenteral ligand mimetics (<span class="dropBlock reference-citations"><a id="body-ref-sref64-1" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-1" aria-controls="sref64-1">Scarborough and Gretler, 2000</a><div class="dropBlock__holder" data-db-target-of="sref64-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Scarborough, R.M. ∙ Gretler, D.D.</div><div><strong>Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2000; <strong>43</strong>:3453-3473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm000022w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034699501" target="_blank" aria-label="Open Scopus in new tab">Scopus (110)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10999999/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm000022w&amp;pmid=10999999" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was fueled by anticipation of “the dawn of a new era in antithrombotic therapy, the era of αIIbβ3 antagonism” (<span class="dropBlock reference-citations"><a id="body-ref-sref72-1" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-1" aria-controls="sref72-1">Topol et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref72-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Topol, E.J. ∙ Byzova, T.V. ∙ Plow, E.F.</div><div><strong>Platelet GPIIb-IIIa blockers</strong></div><div><em>Lancet.</em> 1999; <strong>353</strong>:227-231</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0140-6736%2898%2911086-3&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0140-6736%2898%2911086-3&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0033573790" target="_blank" aria-label="Open Scopus in new tab">Scopus (521)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9923894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2898%2911086-3&amp;pmid=9923894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, oral integrin antagonists (<span class="dropBlock reference-citations"><a id="body-ref-sref14-1" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-1" aria-controls="sref14-1">Chew et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref14-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chew, D.P. ∙ Bhatt, D.L. ∙ Sapp, S. ...</div><div><strong>Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials</strong></div><div><em>Circulation.</em> 2001; <strong>103</strong>:201-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.103.2.201" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035895332" target="_blank" aria-label="Open Scopus in new tab">Scopus (374)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11208677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.103.2.201&amp;pmid=11208677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73-1" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-1" aria-controls="sref73-1">Topol et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref73-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Topol, E.J. ∙ Easton, D. ∙ Harrington, R.A. ...</div><div><strong>Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease</strong></div><div><em>Circulation.</em> 2003; <strong>108</strong>:399-406</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.0000084501.48570.F6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0043166526" target="_blank" aria-label="Open Scopus in new tab">Scopus (199)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12874182/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.0000084501.48570.F6&amp;pmid=12874182" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), as well as longer-term dosing of parenteral inhibitors (<span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Théroux et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Théroux, P. ∙ Catella-Lawson, F. ∙ Armstrong, P. ...</div><div><strong>Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 1998; <strong>338</strong>:1488-1497</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJM199805213382102" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-2642599026" target="_blank" aria-label="Open Scopus in new tab">Scopus (1677)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9599103/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJM199805213382102&amp;pmid=9599103" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), were beset with massive failure. Five phase III trials of oral αIIbβ3 inhibitors in a total of 42,530 patients failed (<span class="dropBlock reference-citations"><a id="body-ref-sref14-2" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-2" aria-controls="sref14-2">Chew et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref14-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chew, D.P. ∙ Bhatt, D.L. ∙ Sapp, S. ...</div><div><strong>Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials</strong></div><div><em>Circulation.</em> 2001; <strong>103</strong>:201-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.103.2.201" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035895332" target="_blank" aria-label="Open Scopus in new tab">Scopus (374)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11208677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.103.2.201&amp;pmid=11208677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73-2" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-2" aria-controls="sref73-2">Topol et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref73-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Topol, E.J. ∙ Easton, D. ∙ Harrington, R.A. ...</div><div><strong>Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease</strong></div><div><em>Circulation.</em> 2003; <strong>108</strong>:399-406</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.0000084501.48570.F6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0043166526" target="_blank" aria-label="Open Scopus in new tab">Scopus (199)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12874182/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.0000084501.48570.F6&amp;pmid=12874182" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In all trials, mortality was significantly higher in treated patients than in the placebo control, although the need for urgent revascularization was significantly reduced. Mortality was lessened by concurrent aspirin treatment, suggesting that platelet-mediated events were responsible for the bad outcome. The contrast between the benefit of short-term and harm of long-term αIIbβ3 therapy was striking and suggested “the presence of clinically relevant ‘toxic’ mechanisms” (<span class="dropBlock reference-citations"><a id="body-ref-sref14-3" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-3" aria-controls="sref14-3">Chew et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref14-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Chew, D.P. ∙ Bhatt, D.L. ∙ Sapp, S. ...</div><div><strong>Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials</strong></div><div><em>Circulation.</em> 2001; <strong>103</strong>:201-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.103.2.201" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035895332" target="_blank" aria-label="Open Scopus in new tab">Scopus (374)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11208677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.103.2.201&amp;pmid=11208677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0065" role="paragraph">The reason for these failures appeared to stem, at least in part, from agonism derived from integrin conformational change (<span class="dropBlock reference-citations"><a id="body-ref-sref3-1" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-1" aria-controls="sref3-1">Aga et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref3-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Aga, Y. ∙ Baba, K. ∙ Tam, S. ...</div><div><strong>UR-3216: a new generation oral platelet GPIIb/IIIa antagonist</strong></div><div><em>Curr. Pharm. Des.</em> 2004; <strong>10</strong>:1597-1601</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2174/1381612043384592" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-2342443223" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15134558/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2174%2F1381612043384592&amp;pmid=15134558" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref18-1" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-1" aria-controls="sref18-1">Cox et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref18-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cox, D. ∙ Smith, R. ∙ Quinn, M. ...</div><div><strong>Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes</strong></div><div><em>J.&nbsp;Am. Coll. Cardiol.</em> 2000; <strong>36</strong>:1514-1519</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0735-1097(00)00919-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034332785" target="_blank" aria-label="Open Scopus in new tab">Scopus (109)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11079651/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0735-1097%2800%2900919-0&amp;pmid=11079651" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55-1" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-1" aria-controls="sref55-1">Murphy et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref55-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Murphy, N.P. ∙ Pratico, D. ∙ Fitzgerald, D.J.</div><div><strong>Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in&nbsp;vivo</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 1998; <strong>286</strong>:945-951</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=fulltext&amp;site=jpet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=pdf&amp;site=jpet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9694954/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0022-3565%2824%2937673-6&amp;pmid=9694954" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Peter et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Peter, K. ∙ Schwarz, M. ∙ Nordt, T. ...</div><div><strong>Intrinsic activating properties of GP IIb/IIIa blockers</strong></div><div><em>Thromb. Res.</em> 2001; <strong>103</strong>:S21-S27</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2801%2900300-0&amp;cf=fulltext&amp;site=tr-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2801%2900300-0&amp;cf=pdf&amp;site=tr-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035975625" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11567665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0049-3848%2801%2900300-0&amp;pmid=11567665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Most integrins, including αIIbβ3, are present predominantly in a low-affinity, bent-closed (BC) conformation on cell surfaces but change to a high-affinity extended-open (EO) state when bound to their biological ligands (<span class="dropBlock reference-citations"><a id="body-ref-sref27-1" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-1" aria-controls="sref27-1">Frelinger et&nbsp;al., 1988</a><div class="dropBlock__holder" data-db-target-of="sref27-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Frelinger, A.L. ∙ Lam, S.C.T. ∙ Plow, E.F. ...</div><div><strong>Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1988; <strong>263</strong>:12397-12402</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2818%2937769-X&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2818%2937769-X&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2457583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2818%2937769-X&amp;pmid=2457583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-1" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-1" aria-controls="sref40-1">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Takagi et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Takagi, J. ∙ Petre, B.M. ∙ Walz, T. ...</div><div><strong>Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling</strong></div><div><em>Cell.</em> 2002; <strong>110</strong></div><div>599-511</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0092-8674%2802%2900935-2&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0092-8674%2802%2900935-2&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0037031906" target="_blank" aria-label="Open Scopus in new tab">Scopus (981)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12230977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2802%2900935-2&amp;pmid=12230977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0245" href="#fig1">Figure&nbsp;1</a>A). A known complication of αIIbβ3 antagonism is pre-existing or drug exposure-stimulated production of antibodies to integrin conformational epitopes or ligand-induced binding sites (LIBSs) (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Bosco et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Bosco, A. ∙ Kidson-Gerber, G. ∙ Dunkley, S.</div><div><strong>Delayed tirofiban-induced thrombocytopenia: two case reports</strong></div><div><em>J.&nbsp;Thromb. Haemost.</em> 2005; <strong>3</strong>:1109-1110</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1538-7836.2005.01296.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-23844531640" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15869625/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1538-7836.2005.01296.x&amp;pmid=15869625" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Bougie et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Bougie, D.W. ∙ Rasmussen, M. ∙ Zhu, J. ...</div><div><strong>Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin</strong></div><div><em>Blood.</em> 2012; <strong>119</strong>:6317-6325</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2012-01-406322" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863510984" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22490676/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2012-01-406322&amp;pmid=22490676" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59" aria-controls="sref59">Onitilo, 2006</a><div class="dropBlock__holder" data-db-target-of="sref59"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Onitilo, A.A.</div><div><strong>Delayed profound thrombocytopenia associated with eptifibatide</strong></div><div><em>Am. J. Hematol.</em> 2006; <strong>81</strong>:984</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ajh.20609" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-33845243141" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16804935/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fajh.20609&amp;pmid=16804935" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref72-2" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72-2" aria-controls="sref72-2">Topol et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref72-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Topol, E.J. ∙ Byzova, T.V. ∙ Plow, E.F.</div><div><strong>Platelet GPIIb-IIIa blockers</strong></div><div><em>Lancet.</em> 1999; <strong>353</strong>:227-231</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0140-6736%2898%2911086-3&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0140-6736%2898%2911086-3&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0033573790" target="_blank" aria-label="Open Scopus in new tab">Scopus (521)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9923894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2898%2911086-3&amp;pmid=9923894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). After the phase III failures, αIIbβ3 antagonist research and development was shut down, and publications in the field greatly declined.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/529457c5-f126-45a3-b733-68c672d47048/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2022.08.008/asset/fd8ef6f0-53fc-4b92-93a2-989a64a488ca/main.assets/gr1.jpg" height="867" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/529457c5-f126-45a3-b733-68c672d47048/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Integrin domains, conformational change, and effect of drugs on the αIIbβ3 headpiece</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Integrin domain organization and conformational states. In integrin headpiece opening, which increases affinity for biological ligands, pistoning of the α7-helix (purple bar) of the βI domain is linked to α1-helix pistoning (red bar), swing-out of the hybrid domain (curved arrow) and (B)&nbsp;rearrangement of loops at the ligand-binding site.</div><div id="fspara0020" role="paragraph">(B) Shows αIIbβ3 bound to RGD in the closed (cyan carbons and metals) and open (wheat carbons and metals) conformations from PDB: <a id="intref0080" href="http://firstglance.jmol.org/fg.htm?mol3ZDY" target="_blank">3ZDY</a> and PDB: <a id="intref0085" href="http://firstglance.jmol.org/fg.htm?mol3ZE2" target="_blank">3ZE2</a> chains C&nbsp;+ D&nbsp;+ J, respectively. Loops and helices are thin and thicker tubes. Key metal coordinating sidechains, backbone, and the RGD Asp sidechain are shown in stick. Oxygens are red and nitrogens are blue. Metal ions and water 1 are shown as spheres.</div><div id="fspara0025" role="paragraph">(C–H) Overlaid Superdex 200 chromatograms in absence (control, black) and presence of 10&nbsp;μM drug in running buffer with curves in same color as the name of the drug. Running buffer contained 1&nbsp;mM Mg<sup>2+</sup> and 1&nbsp;mM Ca<sup>2+</sup> or 2&nbsp;mM Mn<sup>2+</sup> and 0.2&nbsp;mM Ca<sup>2+</sup> as indicated. Open and closed headpieces are shown schematically.</div><div id="fspara0030" role="paragraph">(I) Summary of effects of drugs in gel filtration and when soaked into closed αIIbβ3 headpiece crystals.</div><div id="fspara0035" role="paragraph"><sup>a</sup>Hydrodynamic radii from Superdex 200 gel filtration. Control and tirofiban measurements are mean and SD of ≥3 experiments; other measurements are mean and difference from mean of two experiments, except for eptifibatide and gantofiban which were run once.</div><div id="fspara0040" role="paragraph"><sup>b</sup>Conformational states (<span class="dropBlock reference-citations"><a id="body-ref-sref87-1" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-1" aria-controls="sref87-1">Zhu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref87-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). MIDAS metal ion-Ser-123 sidechain oxygen atom distances are shown as mean and difference for the two headpiece molecules in the asymmetric unit.</div></div></div></div></figcaption></figure></div><div id="p0070" role="paragraph">Thus, the story of how a just-emerging class of αIIbβ3 antagonist worked—which did not induce LIBS—was never told. Several inhibitors were published as non-LIBS inducers, but how they were discovered and the chemical properties that differentiated them from LIBS inducers were not described (<span class="dropBlock reference-citations"><a id="body-ref-sref3-2" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-2" aria-controls="sref3-2">Aga et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref3-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Aga, Y. ∙ Baba, K. ∙ Tam, S. ...</div><div><strong>UR-3216: a new generation oral platelet GPIIb/IIIa antagonist</strong></div><div><em>Curr. Pharm. Des.</em> 2004; <strong>10</strong>:1597-1601</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2174/1381612043384592" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-2342443223" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15134558/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2174%2F1381612043384592&amp;pmid=15134558" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref8-1" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-1" aria-controls="sref8-1">Baba et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref8-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Baba, K. ∙ Aga, Y. ∙ Nakanishi, T. ...</div><div><strong>UR-3216: a manageable oral GPIIb/IIIa antagonist</strong></div><div><em>Cardiovasc. Drug Rev.</em> 2001; <strong>19</strong>:25-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1527-3466.2001.tb00181.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035066822" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11314599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1527-3466.2001.tb00181.x&amp;pmid=11314599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref11-1" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-1" aria-controls="sref11-1">Breth et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref11-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Breth, L. ∙ Kochie, J. ∙ Combs, A. ...</div><div><strong>Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2005; <strong>301</strong>:11-20</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2005.02.008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-21844466714" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15992818/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2005.02.008&amp;pmid=15992818" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref20-1" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-1" aria-controls="sref20-1">Dickfeld et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref20-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Dickfeld, T. ∙ Ruf, A. ∙ Pogatsa-Murray, G. ...</div><div><strong>Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists</strong></div><div><em>Thromb. Res.</em> 2001; <strong>101</strong>:53-64</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2800%2900385-6&amp;cf=fulltext&amp;site=tr-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2800%2900385-6&amp;cf=pdf&amp;site=tr-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035862627" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11342206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0049-3848%2800%2900385-6&amp;pmid=11342206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, development of αIIbβ3 antagonists was stopped prior to their first structures bound to αIIbβ3, which were all with LIBS inducers (<span class="dropBlock reference-citations"><a id="body-ref-sref80-1" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-1" aria-controls="sref80-1">Xiao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref80-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Xiao, T. ∙ Takagi, J. ∙ Coller, B.S. ...</div><div><strong>Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics</strong></div><div><em>Nature.</em> 2004; <strong>432</strong>:59-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02976" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-8544259562" target="_blank" aria-label="Open Scopus in new tab">Scopus (718)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15378069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02976&amp;pmid=15378069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A subsequently developed LIBS-inducing integrin αVβ3 inhibitor also failed in clinical trials in cancer and was suggested to be agonistic (<span class="dropBlock reference-citations"><a id="body-ref-sref36-2" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36-2" aria-controls="sref36-2">Ley et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref36-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Ley, K. ∙ Rivera-Nieves, J. ∙ Sandborn, W.J. ...</div><div><strong>Integrin-based therapeutics: biological basis, clinical use and new drugs</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2016; <strong>15</strong>:173-183</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd.2015.10" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84959369497" target="_blank" aria-label="Open Scopus in new tab">Scopus (321)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26822833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd.2015.10&amp;pmid=26822833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37-1" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-1" aria-controls="sref37-1">Li et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref37-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Li, J. ∙ Fukase, Y. ∙ Shang, Y. ...</div><div><strong>Novel pure αVβ3 integrin antagonists that do not induce receptor extension, prime the receptor, or enhance angiogenesis at low concentrations</strong></div><div><em>ACS Pharmacol. Transl. Sci.</em> 2019; <strong>2</strong>:387-401</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acsptsci.9b00041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85087732052" target="_blank" aria-label="Open Scopus in new tab">Scopus (23)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32259072/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facsptsci.9b00041&amp;pmid=32259072" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Reynolds et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Reynolds, A.R. ∙ Hart, I.R. ∙ Watson, A.R. ...</div><div><strong>Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors</strong></div><div><em>Nat. Med.</em> 2009; <strong>15</strong>:392-400</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.1941" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-64149106522" target="_blank" aria-label="Open Scopus in new tab">Scopus (405)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19305413/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.1941&amp;pmid=19305413" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although non-LIBS-inducing αIIbβ3 and αVβ3 inhibitors have been reported by academic investigators, they have not been extended to integrins with other β-subunits (<span class="dropBlock reference-citations"><a id="body-ref-sref1-1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-1" aria-controls="sref1-1">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref34-1" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-1" aria-controls="sref34-1">Kereiakes et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref34-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Kereiakes, D.J. ∙ Henry, T.D. ∙ DeMaria, A.N. ...</div><div><strong>First human use of RUC-4: A nonactivating second-generation small-molecule platelet glycoprotein IIb/IIIa (integrin αiibβ3) inhibitor designed for subcutaneous point-of-care treatment of ST-segment-elevation myocardial infarction</strong></div><div><em>J.&nbsp;Am. Heart Assoc.</em> 2020; <strong>9</strong>:e016552</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/JAHA.120.016552" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85090174407" target="_blank" aria-label="Open Scopus in new tab">Scopus (20)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32844723/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FJAHA.120.016552&amp;pmid=32844723" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37-2" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-2" aria-controls="sref37-2">Li et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref37-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Li, J. ∙ Fukase, Y. ∙ Shang, Y. ...</div><div><strong>Novel pure αVβ3 integrin antagonists that do not induce receptor extension, prime the receptor, or enhance angiogenesis at low concentrations</strong></div><div><em>ACS Pharmacol. Transl. Sci.</em> 2019; <strong>2</strong>:387-401</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acsptsci.9b00041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85087732052" target="_blank" aria-label="Open Scopus in new tab">Scopus (23)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32259072/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facsptsci.9b00041&amp;pmid=32259072" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref86-1" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86-1" aria-controls="sref86-1">Zhu et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref86-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Zhu, J. ∙ Choi, W.-S. ∙ McCoy, J.G. ...</div><div><strong>Structure-guided design of a high affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg2+ binding to the MIDAS</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003576" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863375270" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0075" role="paragraph">A principle for inhibiting integrin conformational change by small-molecule antagonists that could be extended to integrins with other β-subunits would be desirable. Consider a dangerous safety signal with firategrast, a dual α4β1/α4β7 integrin antagonist, in a phase II trial in multiple sclerosis (<span class="dropBlock reference-citations"><a id="body-ref-sref48-1" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-1" aria-controls="sref48-1">Miller et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref48-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Miller, D.H. ∙ Weber, T. ∙ Grove, R. ...</div><div><strong>Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial</strong></div><div><em>Lancet Neurol.</em> 2012; <strong>11</strong>:131-139</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84856015884" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22226929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1474-4422%2811%2970299-X&amp;pmid=22226929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). High doses were significantly beneficial, a medium dose had no significant effect, and a low dose was significantly harmful, a profile consistent with action of a partial agonist and induction of the active conformation of the integrin. However, little is known about firategrast, including whether it induces the high-affinity state of α4β1.</div><div id="p0080" role="paragraph">Here, we hypothesized that the rich chemical matter developed for αIIbβ3 antagonism could be used to uncover a chemical principle by which inhibitors could bind but not induce the high-affinity integrin state and that this principle might be broadly transferable to integrin targets of current clinical interest. We determined high-resolution structures of αIIbβ3 bound to opening-stabilizing (LIBS-inducing) and closure-stabilizing (non-LIBS-inducing) compounds. The key chemical principle to emerge, a hydrogen bond to a water molecule of importance in integrin conformational change, is elegant in its simplicity. Drug molecules that stabilize this water not only do not induce LIBS epitope expression but also suppress LIBS expression by stabilizing the closed, low-affinity integrin conformation.</div><div id="p0085" role="paragraph">To challenge our understanding of the chemical features required for closing inhibitors, we extrapolated what we learned from αIIbβ3 to the highly dissimilar integrin α4β1. We found that firategrast, which is no longer in pharmaceutical development, stabilizes the open, high-affinity integrin conformation. Searching the chemical literature for α4β1 antagonists, we found a pair of two compounds that were similar but differed in one position by the presence of a nitrogen atom able to hydrogen bond to water or a carbon atom lacking this ability; these compounds stabilized the closed and open states, respectively. This success and the invariance in integrin β-subunits of the metal ion-dependent adhesion site (MIDAS) Mg<sup>2+</sup> ion and the MIDAS serine sidechain, between which the key water locates, suggest that the closing principle described here is likely extendable to all integrins.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>αIIbβ3 inhibitors stabilize distinct integrin conformations</h3><div id="p0090" role="paragraph">Integrins on cell surfaces and as soluble ectodomain fragments equilibrate between three conformational states, BC, extended-closed (EC), and EO (<a id="crosref0335" href="#fig1">Figures&nbsp;1</a>A and 1B). In the absence of ligand binding, the BC state predominates on cell surfaces: &gt;99.8% for α5β1 and &gt;97.7% for α4β1 (<span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Integrin αIIbβ3 is also predominately in the BC state in absence of ligand, as shown by lack of reactivity with LIBS antibodies (<span class="dropBlock reference-citations"><a id="body-ref-sref27-2" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-2" aria-controls="sref27-2">Frelinger et&nbsp;al., 1988</a><div class="dropBlock__holder" data-db-target-of="sref27-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Frelinger, A.L. ∙ Lam, S.C.T. ∙ Plow, E.F. ...</div><div><strong>Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1988; <strong>263</strong>:12397-12402</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2818%2937769-X&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2818%2937769-X&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2457583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2818%2937769-X&amp;pmid=2457583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). LIBS antibodies to αIIbβ3 map to regions of the upper and lower legs (<a id="crosref0350" href="#fig1">Figure&nbsp;1</a>A) that become exposed upon extension (<span class="dropBlock reference-citations"><a id="body-ref-sref12" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12" aria-controls="sref12">Byron et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Byron, A. ∙ Humphries, J.D. ∙ Askari, J.A. ...</div><div><strong>Anti-integrin monoclonal antibodies</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2009; <strong>122</strong>:4009-4011</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.056770" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-70849109088" target="_blank" aria-label="Open Scopus in new tab">Scopus (135)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19910492/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.056770&amp;pmid=19910492" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref85-1" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85-1" aria-controls="sref85-1">Zhang et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref85-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zhang, C. ∙ Liu, J. ∙ Jiang, X. ...</div><div><strong>Modulation of integrin activation and signaling by α1/α1'-helix unbending at the junction</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2013; <strong>126</strong>:5735-5747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.137828" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890487402" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24144695/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.137828&amp;pmid=24144695" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0095" role="paragraph">Using multiple assays that extend to the end of results, we found that inhibitors either stabilized integrin headpiece opening, closure, or were conformationally neutral. Initially, we tested the effect of compounds on the integrin headpiece fragment, which is truncated at the knees (<a id="crosref0365" href="#fig1">Figure&nbsp;1</a>A). The headpiece responds similarly to ligand-mimetic drugs as the ectodomain and intact integrins but has only two states, closed and open, and thus can directly demonstrate opening in the absence of extension. The integrin headpiece, as demonstrated with α5β1, is more stable in the closed state than the ectodomain and is thus more difficult to activate (<span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Li and Springer, 2017</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Integrin extension enables ultrasensitive regulation by cytoskeletal force</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2017; <strong>114</strong>:4685-4690</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1704171114" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85018292985" target="_blank" aria-label="Open Scopus in new tab">Scopus (111)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28416675/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1704171114&amp;pmid=28416675" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In 1&nbsp;mM Mg<sup>2+</sup>/1&nbsp;mM Ca<sup>2+</sup> (Mg<sup>2+</sup>), the clinically tested oral antagonists roxifiban (<span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Pieniaszek et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Pieniaszek, Jr., H.J. ∙ Sy, S.K. ∙ Ebling, W. ...</div><div><strong>Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of Roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers</strong></div><div><em>J.&nbsp;Clin. Pharmacol.</em> 2002; <strong>42</strong>:738-753</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/009127002401102687" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035998752" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12092741/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F009127002401102687&amp;pmid=12092741" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (BMS/DuPont) and lotrafiban (<span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Mould et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Mould, D. ∙ Chapelsky, M. ∙ Aluri, J. ...</div><div><strong>A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients</strong></div><div><em>Clin. Pharmacol. Ther.</em> 2001; <strong>69</strong>:210-222</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1067/mcp.2001.114925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035035790" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11309549/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1067%2Fmcp.2001.114925&amp;pmid=11309549" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73-3" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73-3" aria-controls="sref73-3">Topol et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref73-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Topol, E.J. ∙ Easton, D. ∙ Harrington, R.A. ...</div><div><strong>Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease</strong></div><div><em>Circulation.</em> 2003; <strong>108</strong>:399-406</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.0000084501.48570.F6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0043166526" target="_blank" aria-label="Open Scopus in new tab">Scopus (199)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12874182/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.0000084501.48570.F6&amp;pmid=12874182" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (Glaxo), like parenteral tirofiban, caused the headpiece to elute earlier in gel filtration, showing its hydrodynamic radius was increased by opening (<a id="crosref0390" href="#fig1">Figure&nbsp;1</a>C). Drugs studied here are shown in <a id="crosref0395" href="#fig2">Figure&nbsp;2</a>; for convenience, we use oral prodrug names for their active forms. Mn<sup>2+</sup> increases integrin intrinsic affinity for ligand and also increases the population of the open state (<span class="dropBlock reference-citations"><a id="body-ref-sref5-1" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-1" aria-controls="sref5-1">Anderson et&nbsp;al., 2022</a><div class="dropBlock__holder" data-db-target-of="sref5-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Anderson, J.M. ∙ Li, J. ∙ Springer, T.A.</div><div><strong>Regulation of integrin α5β1 conformational states and intrinsic affinities by metal ions and the ADMIDAS</strong></div><div><em>Mol. Biol. Cell.</em> 2022; <strong>33</strong>:ar56</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1091/mbc.E21-11-0536" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85130633129" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/35108026/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1091%2Fmbc.E21-11-0536&amp;pmid=35108026" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-2" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-2" aria-controls="sref40-2">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As shown by negative stain electron microscopy of detergent soluble, intact αIIbβ3, Mn<sup>2+</sup> increases population of the EC and EO states and, in presence of a ligand that binds to the open headpiece conformation, enhances population of the EO state (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Eng et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Eng, E.T. ∙ Smagghe, B.J. ∙ Walz, T. ...</div><div><strong>Intact αIIbβ3 extends after activation measured by solution X-ray scattering and electron microscopy</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2011; <strong>286</strong>:35218-35226</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M111.275107&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M111.275107&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-80053434774" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21832081/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M111.275107&amp;pmid=21832081" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/5980c0d3-fc71-4bd6-af8d-b489e8a73cb8/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2022.08.008/asset/93cf154d-56fb-41b5-ab23-ff00facae63c/main.assets/gr2.jpg" height="794" width="659" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5980c0d3-fc71-4bd6-af8d-b489e8a73cb8/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Chemical structures of integrin inhibitors</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0050" role="paragraph">Drawings show the active form used here in the case of prodrugs. Compounds are αIIbβ3 inhibitors, except for four α4β1 inhibitors, shown to the right and below of RUC-4.</div></div></div></div></figcaption></figure></div><div id="p0100" role="paragraph">In gel filtration of the αIIbβ3 headpiece in absence of compound, 2&nbsp;mM Mn<sup>2+</sup>/0.2&nbsp;mM Ca<sup>2+</sup> (Mn<sup>2+</sup>) increased the hydrodynamic radius slightly, from 4.77 in Mg<sup>2+</sup> to 4.88&nbsp;nm in Mn<sup>2+</sup>, which suggested a slight increase in population in the ensemble of the open conformation (<a id="crosref0415" href="#fig1">Figures&nbsp;1</a>C, 1D, and 1I). Although clinically tested lotrafiban, roxifiban, and tirofiban varied in the extent to which they shifted headpiece elution in Mg<sup>2+</sup>, they uniformly increased the hydrodynamic radius to ∼5.36&nbsp;nm in Mn<sup>2+</sup>. Other clinical stage compounds, lamifiban (<span class="dropBlock reference-citations"><a id="body-ref-sref53-1" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-1" aria-controls="sref53-1">Müller et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref53-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Müller, T.H. ∙ Weisenberger, H. ∙ Brickl, R. ...</div><div><strong>Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men</strong></div><div><em>Circulation.</em> 1997; <strong>96</strong>:1130-1138</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.96.4.1130" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0342872079" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9286940/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.96.4.1130&amp;pmid=9286940" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref76-1" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-1" aria-controls="sref76-1">Weller et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref76-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Weller, T. ∙ Alig, L. ∙ Beresini, M. ...</div><div><strong>Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines</strong></div><div><em>J.&nbsp;Med. Chem.</em> 1996; <strong>39</strong>:3139-3147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm9509298" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9344236530" target="_blank" aria-label="Open Scopus in new tab">Scopus (132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8759635/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm9509298&amp;pmid=8759635" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (Roche, Ro 44-9883), sibrafiban (<span class="dropBlock reference-citations"><a id="body-ref-sref76-2" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76-2" aria-controls="sref76-2">Weller et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref76-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>Weller, T. ∙ Alig, L. ∙ Beresini, M. ...</div><div><strong>Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines</strong></div><div><em>J.&nbsp;Med. Chem.</em> 1996; <strong>39</strong>:3139-3147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm9509298" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9344236530" target="_blank" aria-label="Open Scopus in new tab">Scopus (132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8759635/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm9509298&amp;pmid=8759635" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref77" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77" aria-controls="sref77">Wittke et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref77"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Wittke, B. ∙ Mackie, I.J. ∙ Machin, S.J. ...</div><div><strong>Pharmacokinetics and pharmacodynamics of RO 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers</strong></div><div><em>Br. J. Clin. Pharmacol.</em> 1999; <strong>47</strong>:521-530</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1046/j.1365-2125.1999.00931.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0032932924" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10336576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1046%2Fj.1365-2125.1999.00931.x&amp;pmid=10336576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (Roche, Ro 44-3888), and fradafiban (<span class="dropBlock reference-citations"><a id="body-ref-sref53-2" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-2" aria-controls="sref53-2">Müller et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref53-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Müller, T.H. ∙ Weisenberger, H. ∙ Brickl, R. ...</div><div><strong>Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men</strong></div><div><em>Circulation.</em> 1997; <strong>96</strong>:1130-1138</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.96.4.1130" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0342872079" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9286940/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.96.4.1130&amp;pmid=9286940" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (Karl Thomae) did not cause headpiece opening in Mg<sup>2+</sup> (<a id="crosref0445" href="#fig1">Figure&nbsp;1</a>E), consistent with reports that lamifiban did not induce exposure of LIBS epitopes on αIIbβ3 on platelets (<span class="dropBlock reference-citations"><a id="body-ref-sref55-2" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-2" aria-controls="sref55-2">Murphy et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref55-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Murphy, N.P. ∙ Pratico, D. ∙ Fitzgerald, D.J.</div><div><strong>Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in&nbsp;vivo</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 1998; <strong>286</strong>:945-951</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=fulltext&amp;site=jpet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=pdf&amp;site=jpet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9694954/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0022-3565%2824%2937673-6&amp;pmid=9694954" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, in activating Mn<sup>2+</sup> buffer, these three compounds induced headpiece opening as completely as tirofiban (<a id="crosref0455" href="#fig1">Figure&nbsp;1</a>F). We term these “opening” inhibitors because they increase the proportion of the open state in conformational ensembles.</div><div id="p0105" role="paragraph">Another class of compounds did not induce opening in buffer with Mg<sup>2+</sup> or Mn<sup>2+</sup>. We found UR-2922 (Ube Pharmaceuticals), reported not to induce LIBS epitopes on platelets in Mg<sup>2+</sup> (<span class="dropBlock reference-citations"><a id="body-ref-sref8-2" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-2" aria-controls="sref8-2">Baba et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref8-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Baba, K. ∙ Aga, Y. ∙ Nakanishi, T. ...</div><div><strong>UR-3216: a manageable oral GPIIb/IIIa antagonist</strong></div><div><em>Cardiovasc. Drug Rev.</em> 2001; <strong>19</strong>:25-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1527-3466.2001.tb00181.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035066822" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11314599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1527-3466.2001.tb00181.x&amp;pmid=11314599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), in a review on integrin antagonists (<span class="dropBlock reference-citations"><a id="body-ref-sref17-2" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-2" aria-controls="sref17-2">Cox et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Cox, D. ∙ Brennan, M. ∙ Moran, N.</div><div><strong>Integrins as therapeutic targets: lessons and opportunities</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2010; <strong>9</strong>:804-820</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd3266" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-77957363101" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20885411/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd3266&amp;pmid=20885411" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We later found BMS4, also reported not to induce LIBS on platelets in Mg<sup>2+</sup> (<span class="dropBlock reference-citations"><a id="body-ref-sref11-2" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-2" aria-controls="sref11-2">Breth et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref11-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Breth, L. ∙ Kochie, J. ∙ Combs, A. ...</div><div><strong>Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2005; <strong>301</strong>:11-20</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2005.02.008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-21844466714" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15992818/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2005.02.008&amp;pmid=15992818" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), during a serendipitous search for LIBS antibodies. We found that neither UR-2922 nor BMS4 increased the hydrodynamic radius of the αIIbβ3 headpiece in Mg<sup>2+</sup> or Mn<sup>2+</sup> (<a id="crosref0475" href="#fig1">Figures&nbsp;1</a>G and 1H). Furthermore, in Mn<sup>2+</sup>, these inhibitors shifted the headpiece to a smaller hydrodynamic radius than the control, which was indistinguishable from the control in Mg<sup>2+</sup> (<a id="crosref0480" href="#fig1">Figures&nbsp;1</a>G–1I). These results are consistent with the suggestion above that a small population of the αIIbβ3 headpiece is in the open conformation in Mn<sup>2+</sup> and that these compounds preferentially bind to the closed conformation and increase its population. We term these “closing” inhibitors.</div></section><section id="sec-2-2"><h3>Structural features of opening integrin inhibitors</h3><div id="p0110" role="paragraph">In the absence of ligand in Mg<sup>2+</sup>/Ca<sup>2+</sup>, αIIbβ3 headpiece-Fab complexes crystallize in the closed state with two molecules per asymmetric unit, giving two independent structural snapshots (<span class="dropBlock reference-citations"><a id="body-ref-sref87-2" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-2" aria-controls="sref87-2">Zhu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref87-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The key early step in headpiece opening is movement of the loop between the βI domain β1-strand and α1-helix (β1-α1 loop, <a id="crosref0490" href="#fig1">Figures&nbsp;1</a>A and 1B), which bears three sidechains that coordinate the MIDAS metal ion in an Asp-Xaa-Ser-Xaa-Ser (DXSXS) motif that is conserved in all integrin β-subunits. In previous work, we soaked Arg-Gly-Asp (RGD) peptide at different concentrations with Mg<sup>2+</sup>or Mn<sup>2+</sup> into αIIbβ3 crystals and trapped αIIbβ3 in closed state 1, intermediate states 2–7, or open state 8 (<span class="dropBlock reference-citations"><a id="body-ref-sref87-3" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-3" aria-controls="sref87-3">Zhu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref87-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In state 1, the sidechain oxygen of Ser-123 in the MIDAS motif hydrogen bonds to water molecule 1 (W1 in <a id="crosref0500" href="#fig3">Figures&nbsp;3</a>A and 3B), whereas in states 3–8, movement of the β1-α1 loop repositions the Ser-123 sidechain oxygen to take the place of water 1 (<a id="crosref0505" href="#fig1">Figures&nbsp;1</a>B and <a id="crosref0510" href="#fig3">3</a>C).</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/dd511fb4-7aa4-441d-8b6b-b16b0a1bf198/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2022.08.008/asset/3cb1e0ab-4608-4649-b918-ab5ae641496c/main.assets/gr3.jpg" height="853" width="761" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dd511fb4-7aa4-441d-8b6b-b16b0a1bf198/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Crystal structures of the αIIbβ3 headpiece in complex with inhibitors in Mg<sup>2+</sup> or Mn<sup>2+</sup></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0060" role="paragraph">(A–R) Structures after soaking indicated compounds in the indicated metal ion into closed αIIbβ3 crystals. Opening (op.) or closing (cl.) propensity is noted below each compound name. (A)–(C) show comparisons to unsoaked control (A, PDB: 3T3P), (B, 10 mM RGD soaked in presence of 5 mM Mg<sup>2+</sup> and 1 mM Ca<sup>2+</sup> [Mg]), or (C, 2 mM Mn<sup>2+</sup> and 0.1 mM Ca<sup>2+</sup> [Mn]). (B) and (C) show molecule 2 in the asymmetric unit of PDB: 3ZDY and PDB: 3ZE2, respectively). (D)–(R) show molecule 1 in the asymmetric unit with compounds (0.1–1 mM) soaked in 1 or 5 mM Mg<sup>2+</sup> and 1 mM Ca<sup>2+</sup> (Mg) or 2 mM Mn<sup>2+</sup> and 0.2 mM Ca<sup>2+</sup> (Mn) as indicated (<a id="crosref1910" href="#mmc1">Table S1</a>).&nbsp;Structures are superimposed on the β-propeller and βI domains. αIIb, β<sub>3</sub>, and compounds or RGD are shown with carbons in green, cyan, and wheat, respectively. MIDAS Mg<sup>2+</sup>and Mn<sup>2+</sup> ions are shown as spheres in yellow and purple, respectively. Water molecule oxygens are shown as smaller red spheres. Backbone is shown as worm trace or sticks for residues that hydrogen bond to ligand. Sidechains that interact with ligand are shown in stick. Black dashes represent metal coordination, hydrogen, and π-π bonds. Relevant residues are labeled.</div><div id="fspara0065" role="paragraph">See also <a id="crosref1710" href="#mmc1">Table&nbsp;S1</a> and <a id="crosref1715" href="#figs1">Figures&nbsp;S1</a> and <a id="crosref1720" href="#figs2">S2</a>.</div></div></div></div></figcaption></figure></div><div id="p0115" role="paragraph">To test whether differences would emerge from comparisons of crystal structures of opening and closing inhibitors bound to αIIbβ3, we determined structures of 16 compounds soaked in the presence of Mg<sup>2+</sup> or Mn<sup>2+</sup>, including 5 compounds soaked in both metal ion conditions. The 21 structures diffracted to 2.52 ± 0.26&nbsp;Å and were refined to R<sub>free</sub> values of 23.21 ± 1.46 (mean ± SD) with excellent electron density for all drug atoms (<a id="crosref0515" href="#fig3">Figures&nbsp;3</a> and <a id="crosref0520" href="#figs1">S1</a>; <a id="crosref0525" href="#figs2">Figure&nbsp;S2</a>; <a id="crosref0530" href="#mmc1">Table&nbsp;S1</a>).</div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/3d1f99e6-9790-47bd-888e-0ee546b9b5b7/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2022.08.008/asset/b7a5aeb8-7acd-4c51-9a62-30bed9ce9b8d/main.assets/figs1.jpg" height="525" width="506" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/3d1f99e6-9790-47bd-888e-0ee546b9b5b7/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">2Fo-Fc electron density maps of drugs bound to aIIbβ3 headpiece in the order of their appearance in the main text, related to <a id="crosref1805" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0185" role="paragraph">Metal conditions (Mg or Mn) for compound soaking are described in <a id="crosref1810" href="#mmc1">Table&nbsp;S1</a>. Electron density (cyan mesh) is contoured around atoms at 1.5 σ. Colors are as in <a id="crosref1815" href="#fig2">Figure&nbsp;2</a>: Mg<sup>2+</sup> and Mn<sup>2+</sup> ions as gold and purple spheres, respectively, and waters as smaller red spheres. Black dashes represent metal coordination and key hydrogen bonds.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/f1c2efcd-7105-4f54-8b6c-fc3ea8e42357/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2022.08.008/asset/f745bea8-70d7-43ee-883f-5ea4dc3b4d8c/main.assets/figs2.jpg" height="297" width="772" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/f1c2efcd-7105-4f54-8b6c-fc3ea8e42357/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Crystal structures of the αIIbβ3 headpiece in complex with inhibitors in Mg or Mn, related to <a id="crosref1820" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0195" role="paragraph">Structures of molecule 1 in the asymmetric unit (chains A and B) after soaking indicated compounds (1&nbsp;mM) in 1&nbsp;mM Mg<sup>2+</sup> (or 5&nbsp;mM Mg<sup>2+</sup> for UR-2922) and 1&nbsp;mM Ca<sup>2+</sup> (Mg) or 2&nbsp;mM Mn<sup>2+</sup> and 0.2&nbsp;mM Ca<sup>2+</sup> (Mn) as indicated into closed αIIbβ3 crystals. Structures are superimposed on the β-propeller and βI domains. αIIb, β3, and compounds or RGD are shown with carbons in green, cyan, and wheat, respectively. MIDAS Mg<sup>2+</sup> and Mn<sup>2+</sup> ions are shown as spheres in yellow and purple, respectively. Water molecule oxygens are shown as smaller red spheres. Backbone is shown as worm trace or sticks for residues that hydrogen bond to ligand. Sidechains that interact with ligand are shown in stick. Black dashes represent metal coordination, hydrogen, and π-π bonds. Relevant residues are labeled.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/63ae75d9-98c1-4318-bd74-4cf69625a46b/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2022.08.008/asset/78579e06-b4da-4bbf-addf-c484895a02cb/main.assets/figs3.jpg" height="526" width="506" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/63ae75d9-98c1-4318-bd74-4cf69625a46b/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Competitive binding to measure the affinity of αIIbβ3 inhibitors, related to <a id="crosref1825" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0205" role="paragraph">αIIbβ3 inhibitors competed the concentration of FITC-echistatin shown on the y axis for binding to αIIbβ3 WT (A)&nbsp;and to αIIbβ3_N305T (B)&nbsp;expressed on transiently transfected Expi293F α5 and αV KO cells. Mean fluorescence intensity (MFI) was determined by flow cytometry without washing in L15 medium with 0.1% BSA. Competitive binding curves were fitted to <a id="crosref1830" href="#fd4">Equation 4</a> in <a id="crosref1835" href="#sec-4">STAR Methods</a>.</div></div></div></div></figcaption></figure></div><div id="p0120" role="paragraph">Tirofiban, eptifibatide (<span class="dropBlock reference-citations"><a id="body-ref-sref80-2" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-2" aria-controls="sref80-2">Xiao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref80-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Xiao, T. ∙ Takagi, J. ∙ Coller, B.S. ...</div><div><strong>Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics</strong></div><div><em>Nature.</em> 2004; <strong>432</strong>:59-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02976" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-8544259562" target="_blank" aria-label="Open Scopus in new tab">Scopus (718)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15378069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02976&amp;pmid=15378069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), lotrafiban, and EF-5154 in Mg<sup>2+</sup> and roxifiban in Mn<sup>2+</sup> bound in the αIIbβ3 groove with their Arg-mimetic nitrogen hydrogen bonded to αIIb residue Asp-224 and their Asp-mimetic carboxyl group coordinated to the β3 MIDAS metal ion (<a id="crosref0540" href="#fig3">Figures&nbsp;3</a>D–3G; <a id="crosref0545" href="#figs1">Figures&nbsp;S1</a>A–S1E and <a id="crosref0550" href="#figs2">S2</a>A). Furthermore, β1-α1 loop movement brought the Tyr-122 backbone into position to hydrogen bond to the drug carboxyl group and Ser-123 displaced water 1 to coordinate directly to the MIDAS metal ion. These opening compounds thus acted similarly to RGD peptides. Three other opening compounds, lamifiban, sibrafiban, and fradafiban, did not cause any conformational change in Mg<sup>2+</sup> (<a id="crosref0555" href="#fig1">Figures&nbsp;1</a>I and <a id="crosref0560" href="#fig3">3</a>H; <a id="crosref0565" href="#figs1">Figures&nbsp;S1</a>F, S1H, S1J, <a id="crosref0570" href="#figs2">S2</a>B, and S2D). In contrast, in Mn<sup>2+</sup>, they induced a 2&nbsp;Å movement in the β1-α1 loop at the Cα atom of Ser-123 toward ligand and brought its sidechain oxygen within 2.3–2.7&nbsp;Å of the MIDAS Mn<sup>2+</sup> ion, thus displacing and occupying the position of water 1 (<a id="crosref0575" href="#fig1">Figures&nbsp;1</a>I, <a id="crosref0580" href="#fig3">3</a>I, and 3J; <a id="crosref0585" href="#figs1">Figures&nbsp;S1</a>G, S1I, S1K, and <a id="crosref0590" href="#figs2">S2</a>C). Moreover, movement also brought the backbone of Tyr-122 into position to form a hydrogen bond to the non-MIDAS coordinating carboxyl oxygen of the drug. 2F<sub>o</sub>-F<sub>c</sub> density maps at 1.5 σ near the βI domain MIDAS region clearly document displacement of the water by the Ser-123 sidechain (<a id="crosref0595" href="#figs1">Figures&nbsp;S1</a>F–S1K). These results agreed with increased headpiece hydrodynamic radius with lamifiban, sibrafiban, and fradafiban in solution in Mn<sup>2+</sup> but not in Mg<sup>2+</sup> (<a id="crosref0600" href="#fig1">Figure&nbsp;1</a>I). We could identify no chemical properties or interactions such as hydrogen bonds with αIIbβ3 that uniquely distinguished the compounds that opened the headpiece in Mn<sup>2+</sup> and not in Mg<sup>2+</sup> (<a id="crosref0605" href="#fig3">Figures&nbsp;3</a>D–3J and <a id="crosref0610" href="#figs2">S2</a>A–S2D).</div></section><section id="sec-2-3"><h3>A fundamental chemical principle that defines closing integrin inhibitors</h3><div id="p0125" role="paragraph">In contrast to the results with opening integrin inhibitors, soaking with UR-2922 and BMS4 caused no structural perturbation of the closed αIIbβ3 headpiece in Mg<sup>2+</sup> or Mn<sup>2+</sup> (<a id="crosref0615" href="#fig3">Figures&nbsp;3</a>K, 3L, <a id="crosref0620" href="#figs1">S1</a>L–S1O, <a id="crosref0625" href="#figs2">S2</a>E, and S2F). Seeing no unique structural contacts between the integrin and the closing inhibitors, we at first were puzzled by how they stabilized the closed state. During opening, integrin β1-α1 loop movement is linked to sliding of the entire RGD ligand in its binding groove toward Asp-224 in the αIIb subunit (<a id="crosref0630" href="#fig1">Figures&nbsp;1</a>B, <a id="crosref0635" href="#fig3">3</a>B, and 3C; <span class="dropBlock reference-citations"><a id="body-ref-sref87-4" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-4" aria-controls="sref87-4">Zhu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref87-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We wondered if closing inhibitors might be longer and more rigid than RGD and block this movement. Pursuing this hypothesis, we synthesized a shorter BMS4 analog, BMS4-1, and the even shorter BMS4-3 (<a id="crosref0645" href="#fig2">Figure&nbsp;2</a>). Gel filtration showed that BMS4-1 and BMS4-3 were closure stabilizing (<a id="crosref0650" href="#fig1">Figures&nbsp;1</a>G–1I). Crystal structures showed that αIIbβ3 remained in the closed state in Mn<sup>2+</sup> and bound to BMS4-1 and BMS4-3 essentially identically to BMS4, except that BMS4-3 was so shortened that its piperidine group did not reach αIIb Asp-244 and interacted with it through a network of water molecules (<a id="crosref1870" href="#fig3">Figures&nbsp;3</a>M, 3N, <a id="crosref0655" href="#figs1">S1</a>P, and S1Q). These results falsified the hypothesis that closing propensity of the BMS series was a function of compound length.</div><div id="p0130" role="paragraph">The inspirational moment finally came when we noticed that closing compounds either directly hydrogen bonded water 1 (W1), which bridges the MIDAS metal ion to the sidechain of MIDAS residue Ser-123 (UR-2922, <a id="crosref0660" href="#fig3">Figure&nbsp;3</a>K), or indirectly hydrogen bonded to water 1 through water 2 (W2) as in the case of BMS4, BMS4-3, and BMS4-1 (<a id="crosref0665" href="#fig3">Figures&nbsp;3</a>L–3N). As water 1 is displaced by the Ser-123 sidechain early in integrin opening and in the final open state (<span class="dropBlock reference-citations"><a id="body-ref-sref80-3" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-3" aria-controls="sref80-3">Xiao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref80-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Xiao, T. ∙ Takagi, J. ∙ Coller, B.S. ...</div><div><strong>Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics</strong></div><div><em>Nature.</em> 2004; <strong>432</strong>:59-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02976" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-8544259562" target="_blank" aria-label="Open Scopus in new tab">Scopus (718)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15378069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02976&amp;pmid=15378069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref87-5" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-5" aria-controls="sref87-5">Zhu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref87-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), stabilizing water 1 specifically stabilizes the closed conformation.</div><div id="p0135" role="paragraph">UR-2922 has a pyrazole ring with two nitrogens, one of which (N2) hydrogen bonds to water 1 (<a id="crosref0680" href="#fig2">Figures&nbsp;2</a>, <a id="crosref0685" href="#fig3">3</a>K, and <a id="crosref0690" href="#fig4">4</a>A). Neither nitrogen has a hydrogen. Thus, one of the hydrogens of water 1 donates a hydrogen bond to the electron lone pair of N2; in turn, one water 1 oxygen electron lone pair forms a partially covalent (2.1&nbsp;Å) coordination to the MIDAS metal ion. The UR-2922 complex structures are virtually identical in Mn<sup>2+</sup> and Mg<sup>2+</sup> (<a id="crosref0695" href="#fig3">Figure&nbsp;3</a>K; <a id="crosref0700" href="#figs2">Figure&nbsp;S2</a>F) and have strong electron density for water 1 (<a id="crosref0705" href="#fig4">Figures 4</a>A, <a id="crosref0710" href="#figs1">S1</a>L, and S1M).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/0bb95bd9-4c8a-4ce5-8039-a5afb89e0c23/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2022.08.008/asset/f374fd5f-eae3-4cad-8f42-04007aad8c1c/main.assets/gr4.jpg" height="445" width="497" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/0bb95bd9-4c8a-4ce5-8039-a5afb89e0c23/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">Stabilization of the water between the MIDAS metal ion and Ser-123 sidechain by closing antagonists</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0075" role="paragraph">(A–F) The environment around the indicated compound substructures near the MIDAS metal ion, waters, and Ser-123 is shown after superposition on the βI domain. 2F<sub>o</sub>-F<sub>c</sub> electron density (cyan mesh) is contoured around atoms at 1.5 σ. Colors are as in <a id="crosref1725" href="#fig2">Figure&nbsp;2</a>, including Mg<sup>2+</sup> and Mn<sup>2+</sup> ions as gold and purple spheres, respectively, and waters as smaller red spheres. Black dashes represent coordination and hydrogen bonds.</div></div></div></div></figcaption></figure></div><div id="p0140" role="paragraph">The BMS4-bound structures in Mn<sup>2+</sup> and Mg<sup>2+</sup> and the BMS4-3 and BMS4-1 complexes in Mn<sup>2+</sup> all show strong density for both water 1 and water 2 (<a id="crosref0715" href="#fig4">Figures&nbsp;4</a>B–4D and <a id="crosref0720" href="#figs1">S1</a>N–S1Q). Density for water in a similar location to water 2 was not observed in any of the complexes with opening-stabilizing inhibitors or in UR-2922 complexes (<a id="crosref0725" href="#fig4">Figures&nbsp;4</a>A and <a id="crosref0730" href="#figs1">S1</a>A–S1K). The piperazine N1 atom is highly basic and is protonated (positively charged) at neutral pH. Thus, water 2 serves as a polarized hydrogen bond acceptor for the protonated piperazine nitrogen N1. Among the BMS4, BMS4-1, and BMS4-3 complex structures, three in Mn<sup>2+</sup> and one in Mg<sup>2+</sup>, each with two independent molecules in the crystal lattice, the strength of the piperazine N-water 2 and water 2-water 1 hydrogen bonds is evidenced by their short heavy atom distances of 2.79 ± 0.18 and 2.64 ± 0.11 (mean ± SD, n&nbsp;= 6), respectively.</div><div id="p0145" role="paragraph">These results define a fundamental chemical principle for designing closing integrin inhibitors: they include a polar atom in the compound that is positioned (1) to accept a hydrogen bond from water 1 or (2) to donate a hydrogen bond to water 2, which in turn accepts a hydrogen bond from water 1. The net effect is to stabilize water 1 and prevent its expulsion in integrin opening. These features are specific to closing inhibitors, since no hydrogen bond donors or acceptors, including water, are within 3.5&nbsp;Å of the position occupied by water 1 in crystal structures of opening inhibitors including RGD (<a id="crosref0735" href="#fig3">Figures&nbsp;3</a>B–3J, <a id="crosref0740" href="#figs1">S1</a>A–S1K, and <a id="crosref0745" href="#figs2">S2</a>A–S2D).</div></section><section id="sec-2-4"><h3>Testing the chemical hypothesis and its ability to identify further closing αIIbβ3 inhibitors</h3><div id="p0150" role="paragraph">We challenged the chemical hypothesis by synthesizing BMS4-2, which substituted the piperazine N1 atom in BMS4-1 with a carbon atom (<a id="crosref0750" href="#fig2">Figure&nbsp;2</a>). BMS4-2 soaked into closed αIIbβ3 headpiece crystals in Mn<sup>2+</sup> shifted the molecules in the crystal lattice to state 2, in contrast to all closing inhibitors (<a id="crosref0755" href="#fig1">Figure&nbsp;1</a>I). Water 1 remained between the MIDAS and Ser-123 sidechain (<a id="crosref0760" href="#fig3">Figure&nbsp;3</a>O); however, Ser-123 moved closer to the MIDAS Mn<sup>2+</sup> ion with a distance of 3.7 ± 0.1&nbsp;Å, whereas all closing inhibitors showed Ser-123-Mn<sup>2+</sup> distances of 4.2–4.4&nbsp;Å (<a id="crosref0765" href="#fig1">Figure&nbsp;1</a>I). Furthermore, there was no density for water 2 with BMS4-2 (<a id="crosref0770" href="#fig4">Figure&nbsp;4</a>E). In gel filtration, BMS4-2 stabilized headpiece opening in Mn<sup>2+</sup> and not in Mg<sup>2+</sup> (<a id="crosref0775" href="#fig1">Figures&nbsp;1</a>E, 1F, and 1I). As BMS4-1 and BMS4-2 differ by a single atom (<a id="crosref0780" href="#fig2">Figure&nbsp;2</a>), these results demonstrated that the piperazine N1 atom is essential for stabilizing the closed integrin state and for positioning water 2 to hydrogen bond to water 1.</div><div id="p0155" role="paragraph">Further αIIbβ3 inhibitors with piperazine or piperidine acetic acid moieties were found in review articles and using SciFinder (<a id="intref0010" href="http://scifinder.cas.org" target="_blank">scifinder.cas.org</a>). Gantofiban (EMD 122347, Merck KGA) is optimized for blocking platelet functions and oral bioavailability in guinea pigs (<span class="dropBlock reference-citations"><a id="body-ref-sref28-1" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28-1" aria-controls="sref28-1">Gante et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref28-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Gante, J. ∙ Juraszyk, H. ∙ Raddatz, P. ...</div><div><strong>New peptidomimetics in the chemistry of fibrinogen receptor antagonists</strong></div><div><em>Lett. Pept. Sci.</em> 1995; <strong>2</strong>:135-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/BF00119139" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0000574181" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2FBF00119139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0790" href="#fig2">Figure&nbsp;2</a>). Coincidentally, we later found that EMD 122347 had been reported to decrease LIBS exposure on platelets (<span class="dropBlock reference-citations"><a id="body-ref-sref20-2" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20-2" aria-controls="sref20-2">Dickfeld et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref20-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Dickfeld, T. ∙ Ruf, A. ∙ Pogatsa-Murray, G. ...</div><div><strong>Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists</strong></div><div><em>Thromb. Res.</em> 2001; <strong>101</strong>:53-64</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2800%2900385-6&amp;cf=fulltext&amp;site=tr-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2800%2900385-6&amp;cf=pdf&amp;site=tr-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035862627" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11342206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0049-3848%2800%2900385-6&amp;pmid=11342206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although no results were published, gantofiban entered phase II clinical trials in Europe (Merck KGA) and Japan (Yamanouchi) (<a id="intref0015" href="https://adisinsight.springer.com" target="_blank">https://adisinsight.springer.com</a>). We synthesized gantofiban, which is most active as the (R)-stereoisomer, and its analog with a one-carbon-longer carboxylic acid, which is most active as the (S)-stereoisomer (<span class="dropBlock reference-citations"><a id="body-ref-sref28-2" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28-2" aria-controls="sref28-2">Gante et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref28-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Gante, J. ∙ Juraszyk, H. ∙ Raddatz, P. ...</div><div><strong>New peptidomimetics in the chemistry of fibrinogen receptor antagonists</strong></div><div><em>Lett. Pept. Sci.</em> 1995; <strong>2</strong>:135-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/BF00119139" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0000574181" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2FBF00119139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0805" href="#fig2">Figure&nbsp;2</a>). Gantofiban does not induce headpiece opening in Mn<sup>2+</sup> (<a id="crosref0810" href="#fig1">Figure&nbsp;1</a>H); however, its analog does in both Mg<sup>2+</sup> and Mn<sup>2+</sup> (<a id="crosref0815" href="#fig1">Figures&nbsp;1</a>C and 1D). Crystal soaking in Mn<sup>2+</sup> showed that gantofiban bound to αIIbβ3 without perturbing its structure and that its piperazine nitrogen hydrogen bonded to water 2 which in turn hydrogen bonded to water 1 (<a id="crosref0820" href="#fig3">Figure&nbsp;3</a>P; <a id="crosref0825" href="#figs1">Figure&nbsp;S1</a>S). In contrast, the gantofiban analog induced movement of the β1-α1 loop and Ser-123 sidechain oxygen into the position of water 1 and had no equivalent of water 2 (<a id="crosref0830" href="#fig3">Figures&nbsp;3</a>Q and <a id="crosref0835" href="#figs1">S1</a>T). Compared with gantofiban, the one-carbon extension of the acid group in its analog displaced the piperazine nitrogen only 1.3&nbsp;Å further away from the carboxyl group. These results demonstrate the precision with which the hydrogen bond donor for water 2 must be located to stabilize the closed integrin state.</div><div id="p0160" role="paragraph">GR144053 (<a id="crosref0840" href="#fig2">Figure&nbsp;2</a>) was selected at Glaxo for potency and long duration of action after oral administration in the cynomolgus monkey (<span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Eldred et&nbsp;al., 1994</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Eldred, C.D. ∙ Evans, B. ∙ Hindley, S. ...</div><div><strong>Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent</strong></div><div><em>J.&nbsp;Med. Chem.</em> 1994; <strong>37</strong>:3882-3885</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm00049a006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0027948111" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7966149/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm00049a006&amp;pmid=7966149" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Size-exclusion chromatography showed that GR144053 was indeed closing in Mg<sup>2+</sup> and Mn<sup>2+</sup> (<a id="crosref0850" href="#fig1">Figures&nbsp;1</a>G–1I). Crystal structures of αIIbβ3 bound to GR144053 with Mn<sup>2+</sup> showed that the headpiece remained in state 1 (<a id="crosref0855" href="#fig1">Figures&nbsp;1</a>I and <a id="crosref0860" href="#fig3">3</a>R). Strong 2F<sub>o</sub>-F<sub>c</sub> electron density showed the presence of waters 1 and 2 and the piperidine N1 of GR144053 in a strong hydrogen bond network (<a id="crosref0865" href="#fig4">Figures&nbsp;4</a>F and <a id="crosref0870" href="#figs1">S1</a>U). Thus, the chemical principles required for closing compounds survived key tests with chemical substitutions and enabled identification of further αIIbβ3 closing compounds.</div></section><section id="sec-2-5"><h3>Transferring the chemical principle of antagonistic inhibitors to a dissimilar integrin</h3><div id="p0165" role="paragraph">SciFinder substructure searches for VLA-4 (α4β1) inhibitors found the Daiichi Sankyo (DS) compound 13g (DS 13g) (<a id="crosref0875" href="#fig2">Figure&nbsp;2</a>). We synthesized DS 13g and purchased commercially available DS 13d, which was described in the same publication (<span class="dropBlock reference-citations"><a id="body-ref-sref15-1" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15-1" aria-controls="sref15-1">Chiba et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref15-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Chiba, J. ∙ Machinaga, N. ∙ Takashi, T. ...</div><div><strong>Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 2005; <strong>15</strong>:41-45</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bmcl.2004.10.041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9644291524" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15582407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bmcl.2004.10.041&amp;pmid=15582407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and is similar but contains a carbon atom in place of the nitrogen shown to be essential for stabilizing closure of αIIbβ3 (<a id="crosref0885" href="#fig2">Figure&nbsp;2</a>). We also tested the potent α4β1 antagonist Roche (Ro) 29 (compound 29 of <span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Tilley et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Tilley, J.W. ∙ Sidduri, A. ∙ Lou, J. ...</div><div><strong>Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 2013; <strong>23</strong>:1036-1040</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bmcl.2012.12.019" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84872914454" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23312471/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bmcl.2012.12.019&amp;pmid=23312471" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and in later experiments firategrast, which had partial agonist-like properties in phase II clinical trials (<span class="dropBlock reference-citations"><a id="body-ref-sref48-2" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-2" aria-controls="sref48-2">Miller et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref48-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Miller, D.H. ∙ Weber, T. ∙ Grove, R. ...</div><div><strong>Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial</strong></div><div><em>Lancet Neurol.</em> 2012; <strong>11</strong>:131-139</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84856015884" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22226929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1474-4422%2811%2970299-X&amp;pmid=22226929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0900" href="#fig2">Figure&nbsp;2</a>). Gel filtration in Mn<sup>2+</sup> showed that both DS 13d and Ro 29 induced opening of the α4β1 headpiece, whereas DS 13g did not (<a id="crosref0905" href="#fig5">Figure&nbsp;5</a>A).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/c875c7b0-dc35-45bf-b1cb-125d8b38ba7f/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2022.08.008/asset/e33c973d-6410-48c2-ace1-8f0aacd17a8a/main.assets/gr5.jpg" height="923" width="765" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/c875c7b0-dc35-45bf-b1cb-125d8b38ba7f/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Closing and opening α4β1 inhibitors and their conformational preferences</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0085" role="paragraph">(A) Overlaid size-exclusion chromatograms of the α4β1 headpiece in the absence (control) and presence of 10&nbsp;μM drug in running buffer with Mn<sup>2+</sup>.</div><div id="fspara0090" role="paragraph">(B) Drug-induced HUTS-21 LIBS epitope exposure in Jurkat T lymphoma cells in 1&nbsp;mM Mg<sup>2+</sup> and 1&nbsp;mM Ca<sup>2+</sup> (closed bars) or in 1&nbsp;mM Mn<sup>2+</sup> (open bars). Mean fluorescence intensity is shown as % of that with antibody 9F10 to the α4 subunit.</div><div id="fspara0095" role="paragraph">(C–E) Competition with FITC-LDVP (concentration on the y axis) binding by α4β1 inhibitors and VCAM D1D2 to Jurkat cells in L15 medium with 1% BSA. Mean fluorescence intensity (MFI) was determined by flow cytometry without washing. (C) EO state stabilized with 4μM 9EG7 Fab and 15&nbsp;nM HUTS4 Fab; (D)&nbsp;closed states stabilized with 5&nbsp;μM SG19 Fab; (E)&nbsp;basal ensemble. Competition experiments were done multiple times with similar results.</div><div id="fspara0100" role="paragraph">(F) <i>K</i><sub>d</sub> and preference for the EO state (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript upper C Baseline divided by upper K Subscript d Superscript upper E upper O" tabindex="0" ctxtmenu_counter="0" style="font-size: 130%;"><mjx-math data-semantic-structure="(14 (4 (3 0 1) 2) 5 (13 (12 6 7) (11 8 10 9)))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="14" data-semantic-children="4,13" data-semantic-content="5" data-semantic-owns="4 5 13" data-semantic-speech="upper K Subscript d Superscript upper C Baseline divided by upper K Subscript d Superscript upper E upper O"><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="4" data-semantic-children="0,1,2" data-semantic-parent="14" data-semantic-collapsed="(4 (3 0 1) 2)" data-semantic-owns="0 1 2"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="4"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="4" style="margin-left: 0.13em;"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="4"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="5" data-semantic-parent="14" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="13" data-semantic-children="6,7,11" data-semantic-parent="14" data-semantic-collapsed="(13 (12 6 7) 11)" data-semantic-owns="6 7 11"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="13"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:simple;clearspeak:unit" data-semantic-id="11" data-semantic-children="8,9" data-semantic-content="10" data-semantic-parent="13" data-semantic-owns="8 10 9" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="11"><mjx-c class="mjx-c1D438">𝐸</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="10" data-semantic-parent="11" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="11"><mjx-c class="mjx-c1D442">𝑂</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="13"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>) from (C)–(E) and for FITC-LDVP from <span class="dropBlock reference-citations"><a id="body-ref-sref39-2" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-2" aria-controls="sref39-2">Li and Springer (2018)</a><div class="dropBlock__holder" data-db-target-of="sref39-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>. <i>K</i><sub>d</sub> determined from competitive binding assays with nonlinear least square fits and error propagation (<a id="crosref1735" href="#fd2">Equation 2</a>; <a id="crosref1740" href="#sec-4">STAR Methods</a>).</div><div id="fspara0105" role="paragraph">(G–I) Effect of inhibitors on the binding of conformation-specific antibodies to the β1 subunit. Binding of fluorescently labeled antibodies defined on the y axis was measured by flow cytometry without washing. EC<sub>50</sub> values are from fits to <a id="crosref1745" href="#fd1">Equation 1</a> with errors from nonlinear least square fits (<a id="crosref1750" href="#sec-4">STAR Methods</a>). No fits are shown when the error was large (one condition each in D and I).</div><div id="fspara0110" role="paragraph">See also <a id="crosref1755" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div><div id="p0170" role="paragraph">The effect of these α4β1 inhibitors on cell surface α4β1 conformation was examined using HUTS-21 mAb, which binds to the same epitope in the hybrid domain as HUTS-4 (<span class="dropBlock reference-citations"><a id="body-ref-sref44-1" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-1" aria-controls="sref44-1">Luque et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref44-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Luque, A. ∙ Gómez, M. ∙ Puzon, W. ...</div><div><strong>Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common β1 chain</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1996; <strong>271</strong>:11067-11075</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-15844363687" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8626649/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.271.19.11067&amp;pmid=8626649" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which is specific for the open conformation (<span class="dropBlock reference-citations"><a id="body-ref-sref40-3" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-3" aria-controls="sref40-3">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). DS 13d and Ro 29 strongly induced HUTS-21 epitope exposure on Jurkat T&nbsp;cells in Mg<sup>2+</sup>, whereas DS 13g did not (<a id="crosref0920" href="#fig5">Figure&nbsp;5</a>B). Moreover, exposure of the HUTS-21 epitope by Mn<sup>2+</sup> was strongly inhibited by DS 13g, but not by DS 13d or Ro 29.</div><div id="p0175" role="paragraph">In the ensemble theory of conformational states (<span class="dropBlock reference-citations"><a id="body-ref-sref40-4" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-4" aria-controls="sref40-4">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), compounds stabilize particular states by having higher affinity for them than alternative states. We therefore measured compound affinities for the closed and open conformations of α4β1 on Jurkat cells. Conformations were stabilized with conformation-specific Fab used at &gt;100-fold their EC<sub>50</sub> values (<span class="dropBlock reference-citations"><a id="body-ref-sref39-3" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-3" aria-controls="sref39-3">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The biological ligand vascular cell adhesion molecule (VCAM) bound with &gt;1,900-fold higher affinity to the open than closed state, whereas firategrast, DS 13d, and the FITC-diphenylurea Leu-Asp-Val-Pro (LDVP) probe (<span class="dropBlock reference-citations"><a id="body-ref-sref39-4" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-4" aria-controls="sref39-4">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) bound 175-, and 52-, and 680-fold better to the open state, respectively (<a id="crosref0940" href="#fig5">Figures&nbsp;5</a>C–5F). In contrast, DS 13g bound 2.8-fold better to the closed than the open state.</div><div id="p0180" role="paragraph">Conversely, we measured the ability of compounds to shift the basal α4β1 conformational ensemble on Jurkat cells toward the states that they stabilize using fluorescent, conformation-specific antibodies. These antibodies sensitively report the change in population of the closed, open, and extended conformations when used near their EC<sub>50</sub> values. (<a id="crosref0945" href="#fig5">Figures&nbsp;5</a>G–5I). Firategrast and DS 13d increased the population of the EO state on Jurkat cells, whereas DS 13g decreased its population (<a id="crosref0950" href="#fig5">Figure&nbsp;5</a>G). The compounds had cognate effects on the extended conformations (EC&nbsp;+ EO), in agreement with the finding that the open state is always extended (<a id="crosref0955" href="#fig5">Figure&nbsp;5</a>H). In contrast, firategrast and DS 13d decreased the population of the closed states (BC&nbsp;+ EC), whereas DS 13g had no measurable effect (<a id="crosref0960" href="#fig5">Figure&nbsp;5</a>I). The latter result is consistent with the finding that the BC+EC states are 98.9% basally populated on Jurkat cells (<a id="crosref0965" href="#fig4">Figure&nbsp;4</a>D in <span class="dropBlock reference-citations"><a id="body-ref-sref39-5" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-5" aria-controls="sref39-5">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The greater decrease of closed states by firategrast than DS 13d (<a id="crosref0975" href="#fig5">Figure&nbsp;5</a>I) is explicated by the greater selectivity of firategrast than DS 13d for the open state, 175- versus 52-fold, respectively (<a id="crosref0980" href="#fig5">Figure&nbsp;5</a>F). In summary, a chemical principle for creating closing integrin inhibitors was transferrable from αIIbβ3 to a distant integrin relative and allowed us to identify a closing α4β1 integrin inhibitor, DS 13g, that was “hiding” in plain view in the chemical literature.</div></section><section id="sec-2-6"><h3>Quantifying affinities and conformational preferences of αIIbβ3 antagonists, comparisons to recently described inhibitors, and studies on platelets</h3><div id="p0185" role="paragraph">As antibodies are lacking to stabilize the closed and open conformations of β3 integrins, we measured affinity for wild-type (WT) αIIbβ3 on the surface of Expi293F transfectants, where it is predominantly in the BC state as shown by little LIBS exposure, or with an activating glycan wedge (β3 N305T) mutation (<span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">Luo et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Luo, B.H. ∙ Springer, T.A. ∙ Takagi, J.</div><div><strong>Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2003; <strong>100</strong>:2403-2408</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0438060100" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0037418254" target="_blank" aria-label="Open Scopus in new tab">Scopus (126)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12604783/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0438060100&amp;pmid=12604783" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) that increases the proportion of the EO state. After measuring affinity of FITC-echistatin (<a id="crosref0990" href="#fig6">Figure&nbsp;6</a>A), we measured its competition by αIIbβ3 inhibitors (<a id="crosref0995" href="#fig6">Figures&nbsp;6</a>B, 6C, and <a id="crosref1000" href="#figs3">S3</a>) and determined inhibitor affinity (<a id="crosref1005" href="#fig6">Figure&nbsp;6</a>D). The affinity of FITC-echistatin for αIIbβ3 was increased approximately 6-fold in the αIIbβ3 N305T ensemble. Similarly, all inhibitors characterized in other assays as opening showed higher affinity for the activated mutant than WT αIIbβ3 (lotrafibin, eptifibatide, tirofiban, roxifiban, gantofiban analog, EF-5154, sibrafiban, lamifiban, fradafiban, and BMS4-2). The concentration of cell surface αIIbβ3 in the assays, which was estimated by the ligand depletion effect, was higher than the <i>K</i><sub><i>D</i></sub> values of the two highest affinity inhibitors, roxifiban and UR-2922 (<a id="crosref1010" href="#sec-4">STAR Methods</a>), which made the error large for UR-2922. Other closing compounds showed higher affinities for the WT than the activated mutant αIIbβ3 (GR144053, gantofiban, BMS4, and BMS4-1).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/dc66897d-5472-412c-ae81-57710e544033/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2022.08.008/asset/bc35dcae-da90-4f9c-9fe8-a0dcb6b2b5b0/main.assets/gr6.jpg" height="484" width="761" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dc66897d-5472-412c-ae81-57710e544033/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Binding affinity and conformational preference of αIIbβ3 inhibitors</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0120" role="paragraph">(A) Binding affinity of FITC-echistatin for αIIbβ3 wild type (WT) and αIIbβ3_N305T transfectants determined using 5&nbsp;nM Alexa647-MBC319.4 Fab as reporter in L15 medium with 0.1% BSA. <i>K</i><sub>d</sub> was obtained by fitting to <a id="crosref1760" href="#fd3">Equation 3</a> (<a id="crosref1765" href="#sec-4">STAR Methods</a>). Errors are standard fitting errors from the nonlinear least square fits.</div><div id="fspara0125" role="paragraph">(B and C) Competition of representative αIIbβ3 inhibitors with FITC-echistatin (concentration on y axis) for binding to αIIbβ3 WT (B)&nbsp;and to αIIbβ3_N305T (C)&nbsp;on transfectants in L15 medium with 0.1% BSA. Binding assays shown here and in <a id="crosref1770" href="#figs3">Figure&nbsp;S3</a> with other inhibitors were determined multiple times with similar results. Inhibitor concentration range used in the experiment shown was designed based on previous competitive binding curves.</div><div id="fspara0130" role="paragraph">(D) Binding affinities determined from competitive binding assays with nonlinear least square fits and error propagation (<a id="crosref1775" href="#fd4">Equation 4</a>; <a id="crosref1780" href="#sec-4">STAR Methods</a>).</div><div id="fspara0135" role="paragraph">(E and F) Effect of αIIbβ3 inhibitors on integrin extension measured with the binding of 20&nbsp;nM Alexa647-MBC319.4 Fab to αIIbβ3 WT (E)&nbsp;and αIIbβ3_N305T (F)&nbsp;transfectants by flow cytometry without washing in L15 medium with 0.1% BSA. Inhibitors were used at 100× their K<sub>d</sub> values for αIIbβ3 WT reported in (D). Background MFI of 20&nbsp;nM Alexa647-MBC319.4 Fab in the presence of 2&nbsp;μM unlabeled MBC319.4 antibody was subtracted from the MFI values of cells treated with or without inhibitors. Binding was measured three times; data show mean and standard deviation. Unpaired two-tailed Student’s t test was between the inhibitor and no drug groups: <sup>∗</sup>p&nbsp;&lt;&nbsp;0.05, <sup>∗∗</sup>p&nbsp;&lt;&nbsp;0.01, and <sup>∗∗∗</sup>p&nbsp;&lt;&nbsp;0.001.</div><div id="fspara0140" role="paragraph">See also <a id="crosref1875" href="#figs3">Figures&nbsp;S3</a>, <a id="crosref1880" href="#figs4">S4</a>, and <a id="crosref1885" href="#figs7">S7</a>.</div></div></div></div></figcaption></figure></div><div id="p0190" role="paragraph">To extend beyond industrial αIIbβ3 antagonists, we examined academic αIIbβ3 antagonists reported not to induce LIBS, RUC-4 (<span class="dropBlock reference-citations"><a id="body-ref-sref34-2" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-2" aria-controls="sref34-2">Kereiakes et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref34-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Kereiakes, D.J. ∙ Henry, T.D. ∙ DeMaria, A.N. ...</div><div><strong>First human use of RUC-4: A nonactivating second-generation small-molecule platelet glycoprotein IIb/IIIa (integrin αiibβ3) inhibitor designed for subcutaneous point-of-care treatment of ST-segment-elevation myocardial infarction</strong></div><div><em>J.&nbsp;Am. Heart Assoc.</em> 2020; <strong>9</strong>:e016552</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/JAHA.120.016552" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85090174407" target="_blank" aria-label="Open Scopus in new tab">Scopus (20)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32844723/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FJAHA.120.016552&amp;pmid=32844723" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref41-1" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-1" aria-controls="sref41-1">Li et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref41-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Li, J. ∙ Vootukuri, S. ∙ Shang, Y. ...</div><div><strong>RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction</strong></div><div><em>Arterioscler. Thromb. Vasc. Biol.</em> 2014; <strong>34</strong>:2321-2329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/ATVBAHA.114.303724" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84913554789" target="_blank" aria-label="Open Scopus in new tab">Scopus (67)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25147334/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FATVBAHA.114.303724&amp;pmid=25147334" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref86-2" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86-2" aria-controls="sref86-2">Zhu et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref86-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Zhu, J. ∙ Choi, W.-S. ∙ McCoy, J.G. ...</div><div><strong>Structure-guided design of a high affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg2+ binding to the MIDAS</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003576" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863375270" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and M-tirofiban (<span class="dropBlock reference-citations"><a id="body-ref-sref1-2" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-2" aria-controls="sref1-2">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref1035" href="#fig2">Figure&nbsp;2</a>). We synthesized both M-tirofiban stereoisomers, and both were opening as shown by higher affinity for activated mutant than WT αIIbβ3 ensembles (<a id="crosref1040" href="#fig6">Figure&nbsp;6</a>D). By contrast, RUC-4 had affinities for the WT and mutant ensembles that were indistinguishable.</div><div id="p0195" role="paragraph">Conformational preferences of the inhibitors were independently examined by induction of the LIBS epitope recognized by MBC319.4 antibody, specific for the extended states of β3 integrins (<span class="dropBlock reference-citations"><a id="body-ref-sref85-2" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85-2" aria-controls="sref85-2">Zhang et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref85-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zhang, C. ∙ Liu, J. ∙ Jiang, X. ...</div><div><strong>Modulation of integrin activation and signaling by α1/α1'-helix unbending at the junction</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2013; <strong>126</strong>:5735-5747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.137828" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890487402" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24144695/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.137828&amp;pmid=24144695" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). On WT αIIbβ3 transfectants, lotrafiban and eptifibatide strongly induced LIBS exposure and tirofiban was the next strongest (<a id="crosref1050" href="#fig6">Figure&nbsp;6</a>E). Weaker but significant induction was given by the fibrinogen γ C-terminal dodecapeptide, roxifiban, and EF-5154. High epitope exposure was related to a large increase in affinity for mutationally activated compared with WT αIIbβ3 (<a id="crosref1055" href="#fig6">Figure&nbsp;6</a>E). With the αIIbβ3 N305T ensemble, all compounds that showed significant LIBS induction on the WT αIIbβ3 ensemble gave even higher induction (<a id="crosref1060" href="#fig6">Figure&nbsp;6</a>F). Furthermore, all compounds that were characterized as opening in other assays, as well as M-tirofiban and M-tirofiban isomer, showed significant epitope induction. Conversely, all compounds characterized as closing in other assays, i.e., UR-2922, GR144053, gantofiban, BMS4, and BMS4-1, significantly suppressed LIBS induction. Closing compounds also suppressed LIBS epitope exposure induced by Mn<sup>2+</sup> and mutation of a GFFKR motif in the αIIb-β3 transmembrane domain interface (<a id="crosref1065" href="#figs4">Figure&nbsp;S4</a>). RUC-4 had no effect on LIBS epitope expression and thus appears to be conformationally neutral.</div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/c1d77444-483c-4879-b29d-95f22677e089/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2022.08.008/asset/5cd3bad9-12b0-4f9f-b09e-a82d2e962343/main.assets/figs4.jpg" height="304" width="663" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/c1d77444-483c-4879-b29d-95f22677e089/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Closing αIIbβ3 inhibitors suppress integrin conformational change on cell surface as detected by LIBS epitope exposure using flow cytometry, related to <a id="crosref1840" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0215" role="paragraph">(A and B) LIBS1 antibody (A)&nbsp;and AP5 antibody (B)&nbsp;binding (as percentage of AP3 fluorescence intensity) in CHO cells stably expressing full-length αIIbβ3 treated with the indicated compounds in the presence of 1&nbsp;mM Mg<sup>2+</sup> and 1&nbsp;mM Ca<sup>2+</sup> (filled bars) or 2&nbsp;mM Mn<sup>2+</sup> and 0.1&nbsp;mM Ca<sup>2+</sup> (open bars).</div><div id="fspara0220" role="paragraph">(C) HEK293T cells transfected with hyperactive αIIbβ3 with a GFFKR/GAAKR mutation in the αIIb transmembrane domain were analyzed for LIBS1 expression as in (A).</div></div></div></div></figcaption></figure></div><div id="p0200" role="paragraph">We next tested compounds for effect on LIBS epitopes on washed platelets with or without activation by thrombin (<a id="crosref1070" href="#fig7">Figure&nbsp;7</a>A). In the absence of thrombin, lamifiban, sibrafiban, and fradafiban modestly but significantly induced integrin extension. Stronger extension was induced by roxifiban, lotrafiban, eptifibatide, and tirofiban. M-tirofiban and RUC-4 had no significant effect, whereas M-tirofiban isomer showed modest but significant enhancement of epitope exposure. After activation with thrombin, epitope exposure was increased in the absence of compounds. All opening compounds including M-tirofiban and its isomer enhanced LIBS exposure, with all showing significant induction except for BMS4-2 (p&nbsp;= 0.06). LIBS exposure was decreased by all closing compounds (UR-2922, BMS4, BMS4-1, and GR144053) but did not reach significance. RUC-4 showed no effect on integrin extension.</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/2f92393d-7055-4739-bd6b-ef413ff11ebd/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2022.08.008/asset/744fc549-7135-4946-9013-550856449705/main.assets/gr7.jpg" height="709" width="770" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2f92393d-7055-4739-bd6b-ef413ff11ebd/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Platelet assays and effect of serum on the affinity of αIIbβ3 inhibitors</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0150" role="paragraph">(A) Platelet LIBS exposure. Washed human platelets were pre-incubated with buffer control or αIIbβ3 inhibitors and then treated with or without 0.5&nbsp;U/mL thrombin and 25&nbsp;nM Alexa647-conjugated MBC319.4 Fab. Binding was measured by flow cytometry without washing and shown as MFI. Data are mean ± SD from three independent experiments. Unpaired two-tailed t test was between the inhibitor and control groups: <sup>∗</sup>p&nbsp;&lt;&nbsp;0.05, <sup>∗∗</sup>p&nbsp;&lt;&nbsp;0.01, <sup>∗∗∗</sup>p&nbsp;&lt;&nbsp;0.001, and <sup>∗∗∗∗</sup>p&nbsp;&lt;&nbsp;0.0001.</div><div id="fspara0155" role="paragraph">(B) Plots of inhibition of clot retraction (1&nbsp;− (clot area/whole reaction area)) for three representative αIIbβ3 inhibitors measured at 30 (closed circles) and 90&nbsp;min (open circles). Data are mean ± SD (n = 3).</div><div id="fspara0160" role="paragraph">(C) IC<sub>50</sub> values for inhibition of clot retraction by αIIbβ3 inhibitors.</div><div id="fspara0165" role="paragraph">(D) Binding affinities of αIIbβ3 inhibitors determined by competing with FITC-echistatin binding to WT αIIbβ3 transfectant in L15 medium supplemented with 0.1% BSA (from <a id="crosref1785" href="#fig6">Figure&nbsp;6</a>) or with different concentrations of serum (<a id="crosref1790" href="#figs5">Figures&nbsp;S5</a>B and S5C). <mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r" tabindex="0" ctxtmenu_counter="1" style="font-size: 130%;"><mjx-math data-semantic-structure="(21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container> values were determined from nonlinear least square fits (<a id="crosref1795" href="#fd4">Equation 4</a>; <a id="crosref1800" href="#sec-4">STAR Methods</a>). Errors are standard fitting errors from nonlinear least square fits. Experiments were repeated multiple times with similar results.</div><div id="fspara0170" role="paragraph">(E) Inhibition of whole blood platelet aggregation by selected αIIbβ3 inhibitors measured by impedance aggregometry. Data are mean ± SEM (n&nbsp;= 3 different donors).</div><div id="fspara0175" role="paragraph">See also <a id="crosref0012" href="#figs5">Figures&nbsp;S5</a>, <a id="crosref0013" href="#figs6">S6</a>, and <a id="crosref0014" href="#figs7">S7</a>.</div></div></div></div></figcaption></figure></div><div id="p0205" role="paragraph">Clot retraction, which follows conversion of fibrinogen to fibrin during clotting, is largely mediated by binding of platelet αIIbβ3 to fibrin (<span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Jansen and Hartmann, 2021</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Jansen, E.E. ∙ Hartmann, M.</div><div><strong>Clot retraction: cellular mechanisms and inhibitors, measuring methods, and clinical implications</strong></div><div><em>Biomedicines.</em> 2021; <strong>9</strong>:1064</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/biomedicines9081064" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85113687594" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34440268/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fbiomedicines9081064&amp;pmid=34440268" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Representatives of all classes of αIIbβ3 inhibitors inhibited clot retraction (<a id="crosref1080" href="#fig7">Figures&nbsp;7</a>B, 7C, and <a id="crosref1085" href="#figs5">S5</a>). Both opening inhibitors (tirofiban, BMS4-2, sibrafiban, roxifiban, M-tirofiban, and M-tirofiban isomer) and closing inhibitors (BMS4-1 and UR-2922), as well as conformationally neutral RUC-4, were effective.</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/9d80281c-f134-4907-9000-f9cb72334b77/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2022.08.008/asset/2a5e664d-386e-49eb-830b-4e6b8101e500/main.assets/figs5.jpg" height="774" width="657" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/9d80281c-f134-4907-9000-f9cb72334b77/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Inhibition of clot retraction by αIIbβ3 inhibitors, related to <a id="crosref1845" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0230" role="paragraph">(A) Human PRP was pre-incubated with buffer control or indicated concentrations of αIIbβ3 inhibitors, and then thrombin was added at 0.75&nbsp;U/mL to stimulate clot retraction. The tubes were imaged at 30 and 90&nbsp;min.</div><div id="fspara0235" role="paragraph">(B) Clot retraction was quantified with ImageJ and presented as 1&nbsp;− (clot area/whole reaction area). Data were fitted with the function of inhibitor versus response (three parameters) in Prism 8. Data are mean ± SD (n = 3).</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/dc64037e-e5e2-4bec-9f7f-82bbf37a2bcf/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2022.08.008/asset/f480ba12-6096-4ec7-9aa6-ac48f556bc1f/main.assets/figs6.jpg" height="575" width="657" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dc64037e-e5e2-4bec-9f7f-82bbf37a2bcf/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Influence of serum on the binding affinities of selected αIIbβ3 inhibitors, related to <a id="crosref1850" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0245" role="paragraph">(A) Binding affinity of αIIbβ3 WT expressed on transiently transfected Expi293F integrin α5 and αV knockout cells for FITC-echistatin determined by binding of 5&nbsp;nM Alexa647-MBC319.4 Fab in L15 medium supplemented with varying concentrations of serum. Binding curves were fitted to <a id="crosref1855" href="#fd3">Equation 3</a> for the binding affinity of FITC-echistatin at different serum concentrations. Errors were standard fitting errors from nonlinear least square fits.</div><div id="fspara0250" role="paragraph">(B and C) Competitive binding to measure the affinity of αIIbβ3 inhibitors. αIIbβ3 inhibitors at the indicated concentrations competed binding of FITC-echistatin at the concentration shown on the y axis to αIIbβ3 WT expressed on transiently transfected Expi293 α5 and αV KO cells. Mean fluorescence intensity (MFI) was determined by flow cytometry without washing.</div></div></div></div></figcaption></figure></div><div id="p0210" role="paragraph">An important pharmacologic property of drugs is binding to proteins in the blood stream such as serum albumin. Therefore, we measured the effect of serum on <i>K</i><sub><i>D</i></sub> values for a representative set of αIIbβ3 inhibitors (<a id="crosref1090" href="#fig7">Figures&nbsp;7</a>D and <a id="crosref1095" href="#figs6">S6</a>). In 95% serum, M-tirofiban and its isomer showed greatly decreased affinities of 80- and 70-fold, respectively, compared with much smaller decreases by other drugs, such as 1.8-fold by tirofiban. Clot retraction assays are done in the presence of plasma. These results explain the previous failure to find inhibition of clot retraction by M-tirofiban (<span class="dropBlock reference-citations"><a id="body-ref-sref1-3" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-3" aria-controls="sref1-3">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We confirmed that M-tirofiban inhibited platelet aggregation in whole blood (<a id="crosref1105" href="#fig7">Figure&nbsp;7</a>E).</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0215" role="paragraph">The previous obscurity of closure-stabilizing integrin inhibitors and the lack of any previous information on their mechanism of action is emphasized by a docking study in a prominent review (<span class="dropBlock reference-citations"><a id="body-ref-sref17-3" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-3" aria-controls="sref17-3">Cox et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Cox, D. ∙ Brennan, M. ∙ Moran, N.</div><div><strong>Integrins as therapeutic targets: lessons and opportunities</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2010; <strong>9</strong>:804-820</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd3266" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-77957363101" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20885411/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd3266&amp;pmid=20885411" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) which suggested that the UR-2922 carboxyl group was not in the αIIbβ3 binding pocket and thus could not coordinate with the MIDAS metal ion and induce the active conformation of αIIbβ3. Instead, our crystal structure and structure-function studies led to an unexpected conclusion. We discovered a general chemical mechanism by which closing inhibitors can harness water to stabilize the resting, closed conformation of integrins. Closing compounds must have polar atoms in precisely the correct position to hydrogen bond directly, or indirectly through a water molecule, to a specific MIDAS water molecule that must be expelled in order for the integrin to convert from the closed to the open conformation. Closing inhibitors have no potential for agonism since their binding does not induce integrin conformational change toward the open state. Additionally, and in contrast to both conformationally neutral RUC-4 and opening inhibitors, they stabilize the closed conformation by suppressing conformational change toward the active integrin state.</div><div id="p0220" role="paragraph">The relationship between affinity of ligand for integrin conformational states and the ability of ligand binding to alter the populations of these states obeys the laws of classical thermodynamics as previously demonstrated for integrins α4β1 and α5β1 (<span class="dropBlock reference-citations"><a id="body-ref-sref39-6" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-6" aria-controls="sref39-6">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-5" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-5" aria-controls="sref40-5">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Although the integrin field typically uses only antibodies specific for the extended or open states as reporters for integrin conformational change, we showed that, as predicted by ensemble theory, antibodies to the closed state can also be used as reporters. Several subtleties and implications of integrin ensembles and thermodynamics should be pointed out. Because the open conformation is not stable in the bent integrin conformation, drugs that stabilize opening and closing stabilize the extended and bent states, respectively, as shown explicitly here for integrin α4β1. Thus, the studies using Fabs to epitopes in extended αIIbβ3 in cellular assays in transfectants and platelets also reported the ability of compounds to stabilize the open or closed conformations. These Fab-based conformational measurements were in excellent agreement with explicit measurements of effects of compounds on opening of the headpiece by hydrodynamic radius in gel filtration and in crystal structures in Mg<sup>2+</sup> and Mn<sup>2+</sup>. RUC-2, a compound similar to RUC-4, was previously shown not to shift the elution of the αIIbβ3 headpiece in gel filtration or its structure in crystals, in agreement with its lack of effect on LIBS expression as confirmed here (<span class="dropBlock reference-citations"><a id="body-ref-sref86-3" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86-3" aria-controls="sref86-3">Zhu et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref86-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Zhu, J. ∙ Choi, W.-S. ∙ McCoy, J.G. ...</div><div><strong>Structure-guided design of a high affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg2+ binding to the MIDAS</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003576" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863375270" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As required by thermodynamics, the relative affinities of the compounds for WT and mutant, more open αIIbβ3 ensembles on transfectants also showed an excellent rank order correlation to ability to induce or suppress an extension-reporting epitope on transfectants and platelets. It appears to have been previously unappreciated in the integrin field that opening ligands can vary widely in their ability to induce LIBS, with closing ligands being an extreme example that suppress LIBS and perhaps warrant a change in nomenclature away from LIBS to name epitopes after the type of conformation they report. Equations and their graphical representation in <a id="crosref1130" href="#figs7">Figure&nbsp;S7</a> provide guidance on use of reporter antibodies and explain why opening inhibitors with stronger conformational preferences are stronger LIBS inducers. The chemical features that define opening propensity, i.e., affinity for the open relative to the closed conformation, are complex; however, the peptidomimetics eptifibatide, lotrafiban, tirofiban, and roxifiban were among the most strongly opening compounds.</div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/8f7391f7-853b-4562-8c25-1b10852a71e7/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2022.08.008/asset/57704890-f2c0-4336-ab2c-8208b04b01ff/main.assets/figs7.jpg" height="425" width="506" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/8f7391f7-853b-4562-8c25-1b10852a71e7/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Influence of inhibitors with varying preference for the open state on extension-stabilizing antibody epitope exposure, called in discussion and related to <a id="crosref1860" href="#fig5">Figures&nbsp;5</a>, <a id="crosref1865" href="#fig6">6</a>, and <a id="crosref1905" href="#fig7">7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0260" role="paragraph">(A) Equations for calculating the population of extended states of integrin (<i>P</i><sup><i>extended</i></sup>) in presence of inhibitors with different binding affinities to the closed (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript upper C" tabindex="0" ctxtmenu_counter="2" style="font-size: 130%;"><mjx-math data-semantic-structure="(4 (3 0 1) 2)" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="4" data-semantic-children="0,1,2" data-semantic-collapsed="(4 (3 0 1) 2)" data-semantic-owns="0 1 2" data-semantic-speech="upper K Subscript d Superscript upper C"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="4"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="4"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="4"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>,&nbsp;<i>inhibitor</i>) and EO (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript upper E upper O" tabindex="0" ctxtmenu_counter="3" style="font-size: 130%;"><mjx-math data-semantic-structure="(7 (6 0 1) (5 2 4 3))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="7" data-semantic-children="0,1,5" data-semantic-collapsed="(7 (6 0 1) 5)" data-semantic-owns="0 1 5" data-semantic-speech="upper K Subscript d Superscript upper E upper O"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="7"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:simple;clearspeak:unit" data-semantic-id="5" data-semantic-children="2,3" data-semantic-content="4" data-semantic-parent="7" data-semantic-owns="2 4 3" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="5"><mjx-c class="mjx-c1D438">𝐸</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="4" data-semantic-parent="5" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="5"><mjx-c class="mjx-c1D442">𝑂</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="7"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>, <i>inhibitor</i>) states.</div><div id="fspara0265" role="paragraph">(B) A scenario to explain why wild type and active mutant integrin αIIbβ3 show different sensitivities in inhibitor-induced LIBS antibody epitope exposure assays. Free energy values used for the BC, EC, and EO states of wild-type αIIBβ3 are −4, −1.8, and 0&nbsp;kcal/mol, respectively; free energy values used for the BC, EC, and EO states of active mutant are −1.2, −1.0, and 0&nbsp;kcal/mol, respectively, representing a 2.8&nbsp;kcal/mol destabilization of the closed states by the mutation.</div><div id="fspara0270" role="paragraph">Any conformation-specific antibody can be a LIBS reporter. However, antibodies must be used at concentrations near their EC<sub>50</sub> values to be sensitive LIBS reporters. It appears that many useful, high-affinity, conformation-specific antibodies are not used in the literature because the typical antibody-concentrations used by investigators, e.g. 10 µg/mL, are too high for high-affinity antibodies to report epitope exposure. All LIBS antibodies must be titrated to find the optimal concentration.</div></div></div></div></figcaption></figure></div><div id="p0225" role="paragraph">For comparison to small molecules, VCAM, a biological ligand for α4β1 was found to have &gt;1,900-fold higher affinity for the open than the closed conformation. This large difference, and that of 6,000-fold for α5β1 binding to fibronectin (<span class="dropBlock reference-citations"><a id="body-ref-sref40-6" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-6" aria-controls="sref40-6">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), contrast with the lower, but wide ranging, differences in affinity for open and closed states found among opening α4β1 inhibitors. Such comparisons will not be possible for αIIbβ3 inhibitors until methods are developed to obtain pure closed and open αIIbβ3 integrin states. However, the findings on α4β1 already raise the interesting possibility that the large affinity difference for biological ligands is an evolved trait that makes the integrin high and low-affinity states on and off-like.</div><div id="p0230" role="paragraph">Previously, lamifiban (Ro-44-9883) and sibrafiban (Ro 48-3657) were found not to induce LIBS epitopes on platelets in platelet-rich plasma (PRP) (<span class="dropBlock reference-citations"><a id="body-ref-sref8-3" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-3" aria-controls="sref8-3">Baba et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref8-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Baba, K. ∙ Aga, Y. ∙ Nakanishi, T. ...</div><div><strong>UR-3216: a manageable oral GPIIb/IIIa antagonist</strong></div><div><em>Cardiovasc. Drug Rev.</em> 2001; <strong>19</strong>:25-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1527-3466.2001.tb00181.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035066822" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11314599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1527-3466.2001.tb00181.x&amp;pmid=11314599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55-3" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-3" aria-controls="sref55-3">Murphy et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref55-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Murphy, N.P. ∙ Pratico, D. ∙ Fitzgerald, D.J.</div><div><strong>Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in&nbsp;vivo</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 1998; <strong>286</strong>:945-951</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=fulltext&amp;site=jpet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=pdf&amp;site=jpet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9694954/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0022-3565%2824%2937673-6&amp;pmid=9694954" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which could be consistent with differing assay sensitivities or a more activated αIIbβ3 ensemble on washed platelets than on platelets in PRP. Roche disclosed that it took lamifiban forward in clinical trials because of its potency and low induction of LIBS compared with other inhibitors (<span class="dropBlock reference-citations"><a id="body-ref-sref64-2" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-2" aria-controls="sref64-2">Scarborough and Gretler, 2000</a><div class="dropBlock__holder" data-db-target-of="sref64-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Scarborough, R.M. ∙ Gretler, D.D.</div><div><strong>Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2000; <strong>43</strong>:3453-3473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm000022w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034699501" target="_blank" aria-label="Open Scopus in new tab">Scopus (110)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10999999/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm000022w&amp;pmid=10999999" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0235" role="paragraph">Two academically developed drugs were interesting comparators. M-tirofiban has a large hydrophobic substituent relative to tirofiban that was designed to block movement of the βI domain toward the open state and was reported to not induce opening and to block thrombosis without inhibiting hemostasis or clot retraction (<span class="dropBlock reference-citations"><a id="body-ref-sref1-4" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-4" aria-controls="sref1-4">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We found that M-tirofiban showed a lesser preference for activated mutant αIIbβ3 than tirofiban but remained an opening compound, albeit a weak one, and induced statistically significant LIBS exposure both on activated mutant αIIbβ3 transfectants and thrombin-stimulated platelets. The original report showed LIBS exposure by ADP-stimulated platelets that was increased with M-tirofiban but did not reach significance (<span class="dropBlock reference-citations"><a id="body-ref-sref1-5" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-5" aria-controls="sref1-5">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); thrombin is a stronger platelet stimulator than ADP. The previous report tested only a single concentration of M-tirofiban, and a single, 10-fold lower concentration of tirofiban, for inhibition of clot retraction in 20% plasma (<span class="dropBlock reference-citations"><a id="body-ref-sref1-6" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-6" aria-controls="sref1-6">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, we found that in 20% serum, the apparent affinity of M-tirofiban is 175-fold lower than tirofiban and that M-tirofiban completely inhibited clot retraction at the appropriate concentration. The lower potency of M-tirofiban may result from binding of its bulky aromatic modification relative to tirofiban (<a id="crosref1170" href="#fig2">Figure&nbsp;2</a>) to hydrophobic binding sites on serum albumin. Our results also call into question the finding that hemostasis was significantly inhibited by tirofiban and not M-tirofiban at 10-fold higher doses in mice with 40% human platelets, since M-tirofiban is 470-fold lower in affinity than tirofiban in 95% serum. All other tested αIIbβ3 inhibitors have been found to inhibit hemostasis as well as thrombosis (<span class="dropBlock reference-citations"><a id="body-ref-sref64-3" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-3" aria-controls="sref64-3">Scarborough and Gretler, 2000</a><div class="dropBlock__holder" data-db-target-of="sref64-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Scarborough, R.M. ∙ Gretler, D.D.</div><div><strong>Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2000; <strong>43</strong>:3453-3473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm000022w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034699501" target="_blank" aria-label="Open Scopus in new tab">Scopus (110)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10999999/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm000022w&amp;pmid=10999999" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and no significant difference in relative potency of inhibition of platelet aggregation versus bleeding time was found between the closing inhibitor UR-2922, sibrafiban (which resembles M-tirofiban in its opening propensity), and xemilofiban, which is a stronger LIBS inducer (<span class="dropBlock reference-citations"><a id="body-ref-sref8-4" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-4" aria-controls="sref8-4">Baba et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref8-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Baba, K. ∙ Aga, Y. ∙ Nakanishi, T. ...</div><div><strong>UR-3216: a manageable oral GPIIb/IIIa antagonist</strong></div><div><em>Cardiovasc. Drug Rev.</em> 2001; <strong>19</strong>:25-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1527-3466.2001.tb00181.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035066822" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11314599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1527-3466.2001.tb00181.x&amp;pmid=11314599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Additionally, we find that M-tirofiban is less efficacious in inhibiting platelet aggregation in whole blood (IC<sub>50</sub> of 3,140 ± 1,040&nbsp;nM, 420-fold less potent than tirofiban) than originally reported (IC<sub>50</sub> of 18 ± 5&nbsp;nM, 13-fold less potent than tirofiban).</div><div id="p0240" role="paragraph">RUC-4 is an academically developed αIIbβ3 inhibitor in clinical trials for first point-of-care treatment of myocardial infarction (<span class="dropBlock reference-citations"><a id="body-ref-sref34-3" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-3" aria-controls="sref34-3">Kereiakes et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref34-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Kereiakes, D.J. ∙ Henry, T.D. ∙ DeMaria, A.N. ...</div><div><strong>First human use of RUC-4: A nonactivating second-generation small-molecule platelet glycoprotein IIb/IIIa (integrin αiibβ3) inhibitor designed for subcutaneous point-of-care treatment of ST-segment-elevation myocardial infarction</strong></div><div><em>J.&nbsp;Am. Heart Assoc.</em> 2020; <strong>9</strong>:e016552</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/JAHA.120.016552" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85090174407" target="_blank" aria-label="Open Scopus in new tab">Scopus (20)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32844723/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FJAHA.120.016552&amp;pmid=32844723" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref41-2" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41-2" aria-controls="sref41-2">Li et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref41-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Li, J. ∙ Vootukuri, S. ∙ Shang, Y. ...</div><div><strong>RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction</strong></div><div><em>Arterioscler. Thromb. Vasc. Biol.</em> 2014; <strong>34</strong>:2321-2329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/ATVBAHA.114.303724" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84913554789" target="_blank" aria-label="Open Scopus in new tab">Scopus (67)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25147334/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FATVBAHA.114.303724&amp;pmid=25147334" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Like the earlier described compound pentamidine (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Cox et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Cox, D. ∙ Aoki, T. ∙ Seki, J. ...</div><div><strong>Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist</strong></div><div><em>Thromb. Haemost.</em> 1996; <strong>75</strong>:503-509</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1055/s-0038-1650305" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0029987083" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8701416/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1055%2Fs-0038-1650305&amp;pmid=8701416" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), RUC compounds are specific αIIbβ3 inhibitors that lack a carboxyl group and do not induce LIBS epitopes or integrin headpiece opening (<span class="dropBlock reference-citations"><a id="body-ref-sref86-4" href="#" role="doc-biblioref" data-xml-rid="bib86" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref86-4" aria-controls="sref86-4">Zhu et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref86-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">86.</div><div>Zhu, J. ∙ Choi, W.-S. ∙ McCoy, J.G. ...</div><div><strong>Structure-guided design of a high affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg2+ binding to the MIDAS</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003576" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863375270" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). RUC-4 occupied a unique intermediate position in our study between opening and closing compounds as a conformationally neutral compound. It had equal affinity for WT and mutant activated αIIbβ3 transfectants and neither enhanced nor suppressed LIBS epitope exposure.</div><div id="p0245" role="paragraph">An aspirational goal in the integrin field has been to create small-molecule integrin inhibitors that do not induce integrin conformational change or activation. We now have taken this concept one step further, by discovering that closing compounds can suppress integrin opening by shifting the conformational ensemble toward the low-affinity closed states. This feature may offer additional clinical benefit. For example, platelets of patients with acute coronary syndrome are significantly more activated than healthy controls even after clinical stabilization (<span class="dropBlock reference-citations"><a id="body-ref-sref7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7" aria-controls="sref7">Ault et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Ault, K.A. ∙ Cannon, C.P. ∙ Mitchell, J. ...</div><div><strong>Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in myocardial infarction</strong></div><div><em>J.&nbsp;Am. Coll. Cardiol.</em> 1999; <strong>33</strong>:634-639</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0735-1097(98)00635-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0006870550" target="_blank" aria-label="Open Scopus in new tab">Scopus (254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10080462/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0735-1097%2898%2900635-4&amp;pmid=10080462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref19" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19" aria-controls="sref19">Davì and Patrono, 2007</a><div class="dropBlock__holder" data-db-target-of="sref19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Davì, G. ∙ Patrono, C.</div><div><strong>Platelet activation and atherothrombosis</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2007; <strong>357</strong>:2482-2494</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMra071014" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-37249068049" target="_blank" aria-label="Open Scopus in new tab">Scopus (1827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18077812/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMra071014&amp;pmid=18077812" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Fitzgerald et&nbsp;al., 1986</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Fitzgerald, D.J. ∙ Roy, L. ∙ Catella, F. ...</div><div><strong>Platelet activation in unstable coronary disease</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 1986; <strong>315</strong>:983-989</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJM198610163151602" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0022457212" target="_blank" aria-label="Open Scopus in new tab">Scopus (1051)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3531859/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJM198610163151602&amp;pmid=3531859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref74" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74" aria-controls="sref74">Trip et&nbsp;al., 1990</a><div class="dropBlock__holder" data-db-target-of="sref74"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Trip, M.D. ∙ Cats, V.M. ∙ van Capelle, F.J. ...</div><div><strong>Platelet hyperreactivity and prognosis in survivors of myocardial infarction</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 1990; <strong>322</strong>:1549-1554</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJM199005313222201" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0025280866" target="_blank" aria-label="Open Scopus in new tab">Scopus (562)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2336086/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJM199005313222201&amp;pmid=2336086" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, treatment of such patients with the αIIbβ3 inhibitor orbofiban increased αIIbβ3 conformational change, antibody-stimulated thromboxane B2 production, and CD63 expression (<span class="dropBlock reference-citations"><a id="body-ref-sref18-2" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18-2" aria-controls="sref18-2">Cox et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref18-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cox, D. ∙ Smith, R. ∙ Quinn, M. ...</div><div><strong>Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes</strong></div><div><em>J.&nbsp;Am. Coll. Cardiol.</em> 2000; <strong>36</strong>:1514-1519</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0735-1097(00)00919-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034332785" target="_blank" aria-label="Open Scopus in new tab">Scopus (109)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11079651/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0735-1097%2800%2900919-0&amp;pmid=11079651" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Many αIIbβ3 closing compounds with excellent drug-like properties are currently available. These include gantofiban, which entered phase II clinical trials, and UR-2922. Moreover, GR144053 is commercially available and has been used without knowledge of its closing property in animals with tissue plasminogen activator or losartan after thrombotic injury to suppress neointima formation (<span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Matsuno et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Matsuno, H. ∙ Kozawa, O. ∙ Niwa, M. ...</div><div><strong>GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster</strong></div><div><em>Br. J. Pharmacol.</em> 1997; <strong>122</strong>:1099-1104</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/sj.bjp.0701500" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0030781335" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9480031/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsj.bjp.0701500&amp;pmid=9480031" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" aria-label="Reference 1998" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">1998</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Matsuno, H. ∙ Kozawa, O. ∙ Niwa, M. ...</div><div><strong>Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster</strong></div><div><em>J.&nbsp;Cardiovasc. Pharmacol.</em> 1998; <strong>32</strong>:191-197</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/00005344-199808000-00004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0031828205" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9700979/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2F00005344-199808000-00004&amp;pmid=9700979" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0250" role="paragraph">Our results demonstrated that the phase II trial of firategrast in relapsing remitting multiple sclerosis was conducted with an opening inhibitor (<span class="dropBlock reference-citations"><a id="body-ref-sref48-3" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-3" aria-controls="sref48-3">Miller et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref48-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Miller, D.H. ∙ Weber, T. ∙ Grove, R. ...</div><div><strong>Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial</strong></div><div><em>Lancet Neurol.</em> 2012; <strong>11</strong>:131-139</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84856015884" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22226929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1474-4422%2811%2970299-X&amp;pmid=22226929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The significant increase in gadolinium-enhanced lesions at the lowest dose, lack of effect at the middle dose, and significant decrease at the highest dose are consistent with partial agonism. Drug blood concentrations were measured but not reported. This is unfortunate because we could have used the data reported here on firategrast binding affinity to cells and opening propensity to estimate at each drug concentration the percentage of drug-bound α4β1 and the percentage of α4β1 that transitioned from BC to extended and open conformations.</div><div id="p0255" role="paragraph">It is common for companies and academic investigators alike to measure the potency of integrin inhibitors and biological ligands in Mn<sup>2+</sup>. Mn<sup>2+</sup> increases affinity by two mechanisms: replacing Mg<sup>2+</sup> at the MIDAS increases integrin affinity independently of conformation, and replacing Ca<sup>2+</sup> at the adjacent to MIDAS (ADMIDAS) stabilizes the open conformation (<span class="dropBlock reference-citations"><a id="body-ref-sref5-2" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-2" aria-controls="sref5-2">Anderson et&nbsp;al., 2022</a><div class="dropBlock__holder" data-db-target-of="sref5-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Anderson, J.M. ∙ Li, J. ∙ Springer, T.A.</div><div><strong>Regulation of integrin α5β1 conformational states and intrinsic affinities by metal ions and the ADMIDAS</strong></div><div><em>Mol. Biol. Cell.</em> 2022; <strong>33</strong>:ar56</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1091/mbc.E21-11-0536" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85130633129" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/35108026/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1091%2Fmbc.E21-11-0536&amp;pmid=35108026" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The latter mechanism artefactually inflates the affinity of opening compared with closing inhibitors. Thus, we caution against using Mn<sup>2+</sup> to measure drug potency, which might have been one factor that influenced Daiiichi Sanko to put an α4β1 inhibitor into patients that based on its structure is opening (<span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Muro et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Muro, F. ∙ Iimura, S. ∙ Sugimoto, Y. ...</div><div><strong>Discovery of trans-4-[1-[[2, 5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2009; <strong>52</strong>:7974-7992</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm901154c" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-73249123942" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19891440/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm901154c&amp;pmid=19891440" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0260" role="paragraph">Many other closing compound scaffolds can be created based on the essential chemical features that we have established here. Compounds must have carboxyl groups and nearby polar atoms in positions to either accept a hydrogen bond from water 1 or donate a hydrogen bond to water 2. Water 1 in the UR-2922 structure is polarized because one of its hydrogens must orient toward the N atom in UR-2922 and one of its lone electron pairs must orient toward the MIDAS metal ion. Notably, hydrogen bond donation by the protonated piperazine or piperidine nitrogen in the other compound class to relay water 2 may result in the same proposed polarity of water 1 as deduced from first chemical principles from the UR-2922 structure. The importance of donating rather than accepting a hydrogen bond to water 2 is emphasized by comparison to sibrafiban and lamifiban. These opening inhibitors have an oxygen two atoms away from the carboxyl group, in the same position as the nitrogen in closing compounds such as BMS4 (<a id="crosref1255" href="#fig2">Figure&nbsp;2</a>); however, such an ether oxygen cannot donate a hydrogen bond. Not only are sibrafiban and lamifiban not closing but they also do not have a bound water 2, suggesting that proper hydrogen bond polarity is important for forming a water network around the MIDAS metal ion. In contrast to the ether oxygen, it might be possible to create a closing compound with a suitably positioned hydroxyl oxygen. Although the hydrogen bond donor for water 2 is in piperidine or piperazine rings in the structures identified here, linear structures or rings of other size also should be possible.</div><div id="p0265" role="paragraph">The integrin family may be divided into five subfamilies with distinct ligand specificities. Despite their distant relationship in different subfamilies, we were able to extend the discovery of closing compounds from integrin αIIbβ3 to integrin α4β1. Unlike αIIbβ3, α4β1 inhibitors to the best of our knowledge had not been examined for their ability to induce LIBS epitopes. Our ability to use the chemical principles we had discovered with αIIbβ3 to discover a closing inhibitor of α4β1 validates the generality of these principles. The DSXSX MIDAS motif is invariant in integrin β subunits. Furthermore, the movement of Ser<sub>2</sub> in this motif into the position of water 1 has been seen in all structurally characterized integrins, including the β3 integrins αIIbβ3 and αVβ3 (<span class="dropBlock reference-citations"><a id="body-ref-sref80-4" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-4" aria-controls="sref80-4">Xiao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref80-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Xiao, T. ∙ Takagi, J. ∙ Coller, B.S. ...</div><div><strong>Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics</strong></div><div><em>Nature.</em> 2004; <strong>432</strong>:59-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02976" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-8544259562" target="_blank" aria-label="Open Scopus in new tab">Scopus (718)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15378069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02976&amp;pmid=15378069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref81" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81" aria-controls="sref81">Xiong et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref81"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Xiong, J.P. ∙ Stehle, T. ∙ Zhang, R. ...</div><div><strong>Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand</strong></div><div><em>Science.</em> 2002; <strong>296</strong>:151-155</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1069040" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0037023363" target="_blank" aria-label="Open Scopus in new tab">Scopus (1461)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11884718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1069040&amp;pmid=11884718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref87-6" href="#" role="doc-biblioref" data-xml-rid="bib87" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref87-6" aria-controls="sref87-6">Zhu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref87-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">87.</div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the β1 integrins α5β1 and α6β1 (<span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Arimori et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Arimori, T. ∙ Miyazaki, N. ∙ Mihara, E. ...</div><div><strong>Structural mechanism of laminin recognition by integrin</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:4012</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-021-24184-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85109030424" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34188035/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-021-24184-8&amp;pmid=34188035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56" aria-controls="sref56">Nagae et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref56"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Nagae, M. ∙ Re, S. ∙ Mihara, E. ...</div><div><strong>Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2012; <strong>197</strong>:131-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201111077" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84860273145" target="_blank" aria-label="Open Scopus in new tab">Scopus (181)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22451694/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201111077&amp;pmid=22451694" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Schumacher et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Schumacher, S. ∙ Dedden, D. ∙ Nunez, R.V. ...</div><div><strong>Structural insights into integrin α5β1 opening by fibronectin ligand</strong></div><div><em>Sci. Adv.</em> 2021; <strong>7</strong>:eabe9716</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/sciadv.abe9716" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85105706612" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33962943/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fsciadv.abe9716&amp;pmid=33962943" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref79" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79" aria-controls="sref79">Xia and Springer, 2014</a><div class="dropBlock__holder" data-db-target-of="sref79"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Xia, W. ∙ Springer, T.A.</div><div><strong>Metal ion and ligand binding of integrin α5β1</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2014; <strong>111</strong>:17863-17868</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1420645111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84919363205" target="_blank" aria-label="Open Scopus in new tab">Scopus (76)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25475857/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1420645111&amp;pmid=25475857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the β2 integrin αXβ2 (<span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">Sen et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Sen, M. ∙ Yuki, K. ∙ Springer, T.A.</div><div><strong>An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>203</strong>:629-642</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201308083" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890230123" target="_blank" aria-label="Open Scopus in new tab">Scopus (76)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24385486/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201308083&amp;pmid=24385486" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the β6 integrin αVβ6 (<span class="dropBlock reference-citations"><a id="body-ref-sref21" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21" aria-controls="sref21">Dong et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Dong, X. ∙ Hudson, N.E. ∙ Lu, C. ...</div><div><strong>Structural determinants of integrin β-subunit specificity for latent TGF-β</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2014; <strong>21</strong>:1091-1096</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.2905" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84924179168" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25383667/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.2905&amp;pmid=25383667" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the β7 integrin α4β7 (<span class="dropBlock reference-citations"><a id="body-ref-sref83-1" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-1" aria-controls="sref83-1">Yu et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref83-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Yu, Y. ∙ Zhu, J. ∙ Mi, L.Z. ...</div><div><strong>Structural specializations of α4β7 an integrin that mediates rolling adhesion</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2012; <strong>196</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201110023" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863012638" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22232704/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201110023&amp;pmid=22232704" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and even in the atypical β8 integrin αVβ8 (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Campbell et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Campbell, M.G. ∙ Cormier, A. ∙ Ito, S. ...</div><div><strong>Cryo-EM reveals integrin-mediated TGF-β activation without release from latent TGF-β</strong></div><div><em>Cell.</em> 2020; <strong>180</strong>:490-501</div><div>e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2Fj.cell.2019.12.030&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2Fj.cell.2019.12.030&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078807979" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31955848/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.12.030&amp;pmid=31955848" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref75" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75" aria-controls="sref75">Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref75"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Wang, J. ∙ Su, Y. ∙ Iacob, R.E. ...</div><div><strong>General structural features that regulate integrin affinity revealed by atypical αVβ8</strong></div><div><em>Nat. Commun.</em> 2019; <strong>10</strong>:5481</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13248-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85075945737" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31792290/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13248-5&amp;pmid=31792290" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Thus, the general design principles reported here for building closure-stabilizing integrin inhibitors can serve to guide designs of antagonists for other integrins, many of which are currently being pursued in biopharma in challenging diseases including ulcerative colitis, fibrosis, and cancer. Closing integrin inhibitors should not have paradoxical activating effects since they not only potently block ligand binding but also stabilize the resting integrin conformation against activating stress. This property is distinct from their ability to inhibit ligand binding, which for both closing and opening inhibitors is controlled by their concentrations relative to their IC<sub>90</sub> values. The efficacy of closing inhibitors will need to be further tested in animal studies, as well as in clinical trials.</div><section id="sec-3-1"><h3>Limitations of the study</h3><div id="p0270" role="paragraph">The molecular mechanisms by which opening integrin inhibitors cause partial agonism remain to be fully defined. Many other factors besides partial agonism may have contributed to clinical failure of parenteral and oral integrin antagonists (<span class="dropBlock reference-citations"><a id="body-ref-sref3-3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-3" aria-controls="sref3-3">Aga et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref3-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Aga, Y. ∙ Baba, K. ∙ Tam, S. ...</div><div><strong>UR-3216: a new generation oral platelet GPIIb/IIIa antagonist</strong></div><div><em>Curr. Pharm. Des.</em> 2004; <strong>10</strong>:1597-1601</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2174/1381612043384592" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-2342443223" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15134558/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2174%2F1381612043384592&amp;pmid=15134558" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For αIIbβ3, these included the development of antibodies specific for the drug-integrin complex and the difficulty of achieving the desired percentage inhibition of αIIbβ3 in the face of short drug half-lives and causing bleeding at high αIIbβ3 inhibition. Such factors could also lead to the failure of closing antagonists. The ratios of affinities of inhibitors for WT and glycan wedge αIIbβ3 transfectants are for multi-state ensembles and underestimate the difference in affinity between the open and closed states of αIIbβ3. Intact integrins on the cell surface and ectodomain and headpiece fragments differ in free energy difference between open and closed conformations and therefore differ in sensitivity to the effects of opening and closing inhibitors on their conformations. Although we have established principles for creating closure-stabilizing inhibitors that should be applicable to all integrins, successful oral drugs require many other attributes. These include specificity, adsorption, resistance to metabolism and excretion, and long half-life. The breadth of chemical scaffolds that can hydrogen bond to stabilize water 1 directly or through water 2 is likely to be large and not to require that the hydrogen bonding moiety be in a ring but remains to be explored, and thus, the full scope for adding further desirable chemical features to closing compounds remains unknown.</div></section></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0275" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>12G10</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref51-1" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-1" aria-controls="sref51-1">Mould et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref51-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Mould, A.P. ∙ Garratt, A.N. ∙ Askari, J.A. ...</div><div><strong>Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit</strong></div><div><em>FEBS Lett.</em> 1995; <strong>363</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0014-5793(95)00301-O" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0028944308" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7537221/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0014-5793%2895%2900301-O&amp;pmid=7537221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Martin Humphries</td><td>Produced from hybridoma in lab</td></tr><tr><td>9EG7</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref35-1" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-1" aria-controls="sref35-1">Lenter et&nbsp;al., 1993</a><div class="dropBlock__holder" data-db-target-of="sref35-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Lenter, M. ∙ Uhlig, H. ∙ Hamann, A. ...</div><div><strong>A monoclonal antibody against an activation epitope on mouse integrin chain β1 blocks adhesion of lymphocytes to the endothelial integrin α6β1</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1993; <strong>90</strong>:9051-9055</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.90.19.9051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0027421094" target="_blank" aria-label="Open Scopus in new tab">Scopus (240)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7692444/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.90.19.9051&amp;pmid=7692444" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Dietmar Vestweber</td><td>Produced from hybridoma in lab</td></tr><tr><td>SG/19</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref50-1" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-1" aria-controls="sref50-1">Miyake et&nbsp;al., 1992</a><div class="dropBlock__holder" data-db-target-of="sref50-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Miyake, K. ∙ Hasunuma, Y. ∙ Yagita, H. ...</div><div><strong>Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>119</strong>:653-662</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.119.3.653" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0026730043" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1400595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.119.3.653&amp;pmid=1400595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Jun Takagi</td><td>Produced from hybridoma in lab</td></tr><tr><td>MBC319.4</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref85-3" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85-3" aria-controls="sref85-3">Zhang et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref85-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zhang, C. ∙ Liu, J. ∙ Jiang, X. ...</div><div><strong>Modulation of integrin activation and signaling by α1/α1'-helix unbending at the junction</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2013; <strong>126</strong>:5735-5747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.137828" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890487402" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24144695/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.137828&amp;pmid=24144695" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Richard Aster</td><td>Produced from hybridoma in lab</td></tr><tr><td>LIBS1</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref26-1" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-1" aria-controls="sref26-1">Frelinger et&nbsp;al., 1990</a><div class="dropBlock__holder" data-db-target-of="sref26-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Frelinger, A.L. ∙ Cohen, I. ∙ Plow, E.F. ...</div><div><strong>Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1990; <strong>265</strong>:6346-6352</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2819%2939332-9&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2819%2939332-9&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2318856/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2819%2939332-9&amp;pmid=2318856" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Mark Ginsberg</td><td>Produced from hybridoma in lab</td></tr><tr><td>AP5</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref33-1" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-1" aria-controls="sref33-1">Kekomaki et&nbsp;al., 1991</a><div class="dropBlock__holder" data-db-target-of="sref33-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Kekomaki, R. ∙ Dawson, B. ∙ McFarland, J. ...</div><div><strong>Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1991; <strong>88</strong>:847-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI115386" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0025938109" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1715887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI115386&amp;pmid=1715887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Antibody from Dan Bougie, Versiti</td><td>Cat#153747</td></tr><tr><td>HUTS4, HUTS-21</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref44-2" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-2" aria-controls="sref44-2">Luque et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref44-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Luque, A. ∙ Gómez, M. ∙ Puzon, W. ...</div><div><strong>Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common β1 chain</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1996; <strong>271</strong>:11067-11075</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-15844363687" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8626649/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.271.19.11067&amp;pmid=8626649" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Carlos Cabamas</td><td>Produced from hybridoma in lab</td></tr><tr><td>mAb16</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref4-1" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-1" aria-controls="sref4-1">Akiyama et&nbsp;al., 1989</a><div class="dropBlock__holder" data-db-target-of="sref4-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Akiyama, S.K. ∙ Yamada, S.S. ∙ Chen, W.T. ...</div><div><strong>Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1989; <strong>109</strong>:863-875</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.109.2.863" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0024359871" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2527241/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.109.2.863&amp;pmid=2527241" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)<br>Hybridoma from Kenneth Yamada</td><td>Produced from hybridoma in lab</td></tr><tr class="rowsep"><td>17E6</td><td>(<span class="dropBlock reference-citations"><a id="body-ref-sref49-1" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-1" aria-controls="sref49-1">Mitjans et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref49-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Mitjans, F. ∙ Sander, D. ∙ Adán, J. ...</div><div><strong>An anti-α v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice</strong></div><div><em>J.&nbsp;Cell Sci.</em> 1995; <strong>108</strong>:2825-2838</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.108.8.2825" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7593323/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.108.8.2825&amp;pmid=7593323" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) Antibody from Simon Goodman, Merck KGA</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>Thrombin</td><td>Sigma-Aldrich</td><td>Cat#10602400001</td></tr><tr><td>Prostaglandin E1</td><td>Sigma-Aldrich</td><td>Cat#P5515</td></tr><tr><td>FITC-echistatin</td><td>US Biological</td><td>Cat#E0256-01A.1</td></tr><tr><td>FITC-LDVP</td><td>Tocris Bioscience</td><td>Cat#4577</td></tr><tr><td>Alexa Fluor™ 647 NHS Ester</td><td>Thermo Fisher Scientific</td><td>Cat#A20006</td></tr><tr><td>Alexa Fluor™ 488 NHS Ester</td><td>Thermo Fisher Scientific</td><td>Cat#A20000</td></tr><tr><td>Dodecapeptide (HHLGGAKQAGDV)</td><td>Phoenix Pharmaceuticals</td><td>Cat#025-35</td></tr><tr><td>Tirofiban</td><td>Merck</td><td>CAS 144494-65-5</td></tr><tr><td>Eptifibatide</td><td>Sigma-Aldrich</td><td>SML1042; CAS 188627-80-7</td></tr><tr><td>Orbofiban (active form)</td><td>Pfizer</td><td>CAS 199530-77-3</td></tr><tr><td>Roxifiban (active form)</td><td>This paper</td><td>CAS 170725-15-2</td></tr><tr><td>Lotrafiban (active form)</td><td>This paper</td><td>CAS 171049-14-2</td></tr><tr><td>Lamifiban</td><td>Roche</td><td>CAS 144412-49-7</td></tr><tr><td>Sibrafiban (active form)</td><td>Roche</td><td>CAS 144412-18-0</td></tr><tr><td>Fradafiban (active form)</td><td>This paper</td><td>CAS 148396-36-5</td></tr><tr><td>EF-5154</td><td>Meiji Seika Pharma</td><td>CAS 177276-17-4</td></tr><tr><td>UR-2922</td><td>This paper</td><td>CAS 220386-56-1</td></tr><tr><td>BMS4</td><td>This paper</td><td>CAS 270593-59-4</td></tr><tr><td>BMS4-1</td><td>This paper</td><td>CAS 270088-90-9</td></tr><tr><td>BMS4-3</td><td>This paper</td><td>N/A</td></tr><tr><td>BMS4-2</td><td>This paper</td><td>CAS 270088-87-4</td></tr><tr><td>GR144058</td><td>Sigma-Aldrich</td><td>G6418; CAS 150040-23-6</td></tr><tr><td>Gantofiban</td><td>This paper</td><td>CAS 167364-04-7</td></tr><tr><td>Gantofiban analog</td><td>This paper</td><td>CAS 167364-14-9</td></tr><tr><td>RUC-4</td><td>Barry Coller</td><td>CAS 1448313-27-6</td></tr><tr><td>M-tirofiban (both isomers)</td><td>This paper</td><td>(S)-isomer: CAS 2410607-77-9;<br>(R)-isomer: N/A</td></tr><tr><td>Firategrast</td><td>Apexbio</td><td>Cat#A3415 CAS 402567-16-2</td></tr><tr><td>Ro 29</td><td>Roche</td><td>CAS 1421673-59-7</td></tr><tr><td>DS 13d</td><td>Tocris Bioscience</td><td>Cat#TCS 2314 CAS 317353-73-4</td></tr><tr class="rowsep"><td>DS 13g</td><td>This paper</td><td>CAS 819078-63-2</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited data</b></td></tr><tr><td>Drug-bound αIIbβ3 structures</td><td>This paper</td><td>PDB accession IDs for structures are in <a id="crosref1370" href="#mmc1">Table&nbsp;S1</a></td></tr><tr class="rowsep"><td>Drug-bound αIIbβ3 structure diffraction images</td><td>&nbsp;</td><td>SBGRID accession IDs for diffraction images are in <a id="crosref1375" href="#mmc1">Table&nbsp;S1</a>: <a id="intref0020" href="https://data.sbgrid.org/data/" target="_blank">https://data.sbgrid.org/data/</a></td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Cell lines</b></td></tr><tr><td>Jurkat</td><td>ATCC</td><td>Cat#TIB-152</td></tr><tr><td>Expi293F</td><td>Thermo Fisher Scientific</td><td>Cat# A14527</td></tr><tr><td>Expi293F α5&amp;αV knock-out cells</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>HEK293 expression αIIbβ3 with GAAKR mutant</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Luo et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Luo, B.H. ∙ Springer, T.A. ∙ Takagi, J.</div><div><strong>A specific interface between integrin transmembrane helices and affinity for ligand</strong></div><div><em>PLoS Biol.</em> 2004; <strong>2</strong>:e153</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pbio.0020153" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-16644396938" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15208712/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pbio.0020153&amp;pmid=15208712" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>PD2529 CAG αIIb full length</td><td>This paper</td><td>Addgene Plasmid #189796</td></tr><tr><td>PD2529 CAG β3 full length</td><td>This paper</td><td>Addgene Plasmid #189797</td></tr><tr><td>PD2529 CAG β3_N305T full length</td><td>This paper</td><td>Addgene Plasmid #189798</td></tr><tr class="rowsep"><td>pSpCas9n(BB)-2A-puro</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Ran et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Ran, F.A. ∙ Hsu, P.D. ∙ Wright, J. ...</div><div><strong>Genome engineering using the CRISPR-Cas9 system</strong></div><div><em>Nat. Protoc.</em> 2013; <strong>8</strong>:2281-2308</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2013.143" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84887010498" target="_blank" aria-label="Open Scopus in new tab">Scopus (7783)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24157548/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2013.143&amp;pmid=24157548" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>Addgene Plasmid #4814</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>Mathematica</td><td>Wolfram Mathematica version 12</td><td><a id="intref0025" href="https://www.wolfram.com/mathematica/" target="_blank">https://www.wolfram.com/mathematica/</a></td></tr><tr><td>Function F in <a id="crosref1390" href="#fd4">Equation 4</a> and its derivation</td><td>This paper</td><td>Mathematica file <a id="crosref1395" href="#fd4">Equation 4</a>.nb</td></tr><tr><td>Phenix</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref2-1" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-1" aria-controls="sref2-1">Adams et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref2-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>Phenix: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (18485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0030" href="http://www.phenix-online.org" target="_blank">http://www.phenix-online.org</a></td></tr><tr><td>XDS</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Kabsch, 2010</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Kabsch, W.</div><div><em>XDS. Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909047337" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-76449099287" target="_blank" aria-label="Open Scopus in new tab">Scopus (12932)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124692/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909047337&amp;pmid=20124692" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>xds.mpimf-heidelberg.mpg.de</td></tr><tr><td>COOT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Emsley et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0035" href="http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot" target="_blank">http://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot</a></td></tr><tr><td>Maestro, Prime, and Epik</td><td>Schrödinger Inc.</td><td><a id="intref0040" href="https://www.schrodinger.com" target="_blank">https://www.schrodinger.com</a></td></tr><tr><td>PyMOL</td><td>Schrödinger Inc.</td><td><a id="intref0045" href="https://pymol.org/2/" target="_blank">https://pymol.org/2/</a></td></tr><tr><td>SciFinder</td><td><a id="intref0050" href="https://scifinder-n.cas.org" target="_blank">https://scifinder-n.cas.org</a></td><td><a id="intref0055" href="https://scifinder-n.cas.org" target="_blank">https://scifinder-n.cas.org</a></td></tr><tr><td>Plot2</td><td>Apple Inc. App store</td><td><a id="intref0060" href="https://plotdoc.micw.org" target="_blank">https://plotdoc.micw.org</a></td></tr><tr><td>Prism9</td><td>GraphPad</td><td><a id="intref0065" href="https://www.graphpad.com/scientific-software/prism/" target="_blank">https://www.graphpad.com/scientific-software/prism/</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2822%2900995-3" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0280" role="paragraph"><div id="ulist0020" role="list"><div id="u0050" role="listitem"><div class="label">•</div><div class="content"><div id="p0285" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Timothy Springer (<a id="intref0070" href="mailto:springer@crystal.harvard.edu">springer@crystal.harvard.edu</a>).</div></div></div></div></div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0290" role="paragraph"><div id="ulist0025" role="list"><div id="u0055" role="listitem"><div class="label">•</div><div class="content"><div id="p0295" role="paragraph">Plasmids made in this study have been deposited at AddGene:<div id="ulist0125" role="list"><div id="u0060" role="listitem"><div class="label">○</div><div class="content"><div id="p0300" role="paragraph">PD2529 CAG αIIb full length: Addgene Plasmid #189796.</div></div></div><div id="u0065" role="listitem"><div class="label">○</div><div class="content"><div id="p0305" role="paragraph">PD2529 CAG β3 full length: Addgene Plasmid #189797.</div></div></div><div id="u0070" role="listitem"><div class="label">○</div><div class="content"><div id="p0310" role="paragraph">PD2529 CAG β3_N305T full length: Addgene Plasmid #189798.</div></div></div></div></div></div></div><div id="u0075" role="listitem"><div class="label">•</div><div class="content"><div id="p0315" role="paragraph">Compounds can be made by following the published synthetic procedures.</div></div></div><div id="u0080" role="listitem"><div class="label">•</div><div class="content"><div id="p0320" role="paragraph">Other materials are available from the <a id="crosref1415" href="#sec-4-2-1">lead contact</a>.</div></div></div></div></div></section></section><section id="sec-4-3"><h3>Experimental Model and Subject Details</h3><div id="p0325" role="paragraph"><div id="ulist0030" role="list"><div id="u0085" role="listitem"><div class="label">•</div><div class="content"><div id="p0330" role="paragraph">Cell lines were tested for mycoplasma every 60&nbsp;days and were not authenticated.</div></div></div></div></div></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Preparation of integrin headpiece samples</h4><div id="p0335" role="paragraph">Expression and purification of αIIbβ3 headpiece was as described (<span class="dropBlock reference-citations"><a id="body-ref-sref80-5" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-5" aria-controls="sref80-5">Xiao et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref80-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Xiao, T. ∙ Takagi, J. ∙ Coller, B.S. ...</div><div><strong>Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics</strong></div><div><em>Nature.</em> 2004; <strong>432</strong>:59-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02976" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-8544259562" target="_blank" aria-label="Open Scopus in new tab">Scopus (718)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15378069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02976&amp;pmid=15378069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref88-1" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-1" aria-controls="sref88-1">Zhu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref88-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Zhu, J. ∙ Zhu, J. ∙ Negri, A. ...</div><div><strong>Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening</strong></div><div><em>Blood.</em> 2010; <strong>116</strong>:5050-5059</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2010-04-281154" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-78649747986" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2010-04-281154&amp;pmid=20679525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The α4 construct contains the β-propeller and thigh domains, from residue Y1 to R587, with a R558A mutation to eliminate a furin cleavage site in the thigh domain (<span class="dropBlock reference-citations"><a id="body-ref-sref83-2" href="#" role="doc-biblioref" data-xml-rid="bib83" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref83-2" aria-controls="sref83-2">Yu et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref83-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">83.</div><div>Yu, Y. ∙ Zhu, J. ∙ Mi, L.Z. ...</div><div><strong>Structural specializations of α4β7 an integrin that mediates rolling adhesion</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2012; <strong>196</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201110023" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863012638" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22232704/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201110023&amp;pmid=22232704" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The α4 headpiece cDNA fused with a tobacco etch virus (TEV) cleavage site, an ACID coiled-coil, and a StrepII tag was inserted into the pcDNA3.1/Hygro vector. The β1 construct contains PSI, hybrid, βI, and EGF1 domains, from Q1 to E481. The β1 headpiece cDNA fused with a TEV site, a BASE coiled-coil, and a His6 Tag was inserted into the pEF1/Puro vector. The α4β1 headpiece construct was stably expressed in CHO lec 3.2.1.8 cells. Culture supernatant was concentrated and buffer exchanged to TBS buffer (20&nbsp;mM Tris, 150&nbsp;mM NaCl, pH 7.4) using a tangential flow concentrator. The α4β1 headpiece was purified using a Ni-NTA column followed by a Strep-Tactin column. The coiled-coils and tags were then removed by TEV digestion as described (<span class="dropBlock reference-citations"><a id="body-ref-sref82" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82" aria-controls="sref82">Yu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref82"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Yu, Y. ∙ Schürpf, T. ∙ Springer, T.A.</div><div><strong>How natalizumab binds and antagonizes α4 integrins</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2013; <strong>288</strong>:32314-32325</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M113.501668&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M113.501668&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84887434165" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24047894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M113.501668&amp;pmid=24047894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but without the presence of Fab. Finally, the α4β1 headpiece was subjected to Superdex 200 chromatography in TBS buffer with 1&nbsp;mM Mg<sup>2+</sup> and 1&nbsp;mM Ca<sup>2+</sup>.</div></section><section id="sec-4-4-2"><h4>Measuring drug-induced integrin headpiece opening by size-exclusion chromatography</h4><div id="p0340" role="paragraph">For size-exclusion chromatography of αIIbβ3 headpiece, a Superdex 200 column was equilibrated with 10&nbsp;μM of inhibitor in HEPES buffered saline (HBS) plus either 1&nbsp;mM Mg<sup>2+</sup>, 1&nbsp;mM Ca<sup>2+</sup> or 2&nbsp;mM Mn<sup>2+</sup>, 0.2mM Ca<sup>2+</sup>. The αIIbβ3 headpiece samples (30&nbsp;μg) were pre-incubated with 60&nbsp;μM of drug in corresponding buffers for 30&nbsp;minutes at room temperature prior to chromatography. R<sub>h</sub> values were calculated from peak elution volumes using ovalbumin, BSA, catalase, and aldolase as standards of known R<sub>h</sub> (<span class="dropBlock reference-citations"><a id="body-ref-sref88-2" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-2" aria-controls="sref88-2">Zhu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref88-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Zhu, J. ∙ Zhu, J. ∙ Negri, A. ...</div><div><strong>Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening</strong></div><div><em>Blood.</em> 2010; <strong>116</strong>:5050-5059</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2010-04-281154" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-78649747986" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2010-04-281154&amp;pmid=20679525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Conditions were identical for α4β1 headpiece, except a Zenix-C SEC300 size-exclusion column (Sepax Technologies, Newark, DE) was used, 10&nbsp;μg of α4β1 headpiece was used, and data was from 3 or more runs.</div></section><section id="sec-4-4-3"><h4>Crystallization of closed αIIbβ3 headpiece, compound soaking, and structure determination</h4><div id="p0345" role="paragraph">Expression and crystallization of αIIbβ3 headpiece-10E5 Fab complex in the closed conformation was as reported (<span class="dropBlock reference-citations"><a id="body-ref-sref88-3" href="#" role="doc-biblioref" data-xml-rid="bib88" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref88-3" aria-controls="sref88-3">Zhu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref88-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">88.</div><div>Zhu, J. ∙ Zhu, J. ∙ Negri, A. ...</div><div><strong>Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening</strong></div><div><em>Blood.</em> 2010; <strong>116</strong>:5050-5059</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2010-04-281154" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-78649747986" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2010-04-281154&amp;pmid=20679525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Prior to compound soaking, headpiece crystals were stabilized at a higher PEG concentration (15% PEG 8000, 0.2&nbsp;M ammonium sulfate, 0.1M Tris-HCl, pH 8.9), and glycerol was added in 5% increments to 15%. Compound was added (0.1-1&nbsp;mM; see <a id="crosref1450" href="#mmc1">Table&nbsp;S1</a>) together with 1&nbsp;mM MgCl<sub>2</sub> and 1&nbsp;mM CaCl<sub>2</sub> or 2&nbsp;mM MnCl<sub>2</sub> and 0.2&nbsp;mM CaCl<sub>2</sub>, in the final cryo increment to 20% glycerol. After 4&nbsp;h crystals were plunge frozen in liquid N<sub>2</sub>. Diffraction data was collected in GM/CA-CAT at APS. Refinements were with Phenix (<span class="dropBlock reference-citations"><a id="body-ref-sref2-2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-2" aria-controls="sref2-2">Adams et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref2-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>Phenix: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (18485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Ligand geometry and protonation states were calculated using Prime (with OPLS2005 force field) and Epik packages from Schrödinger (New York, NY). Geometry-optimized (with hydrogens) ligand coordinates were input to eLBOW (<span class="dropBlock reference-citations"><a id="body-ref-sref2-3" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-3" aria-controls="sref2-3">Adams et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref2-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>Phenix: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (18485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to generate restraint files for Phenix refinement. Ligands were manually fit to initial F<sub>o</sub>-F<sub>c</sub> difference maps using Coot and complexes were further refined.</div></section><section id="sec-4-4-4"><h4>Antibodies</h4><div id="p0350" role="paragraph">Hybridomas were AP3 (<span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Newman et&nbsp;al., 1985</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Newman, P.J. ∙ Allen, R.W. ∙ Kahn, R.A. ...</div><div><strong>Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3</strong></div><div><em>Blood.</em> 1985; <strong>65</strong>:227-232</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood.V65.1.227.227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3155488/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood.V65.1.227.227&amp;pmid=3155488" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), AP5 (<span class="dropBlock reference-citations"><a id="body-ref-sref33-2" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33-2" aria-controls="sref33-2">Kekomaki et&nbsp;al., 1991</a><div class="dropBlock__holder" data-db-target-of="sref33-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Kekomaki, R. ∙ Dawson, B. ∙ McFarland, J. ...</div><div><strong>Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1991; <strong>88</strong>:847-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI115386" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0025938109" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1715887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI115386&amp;pmid=1715887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), LIBS1 (<span class="dropBlock reference-citations"><a id="body-ref-sref26-2" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-2" aria-controls="sref26-2">Frelinger et&nbsp;al., 1990</a><div class="dropBlock__holder" data-db-target-of="sref26-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Frelinger, A.L. ∙ Cohen, I. ∙ Plow, E.F. ...</div><div><strong>Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1990; <strong>265</strong>:6346-6352</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2819%2939332-9&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2819%2939332-9&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2318856/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2819%2939332-9&amp;pmid=2318856" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), MBC319.4 (<span class="dropBlock reference-citations"><a id="body-ref-sref85-4" href="#" role="doc-biblioref" data-xml-rid="bib85" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref85-4" aria-controls="sref85-4">Zhang et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref85-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">85.</div><div>Zhang, C. ∙ Liu, J. ∙ Jiang, X. ...</div><div><strong>Modulation of integrin activation and signaling by α1/α1'-helix unbending at the junction</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2013; <strong>126</strong>:5735-5747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.137828" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890487402" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24144695/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.137828&amp;pmid=24144695" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), 12G10 (<span class="dropBlock reference-citations"><a id="body-ref-sref51-2" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51-2" aria-controls="sref51-2">Mould et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref51-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Mould, A.P. ∙ Garratt, A.N. ∙ Askari, J.A. ...</div><div><strong>Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit</strong></div><div><em>FEBS Lett.</em> 1995; <strong>363</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0014-5793(95)00301-O" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0028944308" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7537221/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0014-5793%2895%2900301-O&amp;pmid=7537221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), 9EG7 (<span class="dropBlock reference-citations"><a id="body-ref-sref35-2" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-2" aria-controls="sref35-2">Lenter et&nbsp;al., 1993</a><div class="dropBlock__holder" data-db-target-of="sref35-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Lenter, M. ∙ Uhlig, H. ∙ Hamann, A. ...</div><div><strong>A monoclonal antibody against an activation epitope on mouse integrin chain β1 blocks adhesion of lymphocytes to the endothelial integrin α6β1</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1993; <strong>90</strong>:9051-9055</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.90.19.9051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0027421094" target="_blank" aria-label="Open Scopus in new tab">Scopus (240)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7692444/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.90.19.9051&amp;pmid=7692444" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), SG/19 (<span class="dropBlock reference-citations"><a id="body-ref-sref50-2" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-2" aria-controls="sref50-2">Miyake et&nbsp;al., 1992</a><div class="dropBlock__holder" data-db-target-of="sref50-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Miyake, K. ∙ Hasunuma, Y. ∙ Yagita, H. ...</div><div><strong>Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>119</strong>:653-662</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.119.3.653" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0026730043" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1400595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.119.3.653&amp;pmid=1400595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), HUTS4 and HUTS-21 (<span class="dropBlock reference-citations"><a id="body-ref-sref44-3" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44-3" aria-controls="sref44-3">Luque et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref44-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Luque, A. ∙ Gómez, M. ∙ Puzon, W. ...</div><div><strong>Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common β1 chain</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1996; <strong>271</strong>:11067-11075</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-15844363687" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8626649/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.271.19.11067&amp;pmid=8626649" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and mAb16 (<span class="dropBlock reference-citations"><a id="body-ref-sref4-2" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-2" aria-controls="sref4-2">Akiyama et&nbsp;al., 1989</a><div class="dropBlock__holder" data-db-target-of="sref4-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Akiyama, S.K. ∙ Yamada, S.S. ∙ Chen, W.T. ...</div><div><strong>Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1989; <strong>109</strong>:863-875</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.109.2.863" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0024359871" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2527241/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.109.2.863&amp;pmid=2527241" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). IgG produced from hybridoma was purified by protein G. For Fab fragments, antibodies were digested with papain (500:1 IgG:papain) in PBS with 10&nbsp;mM EDTA and 10&nbsp;mM L-Cys at 37°C for 18 h. After buffer exchange with 50&nbsp;mM Tris (pH 9), the Fab was purified by anion exchange chromatography (HiTrap Q HP, GE Healthcare), after which the fractions containing Fab were concentrated, flash frozen, and stored at -80°C for future use. Antibodies and Fabs were fluorescently labeled with Alexa Fluor 647 NHS Ester or Alexa Fluor 488 NHS Ester (ThermoFisher Scientific) in PBS.</div></section><section id="sec-4-4-5"><h4>Quantitative fluorescent flow cytometry for α4β1 inhibitor affinity and conformational preference measurements</h4><div id="p0355" role="paragraph">Jurkat cells (10<sup>6</sup> cells/ml in RPMI-1640 medium and 10% FBS) were washed twice with assay medium (Leibovitz’s L-15 medium and 1% BSA) containing 5&nbsp;mM EDTA, twice with assay medium alone, and resuspended in assay medium. For competitive binding experiments, each 50-μl sample contained 10<sup>6</sup> cells/ml, the indicated concentration of FITC-LDVP (Tocris Bioscience), the indicated Fabs, and varying concentrations of α4β1 inhibitors or VCAM D1D2 (<span class="dropBlock reference-citations"><a id="body-ref-sref39-7" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-7" aria-controls="sref39-7">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) in assay medium. For LIBS antibody epitope exposure assays, each 50-μl sample contained 10<sup>6</sup> cells/ml, the indicated concentration of fluorescently labeled antibody or Fab, and indicated concentrations of α4β1 inhibitors. Mixtures were allowed to equilibrate at 22°C for 2&nbsp;h before flow cytometry (BD FAC SCanto II) without washing (<span class="dropBlock reference-citations"><a id="body-ref-sref39-8" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-8" aria-controls="sref39-8">Li and Springer, 2018</a><div class="dropBlock__holder" data-db-target-of="sref39-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40-7" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40-7" aria-controls="sref40-7">Li et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref40-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Binding of FITC-LDVP or fluorescently labeled LIBS antibodies were measured as mean fluorescence intensity (<i>MFI</i><sub>obs</sub>) at each indicated inhibitor concentration (<i>C</i><sub>inhibitor</sub>). Competitive binding curves and LIBS antibody exposure curves were both fitted with a 3-parameter dose response curve (<a id="crosref1525" href="#fd1">Equation 1</a>) with MFI in absence of inhibitor (<i>MFI</i><sub>0</sub>), MFI at saturating concentration of inhibitor (<i>MFI</i><sub>sat</sub>), and half maximal effective concentration of the inhibitor (EC<sub>50</sub>), as fitting parameters. Affinity of inhibitors (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r" tabindex="0" ctxtmenu_counter="4" style="font-size: 130%;"><mjx-math data-semantic-structure="(21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>) was derived (<a id="crosref1530" href="#fd2">Equation 2</a>) from the fitted EC<sub>50</sub> value in competitive binding curve, the concentration of FITC-LDVP probe (<i>C</i><sub>LDVP</sub>), and the binding affinity of the FITC-LDVP probe ( <mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript upper L upper D upper V upper P" tabindex="0" ctxtmenu_counter="5" style="font-size: 130%;"><mjx-math data-semantic-structure="(11 (10 0 1) (9 2 6 3 7 4 8 5))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="11" data-semantic-children="0,1,9" data-semantic-collapsed="(11 (10 0 1) 9)" data-semantic-owns="0 1 9" data-semantic-speech="upper K Subscript d Superscript upper L upper D upper V upper P"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="11"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="9" data-semantic-children="2,3,4,5" data-semantic-content="6,7,8" data-semantic-parent="11" data-semantic-owns="2 6 3 7 4 8 5" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="9"><mjx-c class="mjx-c1D43F">𝐿</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="6" data-semantic-parent="9" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="9"><mjx-c class="mjx-c1D437">𝐷</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="7" data-semantic-parent="9" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="9"><mjx-c class="mjx-c1D449">𝑉</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="8" data-semantic-parent="9" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="9"><mjx-c class="mjx-c1D443">𝑃</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="11"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container> ). Error for <mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r" tabindex="0" ctxtmenu_counter="6" style="font-size: 130%;"><mjx-math data-semantic-structure="(21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container> was propagated from the errors of EC<sub>50</sub> and <mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript upper L upper D upper V upper P" tabindex="0" ctxtmenu_counter="7" style="font-size: 130%;"><mjx-math data-semantic-structure="(11 (10 0 1) (9 2 6 3 7 4 8 5))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="11" data-semantic-children="0,1,9" data-semantic-collapsed="(11 (10 0 1) 9)" data-semantic-owns="0 1 9" data-semantic-speech="upper K Subscript d Superscript upper L upper D upper V upper P"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="11"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="9" data-semantic-children="2,3,4,5" data-semantic-content="6,7,8" data-semantic-parent="11" data-semantic-owns="2 6 3 7 4 8 5" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="9"><mjx-c class="mjx-c1D43F">𝐿</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="6" data-semantic-parent="9" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="9"><mjx-c class="mjx-c1D437">𝐷</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="7" data-semantic-parent="9" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="9"><mjx-c class="mjx-c1D449">𝑉</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="8" data-semantic-parent="9" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="9"><mjx-c class="mjx-c1D443">𝑃</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="11"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>.<div id="fd1" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper M upper F upper I Subscript o b s Baseline equals upper M upper F upper I 0 minus StartFraction upper M upper F upper I 0 minus upper M upper F upper I Subscript s a t Baseline Over 1 plus upper E upper C 50 divided by upper C Subscript i n h i b i t o r Baseline EndFraction" tabindex="0" ctxtmenu_counter="8" style="font-size: 130%;"><mjx-math data-semantic-structure="(79 (74 0 72 1 73 (9 2 (8 3 6 4 7 5))) 10 (78 (77 11 75 12 76 (15 13 14)) 16 (71 (39 (35 17 33 18 34 (21 19 20)) 22 (38 23 36 24 37 (32 25 (31 26 29 27 30 28)))) (69 40 41 (70 (68 42 67 (45 43 44)) 46 (66 47 (65 48 57 49 58 50 59 51 60 52 61 53 62 54 63 55 64 56)))))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="79" data-semantic-children="74,78" data-semantic-content="10" data-semantic-owns="74 10 78" data-semantic-speech="upper M upper F upper I Subscript o b s Baseline equals upper M upper F upper I 0 minus StartFraction upper M upper F upper I 0 minus upper M upper F upper I Subscript s a t Baseline Over 1 plus upper E upper C 50 divided by upper C Subscript i n h i b i t o r Baseline EndFraction"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="74" data-semantic-children="0,1,9" data-semantic-content="72,73" data-semantic-parent="79" data-semantic-owns="0 72 1 73 9"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="74"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="72" data-semantic-parent="74" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="74"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="73" data-semantic-parent="74" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="9" data-semantic-children="2,8" data-semantic-parent="74" data-semantic-owns="2 8"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="9"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="8" data-semantic-children="3,4,5" data-semantic-content="6,7" data-semantic-parent="9" data-semantic-owns="3 6 4 7 5"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="8"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="6" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="8"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="7" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="8"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="10" data-semantic-parent="79" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="subtraction" data-semantic-id="78" data-semantic-children="77,71" data-semantic-content="16" data-semantic-parent="79" data-semantic-owns="77 16 71"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="77" data-semantic-children="11,12,15" data-semantic-content="75,76" data-semantic-parent="78" data-semantic-owns="11 75 12 76 15"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="77"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="75" data-semantic-parent="77" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="12" data-semantic-parent="77"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="76" data-semantic-parent="77" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="15" data-semantic-children="13,14" data-semantic-parent="77" data-semantic-owns="13 14"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="13" data-semantic-parent="15"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="14" data-semantic-parent="15"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="subtraction" data-semantic-id="16" data-semantic-parent="78" data-semantic-operator="infixop,−"><mjx-c class="mjx-c2212">−</mjx-c></mjx-mo><mjx-mfrac space="3" data-semantic-type="fraction" data-semantic-role="division" data-semantic-id="71" data-semantic-children="39,69" data-semantic-parent="78" data-semantic-owns="39 69"><mjx-frac><mjx-num><mjx-nstrut></mjx-nstrut><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="subtraction" data-semantic-id="39" data-semantic-children="35,38" data-semantic-content="22" data-semantic-parent="71" data-semantic-owns="35 22 38"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="35" data-semantic-children="17,18,21" data-semantic-content="33,34" data-semantic-parent="39" data-semantic-owns="17 33 18 34 21"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="17" data-semantic-parent="35"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="33" data-semantic-parent="35" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="18" data-semantic-parent="35"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="34" data-semantic-parent="35" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="19,20" data-semantic-parent="35" data-semantic-owns="19 20"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="19" data-semantic-parent="21"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="20" data-semantic-parent="21"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="subtraction" data-semantic-id="22" data-semantic-parent="39" data-semantic-operator="infixop,−"><mjx-c class="mjx-c2212">−</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="38" data-semantic-children="23,24,32" data-semantic-content="36,37" data-semantic-parent="39" data-semantic-owns="23 36 24 37 32"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="38"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="36" data-semantic-parent="38" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="38"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="37" data-semantic-parent="38" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="32" data-semantic-children="25,31" data-semantic-parent="38" data-semantic-owns="25 31"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="32"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="31" data-semantic-children="26,27,28" data-semantic-content="29,30" data-semantic-parent="32" data-semantic-owns="26 29 27 30 28"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="31"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="29" data-semantic-parent="31" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="31"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="30" data-semantic-parent="31" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="31"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-num><mjx-dbox><mjx-dtable><mjx-line></mjx-line><mjx-row><mjx-den><mjx-dstrut></mjx-dstrut><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="addition" data-semantic-id="69" data-semantic-children="40,70" data-semantic-content="41" data-semantic-parent="71" data-semantic-owns="40 41 70"><mjx-mn data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="40" data-semantic-parent="69"><mjx-c class="mjx-c31">1</mjx-c></mjx-mn><mjx-mo data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="41" data-semantic-parent="69" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="70" data-semantic-children="68,66" data-semantic-content="46" data-semantic-parent="69" data-semantic-owns="68 46 66"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="68" data-semantic-children="42,45" data-semantic-content="67" data-semantic-parent="70" data-semantic-owns="42 67 45"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="42" data-semantic-parent="68"><mjx-c class="mjx-c1D438">𝐸</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="67" data-semantic-parent="68" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="45" data-semantic-children="43,44" data-semantic-parent="68" data-semantic-owns="43 44"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="43" data-semantic-parent="45"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="44" data-semantic-parent="45"><mjx-c class="mjx-c35" noic="true" style="padding-top: 0.666em;">5</mjx-c><mjx-c class="mjx-c30" style="padding-top: 0.666em;">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="46" data-semantic-parent="70" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="66" data-semantic-children="47,65" data-semantic-parent="70" data-semantic-owns="47 65"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="47" data-semantic-parent="66"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="65" data-semantic-children="48,49,50,51,52,53,54,55,56" data-semantic-content="57,58,59,60,61,62,63,64" data-semantic-parent="66" data-semantic-owns="48 57 49 58 50 59 51 60 52 61 53 62 54 63 55 64 56"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="48" data-semantic-parent="65"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="57" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="49" data-semantic-parent="65"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="58" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="50" data-semantic-parent="65"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="59" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="51" data-semantic-parent="65"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="60" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="52" data-semantic-parent="65"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="61" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="53" data-semantic-parent="65"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="62" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="54" data-semantic-parent="65"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="63" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="55" data-semantic-parent="65"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="64" data-semantic-parent="65" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="56" data-semantic-parent="65"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-den></mjx-row></mjx-dtable></mjx-dbox></mjx-frac></mjx-mfrac></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 1)</div></div><div id="fd2" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r Baseline equals upper E upper C 50 divided by left parenthesis 1 plus upper C Subscript upper L upper D upper V upper P Baseline divided by upper K Subscript d Superscript upper L upper D upper V upper P Baseline right parenthesis" tabindex="0" ctxtmenu_counter="9" style="font-size: 130%;"><mjx-math data-semantic-structure="(61 (21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10)) 22 (60 (59 23 58 (26 24 25)) 27 (57 28 (54 29 30 (55 (40 31 (39 32 36 33 37 34 38 35)) 41 (53 (52 42 43) (51 44 48 45 49 46 50 47)))) 56)))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="61" data-semantic-children="21,60" data-semantic-content="22" data-semantic-owns="21 22 60" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r Baseline equals upper E upper C 50 divided by left parenthesis 1 plus upper C Subscript upper L upper D upper V upper P Baseline divided by upper K Subscript d Superscript upper L upper D upper V upper P Baseline right parenthesis"><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-parent="61" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="22" data-semantic-parent="61" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="60" data-semantic-children="59,57" data-semantic-content="27" data-semantic-parent="61" data-semantic-owns="59 27 57"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="59" data-semantic-children="23,26" data-semantic-content="58" data-semantic-parent="60" data-semantic-owns="23 58 26"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="59"><mjx-c class="mjx-c1D438">𝐸</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="58" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="26" data-semantic-children="24,25" data-semantic-parent="59" data-semantic-owns="24 25"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="26"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="26"><mjx-c class="mjx-c35" noic="true" style="padding-top: 0.666em;">5</mjx-c><mjx-c class="mjx-c30" style="padding-top: 0.666em;">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="27" data-semantic-parent="60" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-mrow space="2" data-semantic-type="fenced" data-semantic-role="leftright" data-semantic-id="57" data-semantic-children="54" data-semantic-content="28,56" data-semantic-parent="60" data-semantic-owns="28 54 56"><mjx-mo data-semantic-type="fence" data-semantic-role="open" data-semantic-id="28" data-semantic-parent="57" data-semantic-operator="fenced"><mjx-c class="mjx-c28 MM-SO">(</mjx-c></mjx-mo><mjx-mrow data-semantic-type="infixop" data-semantic-role="addition" data-semantic-id="54" data-semantic-children="29,55" data-semantic-content="30" data-semantic-parent="57" data-semantic-owns="29 30 55"><mjx-mn data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="54"><mjx-c class="mjx-c31">1</mjx-c></mjx-mn><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="30" data-semantic-parent="54" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-mrow space="3" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="55" data-semantic-children="40,53" data-semantic-content="41" data-semantic-parent="54" data-semantic-owns="40 41 53"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="40" data-semantic-children="31,39" data-semantic-parent="55" data-semantic-owns="31 39"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="31" data-semantic-parent="40"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="39" data-semantic-children="32,33,34,35" data-semantic-content="36,37,38" data-semantic-parent="40" data-semantic-owns="32 36 33 37 34 38 35"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="32" data-semantic-parent="39"><mjx-c class="mjx-c1D43F">𝐿</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="36" data-semantic-parent="39" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="33" data-semantic-parent="39"><mjx-c class="mjx-c1D437">𝐷</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="37" data-semantic-parent="39" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="34" data-semantic-parent="39"><mjx-c class="mjx-c1D449">𝑉</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="38" data-semantic-parent="39" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="35" data-semantic-parent="39"><mjx-c class="mjx-c1D443">𝑃</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="41" data-semantic-parent="55" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="53" data-semantic-children="42,43,51" data-semantic-parent="55" data-semantic-collapsed="(53 (52 42 43) 51)" data-semantic-owns="42 43 51"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="42" data-semantic-parent="53"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="51" data-semantic-children="44,45,46,47" data-semantic-content="48,49,50" data-semantic-parent="53" data-semantic-owns="44 48 45 49 46 50 47" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="44" data-semantic-parent="51"><mjx-c class="mjx-c1D43F">𝐿</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="48" data-semantic-parent="51" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="45" data-semantic-parent="51"><mjx-c class="mjx-c1D437">𝐷</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="49" data-semantic-parent="51" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="46" data-semantic-parent="51"><mjx-c class="mjx-c1D449">𝑉</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="50" data-semantic-parent="51" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="47" data-semantic-parent="51"><mjx-c class="mjx-c1D443">𝑃</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="43" data-semantic-parent="53"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-mrow><mjx-mo data-semantic-type="fence" data-semantic-role="close" data-semantic-id="56" data-semantic-parent="57" data-semantic-operator="fenced"><mjx-c class="mjx-c29 MM-SO">)</mjx-c></mjx-mo></mjx-mrow></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 2)</div></div></div></section><section id="sec-4-4-6"><h4>Expi293F αV &amp; α5 knock-out cell line</h4><div id="p0360" role="paragraph">αV and α5 subunits were sequentially knocked out from Expi293F cells using CRISPR double nicking (<span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Ran et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Ran, F.A. ∙ Hsu, P.D. ∙ Wright, J. ...</div><div><strong>Genome engineering using the CRISPR-Cas9 system</strong></div><div><em>Nat. Protoc.</em> 2013; <strong>8</strong>:2281-2308</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2013.143" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84887010498" target="_blank" aria-label="Open Scopus in new tab">Scopus (7783)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24157548/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2013.143&amp;pmid=24157548" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To make the single-guide RNA (sgRNA) expressing plasmids, double stranded DNA oligos, 5’-CACCG<span data-style="underline">GCCCTTCAAGGATTTGAGAT</span>GTTT-3’ (αV_guide A), 5’-CACCG<span data-style="underline">CGAAGCATGCCACCAAGCTT</span>GTTT-3’ (αV_guide B), 5’-CACCG<span data-style="underline">GTACAGTGGAGCGCATGCCT</span>GTTT-3’ (α5_guide A), and 5’-CACCG<span data-style="underline">GTACAGTGGAGCGCATGCCT</span>GTTT-3’ (α5_guide B), were cloned into the BbSI site of the pSpCas9n(BB)-2A-puro vector (Addgene: 48141). To create the Expi293F αV knock-out, the pair of sgRNA expressing plasmids targeting αV were transfected into Expi293F cells and knock-out cells were selected by two rounds of panning (<span class="dropBlock reference-citations"><a id="body-ref-sref78" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78" aria-controls="sref78">Wysocki and Sato, 1978</a><div class="dropBlock__holder" data-db-target-of="sref78"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Wysocki, L.J. ∙ Sato, V.L.</div><div><strong>"Panning" for lymphocytes: A method for cell selection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1978; <strong>75</strong>:2844-2848</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.75.6.2844" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0018140454" target="_blank" aria-label="Open Scopus in new tab">Scopus (1253)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/351618/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.75.6.2844&amp;pmid=351618" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and one round of FACS sorting, both with αV-specific antibody 17E6 (<span class="dropBlock reference-citations"><a id="body-ref-sref49-2" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-2" aria-controls="sref49-2">Mitjans et&nbsp;al., 1995</a><div class="dropBlock__holder" data-db-target-of="sref49-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Mitjans, F. ∙ Sander, D. ∙ Adán, J. ...</div><div><strong>An anti-α v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice</strong></div><div><em>J.&nbsp;Cell Sci.</em> 1995; <strong>108</strong>:2825-2838</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.108.8.2825" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7593323/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.108.8.2825&amp;pmid=7593323" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To create the Expi293F αV &amp; α5 double knock-out, the pair of sgRNA expressing plasmids targeting α5 were transfected into Expi293F αV knock-out cells and the double knock-out cells were selected by two rounds of panning and one round of FACS sorting, both with α5 specific antibody mAb16 (<span class="dropBlock reference-citations"><a id="body-ref-sref4-3" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-3" aria-controls="sref4-3">Akiyama et&nbsp;al., 1989</a><div class="dropBlock__holder" data-db-target-of="sref4-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Akiyama, S.K. ∙ Yamada, S.S. ∙ Chen, W.T. ...</div><div><strong>Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1989; <strong>109</strong>:863-875</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.109.2.863" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0024359871" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2527241/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.109.2.863&amp;pmid=2527241" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-7"><h4>Quantitative fluorescent flow cytometry for αIIbβ3 inhibitor affinity and conformational preference measurements</h4><div id="p0365" role="paragraph">Measurements were done on Expi293F cells with the integrin α5 and αV subunits knocked out (Expi293F α5&amp;αV KO) transiently transfected with αIIb and β3 expression plasmids, or with αIIb and β3_N305T expression plasmids. For transfection, 0.5ug plasmid coding αIIb subunit in PD2529 vector (Atum) and 0.5ug plasmid coding β3 or β3_N305T in PD2529 vector were incubated with 1&nbsp;μL FectoPro (Polyplus) in 100 uL Opti-MEM (Gibco) for 10&nbsp;min at room temperature were added per ml of Expi293F α5&amp;αV KO cells (3<sup>∗</sup>10<sup>6</sup>/mL) in Expi293 expression medium (Thermo Fisher Scientific). 24&nbsp;hrs after transfection, valproic acid and glucose were added to the culture to final concentrations of 3&nbsp;mM and 0.4%, respectively. 48 hours post transfection, cells were washed twice with assay medium (Leibovitz’s L-15 medium and 0.1% BSA) containing 5&nbsp;mM EDTA, twice with assay medium alone, and resuspended in assay medium or L15 supplemented with the indicated concentration of serum and 50&nbsp;mM HEPES, pH7.4. For measuring the affinity of FITC-echistatin probe (United States Biological) to αIIbβ3 WT or αIIbβ3_N305T mutant, each 50-μl sample contained 10<sup>6</sup> cells/ml, 5&nbsp;nM Alexa647 labeled MBC319.4 Fab (AF647-MBC319.4), and varying concentrations of FITC-echistatin. For competitive binding experiments, each 50-μl sample contained 10<sup>6</sup> cells/ml, indicated concentrations of FITC-echistatin, and varying concentrations of αIIbβ3 inhibitors. For LIBS antibody epitope exposure assays, each 50-μl sample contained 10<sup>6</sup> cells/ml, 20&nbsp;nM Alexa647 labeled MBC319.4 Fab, and αIIbβ3 inhibitors at concentrations equaling100x their <i>K</i><sub>d</sub> values for αIIbβ3 wild type reported in <a id="optoOvfSfBTwL" href="#fig6">Figure 6</a>D. The mixture was allowed to equilibrate at 22°C for 2&nbsp;h before flow cytometry (BD FAC SCanto II) without washing.</div><div id="p0370" role="paragraph">FITC-echistatin concentration (<i>C</i><sub>echistatin</sub>) dependent binding of 5nM AF647-MBC319.4 Fab (<i>MFI</i><sub>obs</sub>) was fitted to <a id="crosref1560" href="#fd3">Equation 3</a> with binding affinity of FITC-echistatin (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript e c h i s t a t i n" tabindex="0" ctxtmenu_counter="10" style="font-size: 130%;"><mjx-math data-semantic-structure="(23 (22 0 1) (21 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 11))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="23" data-semantic-children="0,1,21" data-semantic-collapsed="(23 (22 0 1) 21)" data-semantic-owns="0 1 21" data-semantic-speech="upper K Subscript d Superscript e c h i s t a t i n"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="23"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="21" data-semantic-children="2,3,4,5,6,7,8,9,10,11" data-semantic-content="12,13,14,15,16,17,18,19,20" data-semantic-parent="23" data-semantic-owns="2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 11" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="21"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="21"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="21"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="21"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="21"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="21"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="21"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="21"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="19" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="21"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="20" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="21"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="23"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>), MFI in absence of FITC-echistatin (<i>MFI</i><sub>0</sub>), and MFI at saturating concentration of FITC-echistatin (<i>MFI</i><sub>sat</sub>) as fitting parameters.<div id="fd3" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper M upper F upper I Subscript o b s Baseline equals upper M upper F upper I 0 minus StartFraction upper M upper F upper I 0 minus upper M upper F upper I Subscript s a t Baseline Over 1 plus upper K Subscript d Superscript e c h i s t a t i n Baseline divided by upper C Subscript e c h i s t a t i n Baseline EndFraction" tabindex="0" ctxtmenu_counter="11" style="font-size: 130%;"><mjx-math data-semantic-structure="(99 (94 0 92 1 93 (9 2 (8 3 6 4 7 5))) 10 (98 (97 11 95 12 96 (15 13 14)) 16 (91 (39 (35 17 33 18 34 (21 19 20)) 22 (38 23 36 24 37 (32 25 (31 26 29 27 30 28)))) (89 40 41 (90 (65 (64 42 43) (63 44 54 45 55 46 56 47 57 48 58 49 59 50 60 51 61 52 62 53)) 66 (88 67 (87 68 78 69 79 70 80 71 81 72 82 73 83 74 84 75 85 76 86 77)))))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="99" data-semantic-children="94,98" data-semantic-content="10" data-semantic-owns="94 10 98" data-semantic-speech="upper M upper F upper I Subscript o b s Baseline equals upper M upper F upper I 0 minus StartFraction upper M upper F upper I 0 minus upper M upper F upper I Subscript s a t Baseline Over 1 plus upper K Subscript d Superscript e c h i s t a t i n Baseline divided by upper C Subscript e c h i s t a t i n Baseline EndFraction"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="94" data-semantic-children="0,1,9" data-semantic-content="92,93" data-semantic-parent="99" data-semantic-owns="0 92 1 93 9"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="94"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="92" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="94"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="93" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="9" data-semantic-children="2,8" data-semantic-parent="94" data-semantic-owns="2 8"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="9"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="8" data-semantic-children="3,4,5" data-semantic-content="6,7" data-semantic-parent="9" data-semantic-owns="3 6 4 7 5"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="8"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="6" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="8"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="7" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="8"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="10" data-semantic-parent="99" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="subtraction" data-semantic-id="98" data-semantic-children="97,91" data-semantic-content="16" data-semantic-parent="99" data-semantic-owns="97 16 91"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="97" data-semantic-children="11,12,15" data-semantic-content="95,96" data-semantic-parent="98" data-semantic-owns="11 95 12 96 15"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="97"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="95" data-semantic-parent="97" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="12" data-semantic-parent="97"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="96" data-semantic-parent="97" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="15" data-semantic-children="13,14" data-semantic-parent="97" data-semantic-owns="13 14"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="13" data-semantic-parent="15"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="14" data-semantic-parent="15"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="subtraction" data-semantic-id="16" data-semantic-parent="98" data-semantic-operator="infixop,−"><mjx-c class="mjx-c2212">−</mjx-c></mjx-mo><mjx-mfrac space="3" data-semantic-type="fraction" data-semantic-role="division" data-semantic-id="91" data-semantic-children="39,89" data-semantic-parent="98" data-semantic-owns="39 89"><mjx-frac><mjx-num><mjx-nstrut></mjx-nstrut><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="subtraction" data-semantic-id="39" data-semantic-children="35,38" data-semantic-content="22" data-semantic-parent="91" data-semantic-owns="35 22 38"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="35" data-semantic-children="17,18,21" data-semantic-content="33,34" data-semantic-parent="39" data-semantic-owns="17 33 18 34 21"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="17" data-semantic-parent="35"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="33" data-semantic-parent="35" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="18" data-semantic-parent="35"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="34" data-semantic-parent="35" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="19,20" data-semantic-parent="35" data-semantic-owns="19 20"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="19" data-semantic-parent="21"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="20" data-semantic-parent="21"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="subtraction" data-semantic-id="22" data-semantic-parent="39" data-semantic-operator="infixop,−"><mjx-c class="mjx-c2212">−</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="38" data-semantic-children="23,24,32" data-semantic-content="36,37" data-semantic-parent="39" data-semantic-owns="23 36 24 37 32"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="38"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="36" data-semantic-parent="38" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="38"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="37" data-semantic-parent="38" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="32" data-semantic-children="25,31" data-semantic-parent="38" data-semantic-owns="25 31"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="32"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="31" data-semantic-children="26,27,28" data-semantic-content="29,30" data-semantic-parent="32" data-semantic-owns="26 29 27 30 28"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="31"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="29" data-semantic-parent="31" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="31"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="30" data-semantic-parent="31" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="31"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-num><mjx-dbox><mjx-dtable><mjx-line></mjx-line><mjx-row><mjx-den><mjx-dstrut></mjx-dstrut><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="addition" data-semantic-id="89" data-semantic-children="40,90" data-semantic-content="41" data-semantic-parent="91" data-semantic-owns="40 41 90"><mjx-mn data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="40" data-semantic-parent="89"><mjx-c class="mjx-c31">1</mjx-c></mjx-mn><mjx-mo data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="41" data-semantic-parent="89" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="90" data-semantic-children="65,88" data-semantic-content="66" data-semantic-parent="89" data-semantic-owns="65 66 88"><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="65" data-semantic-children="42,43,63" data-semantic-parent="90" data-semantic-collapsed="(65 (64 42 43) 63)" data-semantic-owns="42 43 63"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="42" data-semantic-parent="65"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.317em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="63" data-semantic-children="44,45,46,47,48,49,50,51,52,53" data-semantic-content="54,55,56,57,58,59,60,61,62" data-semantic-parent="65" data-semantic-owns="44 54 45 55 46 56 47 57 48 58 49 59 50 60 51 61 52 62 53" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="44" data-semantic-parent="63"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="54" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="45" data-semantic-parent="63"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="55" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="46" data-semantic-parent="63"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="56" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="47" data-semantic-parent="63"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="57" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="48" data-semantic-parent="63"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="58" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="49" data-semantic-parent="63"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="59" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="50" data-semantic-parent="63"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="60" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="51" data-semantic-parent="63"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="61" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="52" data-semantic-parent="63"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="62" data-semantic-parent="63" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="53" data-semantic-parent="63"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="43" data-semantic-parent="65"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="66" data-semantic-parent="90" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="88" data-semantic-children="67,87" data-semantic-parent="90" data-semantic-owns="67 87"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="67" data-semantic-parent="88"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="87" data-semantic-children="68,69,70,71,72,73,74,75,76,77" data-semantic-content="78,79,80,81,82,83,84,85,86" data-semantic-parent="88" data-semantic-owns="68 78 69 79 70 80 71 81 72 82 73 83 74 84 75 85 76 86 77"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="87"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="87"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="87"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="71" data-semantic-parent="87"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="81" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="87"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="82" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="73" data-semantic-parent="87"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="74" data-semantic-parent="87"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="84" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="75" data-semantic-parent="87"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="85" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="76" data-semantic-parent="87"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="77" data-semantic-parent="87"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-den></mjx-row></mjx-dtable></mjx-dbox></mjx-frac></mjx-mfrac></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 3)</div></div></div><div id="p0375" role="paragraph">The competitive binding curves of the high affinity αIIbβ3 inhibitors (UR-2922 and roxifban), cannot be reliably fitted with the 3-parameter dose response curve (<a id="crosref1565" href="#fd1">Equation 1</a>) because their K<sub>d</sub> values are smaller than the concentration range of integrins in the cell suspension. Under these conditions, binding to cells can significantly deplete the competitor from solution when used at low concentration, and the total concentration of competitor could not be used as an approximation of its free concentration. To solve this problem, we fit the competitive binding curves considering the competitor depletion effect. In detail, αIIbβ3 inhibitor concentration (<i>C</i><sub>inhibitor</sub>) dependent binding of FITC-echistatin (<i>MFI</i><sub>obs</sub>), for two inhibitors with high binding affinity, UR-2922 and roxifiban, was fitted with affinity of inhibitor (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r" tabindex="0" ctxtmenu_counter="12" style="font-size: 130%;"><mjx-math data-semantic-structure="(21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>), MFI in absence of inhibitor (<i>MFI</i><sub>0</sub>), MFI at saturating concentration of inhibitor (<i>MFI</i><sub>sat</sub>) and the integrin concentration (<i>C</i><sub>integrin</sub>) expressed on transfectants as fitting parameters, with previously determined FITC-echistatin affinity (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript e c h i s t a t i n" tabindex="0" ctxtmenu_counter="13" style="font-size: 130%;"><mjx-math data-semantic-structure="(23 (22 0 1) (21 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 11))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="23" data-semantic-children="0,1,21" data-semantic-collapsed="(23 (22 0 1) 21)" data-semantic-owns="0 1 21" data-semantic-speech="upper K Subscript d Superscript e c h i s t a t i n"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="23"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="21" data-semantic-children="2,3,4,5,6,7,8,9,10,11" data-semantic-content="12,13,14,15,16,17,18,19,20" data-semantic-parent="23" data-semantic-owns="2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 11" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="21"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="21"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="21"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="21"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="21"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="21"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="21"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="21"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="19" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="21"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="20" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="21"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="23"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>), inhibitor concentration (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper C Subscript i n h i b i t o r" tabindex="0" ctxtmenu_counter="14" style="font-size: 130%;"><mjx-math data-semantic-structure="(19 0 (18 1 10 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="19" data-semantic-children="0,18" data-semantic-owns="0 18" data-semantic-speech="upper C Subscript i n h i b i t o r"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="19"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="18" data-semantic-children="1,2,3,4,5,6,7,8,9" data-semantic-content="10,11,12,13,14,15,16,17" data-semantic-parent="19" data-semantic-owns="1 10 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="18"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="10" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="18"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="18"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="18"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="18"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="18"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="18"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="18"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="18"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-math></mjx-container>) and FITC-echistatin concentration (<mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper C Subscript e c h i s t a t i n" tabindex="0" ctxtmenu_counter="15" style="font-size: 130%;"><mjx-math data-semantic-structure="(21 0 (20 1 11 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,20" data-semantic-owns="0 20" data-semantic-speech="upper C Subscript e c h i s t a t i n"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="20" data-semantic-children="1,2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18,19" data-semantic-parent="21" data-semantic-owns="1 11 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="20"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="20"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="20"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="20"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="20"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="20"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="20"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="20"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="20"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="19" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="20"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-math></mjx-container>) as known parameters (<a id="crosref1570" href="#fd4">Equation 4</a>). <a id="crosref1575" href="#fd4">Equation 4</a> was derived based on the definition of affinity and law of mass conservation detailed in <a id="crosref1580" href="#fd5">Equations 5</a>, <a id="crosref1585" href="#fd6">6</a>, <a id="crosref1590" href="#fd7">7</a>, <a id="crosref1595" href="#fd8">8</a>, <a id="crosref1600" href="#fd9">9</a>, and <a id="crosref1605" href="#fd10">10</a>. Function F in <a id="crosref1610" href="#fd4">Equation 4</a> and its derivation are described in the Mathematica file <a id="crosref1615" href="#fd4">Equation 4</a>.nb.<div id="fd4" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper M upper F upper I Subscript o b s Baseline equals upper F left parenthesis upper C Subscript e c h i s t a t i n Baseline comma upper K Subscript d Superscript e c h i s t a t i n Baseline comma upper C Subscript i n h i b i t o r Baseline comma upper C Subscript i n t e g r i n Baseline comma upper K Subscript d Superscript i n h i b i t o r Baseline comma upper M upper F upper I 0 comma upper M upper F upper I Subscript s a t Baseline right parenthesis" tabindex="0" ctxtmenu_counter="16" style="font-size: 130%;"><mjx-math data-semantic-structure="(163 (162 0 161 (160 1 159 (9 2 (8 3 6 4 7 5)))) 10 (158 11 157 (156 12 (154 (34 13 (33 14 24 15 25 16 26 17 27 18 28 19 29 20 30 21 31 22 32 23)) 35 (60 (59 37 38) (58 39 49 40 50 41 51 42 52 43 53 44 54 45 55 46 56 47 57 48)) 61 (82 63 (81 64 73 65 74 66 75 67 76 68 77 69 78 70 79 71 80 72)) 83 (102 85 (101 86 94 87 95 88 96 89 97 90 98 91 99 92 100 93)) 103 (126 (125 105 106) (124 107 116 108 117 109 118 110 119 111 120 112 121 113 122 114 123 115)) 127 (149 129 148 (147 130 146 (133 131 132))) 134 (153 136 152 (151 137 150 (145 138 (144 139 142 140 143 141))))) 155)))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="163" data-semantic-children="162,158" data-semantic-content="10" data-semantic-owns="162 10 158" data-semantic-speech="upper M upper F upper I Subscript o b s Baseline equals upper F left parenthesis upper C Subscript e c h i s t a t i n Baseline comma upper K Subscript d Superscript e c h i s t a t i n Baseline comma upper C Subscript i n h i b i t o r Baseline comma upper C Subscript i n t e g r i n Baseline comma upper K Subscript d Superscript i n h i b i t o r Baseline comma upper M upper F upper I 0 comma upper M upper F upper I Subscript s a t Baseline right parenthesis"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="162" data-semantic-children="0,160" data-semantic-content="161" data-semantic-parent="163" data-semantic-owns="0 161 160"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="162"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="161" data-semantic-parent="162" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="appl" data-semantic-role="simple function" data-semantic-id="160" data-semantic-children="1,9" data-semantic-content="159,1" data-semantic-parent="162" data-semantic-owns="1 159 9"><mjx-mi data-semantic-type="identifier" data-semantic-role="simple function" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="160" data-semantic-operator="appl"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="punctuation" data-semantic-role="application" data-semantic-id="159" data-semantic-parent="160" data-semantic-added="true" data-semantic-operator="appl"><mjx-c class="mjx-c2061">⁡</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="9" data-semantic-children="2,8" data-semantic-parent="160" data-semantic-owns="2 8"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="9"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="8" data-semantic-children="3,4,5" data-semantic-content="6,7" data-semantic-parent="9" data-semantic-owns="3 6 4 7 5"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="8"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="6" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="8"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="7" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="8"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="10" data-semantic-parent="163" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="appl" data-semantic-role="simple function" data-semantic-id="158" data-semantic-children="11,156" data-semantic-content="157,11" data-semantic-parent="163" data-semantic-owns="11 157 156"><mjx-mi data-semantic-type="identifier" data-semantic-role="simple function" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="158" data-semantic-operator="appl"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="punctuation" data-semantic-role="application" data-semantic-id="157" data-semantic-parent="158" data-semantic-added="true" data-semantic-operator="appl"><mjx-c class="mjx-c2061">⁡</mjx-c></mjx-mo><mjx-mrow space="2" data-semantic-type="fenced" data-semantic-role="leftright" data-semantic-id="156" data-semantic-children="154" data-semantic-content="12,155" data-semantic-parent="158" data-semantic-owns="12 154 155"><mjx-mo data-semantic-type="fence" data-semantic-role="open" data-semantic-id="12" data-semantic-parent="156" data-semantic-operator="fenced"><mjx-c class="mjx-c28 MM-SO">(</mjx-c></mjx-mo><mjx-mrow data-semantic-type="punctuated" data-semantic-role="sequence" data-semantic-id="154" data-semantic-children="34,35,60,61,82,83,102,103,126,127,149,134,153" data-semantic-content="35,61,83,103,127,134" data-semantic-parent="156" data-semantic-owns="34 35 60 61 82 83 102 103 126 127 149 134 153"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="34" data-semantic-children="13,33" data-semantic-parent="154" data-semantic-owns="13 33"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="13" data-semantic-parent="34"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="33" data-semantic-children="14,15,16,17,18,19,20,21,22,23" data-semantic-content="24,25,26,27,28,29,30,31,32" data-semantic-parent="34" data-semantic-owns="14 24 15 25 16 26 17 27 18 28 19 29 20 30 21 31 22 32 23"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="14" data-semantic-parent="33"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="24" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="15" data-semantic-parent="33"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="25" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="16" data-semantic-parent="33"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="26" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="17" data-semantic-parent="33"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="27" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="18" data-semantic-parent="33"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="28" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="19" data-semantic-parent="33"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="29" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="20" data-semantic-parent="33"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="30" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="21" data-semantic-parent="33"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="31" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="22" data-semantic-parent="33"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="32" data-semantic-parent="33" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="33"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo data-semantic-type="punctuation" data-semantic-role="comma" data-semantic-id="35" data-semantic-parent="154" data-semantic-operator="punctuated"><mjx-c class="mjx-c2C">,</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-msubsup space="2" data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="60" data-semantic-children="37,38,58" data-semantic-parent="154" data-semantic-collapsed="(60 (59 37 38) 58)" data-semantic-owns="37 38 58"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="37" data-semantic-parent="60"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="58" data-semantic-children="39,40,41,42,43,44,45,46,47,48" data-semantic-content="49,50,51,52,53,54,55,56,57" data-semantic-parent="60" data-semantic-owns="39 49 40 50 41 51 42 52 43 53 44 54 45 55 46 56 47 57 48" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="39" data-semantic-parent="58"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="49" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="40" data-semantic-parent="58"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="50" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="41" data-semantic-parent="58"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="51" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="42" data-semantic-parent="58"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="52" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="43" data-semantic-parent="58"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="53" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="44" data-semantic-parent="58"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="54" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="45" data-semantic-parent="58"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="55" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="46" data-semantic-parent="58"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="56" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="47" data-semantic-parent="58"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="57" data-semantic-parent="58" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="48" data-semantic-parent="58"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="38" data-semantic-parent="60"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo data-semantic-type="punctuation" data-semantic-role="comma" data-semantic-id="61" data-semantic-parent="154" data-semantic-operator="punctuated"><mjx-c class="mjx-c2C">,</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-msub space="2" data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="82" data-semantic-children="63,81" data-semantic-parent="154" data-semantic-owns="63 81"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="82"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="81" data-semantic-children="64,65,66,67,68,69,70,71,72" data-semantic-content="73,74,75,76,77,78,79,80" data-semantic-parent="82" data-semantic-owns="64 73 65 74 66 75 67 76 68 77 69 78 70 79 71 80 72"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="64" data-semantic-parent="81"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="73" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="65" data-semantic-parent="81"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="74" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="66" data-semantic-parent="81"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="75" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="67" data-semantic-parent="81"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="76" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="81"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="77" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="81"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="81"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="71" data-semantic-parent="81"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="81" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="81"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo data-semantic-type="punctuation" data-semantic-role="comma" data-semantic-id="83" data-semantic-parent="154" data-semantic-operator="punctuated"><mjx-c class="mjx-c2C">,</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-msub space="2" data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="102" data-semantic-children="85,101" data-semantic-parent="154" data-semantic-owns="85 101"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="85" data-semantic-parent="102"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="101" data-semantic-children="86,87,88,89,90,91,92,93" data-semantic-content="94,95,96,97,98,99,100" data-semantic-parent="102" data-semantic-owns="86 94 87 95 88 96 89 97 90 98 91 99 92 100 93"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="86" data-semantic-parent="101"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="94" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="87" data-semantic-parent="101"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="95" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="88" data-semantic-parent="101"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="96" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="89" data-semantic-parent="101"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="97" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="90" data-semantic-parent="101"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="98" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="91" data-semantic-parent="101"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="99" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="92" data-semantic-parent="101"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="100" data-semantic-parent="101" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="93" data-semantic-parent="101"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo data-semantic-type="punctuation" data-semantic-role="comma" data-semantic-id="103" data-semantic-parent="154" data-semantic-operator="punctuated"><mjx-c class="mjx-c2C">,</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-msubsup space="2" data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="126" data-semantic-children="105,106,124" data-semantic-parent="154" data-semantic-collapsed="(126 (125 105 106) 124)" data-semantic-owns="105 106 124"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="105" data-semantic-parent="126"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="124" data-semantic-children="107,108,109,110,111,112,113,114,115" data-semantic-content="116,117,118,119,120,121,122,123" data-semantic-parent="126" data-semantic-owns="107 116 108 117 109 118 110 119 111 120 112 121 113 122 114 123 115" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="107" data-semantic-parent="124"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="116" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="108" data-semantic-parent="124"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="117" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="109" data-semantic-parent="124"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="118" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="110" data-semantic-parent="124"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="119" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="111" data-semantic-parent="124"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="120" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="112" data-semantic-parent="124"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="121" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="113" data-semantic-parent="124"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="122" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="114" data-semantic-parent="124"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="123" data-semantic-parent="124" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="115" data-semantic-parent="124"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="106" data-semantic-parent="126"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo data-semantic-type="punctuation" data-semantic-role="comma" data-semantic-id="127" data-semantic-parent="154" data-semantic-operator="punctuated"><mjx-c class="mjx-c2C">,</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-mrow space="2" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="149" data-semantic-children="129,147" data-semantic-content="148" data-semantic-parent="154" data-semantic-owns="129 148 147"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="129" data-semantic-parent="149"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="148" data-semantic-parent="149" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="appl" data-semantic-role="simple function" data-semantic-id="147" data-semantic-children="130,133" data-semantic-content="146,130" data-semantic-parent="149" data-semantic-owns="130 146 133"><mjx-mi data-semantic-type="identifier" data-semantic-role="simple function" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="130" data-semantic-parent="147" data-semantic-operator="appl"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="punctuation" data-semantic-role="application" data-semantic-id="146" data-semantic-parent="147" data-semantic-added="true" data-semantic-operator="appl"><mjx-c class="mjx-c2061">⁡</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="133" data-semantic-children="131,132" data-semantic-parent="147" data-semantic-owns="131 132"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="131" data-semantic-parent="133"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="132" data-semantic-parent="133"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow></mjx-mrow><mjx-mo data-semantic-type="punctuation" data-semantic-role="comma" data-semantic-id="134" data-semantic-parent="154" data-semantic-operator="punctuated"><mjx-c class="mjx-c2C">,</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-mrow space="2" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="153" data-semantic-children="136,151" data-semantic-content="152" data-semantic-parent="154" data-semantic-owns="136 152 151"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="136" data-semantic-parent="153"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="152" data-semantic-parent="153" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="appl" data-semantic-role="simple function" data-semantic-id="151" data-semantic-children="137,145" data-semantic-content="150,137" data-semantic-parent="153" data-semantic-owns="137 150 145"><mjx-mi data-semantic-type="identifier" data-semantic-role="simple function" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="137" data-semantic-parent="151" data-semantic-operator="appl"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="punctuation" data-semantic-role="application" data-semantic-id="150" data-semantic-parent="151" data-semantic-added="true" data-semantic-operator="appl"><mjx-c class="mjx-c2061">⁡</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="145" data-semantic-children="138,144" data-semantic-parent="151" data-semantic-owns="138 144"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="138" data-semantic-parent="145"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="144" data-semantic-children="139,140,141" data-semantic-content="142,143" data-semantic-parent="145" data-semantic-owns="139 142 140 143 141"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="139" data-semantic-parent="144"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="142" data-semantic-parent="144" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="140" data-semantic-parent="144"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="143" data-semantic-parent="144" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="141" data-semantic-parent="144"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-mrow><mjx-mo data-semantic-type="fence" data-semantic-role="close" data-semantic-id="155" data-semantic-parent="156" data-semantic-operator="fenced"><mjx-c class="mjx-c29 MM-SO">)</mjx-c></mjx-mo></mjx-mrow></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 4)</div></div><div id="fd5" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r Baseline equals upper C Subscript u n b o u n d i n t e g r i n Baseline times upper C Subscript u n b o u n d i n h i b i t o r Baseline divided by upper C Subscript i n t e g r i n dot i n h i b i t o r" tabindex="0" ctxtmenu_counter="17" style="font-size: 130%;"><mjx-math data-semantic-structure="(134 (21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10)) 22 (132 (55 23 (54 24 40 25 41 26 42 27 43 28 44 29 45 30 46 32 47 33 48 34 49 35 50 36 51 37 52 38 53 39)) 56 (133 (91 57 (90 58 75 59 76 60 77 61 78 62 79 63 80 64 81 66 82 67 83 68 84 69 85 70 86 71 87 72 88 73 89 74)) 92 (131 93 (130 (120 94 113 95 114 96 115 97 116 98 117 99 118 100 119 101) 102 (129 103 121 104 122 105 123 106 124 107 125 108 126 109 127 110 128 111))))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="134" data-semantic-children="21,132" data-semantic-content="22" data-semantic-owns="21 22 132" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r Baseline equals upper C Subscript u n b o u n d i n t e g r i n Baseline times upper C Subscript u n b o u n d i n h i b i t o r Baseline divided by upper C Subscript i n t e g r i n dot i n h i b i t o r"><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-parent="134" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="22" data-semantic-parent="134" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="132" data-semantic-children="55,133" data-semantic-content="56" data-semantic-parent="134" data-semantic-owns="55 56 133"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="55" data-semantic-children="23,54" data-semantic-parent="132" data-semantic-owns="23 54"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="55"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="54" data-semantic-children="24,25,26,27,28,29,30,32,33,34,35,36,37,38,39" data-semantic-content="40,41,42,43,44,45,46,47,48,49,50,51,52,53" data-semantic-parent="55" data-semantic-owns="24 40 25 41 26 42 27 43 28 44 29 45 30 46 32 47 33 48 34 49 35 50 36 51 37 52 38 53 39"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="54"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="40" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="54"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="41" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="54"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="42" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="54"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="43" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="54"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="44" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="54"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="45" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="30" data-semantic-parent="54"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="46" data-semantic-parent="54" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="32" data-semantic-parent="54"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="47" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="33" data-semantic-parent="54"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="48" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="34" data-semantic-parent="54"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="49" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="35" data-semantic-parent="54"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="50" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="36" data-semantic-parent="54"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="51" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="37" data-semantic-parent="54"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="52" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="38" data-semantic-parent="54"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="53" data-semantic-parent="54" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="39" data-semantic-parent="54"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="56" data-semantic-parent="132" data-semantic-operator="infixop,×"><mjx-c class="mjx-cD7">×</mjx-c></mjx-mo><mjx-mrow space="3" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="133" data-semantic-children="91,131" data-semantic-content="92" data-semantic-parent="132" data-semantic-owns="91 92 131"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="91" data-semantic-children="57,90" data-semantic-parent="133" data-semantic-owns="57 90"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="57" data-semantic-parent="91"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="90" data-semantic-children="58,59,60,61,62,63,64,66,67,68,69,70,71,72,73,74" data-semantic-content="75,76,77,78,79,80,81,82,83,84,85,86,87,88,89" data-semantic-parent="91" data-semantic-owns="58 75 59 76 60 77 61 78 62 79 63 80 64 81 66 82 67 83 68 84 69 85 70 86 71 87 72 88 73 89 74"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="58" data-semantic-parent="90"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="75" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="59" data-semantic-parent="90"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="76" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="60" data-semantic-parent="90"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="77" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="61" data-semantic-parent="90"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="62" data-semantic-parent="90"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="90"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="64" data-semantic-parent="90"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="81" data-semantic-parent="90" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="66" data-semantic-parent="90"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="82" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="67" data-semantic-parent="90"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="90"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="84" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="90"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="85" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="90"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="71" data-semantic-parent="90"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="87" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="90"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="88" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="73" data-semantic-parent="90"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="89" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="74" data-semantic-parent="90"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="92" data-semantic-parent="133" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="131" data-semantic-children="93,130" data-semantic-parent="133" data-semantic-owns="93 130"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="93" data-semantic-parent="131"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="130" data-semantic-children="120,129" data-semantic-content="102" data-semantic-parent="131" data-semantic-owns="120 102 129"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="120" data-semantic-children="94,95,96,97,98,99,100,101" data-semantic-content="113,114,115,116,117,118,119" data-semantic-parent="130" data-semantic-owns="94 113 95 114 96 115 97 116 98 117 99 118 100 119 101"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="94" data-semantic-parent="120"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="113" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="95" data-semantic-parent="120"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="114" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="96" data-semantic-parent="120"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="115" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="97" data-semantic-parent="120"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="116" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="98" data-semantic-parent="120"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="117" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="99" data-semantic-parent="120"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="118" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="100" data-semantic-parent="120"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="119" data-semantic-parent="120" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="101" data-semantic-parent="120"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="102" data-semantic-parent="130" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="129" data-semantic-children="103,104,105,106,107,108,109,110,111" data-semantic-content="121,122,123,124,125,126,127,128" data-semantic-parent="130" data-semantic-owns="103 121 104 122 105 123 106 124 107 125 108 126 109 127 110 128 111"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="103" data-semantic-parent="129"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="121" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="104" data-semantic-parent="129"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="122" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="105" data-semantic-parent="129"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="123" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="106" data-semantic-parent="129"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="124" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="107" data-semantic-parent="129"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="125" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="108" data-semantic-parent="129"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="126" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="109" data-semantic-parent="129"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="127" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="110" data-semantic-parent="129"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="128" data-semantic-parent="129" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="111" data-semantic-parent="129"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 5)</div></div><div id="fd6" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript e c h i s t a t i n Baseline equals upper C Subscript u n b o u n d i n t e g r i n Baseline times upper C Subscript u n b o u n d e c h i s t a t i n Baseline divided by upper C Subscript i n t e g r i n dot e c h i s t a t i n" tabindex="0" ctxtmenu_counter="18" style="font-size: 130%;"><mjx-math data-semantic-structure="(140 (23 (22 0 1) (21 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 11)) 24 (138 (57 25 (56 26 42 27 43 28 44 29 45 30 46 31 47 32 48 34 49 35 50 36 51 37 52 38 53 39 54 40 55 41)) 58 (139 (95 59 (94 60 78 61 79 62 80 63 81 64 82 65 83 66 84 68 85 69 86 70 87 71 88 72 89 73 90 74 91 75 92 76 93 77)) 96 (137 97 (136 (125 98 118 99 119 100 120 101 121 102 122 103 123 104 124 105) 106 (135 107 126 108 127 109 128 110 129 111 130 112 131 113 132 114 133 115 134 116))))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="140" data-semantic-children="23,138" data-semantic-content="24" data-semantic-owns="23 24 138" data-semantic-speech="upper K Subscript d Superscript e c h i s t a t i n Baseline equals upper C Subscript u n b o u n d i n t e g r i n Baseline times upper C Subscript u n b o u n d e c h i s t a t i n Baseline divided by upper C Subscript i n t e g r i n dot e c h i s t a t i n"><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="23" data-semantic-children="0,1,21" data-semantic-parent="140" data-semantic-collapsed="(23 (22 0 1) 21)" data-semantic-owns="0 1 21"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="23"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="21" data-semantic-children="2,3,4,5,6,7,8,9,10,11" data-semantic-content="12,13,14,15,16,17,18,19,20" data-semantic-parent="23" data-semantic-owns="2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10 20 11" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="21"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="21"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="21"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="21"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="21"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="21"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="21"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="21"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="19" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="21"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="20" data-semantic-parent="21" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="21"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="23"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="24" data-semantic-parent="140" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="138" data-semantic-children="57,139" data-semantic-content="58" data-semantic-parent="140" data-semantic-owns="57 58 139"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="57" data-semantic-children="25,56" data-semantic-parent="138" data-semantic-owns="25 56"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="57"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="56" data-semantic-children="26,27,28,29,30,31,32,34,35,36,37,38,39,40,41" data-semantic-content="42,43,44,45,46,47,48,49,50,51,52,53,54,55" data-semantic-parent="57" data-semantic-owns="26 42 27 43 28 44 29 45 30 46 31 47 32 48 34 49 35 50 36 51 37 52 38 53 39 54 40 55 41"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="56"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="42" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="56"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="43" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="56"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="44" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="56"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="45" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="30" data-semantic-parent="56"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="46" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="31" data-semantic-parent="56"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="47" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="32" data-semantic-parent="56"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="48" data-semantic-parent="56" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="34" data-semantic-parent="56"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="49" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="35" data-semantic-parent="56"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="50" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="36" data-semantic-parent="56"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="51" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="37" data-semantic-parent="56"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="52" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="38" data-semantic-parent="56"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="53" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="39" data-semantic-parent="56"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="54" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="40" data-semantic-parent="56"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="55" data-semantic-parent="56" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="41" data-semantic-parent="56"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="58" data-semantic-parent="138" data-semantic-operator="infixop,×"><mjx-c class="mjx-cD7">×</mjx-c></mjx-mo><mjx-mrow space="3" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="139" data-semantic-children="95,137" data-semantic-content="96" data-semantic-parent="138" data-semantic-owns="95 96 137"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="95" data-semantic-children="59,94" data-semantic-parent="139" data-semantic-owns="59 94"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="59" data-semantic-parent="95"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="94" data-semantic-children="60,61,62,63,64,65,66,68,69,70,71,72,73,74,75,76,77" data-semantic-content="78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93" data-semantic-parent="95" data-semantic-owns="60 78 61 79 62 80 63 81 64 82 65 83 66 84 68 85 69 86 70 87 71 88 72 89 73 90 74 91 75 92 76 93 77"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="60" data-semantic-parent="94"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="61" data-semantic-parent="94"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="62" data-semantic-parent="94"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="94"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="81" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="64" data-semantic-parent="94"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="82" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="65" data-semantic-parent="94"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="66" data-semantic-parent="94"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="84" data-semantic-parent="94" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="94"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="85" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="94"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="94"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="87" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="71" data-semantic-parent="94"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="88" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="94"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="89" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="73" data-semantic-parent="94"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="90" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="74" data-semantic-parent="94"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="91" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="75" data-semantic-parent="94"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="92" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="76" data-semantic-parent="94"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="93" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="77" data-semantic-parent="94"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="96" data-semantic-parent="139" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="137" data-semantic-children="97,136" data-semantic-parent="139" data-semantic-owns="97 136"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="97" data-semantic-parent="137"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="136" data-semantic-children="125,135" data-semantic-content="106" data-semantic-parent="137" data-semantic-owns="125 106 135"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="125" data-semantic-children="98,99,100,101,102,103,104,105" data-semantic-content="118,119,120,121,122,123,124" data-semantic-parent="136" data-semantic-owns="98 118 99 119 100 120 101 121 102 122 103 123 104 124 105"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="98" data-semantic-parent="125"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="118" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="99" data-semantic-parent="125"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="119" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="100" data-semantic-parent="125"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="120" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="101" data-semantic-parent="125"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="121" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="102" data-semantic-parent="125"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="122" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="103" data-semantic-parent="125"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="123" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="104" data-semantic-parent="125"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="124" data-semantic-parent="125" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="105" data-semantic-parent="125"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="106" data-semantic-parent="136" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="135" data-semantic-children="107,108,109,110,111,112,113,114,115,116" data-semantic-content="126,127,128,129,130,131,132,133,134" data-semantic-parent="136" data-semantic-owns="107 126 108 127 109 128 110 129 111 130 112 131 113 132 114 133 115 134 116"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="107" data-semantic-parent="135"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="126" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="108" data-semantic-parent="135"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="127" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="109" data-semantic-parent="135"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="128" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="110" data-semantic-parent="135"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="129" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="111" data-semantic-parent="135"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="130" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="112" data-semantic-parent="135"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="131" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="113" data-semantic-parent="135"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="132" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="114" data-semantic-parent="135"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="133" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="115" data-semantic-parent="135"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="134" data-semantic-parent="135" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="116" data-semantic-parent="135"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 6)</div></div><div id="fd7" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper C Subscript i n t e g r i n Baseline equals upper C Subscript u n b o u n d i n t e g r i n Baseline plus upper C Subscript i n t e g r i n dot i n h i b i t o r Baseline plus upper C Subscript i n t e g r i n dot e c h i s t a t i n" tabindex="0" ctxtmenu_counter="19" style="font-size: 130%;"><mjx-math data-semantic-structure="(137 (17 0 (16 1 9 2 10 3 11 4 12 5 13 6 14 7 15 8)) 18 (136 (51 19 (50 20 36 21 37 22 38 23 39 24 40 25 41 26 42 28 43 29 44 30 45 31 46 32 47 33 48 34 49 35)) 53 (93 55 (92 (82 56 75 57 76 58 77 59 78 60 79 61 80 62 81 63) 64 (91 65 83 66 84 67 85 68 86 69 87 70 88 71 89 72 90 73))) 94 (135 95 (134 (123 96 116 97 117 98 118 99 119 100 120 101 121 102 122 103) 104 (133 105 124 106 125 107 126 108 127 109 128 110 129 111 130 112 131 113 132 114)))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="137" data-semantic-children="17,136" data-semantic-content="18" data-semantic-owns="17 18 136" data-semantic-speech="upper C Subscript i n t e g r i n Baseline equals upper C Subscript u n b o u n d i n t e g r i n Baseline plus upper C Subscript i n t e g r i n dot i n h i b i t o r Baseline plus upper C Subscript i n t e g r i n dot e c h i s t a t i n"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="17" data-semantic-children="0,16" data-semantic-parent="137" data-semantic-owns="0 16"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="17"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="16" data-semantic-children="1,2,3,4,5,6,7,8" data-semantic-content="9,10,11,12,13,14,15" data-semantic-parent="17" data-semantic-owns="1 9 2 10 3 11 4 12 5 13 6 14 7 15 8"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="16"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="9" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="16"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="10" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="16"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="16"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="16"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="16"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="16"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="16" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="16"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="18" data-semantic-parent="137" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="addition" data-semantic-id="136" data-semantic-children="51,93,135" data-semantic-content="53,94" data-semantic-parent="137" data-semantic-owns="51 53 93 94 135"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="51" data-semantic-children="19,50" data-semantic-parent="136" data-semantic-owns="19 50"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="19" data-semantic-parent="51"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="50" data-semantic-children="20,21,22,23,24,25,26,28,29,30,31,32,33,34,35" data-semantic-content="36,37,38,39,40,41,42,43,44,45,46,47,48,49" data-semantic-parent="51" data-semantic-owns="20 36 21 37 22 38 23 39 24 40 25 41 26 42 28 43 29 44 30 45 31 46 32 47 33 48 34 49 35"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="20" data-semantic-parent="50"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="36" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="21" data-semantic-parent="50"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="37" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="22" data-semantic-parent="50"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="38" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="50"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="39" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="50"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="40" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="50"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="41" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="50"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="42" data-semantic-parent="50" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="50"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="43" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="50"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="44" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="30" data-semantic-parent="50"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="45" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="31" data-semantic-parent="50"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="46" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="32" data-semantic-parent="50"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="47" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="33" data-semantic-parent="50"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="48" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="34" data-semantic-parent="50"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="49" data-semantic-parent="50" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="35" data-semantic-parent="50"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="53" data-semantic-parent="136" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-msub space="3" data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="93" data-semantic-children="55,92" data-semantic-parent="136" data-semantic-owns="55 92"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="55" data-semantic-parent="93"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="92" data-semantic-children="82,91" data-semantic-content="64" data-semantic-parent="93" data-semantic-owns="82 64 91"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="82" data-semantic-children="56,57,58,59,60,61,62,63" data-semantic-content="75,76,77,78,79,80,81" data-semantic-parent="92" data-semantic-owns="56 75 57 76 58 77 59 78 60 79 61 80 62 81 63"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="56" data-semantic-parent="82"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="75" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="57" data-semantic-parent="82"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="76" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="58" data-semantic-parent="82"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="77" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="59" data-semantic-parent="82"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="60" data-semantic-parent="82"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="61" data-semantic-parent="82"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="62" data-semantic-parent="82"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="81" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="82"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="64" data-semantic-parent="92" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="91" data-semantic-children="65,66,67,68,69,70,71,72,73" data-semantic-content="83,84,85,86,87,88,89,90" data-semantic-parent="92" data-semantic-owns="65 83 66 84 67 85 68 86 69 87 70 88 71 89 72 90 73"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="65" data-semantic-parent="91"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="66" data-semantic-parent="91"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="84" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="67" data-semantic-parent="91"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="85" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="91"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="91"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="87" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="91"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="88" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="71" data-semantic-parent="91"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="89" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="91"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="90" data-semantic-parent="91" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="73" data-semantic-parent="91"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="94" data-semantic-parent="136" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-msub space="3" data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="135" data-semantic-children="95,134" data-semantic-parent="136" data-semantic-owns="95 134"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="95" data-semantic-parent="135"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="134" data-semantic-children="123,133" data-semantic-content="104" data-semantic-parent="135" data-semantic-owns="123 104 133"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="123" data-semantic-children="96,97,98,99,100,101,102,103" data-semantic-content="116,117,118,119,120,121,122" data-semantic-parent="134" data-semantic-owns="96 116 97 117 98 118 99 119 100 120 101 121 102 122 103"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="96" data-semantic-parent="123"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="116" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="97" data-semantic-parent="123"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="117" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="98" data-semantic-parent="123"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="118" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="99" data-semantic-parent="123"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="119" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="100" data-semantic-parent="123"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="120" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="101" data-semantic-parent="123"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="121" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="102" data-semantic-parent="123"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="122" data-semantic-parent="123" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="103" data-semantic-parent="123"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="104" data-semantic-parent="134" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="133" data-semantic-children="105,106,107,108,109,110,111,112,113,114" data-semantic-content="124,125,126,127,128,129,130,131,132" data-semantic-parent="134" data-semantic-owns="105 124 106 125 107 126 108 127 109 128 110 129 111 130 112 131 113 132 114"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="105" data-semantic-parent="133"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="124" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="106" data-semantic-parent="133"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="125" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="107" data-semantic-parent="133"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="126" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="108" data-semantic-parent="133"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="127" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="109" data-semantic-parent="133"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="128" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="110" data-semantic-parent="133"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="129" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="111" data-semantic-parent="133"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="130" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="112" data-semantic-parent="133"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="131" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="113" data-semantic-parent="133"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="132" data-semantic-parent="133" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="114" data-semantic-parent="133"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 7)</div></div><div id="fd8" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper C Subscript i n h i b i t o r Baseline equals upper C Subscript u n b o u n d i n h i b i t o r Baseline plus upper C Subscript i n t e g r i n dot i n h i b i t o r" tabindex="0" ctxtmenu_counter="20" style="font-size: 130%;"><mjx-math data-semantic-structure="(98 (19 0 (18 1 10 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9)) 20 (97 (56 22 (55 23 40 24 41 25 42 26 43 27 44 28 45 29 46 31 47 32 48 33 49 34 50 35 51 36 52 37 53 38 54 39)) 57 (96 58 (95 (85 59 78 60 79 61 80 62 81 63 82 64 83 65 84 66) 67 (94 68 86 69 87 70 88 71 89 72 90 73 91 74 92 75 93 76)))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="98" data-semantic-children="19,97" data-semantic-content="20" data-semantic-owns="19 20 97" data-semantic-speech="upper C Subscript i n h i b i t o r Baseline equals upper C Subscript u n b o u n d i n h i b i t o r Baseline plus upper C Subscript i n t e g r i n dot i n h i b i t o r"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="19" data-semantic-children="0,18" data-semantic-parent="98" data-semantic-owns="0 18"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="19"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="18" data-semantic-children="1,2,3,4,5,6,7,8,9" data-semantic-content="10,11,12,13,14,15,16,17" data-semantic-parent="19" data-semantic-owns="1 10 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="18"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="10" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="18"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="18"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="18"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="18"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="18"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="18"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="18"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="18" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="18"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="20" data-semantic-parent="98" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="addition" data-semantic-id="97" data-semantic-children="56,96" data-semantic-content="57" data-semantic-parent="98" data-semantic-owns="56 57 96"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="56" data-semantic-children="22,55" data-semantic-parent="97" data-semantic-owns="22 55"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="22" data-semantic-parent="56"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="55" data-semantic-children="23,24,25,26,27,28,29,31,32,33,34,35,36,37,38,39" data-semantic-content="40,41,42,43,44,45,46,47,48,49,50,51,52,53,54" data-semantic-parent="56" data-semantic-owns="23 40 24 41 25 42 26 43 27 44 28 45 29 46 31 47 32 48 33 49 34 50 35 51 36 52 37 53 38 54 39"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="23" data-semantic-parent="55"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="40" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="55"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="41" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="55"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="42" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="55"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="43" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="55"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="44" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="55"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="45" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="55"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="46" data-semantic-parent="55" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="31" data-semantic-parent="55"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="47" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="32" data-semantic-parent="55"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="48" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="33" data-semantic-parent="55"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="49" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="34" data-semantic-parent="55"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="50" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="35" data-semantic-parent="55"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="51" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="36" data-semantic-parent="55"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="52" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="37" data-semantic-parent="55"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="53" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="38" data-semantic-parent="55"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="54" data-semantic-parent="55" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="39" data-semantic-parent="55"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="57" data-semantic-parent="97" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-msub space="3" data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="96" data-semantic-children="58,95" data-semantic-parent="97" data-semantic-owns="58 95"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="58" data-semantic-parent="96"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="95" data-semantic-children="85,94" data-semantic-content="67" data-semantic-parent="96" data-semantic-owns="85 67 94"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="85" data-semantic-children="59,60,61,62,63,64,65,66" data-semantic-content="78,79,80,81,82,83,84" data-semantic-parent="95" data-semantic-owns="59 78 60 79 61 80 62 81 63 82 64 83 65 84 66"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="59" data-semantic-parent="85"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="60" data-semantic-parent="85"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="61" data-semantic-parent="85"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="62" data-semantic-parent="85"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="81" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="85"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="82" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="64" data-semantic-parent="85"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="65" data-semantic-parent="85"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="84" data-semantic-parent="85" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="66" data-semantic-parent="85"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="67" data-semantic-parent="95" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="94" data-semantic-children="68,69,70,71,72,73,74,75,76" data-semantic-content="86,87,88,89,90,91,92,93" data-semantic-parent="95" data-semantic-owns="68 86 69 87 70 88 71 89 72 90 73 91 74 92 75 93 76"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="94"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="94"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="87" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="94"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="88" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="71" data-semantic-parent="94"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="89" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="94"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="90" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="73" data-semantic-parent="94"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="91" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="74" data-semantic-parent="94"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="92" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="75" data-semantic-parent="94"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="93" data-semantic-parent="94" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="76" data-semantic-parent="94"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 8)</div></div><div id="fd9" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper C Subscript e c h i s t a t i n Baseline equals upper C Subscript u n b o u n d e c h i s t a t i n Baseline plus upper C Subscript i n t e g r i n dot e c h i s t a t i n" tabindex="0" ctxtmenu_counter="21" style="font-size: 130%;"><mjx-math data-semantic-structure="(104 (21 0 (20 1 11 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10)) 22 (103 (60 24 (59 25 43 26 44 27 45 28 46 29 47 30 48 31 49 33 50 34 51 35 52 36 53 37 54 38 55 39 56 40 57 41 58 42)) 61 (102 62 (101 (90 63 83 64 84 65 85 66 86 67 87 68 88 69 89 70) 71 (100 72 91 73 92 74 93 75 94 76 95 77 96 78 97 79 98 80 99 81)))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="104" data-semantic-children="21,103" data-semantic-content="22" data-semantic-owns="21 22 103" data-semantic-speech="upper C Subscript e c h i s t a t i n Baseline equals upper C Subscript u n b o u n d e c h i s t a t i n Baseline plus upper C Subscript i n t e g r i n dot e c h i s t a t i n"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,20" data-semantic-parent="104" data-semantic-owns="0 20"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="20" data-semantic-children="1,2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18,19" data-semantic-parent="21" data-semantic-owns="1 11 2 12 3 13 4 14 5 15 6 16 7 17 8 18 9 19 10"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="20"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="20"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="20"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="20"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="20"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="20"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="20"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="20"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="20"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="19" data-semantic-parent="20" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="20"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="22" data-semantic-parent="104" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mspace style="width: 0.25em;"></mjx-mspace><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="addition" data-semantic-id="103" data-semantic-children="60,102" data-semantic-content="61" data-semantic-parent="104" data-semantic-owns="60 61 102"><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="60" data-semantic-children="24,59" data-semantic-parent="103" data-semantic-owns="24 59"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="60"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="59" data-semantic-children="25,26,27,28,29,30,31,33,34,35,36,37,38,39,40,41,42" data-semantic-content="43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58" data-semantic-parent="60" data-semantic-owns="25 43 26 44 27 45 28 46 29 47 30 48 31 49 33 50 34 51 35 52 36 53 37 54 38 55 39 56 40 57 41 58 42"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="59"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="43" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="59"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="44" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="59"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="45" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="59"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="46" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="59"><mjx-c class="mjx-c1D462">𝑢</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="47" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="30" data-semantic-parent="59"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="48" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="31" data-semantic-parent="59"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi><mjx-mspace data-semantic-type="operator" data-semantic-role="space" data-semantic-id="49" data-semantic-parent="59" data-semantic-operator="infixop,⁢" style="width: 0.25em;"></mjx-mspace><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="33" data-semantic-parent="59"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="50" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="34" data-semantic-parent="59"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="51" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="35" data-semantic-parent="59"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="52" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="36" data-semantic-parent="59"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="53" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="37" data-semantic-parent="59"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="54" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="38" data-semantic-parent="59"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="55" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="39" data-semantic-parent="59"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="56" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="40" data-semantic-parent="59"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="57" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="41" data-semantic-parent="59"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="58" data-semantic-parent="59" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="42" data-semantic-parent="59"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="addition" data-semantic-id="61" data-semantic-parent="103" data-semantic-operator="infixop,+"><mjx-c class="mjx-c2B">+</mjx-c></mjx-mo><mjx-msub space="3" data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="102" data-semantic-children="62,101" data-semantic-parent="103" data-semantic-owns="62 101"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="62" data-semantic-parent="102"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="101" data-semantic-children="90,100" data-semantic-content="71" data-semantic-parent="102" data-semantic-owns="90 71 100"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="90" data-semantic-children="63,64,65,66,67,68,69,70" data-semantic-content="83,84,85,86,87,88,89" data-semantic-parent="101" data-semantic-owns="63 83 64 84 65 85 66 86 67 87 68 88 69 89 70"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="90"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="64" data-semantic-parent="90"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="84" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="65" data-semantic-parent="90"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="85" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="66" data-semantic-parent="90"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="67" data-semantic-parent="90"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="87" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="68" data-semantic-parent="90"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="88" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="69" data-semantic-parent="90"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="89" data-semantic-parent="90" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="70" data-semantic-parent="90"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="71" data-semantic-parent="101" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="100" data-semantic-children="72,73,74,75,76,77,78,79,80,81" data-semantic-content="91,92,93,94,95,96,97,98,99" data-semantic-parent="101" data-semantic-owns="72 91 73 92 74 93 75 94 76 95 77 96 78 97 79 98 80 99 81"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="72" data-semantic-parent="100"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="91" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="73" data-semantic-parent="100"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="92" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="74" data-semantic-parent="100"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="93" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="75" data-semantic-parent="100"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="94" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="76" data-semantic-parent="100"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="95" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="77" data-semantic-parent="100"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="96" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="78" data-semantic-parent="100"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="97" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="79" data-semantic-parent="100"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="98" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="80" data-semantic-parent="100"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="99" data-semantic-parent="100" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="81" data-semantic-parent="100"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 9)</div></div><div id="fd10" class="display-formula"><div class="equation" role="math"><div class="inner"><mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper M upper F upper I Subscript o b s Baseline equals upper M upper F upper I 0 minus left parenthesis upper M upper F upper I 0 minus upper M upper F upper I Subscript s a t Baseline right parenthesis times upper C Subscript i n t e g r i n dot e c h i s t a t i n Baseline divided by upper C Subscript i n t e g r i n" tabindex="0" ctxtmenu_counter="22" style="font-size: 130%;"><mjx-math data-semantic-structure="(113 (112 0 110 1 111 (9 2 (8 3 6 4 7 5))) 10 (88 (87 11 85 12 86 (15 13 14)) 16 (89 (42 17 (41 (37 18 35 19 36 (22 20 21)) 23 (40 24 38 25 39 (33 26 (32 27 30 28 31 29)))) 34) 43 (109 (84 44 (83 (72 45 65 46 66 47 67 48 68 49 69 50 70 51 71 52) 53 (82 54 73 55 74 56 75 57 76 58 77 59 78 60 79 61 80 62 81 63))) 90 (108 91 (107 92 100 93 101 94 102 95 103 96 104 97 105 98 106 99))))))" class="MM-N" aria-hidden="true"><mjx-mrow data-semantic-type="relseq" data-semantic-role="equality" data-semantic-id="113" data-semantic-children="112,88" data-semantic-content="10" data-semantic-owns="112 10 88" data-semantic-speech="upper M upper F upper I Subscript o b s Baseline equals upper M upper F upper I 0 minus left parenthesis upper M upper F upper I 0 minus upper M upper F upper I Subscript s a t Baseline right parenthesis times upper C Subscript i n t e g r i n dot e c h i s t a t i n Baseline divided by upper C Subscript i n t e g r i n"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="112" data-semantic-children="0,1,9" data-semantic-content="110,111" data-semantic-parent="113" data-semantic-owns="0 110 1 111 9"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="112"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="110" data-semantic-parent="112" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="112"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="111" data-semantic-parent="112" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="9" data-semantic-children="2,8" data-semantic-parent="112" data-semantic-owns="2 8"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="9"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="8" data-semantic-children="3,4,5" data-semantic-content="6,7" data-semantic-parent="9" data-semantic-owns="3 6 4 7 5"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="8"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="6" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="8"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="7" data-semantic-parent="8" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="8"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="4" data-semantic-type="relation" data-semantic-role="equality" data-semantic-id="10" data-semantic-parent="113" data-semantic-operator="relseq,="><mjx-c class="mjx-c3D">=</mjx-c></mjx-mo><mjx-mrow space="4" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="subtraction" data-semantic-id="88" data-semantic-children="87,89" data-semantic-content="16" data-semantic-parent="113" data-semantic-owns="87 16 89"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="87" data-semantic-children="11,12,15" data-semantic-content="85,86" data-semantic-parent="88" data-semantic-owns="11 85 12 86 15"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="11" data-semantic-parent="87"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="85" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="12" data-semantic-parent="87"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="86" data-semantic-parent="87" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="15" data-semantic-children="13,14" data-semantic-parent="87" data-semantic-owns="13 14"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="13" data-semantic-parent="15"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="14" data-semantic-parent="15"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="subtraction" data-semantic-id="16" data-semantic-parent="88" data-semantic-operator="infixop,−"><mjx-c class="mjx-c2212">−</mjx-c></mjx-mo><mjx-mrow space="3" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="89" data-semantic-children="42,109" data-semantic-content="43" data-semantic-parent="88" data-semantic-owns="42 43 109"><mjx-mrow data-semantic-type="fenced" data-semantic-role="leftright" data-semantic-id="42" data-semantic-children="41" data-semantic-content="17,34" data-semantic-parent="89" data-semantic-owns="17 41 34"><mjx-mo data-semantic-type="fence" data-semantic-role="open" data-semantic-id="17" data-semantic-parent="42" data-semantic-operator="fenced"><mjx-c class="mjx-c28">(</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="subtraction" data-semantic-id="41" data-semantic-children="37,40" data-semantic-content="23" data-semantic-parent="42" data-semantic-owns="37 23 40"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="37" data-semantic-children="18,19,22" data-semantic-content="35,36" data-semantic-parent="41" data-semantic-owns="18 35 19 36 22"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="18" data-semantic-parent="37"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="35" data-semantic-parent="37" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="19" data-semantic-parent="37"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="36" data-semantic-parent="37" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="22" data-semantic-children="20,21" data-semantic-parent="37" data-semantic-owns="20 21"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="20" data-semantic-parent="22"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mn size="s" data-semantic-type="number" data-semantic-role="integer" data-semantic-font="normal" data-semantic-annotation="clearspeak:simple" data-semantic-id="21" data-semantic-parent="22"><mjx-c class="mjx-c30">0</mjx-c></mjx-mn></mjx-script></mjx-msub></mjx-mrow><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="subtraction" data-semantic-id="23" data-semantic-parent="41" data-semantic-operator="infixop,−"><mjx-c class="mjx-c2212">−</mjx-c></mjx-mo><mjx-mrow space="3" data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="40" data-semantic-children="24,25,33" data-semantic-content="38,39" data-semantic-parent="41" data-semantic-owns="24 38 25 39 33"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="24" data-semantic-parent="40"><mjx-c class="mjx-c1D440">𝑀</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="38" data-semantic-parent="40" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="25" data-semantic-parent="40"><mjx-c class="mjx-c1D439">𝐹</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="39" data-semantic-parent="40" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="33" data-semantic-children="26,32" data-semantic-parent="40" data-semantic-owns="26 32"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="26" data-semantic-parent="33"><mjx-c class="mjx-c1D43C">𝐼</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.057em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="32" data-semantic-children="27,28,29" data-semantic-content="30,31" data-semantic-parent="33" data-semantic-owns="27 30 28 31 29"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="27" data-semantic-parent="32"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="30" data-semantic-parent="32" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="28" data-semantic-parent="32"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="31" data-semantic-parent="32" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="29" data-semantic-parent="32"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow><mjx-mo data-semantic-type="fence" data-semantic-role="close" data-semantic-id="34" data-semantic-parent="42" data-semantic-operator="fenced"><mjx-c class="mjx-c29">)</mjx-c></mjx-mo></mjx-mrow><mjx-mo space="3" data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="43" data-semantic-parent="89" data-semantic-operator="infixop,×"><mjx-c class="mjx-cD7">×</mjx-c></mjx-mo><mjx-mrow space="3" data-semantic-type="infixop" data-semantic-role="division" data-semantic-id="109" data-semantic-children="84,108" data-semantic-content="90" data-semantic-parent="89" data-semantic-owns="84 90 108"><mjx-mrow><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="84" data-semantic-children="44,83" data-semantic-parent="109" data-semantic-owns="44 83"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="44" data-semantic-parent="84"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="multiplication" data-semantic-id="83" data-semantic-children="72,82" data-semantic-content="53" data-semantic-parent="84" data-semantic-owns="72 53 82"><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="72" data-semantic-children="45,46,47,48,49,50,51,52" data-semantic-content="65,66,67,68,69,70,71" data-semantic-parent="83" data-semantic-owns="45 65 46 66 47 67 48 68 49 69 50 70 51 71 52"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="45" data-semantic-parent="72"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="65" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="46" data-semantic-parent="72"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="66" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="47" data-semantic-parent="72"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="67" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="48" data-semantic-parent="72"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="68" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="49" data-semantic-parent="72"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="69" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="50" data-semantic-parent="72"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="70" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="51" data-semantic-parent="72"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="71" data-semantic-parent="72" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="52" data-semantic-parent="72"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="53" data-semantic-parent="83" data-semantic-operator="infixop,⋅"><mjx-c class="mjx-c22C5">⋅</mjx-c></mjx-mo><mjx-mrow data-semantic-added="true" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="82" data-semantic-children="54,55,56,57,58,59,60,61,62,63" data-semantic-content="73,74,75,76,77,78,79,80,81" data-semantic-parent="83" data-semantic-owns="54 73 55 74 56 75 57 76 58 77 59 78 60 79 61 80 62 81 63"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="54" data-semantic-parent="82"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="73" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="55" data-semantic-parent="82"><mjx-c class="mjx-c1D450">𝑐</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="74" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="56" data-semantic-parent="82"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="75" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="57" data-semantic-parent="82"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="76" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="58" data-semantic-parent="82"><mjx-c class="mjx-c1D460">𝑠</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="77" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="59" data-semantic-parent="82"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="78" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="60" data-semantic-parent="82"><mjx-c class="mjx-c1D44E">𝑎</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="79" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="61" data-semantic-parent="82"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="80" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="62" data-semantic-parent="82"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="81" data-semantic-parent="82" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="63" data-semantic-parent="82"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-mrow><mjx-mspace style="width: 0.25em;"></mjx-mspace></mjx-mrow></mjx-script></mjx-msub></mjx-mrow><mjx-mo data-semantic-type="operator" data-semantic-role="division" data-semantic-id="90" data-semantic-parent="109" data-semantic-operator="infixop,/"><mjx-c class="mjx-c2F">/</mjx-c></mjx-mo><mjx-msub data-semantic-type="subscript" data-semantic-role="latinletter" data-semantic-id="108" data-semantic-children="91,107" data-semantic-parent="109" data-semantic-owns="91 107"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="91" data-semantic-parent="108"><mjx-c class="mjx-c1D436">𝐶</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.15em; margin-left: -0.045em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="107" data-semantic-children="92,93,94,95,96,97,98,99" data-semantic-content="100,101,102,103,104,105,106" data-semantic-parent="108" data-semantic-owns="92 100 93 101 94 102 95 103 96 104 97 105 98 106 99"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="92" data-semantic-parent="107"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="100" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="93" data-semantic-parent="107"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="101" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="94" data-semantic-parent="107"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="102" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="95" data-semantic-parent="107"><mjx-c class="mjx-c1D452">𝑒</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="103" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="96" data-semantic-parent="107"><mjx-c class="mjx-c1D454">𝑔</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="104" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="97" data-semantic-parent="107"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="105" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="98" data-semantic-parent="107"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="106" data-semantic-parent="107" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="99" data-semantic-parent="107"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi></mjx-mrow></mjx-script></mjx-msub></mjx-mrow></mjx-mrow></mjx-mrow></mjx-mrow></mjx-math></mjx-container></div></div><div class="label">(Equation 10)</div></div></div><div id="p0380" role="paragraph">Global fitting of the competitive binding curves of UR-2922 and roxifiban, with <mjx-container class="MathJax CtxtMenu_Attached_0" jax="CHTML" overflow="overflow" aria-label="upper K Subscript d Superscript i n h i b i t o r" tabindex="0" ctxtmenu_counter="23" style="font-size: 130%;"><mjx-math data-semantic-structure="(21 (20 0 1) (19 2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10))" class="MM-N" aria-hidden="true"><mjx-mrow><mjx-msubsup data-semantic-type="subsup" data-semantic-role="latinletter" data-semantic-id="21" data-semantic-children="0,1,19" data-semantic-collapsed="(21 (20 0 1) 19)" data-semantic-owns="0 1 19" data-semantic-speech="upper K Subscript d Superscript i n h i b i t o r"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="0" data-semantic-parent="21"><mjx-c class="mjx-c1D43E">𝐾</mjx-c></mjx-mi><mjx-script style="vertical-align: -0.316em; margin-left: -0.04em;"><mjx-mrow size="s" data-semantic-type="infixop" data-semantic-role="implicit" data-semantic-annotation="clearspeak:unit" data-semantic-id="19" data-semantic-children="2,3,4,5,6,7,8,9,10" data-semantic-content="11,12,13,14,15,16,17,18" data-semantic-parent="21" data-semantic-owns="2 11 3 12 4 13 5 14 6 15 7 16 8 17 9 18 10" style="margin-left: 0.13em;"><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="2" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="11" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="3" data-semantic-parent="19"><mjx-c class="mjx-c1D45B">𝑛</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="12" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="4" data-semantic-parent="19"><mjx-c class="mjx-c210E">ℎ</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="13" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="5" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="14" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="6" data-semantic-parent="19"><mjx-c class="mjx-c1D44F">𝑏</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="15" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="7" data-semantic-parent="19"><mjx-c class="mjx-c1D456">𝑖</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="16" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="8" data-semantic-parent="19"><mjx-c class="mjx-c1D461">𝑡</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="17" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="9" data-semantic-parent="19"><mjx-c class="mjx-c1D45C">𝑜</mjx-c></mjx-mi><mjx-mo data-semantic-type="operator" data-semantic-role="multiplication" data-semantic-id="18" data-semantic-parent="19" data-semantic-added="true" data-semantic-operator="infixop,⁢"><mjx-c class="mjx-c2062">⁢</mjx-c></mjx-mo><mjx-mi data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="10" data-semantic-parent="19"><mjx-c class="mjx-c1D45F">𝑟</mjx-c></mjx-mi></mjx-mrow><mjx-spacer style="margin-top: 0.18em;"></mjx-spacer><mjx-mi size="s" data-semantic-type="identifier" data-semantic-role="latinletter" data-semantic-font="italic" data-semantic-annotation="clearspeak:simple" data-semantic-id="1" data-semantic-parent="21"><mjx-c class="mjx-c1D451">𝑑</mjx-c></mjx-mi></mjx-script></mjx-msubsup></mjx-mrow></mjx-math></mjx-container>, <i>MFI</i><sub>0</sub>, and <i>MFI</i><sub>sat</sub> as individual fitting parameters, and <i>C</i><sub>integrin</sub> as a shared fitting parameter, showed that the effective integrin αIIbβ3 or αIIbβ3_N305T concentration, <i>C</i><sub>integrin</sub>, at 10<sup>6</sup> cells/ml of transfectants could be confidently fitted as 15.3 ± 0.6&nbsp;nM for the WT αIIbβ3 transfectant and 10.2 ± 0.3&nbsp;nM for the αIIbβ3_N305T transfectant. The competitive binding curves of other αIIbβ3 inhibitors were fitted to <a id="crosref1620" href="#fd4">Equation 4</a> in the same way, except that the <i>C</i><sub>integrin</sub> determined using UR-2922 and roxifiban was used as a known parameter.</div></section><section id="sec-4-4-8"><h4>α4β1 LIBS antibody binding assays with secondary anti-IgG</h4><div id="p0385" role="paragraph">Jurkat cells were incubated with 10&nbsp;μM compound, together with 10&nbsp;μg/ml of HUTS-21 IgG or control mAb (mouse IgG) at 4°C in buffer that contained 20&nbsp;mM HEPES, pH 7.2, 150&nbsp;mM NaCl and 1% BSA, plus 1&nbsp;mM MgCl<sub>2</sub> and 1&nbsp;mM CaCl<sub>2</sub> or 1&nbsp;mM MnCl<sub>2</sub>. After 30&nbsp;min, cells were washed 3 times in buffers containing the same compound and metal ions, and FITC-conjugated goat anti-mouse IgG (Caltag Laboratories, Burlingame, CA) was used to detect HUTS-21 binding using flow cytometry.</div></section><section id="sec-4-4-9"><h4>Platelets LIBS exposure assay</h4><div id="p0390" role="paragraph">The study with human blood samples was approved by the Institutional Review Board of Medical College of Wisconsin. Blood samples anticoagulated with acid-citrate-dextrose were collected from healthy donors who had not taken any medication known to inhibit platelet function for at least a week. Platelet-rich plasma (PRP) was obtained by spinning the blood samples at 140×g for 12&nbsp;min at RT. After adding prostaglandin E1 (Sigma, #P5515) to a final concentration of 50&nbsp;ng/ml, the PRP was centrifuged at 1900×g for 10&nbsp;min at RT. The platelet pellet was washed in Ringer's citrate-dextrose buffer (108&nbsp;mM NaCl, 3.8&nbsp;mM KCl, 1.7&nbsp;mM NaHCO3, 21.2&nbsp;mM sodium citrate, 27.8&nbsp;mM glucose, 1.1&nbsp;mM MgCl2, pH 6.5) and resuspended in Tyrode’s buffer (137&nbsp;mM NaCl, 2.7&nbsp;mM KCl, 11.9&nbsp;mM NaHCO3, 0.43&nbsp;mM NaHPO4, 5.5&nbsp;mM glucose, 20&nbsp;mM Hepes, pH 7.4) supplemented with 1% BSA, 1mM CaCl<sub>2</sub>, and 1&nbsp;mM MgCl<sub>2</sub>. 36&nbsp;μl of washed platelets at 0.2×10<sup>8</sup>/ml were mixed with 4&nbsp;μl of buffer control or αIIbβ3 inhibitors and incubated for 20&nbsp;min at RT. Subsequently, 5&nbsp;μl of thrombin at 5&nbsp;U/ml and 5&nbsp;μl of Alexa647-conjugated MBC319.4 Fab at 250&nbsp;nM were added to 40&nbsp;μl of treated platelets for 30&nbsp;min at RT. Final inhibitor concentrations were &gt;70x <i>K</i><sub><i>D</i></sub> measured in 0.1% BSA with WT αIIbβ3 transfectants. Platelet fluorescence without washing was measured by flow cytometry using LSRII (BD Biosciences). The assay was done on three different days with blood samples from two different donors.</div></section><section id="sec-4-4-10"><h4>Clot retraction</h4><div id="p0395" role="paragraph">261&nbsp;μl of citrated-PRP was mixed with 29&nbsp;μl of buffer control or αIIbβ3 inhibitors at different concentrations prepared in Tyrode’s buffer supplemented with 1% BSA for 20&nbsp;min at RT. Clot retraction was initiated by the addition of 30&nbsp;μl of 7.5&nbsp;U/ml thrombin prepared in Tyrode’s buffer supplemented with 1% BSA to a glass tube containing 270&nbsp;μl inhibitor-treated PRP. The clots were allowed to retract at 37<sup>°</sup>C. Images were taken at 15-min intervals. The whole reaction and clot areas were calculated with ImageJ software. The clot retraction was presented as 1–(clot area/whole reaction area). The IC<sub>50</sub> for 30 and 90&nbsp;mins of clot retraction was calculated by fitting the data with the function of inhibitor vs response (three parameters) in Prism 8. The assay was done three times with PRP from three donors.</div></section><section id="sec-4-4-11"><h4>Platelet aggregation</h4><div id="p0400" role="paragraph">Whole blood platelet aggregation was measured by impedance aggregometry using a Chrono-log Model 700 aggregometer. Sodium citrate anticoagulated blood was left at RT for 30min before testing and used within 3h. 0.5&nbsp;ml of whole blood was incubated with 0.5&nbsp;ml physiologic saline supplemented with different concentrations of αIIbβ3 inhibitors (stock solutions prepared in saline) for 5&nbsp;min at 37<sup>°</sup>C without stirring. Aggregation was induced by adding 10&nbsp;μl ADP (final concentration: 20μM). Platelet aggregation was recorded for 6&nbsp;min with stirring at 1200rpm at 37<sup>°</sup>C. Data were presented as the relative aggregation by calculating the background-subtracted impedance (Ohms) as a percentage of impedance in absence of inhibitors. IC<sub>50</sub> was calculated by fitting the data with the function of inhibitor vs response (three parameters) in Prism 8. The assay was done three times with whole blood from three different donors.</div></section><section id="sec-4-4-12"><h4>Integrin inhibitors</h4><div id="p0405" role="paragraph">Lamifiban (CAS 144412-49-7), sibrafiban (CAS 144412-18-0), and α4β1/α4β7 inhibitor compound Ro 29 (CAS 1421673-59-7) were generous gifts from Dr. Paul Gillespie (Roche, Nutley, NJ). RUC-4 was a generous gift of Barry Coller (Rockefeller U., NY, NY). EF-5154 (<span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Nomoto et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Nomoto, M. ∙ Tatebayashi, T. ∙ Morita, J. ...</div><div><strong>Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in&nbsp;vitro intestinal parameters</strong></div><div><em>J.&nbsp;Pharm. Sci.</em> 2009; <strong>98</strong>:1532-1544</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1002%2Fjps.21510&amp;cf=fulltext&amp;site=xphs-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1002%2Fjps.21510&amp;cf=pdf&amp;site=xphs-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-67449149636" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18683862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjps.21510&amp;pmid=18683862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was provided by Meiji Seika Pharma Co. (Yokohama, Japan). Firategrast (CAS 402567-16-2) was purchased from ApexBio Technology (Houston, TX). UR-2922 (CAS 220386-56-1) was synthesized by HDH Pharma (Morrisville, NC). GR144053 (CAS 1215333-48-4) was purchased from Sigma-Aldrich. DS 13d (CAS 317353-73-4) (<span class="dropBlock reference-citations"><a id="body-ref-sref15-2" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15-2" aria-controls="sref15-2">Chiba et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref15-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Chiba, J. ∙ Machinaga, N. ∙ Takashi, T. ...</div><div><strong>Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 2005; <strong>15</strong>:41-45</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bmcl.2004.10.041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9644291524" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15582407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bmcl.2004.10.041&amp;pmid=15582407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was purchased as TCS 2314 from R&amp;D Systems (Minneapolis, MN). DS 13g (CAS 819078-63-2) was synthesized using the reagents and conditions described in Schemes 1 and 2 and the text in <span class="dropBlock reference-citations"><a id="body-ref-sref15-3" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15-3" aria-controls="sref15-3">Chiba et&nbsp;al. (2005)</a><div class="dropBlock__holder" data-db-target-of="sref15-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Chiba, J. ∙ Machinaga, N. ∙ Takashi, T. ...</div><div><strong>Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 2005; <strong>15</strong>:41-45</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bmcl.2004.10.041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9644291524" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15582407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bmcl.2004.10.041&amp;pmid=15582407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>. Other compounds were synthesized as described in the protocols below, based on the following references: BMS4 (CAS 270593-59-4), BMS4-1 (CAS 270593-50-5), BMS4-2 (CAS 270088-87-4), and BMS4-3, (<span class="dropBlock reference-citations"><a id="body-ref-sref90" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref90" aria-controls="sref90">Smallheer et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref90"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div>Smallheer, J.M., Wang, S., and Jadhav, P.K. (2001). Isoxazoline fibrinogen receptor antagonists. US patent US6303609 B1. published October 16, 2001.</div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Smallheer%2C+J.M.%2C+Wang%2C+S.%2C+and+Jadhav%2C+P.K.+%282001%29.+Isoxazoline+fibrinogen+receptor+antagonists.+US+patent+US6303609+B1.+published+October+16%2C+2001." target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); fradafiban (CAS 148396-36-5), (<span class="dropBlock reference-citations"><a id="body-ref-sref89" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref89" aria-controls="sref89">Himmelsbach et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref89"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div>Himmelsbach, F., Volkhard, A., Pieper, H., Linz, G., Weisenberger, J., and Mueller, T. (1996). Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds. US patent US5576444 published Nov. 19 1996.</div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Himmelsbach%2C+F.%2C+Volkhard%2C+A.%2C+Pieper%2C+H.%2C+Linz%2C+G.%2C+Weisenberger%2C+J.%2C+and+Mueller%2C+T.+%281996%29.+Cyclic+imino+derivatives%2C+processes+for+preparing+them+and+pharmaceutical+compositions+containing+these+compounds.+US+patent+US5576444+published+Nov.+19+1996." target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); roxifiban (CAS 170902-52-0), (<span class="dropBlock reference-citations"><a id="body-ref-sref84" href="#" role="doc-biblioref" data-xml-rid="bib84" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref84" aria-controls="sref84">Zhang et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref84"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">84.</div><div>Zhang, Lh ∙ Chung, J.C. ∙ Costello, T.D. ...</div><div><strong>The enantiospecific synthesis of an isoxazoline. A RGD mimic platelet GPIIb/IIIa antagonist</strong></div><div><em>J.&nbsp;Org. Chem.</em> 1997; <strong>62</strong>:2466-2470</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jo9612537" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0030962376" target="_blank" aria-label="Open Scopus in new tab">Scopus (85)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11671583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjo9612537&amp;pmid=11671583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); lotrafiban (CAS 171049-14-2), (<span class="dropBlock reference-citations"><a id="body-ref-sref45" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45" aria-controls="sref45">Ma and Xia, 2001</a><div class="dropBlock__holder" data-db-target-of="sref45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Ma, D. ∙ Xia, C.</div><div><strong>CuI-catalyzed coupling reaction of beta-amino acids or esters with aryl halides at temperature lower than that employed in the normal Ullmann reaction. Facile synthesis of SB-214857</strong></div><div><em>Org. Lett.</em> 2001; <strong>3</strong>:2583-2586</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ol016258r" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035833707" target="_blank" aria-label="Open Scopus in new tab">Scopus (262)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11483066/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fol016258r&amp;pmid=11483066" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); gantofiban (CAS 167364-04-7) and the gantofiban analog (CAS 167364-14-9) (<span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Gante et&nbsp;al., 1996</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Gante, J. ∙ Juraszyk, H. ∙ Raddatz, P. ...</div><div><strong>New antithrombotic RGD-mimetics with high bioavailability</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 1996; <strong>6</strong>:2425-2430</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0960-894X(96)00445-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0030598191" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0960-894X%2896%2900445-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The synthetic route to M-tirofiban and its isomer were not published and were as described below. Purity of all compounds was greater than 95%, as confirmed by NMR, LC-MS, and/or elemental analyses.)</div></section><section id="sec-4-4-13"><h4>Synthetic protocols</h4><div id="p0410" role="paragraph">All solvents and reagents obtained from commercial sources were used without further purification. The final products were purified on Agela Cheetah purification system MP200 equipped with Hilic column (4g) with CH<sub>3</sub>CN/H<sub>2</sub>O as eluent. The <sup>1</sup>H NMR spectra at 400 MHz were performed on a Bruker Avance DRX-400 spectrometer with the chemical shifts (δ in ppm) in the solvent CD<sub>3</sub>OD referenced at 3.31 ppm and D<sub>2</sub>O at 4.79 ppm, and coupling constants (J)&nbsp;were given in hertz. The <sup>13</sup>C NMR spectra at 101 MHz were performed on the Bruker Avance DRX-400 spectrometer with the chemical shifts (δ in ppm) in the solvent CD<sub>3</sub>OD referenced at 49.0 ppm. The high resolution mass spectra (HRMS) were measured by Waters Xevo G2 QTof equipped with ESI.</div></section><section id="sec-4-4-14"><h4>Synthetic scheme of BMS4 (compound 2) (CAS 270593-59-4)</h4><div id="p0415" role="paragraph"><div class="figure-wrap"><figure id="undfig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/174bb340-7755-48f4-a469-64edc80a01f9/main.assets/fx2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx2" alt="Figure undfig2" src="/cms/10.1016/j.cell.2022.08.008/asset/c03269bf-c7d5-4525-8b82-c33db3479c96/main.assets/fx2.jpg" height="234" width="604" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/174bb340-7755-48f4-a469-64edc80a01f9/main.assets/fx2_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-14-1"><h5>4-Cyanobenzaldoxime (2-1)</h5><div id="p0420" role="paragraph">To a solution of 4-benzaldehyde (13.13 g, 100&nbsp;mmol) in EtOH/pyridine (1:1, 200&nbsp;mL) was added hydroxylamine hydrochloride portion-wise (7.64 g, 110&nbsp;mmol) under N<sub>2</sub> protection. After overnight stirring at room temperature, the solvent was removed half volume and ice water (200&nbsp;mL) was added to obtain the precipitation, which was washed with ice water and dried to afford the title compound (9.76 g, 83%).</div></section><section id="sec-4-4-14-2"><h5>4-Cyanobenzaldoximinochloride (2-2)</h5><div id="p0425" role="paragraph">To a solution of 4-cyanobenzaldoxime (10.96 g, 75&nbsp;mmol) in anhydrous DMF (200&nbsp;mL) was added N-chlorosuccimide (11.93 g, 90&nbsp;mmol) in portion-wise at room temperature under N<sub>2</sub> protection for 16 h. The reaction mixture was poured into ice water (250&nbsp;mL) and the precipitation was collected by filtration, washed with water and dried in vacuo to afford the title compound (9.88 g, 73%).</div></section><section id="sec-4-4-14-3"><h5><i>tert</i>-Butyl 4-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazine-1-carboxylate (2-3)</h5><div id="p0430" role="paragraph">Potassium carbonate (18.66 g, 135&nbsp;mmol) was added to a solution of <i>tert</i>-butyl piperazine-1-carboxylate (10.0 g, 54&nbsp;mmol) in anhydrous DMF (100&nbsp;mL) under N<sub>2</sub> protection. The mixture was allowed to stir at room temperature for half an hour, followed by addition of allyl bromide (5.0&nbsp;mL, 59.4&nbsp;mmol) and 4&nbsp;h stirring. Saturated sodium bicarbonate solution (50&nbsp;mL) was then added and the mixture was extracted by ethyl acetate (150&nbsp;mL×3). The organic layers were combined, washed by brine, dried over MgSO<sub>4</sub>, and concentrated to offer <i>tert</i>-butyl 4-allylpiperazine-1-carboxylate (10.02 g, 82%).</div><div id="p0435" role="paragraph">To a solution of 4-cyanobenzaldoximinochloride (5.42 g, 30&nbsp;mmol) and <i>tert</i>-butyl 4-allylpiperazine-1-carboxylate (6.79 g, 30&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (150&nbsp;mL) was dropwise added Et<sub>3</sub>N (3.33 g, 33&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (50&nbsp;mL) in 2&nbsp;h at room temperature. After stirring at room temperature for 16 h, saturated Na<sub>2</sub>CO<sub>3</sub> solution (100&nbsp;mL) was added and the organic phase was separated, dried over MgSO<sub>4</sub>, concentrated under vacuum and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:1) to offer the title product (6.89 g, 62%).</div></section><section id="sec-4-4-14-4"><h5>Ethyl 2-(4-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate (2-5)</h5><div id="p0440" role="paragraph">To a solution of <i>tert</i>-butyl 4-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazine-1-carboxylate (3.70 g, 10&nbsp;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL) was added trifluoroacetic acid (10&nbsp;mL) at 0 °C. After stirring at room temperature for 2 h, the mixture was concentrated and dried. The residue was dissolved in DMF (50&nbsp;mL), followed by the addition of anhydrous K<sub>2</sub>CO<sub>3</sub> (4.14 g, 30&nbsp;mmol) and ethyl bromoacetate (1.46&nbsp;mL, 12&nbsp;mmol) at room temperature under N<sub>2</sub> protection. After stirring overnight, the mixture was diluted with ethyl acetate (100&nbsp;mL) and successively washed with saturated NaHCO<sub>3</sub> solution and brine. The organic phase was dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel chromatography (ethyl acetate/petroleum ether, 5:1) to offer the title product (2.03g, 57%).</div></section><section id="sec-4-4-14-5"><h5>Ethyl 2-(4-((3-(4-(imino(4-methylpiperazin-1-yl)methyl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate (2-6)</h5><div id="p0445" role="paragraph">Acetyl chloride (3.5&nbsp;mL) was added dropwise to dry EtOH (6.5&nbsp;mL) at 0°C under N<sub>2</sub> protection to produce 35% HCl/EtOH/EtOAc solution. To this freshly prepared solution was added 2-(4-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate(0.36 g, 1&nbsp;mmol) at 0°C. After an additional 2&nbsp;h stirring at 0°C, the mixture was stirred at room temperature for another 48 h, and then concentrated and dried in vacuo. The residue was dissolved in EtOH (5&nbsp;mL), treated with N-methyl piperazine (1.00 g, 10&nbsp;mmol) at room temperature under N<sub>2</sub> protection for 16 h. The reaction mixture was concentrated, purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 50:1 to 10:1) to offer the title product (0.22 g, 48%).</div></section><section id="sec-4-4-14-6"><h5>2-(4-((3-(4-(imino(4-methylpiperazin-1-yl)methyl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetic acid (compound 2, BMS4)</h5><div id="p0450" role="paragraph">Ethyl 2-(4-((3-(4-(imino(4-methylpiperazin-1-yl)methyl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate (91&nbsp;mg, 0.2 mmol) was hydrolyzed in methanol (1&nbsp;mL) and H<sub>2</sub>O (1&nbsp;mL), followed by the addition of NaOH (24&nbsp;mg, 0.6&nbsp;mmol) at room temperature. After stirring for 3 h, the resulting mixture was added 1N HCl (0.6&nbsp;mL), and then concentrated, purified by hilic column chromatography to offer BMS4 (30&nbsp;mg, 35%). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ (ppm): 7.82(d, <i>J</i>&nbsp;= 7.2&nbsp;Hz, 2H), 7.61(d, <i>J</i>&nbsp;= 7.2&nbsp;Hz, 2H), 5.05(m, 1H), 3.93(s, 2H), 3.63(m, 5H), 3.29-2.77(m, 15H), 2.71(s, 3H); <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ (ppm): 170.1, 165.4, 158.3, 132.8, 129.3, 128.9, 127.7, 78.9, 60.2, 58.3, 52.7, 51.7, 49.7, 47.4, 43.3, 38.5; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>22</sub>H<sub>33</sub>N<sub>6</sub>O<sub>3</sub>: 429.2614; found 429.2613.</div></section></section><section id="sec-4-4-15"><h4>Synthetic scheme of BMS4-1 (compound 3) (CAS 270593-50-5)</h4><div id="p0455" role="paragraph"><div class="figure-wrap"><figure id="undfig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/5e47632e-baff-4ae9-bbd8-f6c8a3669a89/main.assets/fx3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx3" alt="Figure undfig3" src="/cms/10.1016/j.cell.2022.08.008/asset/e50676e5-7461-4504-bc5f-7ef6d5a60163/main.assets/fx3.jpg" height="40" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5e47632e-baff-4ae9-bbd8-f6c8a3669a89/main.assets/fx3_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0460" role="paragraph">2-5</div><section id="sec-4-4-15-1"><h5>Ethyl 2-(4-((3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate (3-1)</h5><div id="p0465" role="paragraph">To freshly prepared HCl/EtOH/EtOAc solution (35%, 10&nbsp;mL) was added 2-(4-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate <b>(2-5)</b> (0.36 g, 1&nbsp;mmol). After 2&nbsp;h at 0°C, the mixture was further stirred at room temperature for 48 h, and then concentrated and dried in vacuo. The residue was dissolved in EtOH (5&nbsp;mL), treated with ammonium carbonate (1.01 g, 10&nbsp;mmol) at room temperature under N<sub>2</sub> protection for 16 h, concentrated, and purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 50:1 to 10:1) to give the title product (0.29 g, 78%).</div></section><section id="sec-4-4-15-2"><h5>3-(4-((3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetic acid (BMS4-1, compound 3)</h5><div id="p0470" role="paragraph">Ethyl 2-(4-((3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate (<b>3-1</b>, 0.07 g, 0.2&nbsp;mmol) was hydrolyzed in MeOH/H<sub>2</sub>O (1/1, 2&nbsp;mL) with NaOH (24&nbsp;mg, 0.6&nbsp;mmol) at room temperature for 3 h. The reaction was then quenched by 1N HCl (0.6&nbsp;mL), concentrated and purified by silica column chromatography to offer BMS4-1 (29&nbsp;mg, 42%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.94(d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 7.89(d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 5.28(m, 1H), 3.79(s, 2H), 3.72(m, 1H), 3.39-3.31(m, 11H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ (ppm):170.6, 167.8, 157.8, 135.7, 130.8, 129.6, 128.7, 78.7, 60.8, 57.4, 52.3, 51.3, 39.6; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>17</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>: 346.1879; found 346.1870.</div></section><section id="sec-4-4-15-3"><h5>Synthetic scheme of BMS4-2 (CAS 270088-87-4) (compound 5)</h5><div id="p0475" role="paragraph"><div class="figure-wrap"><figure id="undfig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/62550a95-1b51-4d74-985b-041ce5c8ec61/main.assets/fx4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx4" alt="Figure undfig4" src="/cms/10.1016/j.cell.2022.08.008/asset/c5c1978e-bd06-4bde-8899-fda8842ec9c1/main.assets/fx4.jpg" height="216" width="577" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/62550a95-1b51-4d74-985b-041ce5c8ec61/main.assets/fx4_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div></section><section id="sec-4-4-15-4"><h5>4-(5-(hydroxymethyl)-4,5-dihydroisoxazol-3-yl)benzonitrile (5-1)</h5><div id="p0480" role="paragraph">To a vigorously stirred solution of 4-cyano-N-hydroxybenzimidoyl chloride (3.6g, 20&nbsp;mmol) and allyl alcohol (2.32g, 40&nbsp;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100&nbsp;mL) at 0°C was added 8% aqueous solution of NaOCl (37.3&nbsp;mL, 40&nbsp;mmol) dropwise, with the temperature below 5°C. The mixture was stirred at room temperature for an additional 15&nbsp;min. Then the aqueous phase was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub> (100&nbsp;mL×2). The combined organic layers were washed with brine, dried over MgSO<sub>4</sub>, and concentrated, and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:2) to offer the title compound (2.75g, 68%).</div></section><section id="sec-4-4-15-5"><h5>(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl methanesulfonate (5-2)</h5><div id="p0485" role="paragraph">To a solution of 4-(5-(hydroxymethyl)-4,5-dihydroisoxazol-3-yl)benzonitrile(1.01 g, 5&nbsp;mmol) and Et<sub>3</sub>N (0.84&nbsp;mL, 6&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (20&nbsp;mL), methanesulfonyl chloride (0.48&nbsp;mL, 6.00&nbsp;mmol) was added dropwise at 0°C. The mixture was stirred at room temperature for 2 h, and then quenched with water (10&nbsp;mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (20&nbsp;mL×2), and the combined organic phases were successively washed with 1N HCl, saturated NaHCO<sub>3</sub> solution, brinedried over MgSO<sub>4</sub>, and concentrated in vacuo to offer the crude title product (1.21 g, 86%).</div></section><section id="sec-4-4-15-6"><h5>Ethyl 2-(1-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperidin-4-yl)acetate (5-3)</h5><div id="p0490" role="paragraph">To a solution of <i>tert</i>-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate(1.36 g, 5&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL) was added TFA (10&nbsp;mL) at 0°C. The resulting mixture was stirred at room temperature for 2 h, and then concentrated and dried in vacuo without further purification. To a solution of (3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl methanesulfonate (1.12 g, 4&nbsp;mmol) in acetonitrile was added CsCO<sub>3</sub> (6.51 g, 20&nbsp;mmol)and ethyl 2-(piperidin-4-yl)acetate (1.72 g, 5&nbsp;mmol) at room temperature under N<sub>2</sub> protection.The resulting mixture was refluxed for 16&nbsp;h and then concentrated. The residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:1) to offer the title compound (0.82 g, 46%).</div></section><section id="sec-4-4-15-7"><h5>Ethyl 2-(1-((3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperidin-4-yl)acetate (5-4)</h5><div id="p0495" role="paragraph">Ethyl 2-(1-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperidin-4-yl)acetate (0.36 g, 1&nbsp;mmol) was added to freshly prepared HCl/EtOH/EtOAc solution (35%, 10&nbsp;mL) at 0°C over 2 h, followed by stirring at room temperature for 48 h. The reaction mixture was then concentrated and dissolved in EtOH (5&nbsp;mL), followed by the addition of ammonium carbonate (1.01 g, 10&nbsp;mmol). After stirring at room temperature under N<sub>2</sub> protection for 16 h, the mixture was concentrated in vacuo, purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1 to 10:1) to offer the title product (0.25 g, 68%).</div></section><section id="sec-4-4-15-8"><h5>2-(1-((3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperidin-4-yl)acetic acid (compound 5, BMS 4.2)</h5><div id="p0500" role="paragraph">To a solution of ethyl 2-(1-((3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperidin-4-yl)acetate(74&nbsp;mg, 0.2&nbsp;mmol) in methanol/ H<sub>2</sub>O (1:1, 2&nbsp;mL) was added NaOH (24&nbsp;mg, 0.6&nbsp;mmol). After stirring at room temperature for 3 h, the mixture was quenched by 1N HCl (0.6&nbsp;mL), concentrated and purified by silica column chromatography to offer BMS4-2 (26&nbsp;mg, 38%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.95(d, <i>J</i>&nbsp;= 8.8&nbsp;Hz, 2H), 7.89(d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 5.34(m, 1H), 3.74(m, 1H), 3.68(m, 2H), 3.44(d, <i>J</i>&nbsp;= 6.2Hz, 2H),3.34(m, 1H), 3.14(t, <i>J</i>&nbsp;= 12.4Hz, 2H), 2.34(d, <i>J</i>&nbsp;= 6.4&nbsp;Hz, 2H), 2.06(m, 3H), 1.65(m, 2H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ (ppm):175.7, 167.9, 157.7, 135.6, 131.0, 129.6, 128.7, 77.3, 60.7, 54.8, 54.0, 39.9, 31.6, 29.8; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>18</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>: 345.1927; found 345.1927.</div></section></section><section id="sec-4-4-16"><h4>Synthetic scheme of BMS4-3 (compound 10)</h4><div id="p0505" role="paragraph"><div class="figure-wrap"><figure id="undfig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/a81c3073-b71e-425f-bc39-f4b3993e236c/main.assets/fx5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx5" alt="Figure undfig5" src="/cms/10.1016/j.cell.2022.08.008/asset/fd92947d-83f1-4392-bbd9-ad18d0876c40/main.assets/fx5.jpg" height="185" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/a81c3073-b71e-425f-bc39-f4b3993e236c/main.assets/fx5_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-16-1"><h5><i>tert</i>-Butyl 4-(2-ethoxy-2-oxoethyl)piperazine-1-carboxylate (10-1)</h5><div id="p0510" role="paragraph">To a solution of <i>tert</i>-butyl piperazine-1-carboxylate (10.23 g, 55&nbsp;mmol) in DMF (100&nbsp;mL) was added K<sub>2</sub>CO<sub>3</sub> (18.66 g, 135&nbsp;mmol). After stirring at room temperature for 0.5 h, to the mixture was added ethyl bromoacetate (6.6&nbsp;mL, 59.4mmol). The reaction mixture&nbsp;was stirred at room temperature for 4 h, quenched by saturated NaHCO<sub>3</sub> solution (200&nbsp;mL), and extracted with EtOAc (100&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub> and concentrated to offer the title product (12.94 g, 88%).</div></section><section id="sec-4-4-16-2"><h5>Ethyl 2-(4-allylpiperazin-1-yl)acetate (10-3)</h5><div id="p0515" role="paragraph">To a solution of <i>tert</i>-butyl 4-(2-ethoxy-2-oxoethyl)piperazine-1-carboxylate (5.74 g, 20&nbsp;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20&nbsp;mL) was added TFA (20&nbsp;mL) at 0°C. After stirring at room temperature for 2 h, the mixture was concentrated and dried in vacuo. The residue was dissolved in DMF (100&nbsp;mL), followed by the addition of anhydrous K<sub>2</sub>CO<sub>3</sub> (5.52 g, 40&nbsp;mmol) and 3-bromopropene (2.03&nbsp;mL, 24&nbsp;mmol) at room temperature under N<sub>2</sub> protection. After stirring overnight, the mixture was diluted with EtOAc (100&nbsp;mL) and washed with H<sub>2</sub>O (100&nbsp;mL), followed by the addition of saturated NaHCO<sub>3</sub> solution and brine. The organic phase was dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel chromatography (ethyl acetate/petroleum ether, 2:1) to offer the title product (3.31g, 78%).</div></section><section id="sec-4-4-16-3"><h5><i>tert</i>-Butyl (E)-4-((hydroxyimino)methyl)piperidine-1-carboxylate (10-4)</h5><div id="p0520" role="paragraph">To a solution of <i>tert</i>-butyl 4-formylpiperidine-1-carboxylate (10.67 g, 50&nbsp;mmol) in 1:1 EtOH/pyridine (100&nbsp;mL) was added hydroxylamine hydrochloride (3.83 g, 55&nbsp;mmol) portion-wise under N<sub>2</sub> atmosphere. After stirring overnight at room temperature, the solvent was removed half volume and ice water (100&nbsp;mL) was added to obtain the precipitation, which was washed with ice water and dried to offer the title compound (8.68 g, 76%).</div></section><section id="sec-4-4-16-4"><h5><i>tert</i>-Butyl (<i>Z</i>)-4-(chloro(hydroxyimino)methyl)piperidine-1-carboxylate (10-5)</h5><div id="p0525" role="paragraph">To a solution of <i>tert</i>-butyl (E)-4-((hydroxyimino)methyl)piperidine-1-carboxylate (6.85 g, 30&nbsp;mmol) in anhydrous DMF (100&nbsp;mL) was added N-chlorosuccimide (3.01 g, 36&nbsp;mmol) in portion-wise at room temperature under N<sub>2</sub> protection for 16 h. The reaction mixture was poured into ice water (250&nbsp;mL) and the precipitation was collected by filtration, washed with water and dried in vacuo to afford the title compound (5.44 g, 69%).</div></section><section id="sec-4-4-16-5"><h5><i>tert</i>-Butyl 4-(5-((4-(2-ethoxy-2-oxoethyl)piperazin-1-yl)methyl)-4,5-dihydroisoxazol-3-yl)piperidine-1-carboxylate (10-6)</h5><div id="p0530" role="paragraph">To a solution of <i>tert</i>-butyl (<i>Z</i>)-4-(chloro(hydroxyimino)methyl)piperidine-1-carboxylate (2.62 g, 10&nbsp;mmol) and ethyl 2-(4-allylpiperazin-1-yl)acetate (2.12 g, 10&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (100&nbsp;mL) was added dropwise Et<sub>3</sub>N (3.33 g, 33 mol) in dry CH<sub>2</sub>Cl<sub>2</sub> (50&nbsp;mL) in 2&nbsp;h at room temperature. After stirring at room temperature for 16 h, saturated Na<sub>2</sub>CO<sub>3</sub> solution (150&nbsp;mL) was added into the mixture and the organic phase was dried over MgSO<sub>4</sub>, concentrated in vacuo and purified by silica gel chromatography (ethyl acetate/petroleum ether, 5:1) to offer the title product containing <b>10-3</b> (1.67 g).</div></section><section id="sec-4-4-16-6"><h5>Ethyl 2-(4-((3-(piperidin-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate trifluoroacetic acid salt (10-7)</h5><div id="p0535" role="paragraph">To a solution of crude <i>tert</i>-butyl 4-(5-((4-(2-ethoxy-2-oxoethyl)piperazin-1-yl)methyl)-4,5-dihydroisoxazol-3-yl)piperidine-1-carboxylate (0.8 g) in CH<sub>2</sub>Cl<sub>2</sub> (5&nbsp;mL) was added TFA (5&nbsp;mL) at 0 °C. After stirring at room temperature for 2 h, the mixture was concentrated and purified by silica column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH, 50:1 to 10:1) to offer the title product (0.36 g).</div></section><section id="sec-4-4-16-7"><h5>2-(4-((3-(piperidin-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetic acid, BMS4-3 (10)</h5><div id="p0540" role="paragraph">To a solution of ethyl 2-(4-((3-(piperidin-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)piperazin-1-yl)acetate trifluoroacetic acid salt (81&nbsp;mg, 0.2&nbsp;mmol) in methanol (1&nbsp;mL) and H<sub>2</sub>O (1&nbsp;mL) was added NaOH (32&nbsp;mg, 0.8&nbsp;mmol). After stirring at room temperature for 3 h, to the mixture was added 1N HCl (0.8&nbsp;mL). The resulting mixture was concentrated and purified by hilic column chromatography to offer BMS4-3 (11&nbsp;mg, 18%). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ (ppm): 4.97 (m, 1H), 3.75 (s, 2H), 3.53 to 3.31 (m, 7H), 3.12 (m, 6H), 2.87 (m, 4H), 2.22(m, 2H), 1.84 (m, 2H); <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ (ppm):170.2, 163.3, 76.8, 59.9, 51.4, 49.7, 43.3, 39.4, 32.5, 27.6, 25.5; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>15</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>: 311.2083; found 311.2076.</div></section></section><section id="sec-4-4-17"><h4>Synthetic scheme of Fradafiban (CAS 148396-36-5)</h4><div id="p0545" role="paragraph"><div class="figure-wrap"><figure id="undfig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/0cdca29d-b6de-4aeb-b446-2fdc331d109f/main.assets/fx6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx6" alt="Figure undfig6" src="/cms/10.1016/j.cell.2022.08.008/asset/089a6a98-bd54-4282-bc89-c77cc8fbcebb/main.assets/fx6.jpg" height="209" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/0cdca29d-b6de-4aeb-b446-2fdc331d109f/main.assets/fx6_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-17-1"><h5>(<i>S</i>)-5-(Hydroxymethyl)-2-pyrrolidone (F-1)</h5><div id="p0550" role="paragraph">SOCl<sub>2</sub> (8.52&nbsp;mL, 120&nbsp;mmol) was added dropwise to a solution of (<i>S</i>)-5-oxopyrrolidine-2-carboxylic acid (12.91 g, 100&nbsp;mmol) in MeOH (100&nbsp;mL) at 0°C. The resulting mixture was stirred at room temperature for 16 h, concentrated in vacuo, and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:5) to offer intermediate methyl (<i>S</i>)-5-oxopyrrolidine-2-carboxylate (9.88 g, 69%). To this intermediate (7.16 g, 50&nbsp;mmol) in MeOH (20&nbsp;mL) was portion-wise added sodium borohydride (2.08 g, 55&nbsp;mmol) under N<sub>2</sub> protection. The mixture was stirred overnight, quenched by saturated NH<sub>4</sub>Cl (50&nbsp;mL), and concentrated in vacuo. The residue was then dissolved in water (100&nbsp;mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (100&nbsp;mL×5). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, and concentrated to offer the crude title compound (3.01 g, 52%).</div></section><section id="sec-4-4-17-2"><h5>(<i>5S</i>)-5-Trithloxymethyl-2-pyrrolinone (F-2)</h5><div id="p0555" role="paragraph">To a solution of (<i>S</i>)-5-hydroxymethyl-2-pyrrolidinone (2.30 g, 20.0&nbsp;mmol), Et<sub>3</sub>N (4.2&nbsp;mL, 30.0&nbsp;mmol), DMAP (300&nbsp;mg, 2.67&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (200&nbsp;mL) was added triphenylmethyl chloride (8.40 g, 30.0&nbsp;mmol) over 5&nbsp;min at room temperature. After stirring overnight, the mixture was washed with water, dried over MgSO<sub>4</sub>, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:5) to offer the title product (8.25 g, 75%).</div></section><section id="sec-4-4-17-3"><h5>(<i>S</i>)-Benzyl 2-oxo-5-((trityloxy)methyl)pyrrolidine-1-carboxylate (F-3)</h5><div id="p0560" role="paragraph">To a solution of (<i>5S</i>)-5-trityloxymethyl-2-pyrrolinone (7.55 g, 20&nbsp;mmol) in dry THF (100&nbsp;mL) was added a 2.5N solution of <i>n</i>-butyllithium in <i>n</i>-hexane(8.4&nbsp;mL, 21&nbsp;mmol) at -78°C. After stirring for 30&nbsp;min, a solution of benzyl chloroformate (2.86&nbsp;mL, 21&nbsp;mmol) was added dropwise. The reaction mixture was stirred at -78 °C for 8 h, then quenched with saturated NH<sub>4</sub>Cl (20&nbsp;mL). The mixture was concentrated to remove THF, and extracted with diethyl ether (30&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, concentrated in vacuo and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:10) to offer the title compound (4.12 g, 89%).</div></section><section id="sec-4-4-17-4"><h5>(<i>3S,5S</i>)-Benzyl 3-(2-(tert-butoxy)-2-oxoethyl)-2-oxo-5-((trityloxy)methyl)pyrrolidine-1-carboxylate (F-4)</h5><div id="p0565" role="paragraph">To a solution of (<i>S</i>)-benzyl 2-oxo-5-((trityloxy)methyl)pyrrolidine-1-carboxylate (4.92 g, 10&nbsp;mmol) in THF (50&nbsp;mL) was added dropwise lithium hexamethyldisilazide in THF (1 M, 10.5&nbsp;mL) at -65°C under N<sub>2</sub> protection. After 20&nbsp;min, a solution of <i>tert</i>-butyl bromoacetate (1.70&nbsp;mL, 10.5&nbsp;mmol) in THF (5&nbsp;mL) was added dropwise. After stirring at -65°C for 2 h, the mixture was warmed to 0°C, followed by the addition of a saturated NH<sub>4</sub>Cl solution (20&nbsp;mL). The mixture was concentrated in vacuo to remove THF, and extracted with EtOAc (20&nbsp;mL×3). The organic phases were combined and washed with brine, dried over MgSO<sub>4</sub>, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:4) to afford the title product (5.01 g, 76%).</div></section><section id="sec-4-4-17-5"><h5><i>tert</i>-Butyl 2-((<i>3S,5S</i>)-5-(hydroxymethyl)-2-oxopyrrolidin-3-yl)acetate (F-5)</h5><div id="p0570" role="paragraph">To a solution of (<i>3S,5S</i>)-benzyl 3-(2-(tert-butoxy)-2-oxoethyl)-2-oxo-5-((trityloxy)methyl)pyrrolidine-1-carboxylate (3.03 g, 5&nbsp;mmol) in <i>t</i>-butanol (30&nbsp;mL) was added 10% Pd/C (0.45 g) under a hydrogen pressure of 5 bars. The resulting mixture was stirred for 1.5&nbsp;days at 50°C. Then the mixture was filtered off and the filtrate was concentrated in vacuo. The residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 5:1) to offer the title product (0.66 g, 58%).</div></section><section id="sec-4-4-17-6"><h5><i>tert</i>-Butyl 2-((<i>3S,5S</i>)-5-(((4'-cyano-[1,1'-biphenyl]-4-yl)oxy)methyl)-2-oxopyrrolidin-3-yl)acetate (F-7)</h5><div id="p0575" role="paragraph">Methylsulfonyl chloride (0.21&nbsp;mL, 2.65&nbsp;mmol) was added dropwise to a solution of <i>tert</i>-butyl 2-((<i>3S,5S</i>)-5-(hydroxymethyl)-2-oxopyrrolidin-3-yl)acetate (0.57 g, 2.5&nbsp;mmol) and Et<sub>3</sub>N (0.35&nbsp;mL, 2.65&nbsp;mmol) in dry DMF (15&nbsp;mL) at 0°C. After stirring at room temperature for 8 h, the mixture was quenched with water (20&nbsp;mL), extracted by CH<sub>2</sub>Cl<sub>2</sub> (20&nbsp;mL×3), dried over MgSO<sub>4</sub>, and concentrated to offer crude intermediate <b>F-6</b> (0.66 g, 86%).</div><div id="p0580" role="paragraph"><i>t</i>-BuOK (0.34g, 3&nbsp;mmol) was added to a solution of 4’-cyano-4-hydroxybiphenyl (0.59g, 3mmol) in DMF (15&nbsp;mL). After stirring at room temperature for 1 h, <b>F-6</b> (0.46 g, 1.5&nbsp;mmol) was added under N<sub>2</sub> protection. The resulting mixture was stirred for 2&nbsp;days at room temperature. The reaction was quenched by water (20&nbsp;mL) and extracted by CH<sub>2</sub>Cl<sub>2</sub> (20&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, concentrated in vacuo and purified by silica gel chromatography (ethyl acetate/petroleum ether, 10:1) to provide the title product (0.35 g, 58%).</div></section><section id="sec-4-4-17-7"><h5>Ethyl 2-((<i>3S,5S</i>)-5-(((4'-carbamimidoyl-[1,1'-biphenyl]-4-yl)oxy)methyl)-2-oxopyrrolidin-3-yl)acetate (F-8)</h5><div id="p0585" role="paragraph"><i>tert</i>-Butyl 2-((<i>3S,5S</i>)-5-(((4'-cyano-[1,1'-biphenyl]-4-yl)oxy)methyl)-2-oxopyrrolidin-3-yl)acetate (0.20 g, 0.5&nbsp;mmol) was added to freshly prepared HCl/EtOH/EtOAc solution (35%, 5&nbsp;mL) at 0°C over 2 h, and the resulting mixture was stirred at room temperature for 48 h. The mixture was then concentrated, dried and dissolved in EtOH (5&nbsp;mL), followed by the addition of ammonium carbonate (0.50 g, 5&nbsp;mmol). After stirring at room temperature under N<sub>2</sub> protection for 16 h, the mixture was concentrated and purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1 to 10:1) to offer the title product (0.15 g, 73%).</div></section><section id="sec-4-4-17-8"><h5>2-((<i>3S,5S</i>)-5-(((4'-carbamimidoyl-[1,1'-biphenyl]-4-yl)oxy)methyl)-2-oxopyrrolidin-3-yl)acetic acid (Fradafiban)</h5><div id="p0590" role="paragraph">To a solution of ethyl 2-((<i>3S,5S</i>)-5-(((4'-carbamimidoyl-[1,1'-biphenyl]-4-yl)oxy)methyl)-2-oxopyrrolidin-3-yl)acetate (79&nbsp;mg, 0.2&nbsp;mmol) in methanol (1&nbsp;mL) and H<sub>2</sub>O (1&nbsp;mL) was added NaOH (24&nbsp;mg, 0.6&nbsp;mmol). After stirring at room temperature for 3 h, to the mixture was added NH<sub>4</sub>Cl (64&nbsp;mg, 1.2&nbsp;mmol), followed by 1&nbsp;mL of water and stirring for 45&nbsp;min in an ice/water bath. The precipitate was suction filtered, washed with methanol and water/methanol (2:1), and dried to give Fradafiban (43&nbsp;mg, 58%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.87 (dd, <i>J1</i>&nbsp;= 8.8&nbsp;Hz, <i>J2</i>&nbsp;= 8.8&nbsp;Hz, 4H), 7.69 (d, <i>J</i>&nbsp;= 8.7&nbsp;Hz, 2H), 7.11 (d, <i>J</i>&nbsp;= 8.8&nbsp;Hz, 2H), 4.11 (m, 1H), 4.03 (m, 2H), 3.02 (m, 1H), 2.81 (dd, <i>J1</i>&nbsp;= 16.8&nbsp;Hz, <i>J2</i>&nbsp;= 4.1&nbsp;Hz, 1H), 2.47 (dd, <i>J1</i>&nbsp;= 16.8&nbsp;Hz, <i>J2</i>&nbsp;= 8.9&nbsp;Hz, 1H), 2.39 (m, 1H), 2.15 (m, 1H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ (ppm):175.4, 168.2, 160.9, 147.8, 133.0, 130.8, 129.6, 129.5, 128.2, 127.3, 116.3, 71.9, 53.2, 38.7, 36.3, 31.0; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>: 368.1610; found 368.1603.</div></section></section><section id="sec-4-4-18"><h4>Synthetic scheme of Roxifiban (CAS 170902-52-0)</h4><div id="p0595" role="paragraph"><div class="figure-wrap"><figure id="undfig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/2a90c30c-b57b-4afd-b721-645b70e15dcd/main.assets/fx7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx7" alt="Figure undfig7" src="/cms/10.1016/j.cell.2022.08.008/asset/57c3f814-2aa1-4c45-8adb-33f89defaac9/main.assets/fx7.jpg" height="173" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2a90c30c-b57b-4afd-b721-645b70e15dcd/main.assets/fx7_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-18-1"><h5>N<sub>α</sub>-n-Boc-L-asparagine (R-1)</h5><div id="p0600" role="paragraph">To a solution of L-asparagine (6.60 g, 50&nbsp;mmol) in water (100&nbsp;mL) was added Na<sub>2</sub>CO<sub>3</sub> (6.62 g, 62.5 mol) and THF (50&nbsp;mL). The mixture was heated to 50-55°C, and a solution of n-butyl chloroformate (8.19 g, 60&nbsp;mmol) in THF (50&nbsp;mL) was added over a period of 1 h. The reaction was held at 50-55 °C for an additional 1&nbsp;h and then cooled to 15°C. The pH of the reaction mixture was adjusted to 2.5-3.5 with 11% aqueous HCl. The crude product was isolated by filtration, and dried in vacuo to offer the crude title product (8.83 g, 76%).</div></section><section id="sec-4-4-18-2"><h5>(<i>S</i>)-3-amino-2-((butoxycarbonyl)amino)propanoic acid (R-2)</h5><div id="p0605" role="paragraph">To a solution of <i>n</i>-propanol (24&nbsp;mL), EtOAc (24&nbsp;mL) and water (12&nbsp;mL) at 5°C was added N<sub>α</sub>-n-Boc-L-asparagine (6.97 g, 30&nbsp;mmol) and iodosobenzene diacetate (11.12 g, 34.5&nbsp;mmol) under N<sub>2</sub> protection. The mixture was warmed to 25°C over 1&nbsp;h and stirred at the same temperature for an additional 2 h, then slowly heated to 50°C over 90&nbsp;min and cooled to 5°C. The reaction mixture was held at 5°C for 30&nbsp;min, filtered, washed with EtOAc and dried in vacuo to offer the crude title product (4.24 g, 69%).</div></section><section id="sec-4-4-18-3"><h5>(<i>S</i>)-methyl 3-amino-2-((butoxycarbonyl)amino)propanoate hydrochloride (R-3)</h5><div id="p0610" role="paragraph">To a solution of (<i>S</i>)-3-amino-2-((butoxycarbonyl)amino)propanoic acid (3.06 g, 15&nbsp;mmol) in methanol (50&nbsp;mL) was dropwise added thionyl chloride (1.30&nbsp;mL, 18&nbsp;mmol) at 0°C. The resulting mixture was stirred at room temperature for 4 h, then concentrated in vacuo. The residue was used without further purification in the subsequent reaction.</div></section><section id="sec-4-4-18-4"><h5>Isobutyl 2-(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)acetate (R-4)</h5><div id="p0615" role="paragraph">To a solution of 4-cyanobenzaldoximinochloride(1.80 g, 10&nbsp;mmol) and isobutyl vinylacetate (1.42 g, 10&nbsp;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50&nbsp;mL) was added Et<sub>3</sub>N (1.66&nbsp;mL, 12&nbsp;mmol) over a period of 2&nbsp;h at room temperature. After stirring for 16 h, saturated NaHCO<sub>3</sub> solution (50&nbsp;mL) was added into the mixture. The resulting mixture was extracted by CH<sub>2</sub>Cl<sub>2</sub> (50&nbsp;mL), washed with water, dried over MgSO<sub>4</sub>, filtered, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:5) to offer the title compound (1.89 g, 66%).</div></section><section id="sec-4-4-18-5"><h5>2-(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)acetic acid (R-5)</h5><div id="p0620" role="paragraph">To a solution of isobutyl 2-(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)acetate (1.43 g, 5&nbsp;mmol) in THF (10&nbsp;mL) and H<sub>2</sub>O (10&nbsp;mL) was added NaOH (360&nbsp;mg, 9&nbsp;mmol) at room temperature. After stirring for 3 h, to the mixture was added 12&nbsp;mL of 1N HCl and extracted with EtOAc (15&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo to offer the crude title product (0.99 g, 88%) without further purification.</div></section><section id="sec-4-4-18-6"><h5>(2<i>S</i>)-methyl 2-((butoxycarbonyl)amino)-3-(2-(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)acetamido)propanoate (R-6)</h5><div id="p0625" role="paragraph">The crude product 2-(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)acetic acid (0.92 g, 4&nbsp;mmol) was dissolved in DMF (15&nbsp;mL), followed by the addition of EDCI (0.59 g, 4.4&nbsp;mmol) and HOBt (0.74 g, 4.4&nbsp;mmol) at 0°C. After stirring for half an hour, to the resulting mixture was added DIEA (1.03 g, 8&nbsp;mmol) and (<i>S</i>)-methyl 3-amino-2-((butoxycarbonyl)amino)propanoate hydrochloride (1.40 g, 4.4&nbsp;mmol) at 0°C. After stirring at room temperature for 16 h, water (20&nbsp;mL) was added, and the mixture was extracted with EtOAc (20&nbsp;mL&nbsp;×&nbsp;3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:3) to offer the title compound 0.53&nbsp;g (28%).</div></section><section id="sec-4-4-18-7"><h5>(<i>2S</i>)-ethyl 2-((butoxycarbonyl)amino)-3-(2-(3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)acetamido)propanoate (R-7)</h5><div id="p0630" role="paragraph">To freshly prepared HCl/EtOH/EtOAc solution (35%, 10&nbsp;mL) was added (<i>2S</i>)-methyl 2-((butoxycarbonyl)amino)-3-(2-(3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)acetamido)propanoate (0.43 g, 1&nbsp;mmol) at 0°C for 2 h, and the resulting mixture was stirred at room temperature for 48&nbsp;h and then concentrated in vacuo. The residue was dried in vacuo, dissolved in EtOH (5&nbsp;mL), followed by the addition of ammonium carbonate (1.01 g, 10&nbsp;mmol). After stirring at room temperature under N<sub>2</sub> for 16 h, the mixture was concentrated in vacuo, purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 50:1 to 10:1) to offer the title product (0.32 g, 70%).</div></section><section id="sec-4-4-18-8"><h5>(<i>2S</i>)-2-((butoxycarbonyl)amino)-3-(2-(3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)acetamido)propanoic acid (Roxifiban)</h5><div id="p0635" role="paragraph">To a solution of (<i>2S</i>)-ethyl 2-((butoxycarbonyl)amino)-3-(2-(3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)acetamido)propanoate (92&nbsp;mg, 0.2&nbsp;mmol) in methanol/ H<sub>2</sub>O (1:1, 2&nbsp;mL) was added NaOH (24&nbsp;mg, 0.6&nbsp;mmol). After stirring at room temperature for 3 h, 1N HCl (0.6&nbsp;mL) was added to the mixture. The resulting mixture was concentrated in vacuo and purified by hilic column chromatography to offer Roxifiban (31&nbsp;mg, 38%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.86(s, 4H), 5.18(m, 1H), 4.36(t, <i>J</i>&nbsp;= 6.5&nbsp;Hz, 1H), 4.03(m, 2H), 3.67(m, 2H), 3.57-3.50(m, 1H), 3.37-3.30(m, 1H), 2.70(m, 2H), 1.55(m, 2H), 1.31(m, 2H), 0.86(m, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ (ppm):172.8, 166.1, 163.1, 162.8, 158.3, 133.6, 129.5, 128.3, 127.5, 135.7, 130.8, 129.6, 128.7, 78.6, 65.8, 53.8, 40.5, 40.0, 39.1, 30.3, 18.4; 12.8. HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>20</sub>H<sub>28</sub>N<sub>5</sub>O<sub>6</sub>: 434.2040; found 434.2040.</div></section></section><section id="sec-4-4-19"><h4>Synthetic scheme of Lotrafiban (CAS 171049-14-2)</h4><div id="p0640" role="paragraph"><div class="figure-wrap"><figure id="undfig8" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/35a3a600-947d-4e44-a4e8-96d8fabdb95c/main.assets/fx8_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx8" alt="Figure undfig8" src="/cms/10.1016/j.cell.2022.08.008/asset/995e2a22-ac2b-4113-ab9e-ae2b98e309ed/main.assets/fx8.jpg" height="211" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/35a3a600-947d-4e44-a4e8-96d8fabdb95c/main.assets/fx8_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-19-1"><h5><i>tert</i>-Butyl 4-fluoro-3-methylbenzoate (L-1)</h5><div id="p0645" role="paragraph">To a solution of 4-fluoro-3-methylbenzoic acid (3.08 g, 20&nbsp;mmol), di-<i>tert</i>-butyl dicarbonate (8.75 g, 40&nbsp;mmol) in 50&nbsp;mL of 2-methylpropan-2-ol was added N,N-dimethylpyridin-4-amine (1.23 g, 10mmol). The resulting mixture was stirred at 25°C for 12 h. Then the mixture was concentrated to give a residue and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:40) to offer the title compound (3.2 g, 76%).</div></section><section id="sec-4-4-19-2"><h5><i>tert</i>-Butyl 4-fluoro-3-methylaminomethylbenzoate (L-2)</h5><div id="p0650" role="paragraph">To a solution of <i>tert</i>-butyl 4-fluoro-3-methylbenzoate (3.15 g, 15&nbsp;mmol) in CCl<sub>4</sub> (50&nbsp;mL) was added (PhCO<sub>2</sub>)<sub>2</sub> (1.37 g, 5.7&nbsp;mmol) and NBS (12.1 g, 18&nbsp;mmol). The resulting mixture was refluxed for 2&nbsp;days under N<sub>2</sub> protection. After cooling to room temperature, the mixture was washed with water (50&nbsp;mL), and dried over MgSO<sub>4</sub>. The solvent was removed and the residue was dissolved in THF (25&nbsp;mL). A solution of 33% CH<sub>3</sub>NH<sub>2</sub> (4.89&nbsp;mL, 52.5&nbsp;mmol) in THF (25&nbsp;mL) and H<sub>2</sub>O (12.5&nbsp;mL) was added dropwise to the mixture. The resulting mixture was stirred for 1&nbsp;h at room temperature and then concentrated in vacuo. The residue was dissolved by water (50&nbsp;mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (50&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 5:1) to offer the title compound (1.51 g, 42%).</div></section><section id="sec-4-4-19-3"><h5>(<i>S</i>)-<i>tert</i>-butyl 3-((2-(((benzyloxy)carbonyl)amino)-4-methoxy-N-methyl-4-oxobutanamido)methyl)-4-fluorobenzoate (L-3)</h5><div id="p0655" role="paragraph">To a solution of tert-butyl-4-fluoro-3-methylaminomethylbenzoate (1.20 g, 5&nbsp;mmol), (<i>S</i>)-2-(((benzyloxy)carbonyl)amino)-4-methoxy-4-oxobutanoic acid (1.41 g, 5&nbsp;mmol) and HOBt (0.74 g, 5.5&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (25&nbsp;mL) was added a solution of DCC (1.13 g, 5.5&nbsp;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL) at room temperature. After stirring for 1 h, the insoluble solid was filtered off, and the filtrate was washed with brine, dried over MgSO<sub>4</sub>, concentrated in vacuo and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:3) to offer the title compound (1.73 g, 69%).</div></section><section id="sec-4-4-19-4"><h5>(<i>S</i>)-<i>tert</i>-butyl 3-((2-amino-4-methoxy-N-methyl-4-oxobutanamido)methyl)-4-fluorobenzoate (L-4)</h5><div id="p0660" role="paragraph">To a solution of (<i>S</i>)-<i>tert</i>-butyl 3-((2-(((benzyloxy)carbonyl)amino)-4-methoxy-N-methyl-4-oxobutanamido)methyl)-4-fluorobenzoate in methanol (1.51 g, 3&nbsp;mmol) was added 10% Pd/C (0.15 g) with H<sub>2</sub> balloon at room temperature for 4 h. The catalyst was filtered off, and the filtrate was concentrated to offer the crude title product (0.98 g, 89%).</div></section><section id="sec-4-4-19-5"><h5>(<i>S</i>)-<i>tert</i>-butyl 2-(2-methoxy-2-oxoethyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carboxylate (L-5)</h5><div id="p0665" role="paragraph">A mixture of (<i>S</i>)-<i>tert</i>-butyl 3-((2-amino-4-methoxy-N-methyl-4-oxobutanamido)methyl)-4-fluorobenzoate (0.39 g, 1.06&nbsp;mmol) in DMSO (10&nbsp;mL) was stirred at 125°C for 12&nbsp;h under N<sub>2</sub> protection. The resulting mixture was dissolved in water (20&nbsp;mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (20&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:1) to offer the title compound (0.19 g, 49%).</div></section><section id="sec-4-4-19-6"><h5>(<i>S</i>)-<i>tert</i>-butyl 1'-(2-(2-methoxy-2-oxoethyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonyl)-[4,4'-bipiperidine]-1-carboxylate (L-7)</h5><div id="p0670" role="paragraph">To a solution of (<i>S</i>)-<i>tert</i>-butyl 2-(2-methoxy-2-oxoethyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carboxylate(120mg,0.35mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL) was added TFA (5&nbsp;mL) and anisole (0.2&nbsp;mL). After stirring for 3 h, the solvent was evaporated and the residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 5:1) to give the intermediate acid, which was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (5&nbsp;mL). To this solution was added <i>tert</i>-butyl (4,4'-bipiperidine)-1-carboxylate (103&nbsp;mg, 0.38&nbsp;mmol), HOBt (52&nbsp;mg, 0.38&nbsp;mmol) and EDCI (73&nbsp;mg, 0.38&nbsp;mmol). The resulting mixture was stirred for 1&nbsp;h at room temperature, and diluted with water (10&nbsp;mL), then extracted with CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, concentrated and purified by silica gel chromatography (ethyl acetate/petroleum ether, 1:3) to offer the title compound (56&nbsp;mg, 30%).</div></section><section id="sec-4-4-19-7"><h5>(<i>S</i>)-2-(7-([4,4'-bipiperidine]-1-carbonyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-2-yl)acetic acid (Lotrafiban)</h5><div id="p0675" role="paragraph">To a solution of (<i>S</i>)-<i>tert</i>-butyl 1'-(2-(2-methoxy-2-oxoethyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonyl)-[4,4'-bipiperidine]-1-carboxylate (33&nbsp;mg, 0.06&nbsp;mmol) in methanol (1&nbsp;mL) and H<sub>2</sub>O (1&nbsp;mL) was added NaOH (12&nbsp;mg, 0.3&nbsp;mmol). After stirring at room temperature for 8 h, the mixture was concentrated in vacuo. The residue was dissolved in dioxane (2&nbsp;mL) and then treated with 4&nbsp;N HCl/dioxane (1&nbsp;mL) solution for 3 h. The resulting mixture was concentrated in vacuo and purified by hilic column chromatography to offer Lotrafiban (11&nbsp;mg, 39%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.11(m, 2H), 6.62(d, <i>J</i>&nbsp;= 8.8&nbsp;Hz, 1H), 5.58(d, <i>J</i>&nbsp;= 16.4&nbsp;Hz, 1H), 3.89(d, <i>J</i>&nbsp;= 16.6&nbsp;Hz, 1H), 3.41(m, 2H), 3.09(s, 3H), 2.95(m, 4H), 2.65(m, 1H), 2.41 - 2.31 (m, 2H), 1.99(m, 2H), 1.80(m, 2H), 1.48(m, 5H), 1.25(m, 3H); <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) δ (ppm):174.7, 172.6, 172.2, 149.5, 130.7, 129.5, 124.3, 119.5, 116.8, 53.8, 51.9, 45.5, 41.8, 39.7, 36.3, 34.5, 27.2; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>23</sub>H<sub>33</sub>N<sub>4</sub>O<sub>4</sub>: 429.2502; found 429.2490.</div></section></section><section id="sec-4-4-20"><h4>Synthetic scheme of compound 11 (Gantofiban analog) (CAS 167364-14-9)</h4><div id="p0680" role="paragraph"><div class="figure-wrap"><figure id="undfig9" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/2b47bc2a-d02f-4403-8ebe-c60402a21c00/main.assets/fx9_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx9" alt="Figure undfig9" src="/cms/10.1016/j.cell.2022.08.008/asset/45f10f2b-3db7-4429-a76f-f0c23a90a629/main.assets/fx9.jpg" height="248" width="539" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2b47bc2a-d02f-4403-8ebe-c60402a21c00/main.assets/fx9_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-20-1"><h5><i>tert</i>-Butyl 4-(3-Ethoxy-3-oxopropyl)-1-piperazinecarboxylate (11-1)</h5><div id="p0685" role="paragraph">To a solution of <i>tert</i>-butyl-1-piperazine carboxylate (1.86 g, 10&nbsp;mmol) in DMF (30&nbsp;ml) was added potassium carbonate (4.86 g, 20&nbsp;mmol). After 0.5 h, ethyl 3-bromopropanoate (1.29&nbsp;ml, 10&nbsp;mmol) was added to the suspension, and the reaction mixture was stirred overnight at room temperature, quenched by saturated NaHCO<sub>3</sub> solution (60&nbsp;mL), extracted with EtOAc (30&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub> and concentrated to offer the crude title product (2.43 g, 85%).</div></section><section id="sec-4-4-20-2"><h5>Ethyl 3-(piperazin-1-yl)propanoate trifluoroacetic acid salt (11-2)</h5><div id="p0690" role="paragraph">To a solution of <i>tert</i>-Butyl 4-(3-Ethoxy-3-oxopropyl)-1-piperazinecarboxylate (1.43 g, 5&nbsp;mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL) was added TFA (10&nbsp;mL) at 0°C. After stirring at room temperature for 2 h, the mixture was concentrated in vacuo, dried in vacuo to offer the crude title compound (1.45 g).</div></section><section id="sec-4-4-20-3"><h5>(<i>R</i>)-4-((2,3-dihydroxypropyl)amino)benzonitrile (11-3)</h5><div id="p0695" role="paragraph">A mixture of 4-aminobenzonitrile (11.8 g, 100&nbsp;mmol) and (<i>S</i>)-oxiran-2-ylmethanol (3.76&nbsp;mL, 56&nbsp;mmol) in MeOH (80&nbsp;mL) in a sealed tube was heated at 110°C for 3 h. The resulting mixture was concentrated in vacuo, the residue was dissolved in water (300&nbsp;mL) and extracted with ethyl acetate (300&nbsp;mL×3). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel chromatography (ethyl acetate/petroleum ether, 3:1) to offer the title product (2.86 g, 15%).</div></section><section id="sec-4-4-20-4"><h5>(<i>R</i>)-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzonitrile (11-4)</h5><div id="p0700" role="paragraph">To a mixture of (<i>R</i>)-4-((2,3-dihydroxypropyl)amino)benzonitrile (2.30 g, 12&nbsp;mmol) in diethyl carbonate (30&nbsp;mL, 208&nbsp;mmol) was added 25% sodium methoxide in methanol (1&nbsp;mL). After the mixture was stirred overnight at 105°C, additional 25% sodium methoxide in methanol (1&nbsp;mL) was added. After stirring for 5 h, the reaction was quenched by saturated NaHCO<sub>3</sub> solution (60&nbsp;mL), and extracted with EtOAc (60&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub> and concentrated, purified by silica column chromatography (ethyl acetate/petroleum ether, 1:1) to offer the title product (1.75 g, 67%).</div></section><section id="sec-4-4-20-5"><h5>(R)-N'-hydroxy-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzimidamide (11-5)</h5><div id="p0705" role="paragraph">To a solution of (<i>R</i>)-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzonitrile (1.10 g, 5&nbsp;mmol) in MeOH (50&nbsp;mL) was added NH<sub>2</sub>OH·HCl (1.04 g, 15&nbsp;mmol) and Na<sub>2</sub>CO<sub>3</sub> (2.12 g, 20&nbsp;mmol). After stirring for 10&nbsp;min at room temperature, the reaction mixture was heated to 80 °C and stirred for 6 h. The solvent was removed in vacuo, and the residue was dissolved in water (30&nbsp;mL), extracted with CH<sub>2</sub>Cl<sub>2</sub> (30&nbsp;mL×3). The combined organic phases were washed by saturated NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and concentrated to offer the crude title compound (0.58 g, 46%).</div></section><section id="sec-4-4-20-6"><h5>(<i>R</i>)-5-(hydroxymethyl)-3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)oxazolidin-2-one (11-6)</h5><div id="p0710" role="paragraph">(<i>R</i>)-N'-hydroxy-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzimidamide (0.50 g, 2&nbsp;mmol) was dissolved in Ac<sub>2</sub>O (20&nbsp;mL), and the mixture was refluxed for 4 h. Then the solvent was removed under the vacuum. The intermediate was dissolved in MeOH (20&nbsp;mL), to the mixture was added K<sub>2</sub>CO<sub>3</sub> (0.35 g, 2.5&nbsp;mmol) and refluxed for 6 h. The solvent was removed in vacuo, and the residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 2:1) to obtain the title compound (0.39 g, 73%).</div></section><section id="sec-4-4-20-7"><h5>(<i>R</i>)-(3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate (11-7)</h5><div id="p0715" role="paragraph">To a solution of (<i>R</i>)-5-(hydroxymethyl)-3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)oxazolidin-2-one (0.33 g, 1.2&nbsp;mmol) and Et<sub>3</sub>N (0.20&nbsp;mL, 1.44&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL), methanesulfonyl chloride (0.12&nbsp;mL, 1.44&nbsp;mmol) was added dropwise at 0°C. The mixture was stirred at room temperature for 2&nbsp;h and then quenched with water (10&nbsp;mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL×2), and the combined organic phases were successively washed with 1N HCl, saturated NaHCO<sub>3</sub> solution, brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to offer the crude title product (0.36 g, 86%).</div></section><section id="sec-4-4-20-8"><h5>Ethyl (<i>S</i>)-3-(4-((3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)piperazin-1-yl)propanoate (11-8)</h5><div id="p0720" role="paragraph">To a solution of (<i>R</i>)-(3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate (0.22 g, 0.6 mmol) in acetonitrile was added CsCO<sub>3</sub> (0.98 g, 3&nbsp;mmol) and ethyl 3-(piperazin-1-yl)propanoate trifluoroacetic acid salt <b>(11-2)</b> (0.21 g, 0.75&nbsp;mmol) at room temperature under N<sub>2</sub> protection. The resulting mixture was refluxed for 16&nbsp;h and then concentrated. The residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 10:1) to offer the title compound (0.16 g, 38%).</div></section><section id="sec-4-4-20-9"><h5>(<i>S</i>)-3-(4-((3-(4-carbamimidoylphenyl)-2-oxooxazolidin-5-yl)methyl)piperazin-1-yl)propanoic acid (11, Gantofiban analog)</h5><div id="p0725" role="paragraph">To a solution of ethyl (<i>S</i>)-3-(4-((3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)piperazin-1-yl)propanoate (0.088 g, 0.2&nbsp;mmol) in MeOH (5&nbsp;mL) was added 10% Pd/C (20% w/w). The suspension was vigorously stirred under H<sub>2</sub> atmosphere overnight. The mixture was filtered through a pad of Celite, and the filtrate was concentrated in vacuo to obtain the crude intermediate To the intermediate dissolved in methanol/H<sub>2</sub>O (1:1, 2&nbsp;mL) was added NaOH (24&nbsp;mg, 0.6&nbsp;mmol). After stirring at room temperature for 3 h, the mixture was quenched by 1N HCl (0.6&nbsp;mL), concentrated and purified by hilic column chromatography to offer the Gantofiban analog (5.6&nbsp;mg, 6%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.86(s, 4H), 4.98 – 4.92(m, 1H), 4.25(t, <i>J</i>&nbsp;= 8.0Hz, 1H), 3.98 – 3.88(m, 1H), 3.35 – 3.21(m, 8H), 2.92 – 2.88 (m, 4H), 2.67(t, <i>J</i>&nbsp;= 8.0Hz, 2H).</div></section></section><section id="sec-4-4-21"><h4>Synthetic scheme of Gantofiban (CAS 167364-04-7)</h4><div id="p0730" role="paragraph"><div class="figure-wrap"><figure id="undfig10" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/266b2567-dfec-4697-ba78-cc54221fe8f2/main.assets/fx10_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx10" alt="Figure undfig10" src="/cms/10.1016/j.cell.2022.08.008/asset/80a22bd2-d91d-4db4-927e-b7c962c6e35e/main.assets/fx10.jpg" height="212" width="606" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/266b2567-dfec-4697-ba78-cc54221fe8f2/main.assets/fx10_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><section id="sec-4-4-21-1"><h5>(<i>S</i>)-4-((2,3-dihydroxypropyl)amino)benzonitrile (G-1)</h5><div id="p0735" role="paragraph">A mixture of 4-aminobenzonitrile (11.8 g, 100&nbsp;mmol) and (<i>R</i>)-oxiran-2-ylmethanol (3.76&nbsp;mL, 56&nbsp;mmol) in MeOH (80&nbsp;mL) in a sealed tube was heated at 110°C for 3 h. The resulting mixture was concentrated in vacuo, the residue was dissolved in water (300&nbsp;mL) and extracted with ethyl acetate (300&nbsp;mL×3). The combined organic phases were dried over MgSO<sub>4</sub>, filtered, concentrated, and purified by silica gel chromatography (ethyl acetate/petroleum ether, 3:1) to offer the title product (2.38 g, 12%).</div></section><section id="sec-4-4-21-2"><h5>(<i>S</i>)-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzonitrile (G-2)</h5><div id="p0740" role="paragraph">To a mixture of (<i>S</i>)-4-((2,3-dihydroxypropyl)amino)benzonitrile (2.30 g, 12&nbsp;mmol) in diethyl carbonate (30&nbsp;mL, 208&nbsp;mmol) was added 25% sodium methoxide in methanol (1&nbsp;mL). After the mixture was stirred overnight at 105°C, additional 25% sodium methoxide in methanol (1&nbsp;mL) was added. After stirring for 5 h, the reaction was quenched by saturated NaHCO<sub>3</sub> solution (60&nbsp;mL), extracted with EtOAc (60&nbsp;mL×3). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub> and concentrated, purified by silica column chromatography (ethyl acetate/petroleum ether, 1:1) to offer the title product (1.85 g, 70%).</div></section><section id="sec-4-4-21-3"><h5>(<i>S</i>)-N'-hydroxy-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzimidamide (G-3)</h5><div id="p0745" role="paragraph">To a solution of (<i>S</i>)-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzonitrile (1.10 g, 5&nbsp;mmol) in MeOH (50&nbsp;mL) was added NH<sub>2</sub>OH·HCl (1.04 g, 15&nbsp;mmol), Na<sub>2</sub>CO<sub>3</sub> (2.12 g, 20&nbsp;mmol). After stirring for 10&nbsp;min at room temperature, the reaction mixture was heated to 80°C and stirred for 6 h. The solvent was removed in vacuo, and the residue was dissolved in water (30&nbsp;mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (30&nbsp;mL×3). The combined organic phases were washed by saturated NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, and concentrated to offer the crude title compound (0.61 g, 48%).</div></section><section id="sec-4-4-21-4"><h5>(<i>S</i>)-5-(hydroxymethyl)-3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)oxazolidin-2-one (G-4)</h5><div id="p0750" role="paragraph">(<i>S</i>)-N'-hydroxy-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)benzimidamide (0.50 g, 2&nbsp;mmol) was dissolved in Ac<sub>2</sub>O (20&nbsp;mL), and the mixture was refluxed for 4 h. Then the solvent was removed under the vacuum. The intermediate was dissolved in MeOH (20&nbsp;mL), to the mixture was added K<sub>2</sub>CO<sub>3</sub> (0.35 g, 2.5&nbsp;mmol) and refluxed for 6 h. The solvent was removed in vacuo, and the residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 2:1) to obtain the title compound (0.44 g, 78%).</div></section><section id="sec-4-4-21-5"><h5>(<i>S</i>)-(3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate (G-5)</h5><div id="p0755" role="paragraph">To a solution of (<i>R</i>)-5-(hydroxymethyl)-3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)oxazolidin-2-one (0.33 g, 1.2&nbsp;mmol) and Et<sub>3</sub>N (0.20&nbsp;mL, 1.44&nbsp;mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL), methanesulfonyl chloride (0.12&nbsp;mL, 1.44&nbsp;mmol) was added dropwise at 0°C. The mixture was stirred at room temperature for 2 h, and then quenched with water (10&nbsp;mL). The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (10&nbsp;mL×2), and the combined organic phases were successively washed with 1N HCl, saturated NaHCO<sub>3</sub> solution, brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to offer the crude title product (0.35 g, 85%).</div></section><section id="sec-4-4-21-6"><h5>Ethyl (<i>R</i>)-3-(4-((3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)piperazin-1-yl)acetate (G-6)</h5><div id="p0760" role="paragraph">To a solution of (<i>S</i>)-(3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl methanesulfonate (0.22 g, 0.6&nbsp;mmol) in acetonitrile was added CsCO<sub>3</sub> (0.98 g, 3&nbsp;mmol) and ethyl 3-(piperazin-1-yl)acetate trifluoroacetic acid salt (<b>10-2</b>) (0.20 g, 0.75&nbsp;mmol) at room temperature under N<sub>2</sub> protection. The resulting mixture was refluxed for 16&nbsp;h and then concentrated. The residue was purified by silica gel chromatography (ethyl acetate/petroleum ether, 10:1) to offer the title compound (0.17 g, 41%).</div></section><section id="sec-4-4-21-7"><h5>(R)-3-(4-((3-(4-carbamimidoylphenyl)-2-oxooxazolidin-5-yl)methyl)piperazin-1-yl)acetic acid (Gantofiban)</h5><div id="p0765" role="paragraph">To a solution of ethyl (<i>S</i>)-3-(4-((3-(4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)piperazin-1-yl)acetate (0.085 g, 0.2&nbsp;mmol) in MeOH (5&nbsp;mL) was added 10% Pd/C (20% w/w). The suspension was vigorously stirred under H<sub>2</sub> atmosphere overnight. The mixture was filtered through a pad of Celite, and the filtrate was concentrated in vacuo to obtain the crude intermediate. To the intermediate dissolved in methanol/ H<sub>2</sub>O (1:1, 2&nbsp;mL) was added NaOH (24&nbsp;mg, 0.6&nbsp;mmol). After stirring at room temperature for 3 h, the mixture was quenched by 1N HCl (0.6&nbsp;mL), concentrated and purified by hilic column chromatography to offer Gantofiban (5.8&nbsp;mg, 8%). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ (ppm): 7.87(d, <i>J</i>&nbsp;= 8.0Hz, 2H), 7.74(d, <i>J</i>&nbsp;= 8.0Hz, 2H), 5.27 – 5.20 (m, 1H), 4.41 (t, <i>J</i>&nbsp;= 8.0Hz, 1H), 3.98 – 3.94 (m, 1H), 3.84 (s, 2H), 3.55 (br, 4H), 3.46 – 3.30 (m, 6H). <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ (ppm):168.9, 167.5, 155.9, 144.9, 130.0, 123.9, 119.2, 72.6, 60.4, 56.9, 53.1, 51.7, 50.1; HRMS (m/z): [M+H]<sup>+</sup> calcd. for C<sub>17</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub>: 362.1828; found 362.1823.</div></section></section><section id="sec-4-4-22"><h4>Summary of M-tirofiban and M-tirofiban isomer synthesis</h4><div id="p0770" role="paragraph">Synthesis of M-tirofiban was delayed by lack of publication of its synthetic route (<span class="dropBlock reference-citations"><a id="body-ref-sref1-7" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-7" aria-controls="sref1-7">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our first attempt of stereo-specific synthesis resulted in a major product with a small amount of side product. A second synthesis resulted in M-tirofiban and its stereo-isomer, M-tirofiban isomer. Neither the side-product nor the stereoisomers would be distinguished by the reported mass spectrometry results (<span class="dropBlock reference-citations"><a id="body-ref-sref1-8" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-8" aria-controls="sref1-8">Adair et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1-8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-23"><h4>Successful second synthesis scheme of M-tirofiban and M-tirofiban isomer</h4><div id="p0775" role="paragraph"><div class="figure-wrap"><figure id="undfig19" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/5c510958-1912-4108-b3eb-002b9a6d4f3e/main.assets/sc1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="sc1" alt="Figure undfig19" src="/cms/10.1016/j.cell.2022.08.008/asset/05f0117a-2878-4f46-be49-907749b39e4b/main.assets/sc1.jpg" height="615" width="761" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5c510958-1912-4108-b3eb-002b9a6d4f3e/main.assets/sc1_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div></section><section id="sec-4-4-24"><h4>Failed first synthesis of M-tirofiban</h4><div id="p0780a" role="paragraph"><div class="figure-wrap"><figure id="undfig20" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/4af31048-0970-48e4-bf12-3e0daefab39c/main.assets/sc2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="sc2" alt="Figure undfig20" src="/cms/10.1016/j.cell.2022.08.008/asset/e09b0f58-2da5-49f2-9ee6-34b2f1a625d5/main.assets/sc2.jpg" height="443" width="761" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/4af31048-0970-48e4-bf12-3e0daefab39c/main.assets/sc2_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div>In failed first synthesis of M-tirofiban and M-tirofiban isomer, the title compound was obtained after prep-HPLC separation. However, there were two sets of <sup>1</sup>H NMR peaks. We analyzed the HNMR and the synthetic route carefully again. The suspected impurity was the M-tirofiban-byproduct which would be difficult to remove by prep-HPLC due to the very close polarity.</div><div id="p0780" role="paragraph">The impurity should have been formed during synthesis of compound 3 due to the excess NaH. Thus, a new batch was synthesized using synthetic synthetic scheme 1 (top) of M-tirofiban and M-tirofiban isomer.</div></section><section id="sec-4-4-25"><h4>Successful synthesis of M-tirofiban and M-tirofiban isomer</h4><section id="sec-4-4-25-1"><h5>Compound 2</h5><div id="p0790" role="paragraph"><div class="figure-wrap"><figure id="undfig11" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/9a540885-366f-43a9-afd0-ede39e6ebaae/main.assets/fx11_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx11" alt="Figure undfig11" src="/cms/10.1016/j.cell.2022.08.008/asset/7337d909-3e75-4205-a45f-cc7e176366b7/main.assets/fx11.jpg" height="84" width="356" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/9a540885-366f-43a9-afd0-ede39e6ebaae/main.assets/fx11_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0795" role="paragraph">Compound 1 (700&nbsp;mg, 2.72&nbsp;mmol, 1.00 <i>eq</i>) was added to a round bottom flask charged with ACN (3.0&nbsp;mL), then PPh<sub>3</sub> (1.07 g, 4.08&nbsp;mmol, 1.50 <i>eq</i>) and CBr<sub>4</sub> (1.35 g, 4.08&nbsp;mmol, 1.50 <i>eq</i>) were added at 0°C. The mixture was stirred at 20°C for 12 hour. TLC (petroleum ether: ethyl acetate&nbsp;= 5:1, R<sub>f</sub>&nbsp;= 0.43) indicated compound 1 was consumed completely and one new main spot formed. The reaction was quenched by ice-water (10&nbsp;mL) at 0°C, and then extracted with MTBE (20&nbsp;mL and 10&nbsp;mL). The combined organic layers were concentrated under reduced pressure to give a residue. The crude product was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate= 20/1 to 5/1) to give compound 2 (800&nbsp;mg, 2.50&nbsp;mmol, 91.8% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) <i>δ</i> 4.03 - 4.07 (m, 2H), 3.39 (t, <i>J</i>&nbsp;= 6.8&nbsp;Hz, 2H), 2.61 - 2.68 (m, 2H), 1.80 - 1.86 (m, 2H), 1.61 - 1.65 (m, 2H), 1.42 - 1.43 (m, 11H), 1.22 - 1.26 (m, 2H), 1.06 - 1.07 (m, 2H).</div></section><section id="sec-4-4-25-2"><h5>Compound 2b</h5><div id="p0800" role="paragraph"><div class="figure-wrap"><figure id="undfig12" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/8d7d498f-d730-4dfe-b094-c7a5eed3b682/main.assets/fx12_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx12" alt="Figure undfig12" src="/cms/10.1016/j.cell.2022.08.008/asset/4ffde0af-a762-434f-bdf5-31c717144d38/main.assets/fx12.jpg" height="68" width="273" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/8d7d498f-d730-4dfe-b094-c7a5eed3b682/main.assets/fx12_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0805" role="paragraph">To a solution of compound 2a (400&nbsp;mg, 1.98&nbsp;mmol, 1.00 <i>eq</i>) in DCM (2&nbsp;mL) was added dropwise (COCl)<sub>2</sub> (301&nbsp;mg, 2.37&nbsp;mmol, 207 uL, 1.20 <i>eq</i>) at 0°C. The resulting mixture was stirred at 20°C for 3&nbsp;hrs. TLC (petroleum ether: ethyl acetate&nbsp;= 3:1, R<sub>f</sub>&nbsp;= 0.43) indicated intermediate (quenched by MeOH) was consumed completely and one new spot formed. The reaction mixture was concentrated under reduced pressure below 40°C to give compound 2b (350&nbsp;mg, 1.93&nbsp;mmol, 97.5% yield) as purple solid, which was used in the next step without further purification.</div></section><section id="sec-4-4-25-3"><h5>Compound 2d</h5><div id="p0810" role="paragraph"><div class="figure-wrap"><figure id="undfig13" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/5b1eee4c-f4a7-4ab0-ab7c-992c643e6000/main.assets/fx13_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx13" alt="Figure undfig13" src="/cms/10.1016/j.cell.2022.08.008/asset/2a60371d-58c4-4960-853c-70036cd394d9/main.assets/fx13.jpg" height="130" width="367" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5b1eee4c-f4a7-4ab0-ab7c-992c643e6000/main.assets/fx13_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0815" role="paragraph">To a solution of compound 2c (400&nbsp;mg, 1.69&nbsp;mmol, 1.00 <i>eq</i>) in DCM (5&nbsp;mL) was added dropwise DIEA (436&nbsp;mg, 3.37&nbsp;mmol, 587 uL, 2.00 <i>eq</i>) and compound 2b (306&nbsp;mg, 1.69&nbsp;mmol, 1.00 <i>eq</i>) at 0°C. The resulting mixture was stirred at 20 °C for 3&nbsp;hrs. LCMS showed no compound 2c remained, and one major new peak (Rt&nbsp;= 1.888&nbsp;min, m/z -55&nbsp;= 327.3) with desired product was detected. The reaction was quenched by ice-water (10&nbsp;mL) at 0°C, and then extracted with EtOAc (20&nbsp;mL, then 10&nbsp;mL). The combined organic layers were concentrated under reduced pressure to give compound <b>2d</b> (500&nbsp;mg, 1.31&nbsp;mmol, 77.6% yield) as a red oil, which was used in the next step without purification.</div></section><section id="sec-4-4-25-4"><h5>Compound 3</h5><div id="p0820" role="paragraph"><div class="figure-wrap"><figure id="undfig14" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/fdd64923-8056-4a27-93f7-ab521294c0d7/main.assets/fx14_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx14" alt="Figure undfig14" src="/cms/10.1016/j.cell.2022.08.008/asset/8236bf1e-2cfa-469f-a4ad-5e3dc0a7ff8b/main.assets/fx14.jpg" height="108" width="414" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/fdd64923-8056-4a27-93f7-ab521294c0d7/main.assets/fx14_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0825" role="paragraph">To a solution of compound <b>2d</b> (500&nbsp;mg, 1.31&nbsp;mmol, 1.00 <i>eq</i>) and compound 2 (419&nbsp;mg, 1.31&nbsp;mmol, 1.00 <i>eq</i>) in DMF (8&nbsp;mL) was add K<sub>2</sub>CO<sub>3</sub> (271&nbsp;mg, 1.96&nbsp;mmol, 1.50 <i>eq</i>) at 25°C. The resulting mixture was stirred at 60°C for 20&nbsp;hrs. LCMS showed no compound <b>2d</b> remained, and one major new peak (Rt&nbsp;= 1.058, m/z&nbsp;= 466.1) with desired product was detected. The reaction was quenched by ice-water (30&nbsp;mL) at 0°C, and then extracted with EtOAc (20&nbsp;mL, 10&nbsp;mL). The combined organic layers were concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate&nbsp;= 4/1 to 2/1, R<sub>f</sub>&nbsp;= 0.43) to give compound 3 (350&nbsp;mg, 563&nbsp;μmol, 43.1% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) <i>δ</i> 7.85 (d, <i>J</i>&nbsp;= 8.0&nbsp;Hz, 1H), 7.68 - 7.77 (m, 2H), 7.47 - 7.54 (m, 2H), 7.16 (d, <i>J</i>&nbsp;= 8.0&nbsp;Hz, 2H), 6.84 (d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 4.95 - 5.00 (m, 1H), 4.06 - 4.08 (m, 2H), 4.10 - 4.19 (m, 2H), 3.95 (t, <i>J</i>&nbsp;= 6.4&nbsp;Hz, 2H), 3.16 - 3.28 (m, 2H), 1.67 - 1.80 (m, 2H), 1.30 - 1.49 (m, 27H), 1.07 - 1.30 (m, 2H).</div></section><section id="sec-4-4-25-5"><h5>Compound 4</h5><div id="p0830" role="paragraph"><div class="figure-wrap"><figure id="undfig15" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/4f6fd470-3d18-4fef-a548-ed34aa93b8e5/main.assets/fx15_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx15" alt="Figure undfig15" src="/cms/10.1016/j.cell.2022.08.008/asset/e532f359-ba6d-4eea-b052-d936be3250c9/main.assets/fx15.jpg" height="96" width="444" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/4f6fd470-3d18-4fef-a548-ed34aa93b8e5/main.assets/fx15_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0835" role="paragraph">To a solution of compound 3 (350&nbsp;mg, 563&nbsp;μmol, 1.00 <i>eq</i>) in EtOAc (2.0&nbsp;mL) was added dropwise HCl/EtOAc (4 M, 1.41&nbsp;mL, 10.0 <i>eq</i>) at 0°C. The resulting mixture was stirred at 20°C for 4&nbsp;hrs. LCMS showed no compound 3 remained, and one major new peak (Rt&nbsp;= 2.047, m/z&nbsp;= 466) with desired mass was detected. The reaction mixture was concentrated under reduced pressure to give a residue. The residue was purified by prep-HPLC (HCl condition). Column: Phenomenex Luna C18 200×40mm×10um; mobile phase: [water (0.04%HCl)-ACN]; B%: 10%-50% ACN, 8&nbsp;min). The fractions after prep-HPLC were lyophilized directly to give Compound 4 (150&nbsp;mg, 322&nbsp;μmol, 57.2% yield) as a white solid. <sup>1</sup>H NMR (400 MHz DMSO) <i>δ</i> 13.01 (br s, 1H), 9.34 (d, <i>J</i>&nbsp;= 8.0&nbsp;Hz, 1H), 8.92 (br s, 1H), 8.66 (br s, 1H), 7.83 - 7.90 (m, 2H), 7.53 – 7.56 (m, 2H), 7.16 (d, <i>J</i>&nbsp;= 8.8&nbsp;Hz, 1H), 6.77 (d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 4.58 - 4.64 (m, 1H), 3.85 (t, <i>J</i>&nbsp;= 6.4&nbsp;Hz, 2H), 3.07 - 3.17 (m, 4H), 2.73 - 2.76 (m, 2H), 1.70 - 1.73 (m, 4H), 1.30 - 1.34 (m, 1H), 1.19 - 1.25 (m, 6H).</div><div id="p0900" role="paragraph">After this step, two peaks of target compound were detected by chiral HPLC. Racemization would have occurred in the alkylation reaction of step 2. The HCl salt of the final product could not be separated by chiral chromatography i.e., supercritical fluid chromatography (SFC). Therefore, Boc was re-added to the amine and then the isomers were separated by SFC. Finally, M-tirofiban and M-tirofiban isomer were obtained after Boc removal.</div></section><section id="sec-4-4-25-6"><h5>Compounds 5A&amp;5B</h5><div id="p0840" role="paragraph"><div class="figure-wrap"><figure id="undfig16" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/a246cce0-d59b-4e11-83bf-7f3572709714/main.assets/fx16_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx16" alt="Figure undfig16" src="/cms/10.1016/j.cell.2022.08.008/asset/af49f849-08ad-4eab-804c-33b2683a28ff/main.assets/fx16.jpg" height="101" width="567" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/a246cce0-d59b-4e11-83bf-7f3572709714/main.assets/fx16_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0845" role="paragraph">To a solution of compound 4 (150&nbsp;mg, 299&nbsp;μmol, 1.00 <i>eq</i>, HCl) in DCM (3&nbsp;mL) was added Boc<sub>2</sub>O (78.3&nbsp;mg, 359&nbsp;μmol, 82.4 uL, 1.20 <i>eq</i>) and Et<sub>3</sub>N (45.3&nbsp;mg, 448&nbsp;μmol, 62.4 uL, 1.50 <i>eq</i>) at 0°C. The resulting mixture was stirred at 20 °C for 4&nbsp;hrs. LCMS showed no compound 4 remained, and one major new peak (Rt&nbsp;= 0.873, m/z&nbsp;= 466) with desired product was detected. The reaction mixture was poured into 20% citric acid (∼ 5&nbsp;mL) and extracted with EtOAc (∼ 20&nbsp;mL, 10&nbsp;mL), the organic layers were washed with brine (10&nbsp;mL), dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the product. The product was separated further by chiral SFC (Thar SFC 80) using a DAICEL Chiralpak AD column (250mm×30mm,10um); mobile phase: A: CO<sub>2</sub> and isocratic elution with B: 38% 0.1%NH3H2O ETOH for 6&nbsp;min at 40°C with a system back pressure of 100 bar. The fractions after SFC were concentrated to give compound <b>5A</b> (65.0&nbsp;mg, 115&nbsp;μmol, 76.9% yield) as a light-yellow solid and Compound <b>5B</b> (70.0&nbsp;mg, 123. μmol, 82.8% yield) as a light-yellow solid. Comparison of the elution in SFC of the 95% pure, chiral M-tirofiban synthesized in scheme 1 showed that peak 2 in SFC was compound 5A, the desired (<i>S</i>)-M-tirofiban; peak 1 was compound 5B, the undesired (<i>R</i>)-M-tirofiban isomer.</div></section><section id="sec-4-4-25-7"><h5>(<i>S</i>)-M-tirofiban</h5><div id="p0850" role="paragraph"><div class="figure-wrap"><figure id="undfig17" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/6b9fd090-1496-4b07-99b4-d79ec44b2b6e/main.assets/fx17_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx17" alt="Figure undfig17" src="/cms/10.1016/j.cell.2022.08.008/asset/cd86ca33-e62d-496b-bb32-de2fc0a58edd/main.assets/fx17.jpg" height="120" width="463" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/6b9fd090-1496-4b07-99b4-d79ec44b2b6e/main.assets/fx17_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0855" role="paragraph">To a solution of compound <b>5A</b> (65.0&nbsp;mg, 115&nbsp;μmol, 1.00 <i>eq</i>) in MTBE (2.0&nbsp;mL) was added dropwise HCl/MTBE (4.0 M, 287 uL, 10.0 <i>eq</i>) at 0°C. The resulting mixture was stirred at 15°C for 6&nbsp;hrs. TLC (petroleum ether: ethyl acetate&nbsp;= 0:1, R<sub>f</sub>&nbsp;= 0.01) indicated the intermediate was consumed completely and one new spot formed. The reaction mixture was concentrated under reduced pressure below 40°C to give a residue. The crude product was triturated with MTBE (2&nbsp;mL) at 20°C for 20&nbsp;min, and then lyophilized to remove the solvent residue. Compound <b>(<i>S</i>)-M-tirofiban</b> (22.0&nbsp;mg, 43.8&nbsp;μmol, 38.1% yield, HCl) was obtained as a thick white solid. <sup>1</sup>H NMR (400 MHz DMSO) <i>δ</i> 12.98 (br s, 1H), 9.30 (d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 1H), 8.92 (br s, 1H), 8.66 (br s, 1H), 7.83 - 7.90 (m, 2H), 7.53 – 7.56 (m, 2H), 7.16 (d, <i>J</i>&nbsp;= 8.8&nbsp;Hz, 1H), 6.77 (d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 4.60 - 4.64 (m, 1H), 3.85 (t, <i>J</i>&nbsp;= 6.4&nbsp;Hz, 2H), 3.07 - 3.17 (m, 4H), 2.73 - 2.76 (m, 2H), 1.70 - 1.73 (m, 4H), 1.19 - 1.35 (m, 7H).</div></section><section id="sec-4-4-25-8"><h5>(<i>R</i>)-M-tirofiban isomer</h5><div id="p0860" role="paragraph"><div class="figure-wrap"><figure id="undfig18" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2022.08.008/asset/20354254-3a1d-4d32-af76-79259df3d3f1/main.assets/fx18_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx18" alt="Figure undfig18" src="/cms/10.1016/j.cell.2022.08.008/asset/5582fc37-5340-41bf-9ee2-10ff17a05952/main.assets/fx18.jpg" height="113" width="456" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/20354254-3a1d-4d32-af76-79259df3d3f1/main.assets/fx18_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div><div id="p0865" role="paragraph">To a solution of compound <b>5B</b> (70.0&nbsp;mg, 124&nbsp;μmol, 1.00 eq) in MTBE (2.0&nbsp;mL) was added dropwise HCl/MTBE (4.0 M, 309 uL, 10.0 eq) at 0°C. The resulting mixture was stirred at 15°C for 6&nbsp;hrs. TLC (petroleum ether: ethyl acetate&nbsp;= 0:1, R<sub>f</sub>&nbsp;= 0.01) indicated the intermediate was consumed completely and one new spot formed. The reaction mixture was concentrated under reduced pressure below 40°C to give a residue. The crude product was triturated with MTBE (2&nbsp;mL) at 20°C for 20&nbsp;min, and then lyophilized to remove the solvent residue. Compound <b>(<i>R</i>)-M-tirofiban-isomer</b> (58.0&nbsp;mg, 115. μmol, 93.4% yield, HCl) was obtained as a white solid. <sup>1</sup>H NMR (400 MHz CDCl<sub>3</sub>) <i>δ</i> 12.99 (br s, 1H), 9.28 (d, <i>J</i>&nbsp;= 8.0&nbsp;Hz, 1H), 8.57 (br s, 2H), 7.83 - 7.90 (m, 2H), 7.53 – 7.56 (m, 2H), 7.16 (d, <i>J</i>&nbsp;= 8.8&nbsp;Hz, 1H), 6.77 (d, <i>J</i>&nbsp;= 8.4&nbsp;Hz, 2H), 4.59 - 4.60 (m, 1H), 3.85 (t, <i>J</i>&nbsp;= 6.4&nbsp;Hz, 2H), 3.07 - 3.17 (m, 4H), 2.73 - 2.76 (m, 2H), 1.70 - 1.73 (m, 4H), 1.22 - 1.35 (m, 8H).</div></section></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><div id="p0870" role="paragraph">All of the statistical analyses and how significance was defined are described in Figure&nbsp;legends. Equations and software used are described in the <a id="crosref1695" href="#sec-4">STAR Methods</a>.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0875" role="paragraph">We thank Rui Qiu and Christine Hwang for experimental work early in this project. Supported by NIH grants HL131729 (T.A.S.) and HL131836 (Jieqing Zhu). We thank the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357 for beamline support.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0880" role="paragraph">Jieqing Zhu found that UR-2922 was a closing compound in gel filtration and grew crystals with UR-2922, tirofiban, eptifibatide, and EF-5154 in Mg<sup>2+</sup> with which Jianghai Zhu collected data and refined structures. Jieqing Zhu later as an independent investigator supervised T.T.H.N., and they collected and analyzed data on LIBS epitope induction on platelets and inhibition of clot retraction and platelet aggregation by compounds and wrote methods and figure legends. F.-Y.L. found BMS4 in the literature and later gantofiban, GR144508, DS 13d, DS 13g, and BMS4-2, as well as other control compounds. Y.Z. supervised Y.X. in synthesizing these and related compounds including clinically tested αIIbβ3 inhibitors. F.-Y.L. determined which of these compounds were closing and opening by gel filtration and LIBS exposure and crystallized, collected data, and refined the other 17 αIIbβ3—compound complex structures in Mg<sup>2+</sup> and Mn<sup>2+</sup>. F.-Y.L. first observed that closing compounds uniquely hydrogen bonded to water 1 or 2 to stabilize the closed conformation. Together, Jianghai Zhu and F.-Y.L. deposited 21 crystal structures. F.-Y.L. extended closing compounds to integrin α4β1. J.L. quantitatively measured affinities of α4β1 inhibitors for the EO state, BC+EC ensemble, and basal ensemble and measured their ability to induce LIBS epitopes for the extended, closed, and open conformations. J.L. also measured affinities of αIIbβ3 inhibitors for WT and mutant activated αIIbβ3, assessed the induction of LIBS epitopes, and the effect of serum on affinity, and wrote equations and analyzed data. Jieqing Zhu and F.-Y.L. each drafted separate earlier manuscripts with T.A.S. T.A.S. supervised the overall project and drafted a new manuscript. All authors contributed portions of writing, figures, or tables.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0885" role="paragraph">T.A.S. is a founder, stock owner, and director of Morphic Therapeutic. F.-Y.L. is an employee of Morphic Therapeutic.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (2)</h2><div id="p0895" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2022.08.008/attachment/f528529c-6e82-4df5-b46e-3c756b3ad72d/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (192.32 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table&nbsp;S1. X-ray diffraction and structure refinement, related to Figures&nbsp;3, S1, and S2</div></div></div><div class="core-supplementary-material" data-category="archive"><div class="core-link"><a href="/cms/10.1016/j.cell.2022.08.008/attachment/388c37fe-9bf3-45e6-8bac-4c17dbed95e7/mmc2.zip" download="mmc2.zip" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Archive (5.85 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Data S1. Equation 4, related to Figures&nbsp;6 and S3</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030" role="paragraph"><div id="ulist0015" role="list"><div id="u0030" role="listitem"><div class="label">•</div><div class="content"><div id="p0035" role="paragraph">All structural data has been deposited at the Protein Data Bank.</div></div></div><div id="u0035" role="listitem"><div class="label">•</div><div class="content"><div id="p0040" role="paragraph">Diffraction images have been deposited at SBGRID. Datasets for <a id="crosref0105" href="#fig5">Figures&nbsp;5</a>C–5E, 5G–5I, <a id="crosref1890" href="#fig6">6</a>A–6C, 6E, 6F, <a id="crosref0110" href="#figs3">S3</a>, <a id="crosref0115" href="#figs6">S6</a>, and <a id="crosref0120" href="#figs7">S7</a> have been deposited at Harvard Dataverse.</div></div></div><div id="u0040" role="listitem"><div class="label">•</div><div class="content"><div id="p0045" role="paragraph">Executable Mathematica code for fitting competitive binding data in <a id="crosref0125" href="#fig6">Figures&nbsp;6</a>B, 6C, and <a id="crosref0130" href="#figs3">S3</a>, entitled “<a id="crosref0135" href="#mmc1">Data S1</a>-<a id="crosref0140" href="#fd4">Equation 4</a>.nb” is available in this paper’s <a id="crosref0145" href="#mmc1">supplemental information</a>.</div></div></div><div id="u0045" role="listitem"><div class="label">•</div><div class="content"><div id="p0050" role="paragraph">Other data is available on request from the <a id="crosref0150" href="#sec-4-2-1">lead contact</a> for 3 years.</div></div></div></div></div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1-1" title="View in article">1.</a></div><div>Adair, B.D. ∙ Alonso, J.L. ∙ van Agthoven, J. ...</div><div><strong>Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis</strong></div><div><em>Nat. Commun.</em> 2020; <strong>11</strong>:398</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13928-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078202712" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31964886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13928-2&amp;pmid=31964886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2-1" title="View in article">2.</a></div><div>Adams, P.D. ∙ Afonine, P.V. ∙ Bunkóczi, G. ...</div><div><strong>Phenix: a comprehensive Python-based system for macromolecular structure solution</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:213-221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909052925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-76449098262" target="_blank" aria-label="Open Scopus in new tab">Scopus (18485)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124702/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909052925&amp;pmid=20124702" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3-1" title="View in article">3.</a></div><div>Aga, Y. ∙ Baba, K. ∙ Tam, S. ...</div><div><strong>UR-3216: a new generation oral platelet GPIIb/IIIa antagonist</strong></div><div><em>Curr. Pharm. Des.</em> 2004; <strong>10</strong>:1597-1601</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2174/1381612043384592" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-2342443223" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15134558/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2174%2F1381612043384592&amp;pmid=15134558" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4-1" title="View in article">4.</a></div><div>Akiyama, S.K. ∙ Yamada, S.S. ∙ Chen, W.T. ...</div><div><strong>Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1989; <strong>109</strong>:863-875</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.109.2.863" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0024359871" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2527241/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.109.2.863&amp;pmid=2527241" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5-1" title="View in article">5.</a></div><div>Anderson, J.M. ∙ Li, J. ∙ Springer, T.A.</div><div><strong>Regulation of integrin α5β1 conformational states and intrinsic affinities by metal ions and the ADMIDAS</strong></div><div><em>Mol. Biol. Cell.</em> 2022; <strong>33</strong>:ar56</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1091/mbc.E21-11-0536" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85130633129" target="_blank" aria-label="Open Scopus in new tab">Scopus (8)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/35108026/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1091%2Fmbc.E21-11-0536&amp;pmid=35108026" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">6.</a></div><div>Arimori, T. ∙ Miyazaki, N. ∙ Mihara, E. ...</div><div><strong>Structural mechanism of laminin recognition by integrin</strong></div><div><em>Nat. Commun.</em> 2021; <strong>12</strong>:4012</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-021-24184-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85109030424" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34188035/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-021-24184-8&amp;pmid=34188035" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7" title="View in article">7.</a></div><div>Ault, K.A. ∙ Cannon, C.P. ∙ Mitchell, J. ...</div><div><strong>Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in myocardial infarction</strong></div><div><em>J.&nbsp;Am. Coll. Cardiol.</em> 1999; <strong>33</strong>:634-639</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0735-1097(98)00635-4" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0006870550" target="_blank" aria-label="Open Scopus in new tab">Scopus (254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10080462/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0735-1097%2898%2900635-4&amp;pmid=10080462" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8-1" title="View in article">8.</a></div><div>Baba, K. ∙ Aga, Y. ∙ Nakanishi, T. ...</div><div><strong>UR-3216: a manageable oral GPIIb/IIIa antagonist</strong></div><div><em>Cardiovasc. Drug Rev.</em> 2001; <strong>19</strong>:25-40</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1527-3466.2001.tb00181.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035066822" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11314599/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1527-3466.2001.tb00181.x&amp;pmid=11314599" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">9.</a></div><div>Bosco, A. ∙ Kidson-Gerber, G. ∙ Dunkley, S.</div><div><strong>Delayed tirofiban-induced thrombocytopenia: two case reports</strong></div><div><em>J.&nbsp;Thromb. Haemost.</em> 2005; <strong>3</strong>:1109-1110</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1538-7836.2005.01296.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-23844531640" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15869625/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1538-7836.2005.01296.x&amp;pmid=15869625" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">10.</a></div><div>Bougie, D.W. ∙ Rasmussen, M. ∙ Zhu, J. ...</div><div><strong>Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin</strong></div><div><em>Blood.</em> 2012; <strong>119</strong>:6317-6325</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2012-01-406322" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863510984" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22490676/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2012-01-406322&amp;pmid=22490676" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11-1" title="View in article">11.</a></div><div>Breth, L. ∙ Kochie, J. ∙ Combs, A. ...</div><div><strong>Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes</strong></div><div><em>J.&nbsp;Immunol. Methods.</em> 2005; <strong>301</strong>:11-20</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jim.2005.02.008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-21844466714" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15992818/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jim.2005.02.008&amp;pmid=15992818" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12" title="View in article">12.</a></div><div>Byron, A. ∙ Humphries, J.D. ∙ Askari, J.A. ...</div><div><strong>Anti-integrin monoclonal antibodies</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2009; <strong>122</strong>:4009-4011</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.056770" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-70849109088" target="_blank" aria-label="Open Scopus in new tab">Scopus (135)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19910492/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.056770&amp;pmid=19910492" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Campbell, M.G. ∙ Cormier, A. ∙ Ito, S. ...</div><div><strong>Cryo-EM reveals integrin-mediated TGF-β activation without release from latent TGF-β</strong></div><div><em>Cell.</em> 2020; <strong>180</strong>:490-501</div><div>e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2Fj.cell.2019.12.030&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2Fj.cell.2019.12.030&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85078807979" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31955848/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.12.030&amp;pmid=31955848" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14-1" title="View in article">14.</a></div><div>Chew, D.P. ∙ Bhatt, D.L. ∙ Sapp, S. ...</div><div><strong>Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials</strong></div><div><em>Circulation.</em> 2001; <strong>103</strong>:201-206</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.103.2.201" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035895332" target="_blank" aria-label="Open Scopus in new tab">Scopus (374)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11208677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.103.2.201&amp;pmid=11208677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15-1" title="View in article">15.</a></div><div>Chiba, J. ∙ Machinaga, N. ∙ Takashi, T. ...</div><div><strong>Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 2005; <strong>15</strong>:41-45</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bmcl.2004.10.041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9644291524" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15582407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bmcl.2004.10.041&amp;pmid=15582407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">16.</a></div><div>Cox, D. ∙ Aoki, T. ∙ Seki, J. ...</div><div><strong>Pentamidine is a specific, non-peptide, GPIIb/IIIa antagonist</strong></div><div><em>Thromb. Haemost.</em> 1996; <strong>75</strong>:503-509</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1055/s-0038-1650305" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0029987083" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8701416/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1055%2Fs-0038-1650305&amp;pmid=8701416" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17-1" title="View in article">17.</a></div><div>Cox, D. ∙ Brennan, M. ∙ Moran, N.</div><div><strong>Integrins as therapeutic targets: lessons and opportunities</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2010; <strong>9</strong>:804-820</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd3266" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-77957363101" target="_blank" aria-label="Open Scopus in new tab">Scopus (399)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20885411/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd3266&amp;pmid=20885411" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18-1" title="View in article">18.</a></div><div>Cox, D. ∙ Smith, R. ∙ Quinn, M. ...</div><div><strong>Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes</strong></div><div><em>J.&nbsp;Am. Coll. Cardiol.</em> 2000; <strong>36</strong>:1514-1519</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0735-1097(00)00919-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034332785" target="_blank" aria-label="Open Scopus in new tab">Scopus (109)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11079651/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0735-1097%2800%2900919-0&amp;pmid=11079651" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19" title="View in article">19.</a></div><div>Davì, G. ∙ Patrono, C.</div><div><strong>Platelet activation and atherothrombosis</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2007; <strong>357</strong>:2482-2494</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMra071014" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-37249068049" target="_blank" aria-label="Open Scopus in new tab">Scopus (1827)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18077812/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMra071014&amp;pmid=18077812" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20-1" title="View in article">20.</a></div><div>Dickfeld, T. ∙ Ruf, A. ∙ Pogatsa-Murray, G. ...</div><div><strong>Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists</strong></div><div><em>Thromb. Res.</em> 2001; <strong>101</strong>:53-64</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2800%2900385-6&amp;cf=fulltext&amp;site=tr-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2800%2900385-6&amp;cf=pdf&amp;site=tr-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035862627" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11342206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0049-3848%2800%2900385-6&amp;pmid=11342206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21" title="View in article">21.</a></div><div>Dong, X. ∙ Hudson, N.E. ∙ Lu, C. ...</div><div><strong>Structural determinants of integrin β-subunit specificity for latent TGF-β</strong></div><div><em>Nat. Struct. Mol. Biol.</em> 2014; <strong>21</strong>:1091-1096</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsmb.2905" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84924179168" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25383667/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsmb.2905&amp;pmid=25383667" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">22.</a></div><div>Eldred, C.D. ∙ Evans, B. ∙ Hindley, S. ...</div><div><strong>Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent</strong></div><div><em>J.&nbsp;Med. Chem.</em> 1994; <strong>37</strong>:3882-3885</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm00049a006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0027948111" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7966149/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm00049a006&amp;pmid=7966149" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">23.</a></div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">24.</a></div><div>Eng, E.T. ∙ Smagghe, B.J. ∙ Walz, T. ...</div><div><strong>Intact αIIbβ3 extends after activation measured by solution X-ray scattering and electron microscopy</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2011; <strong>286</strong>:35218-35226</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M111.275107&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M111.275107&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-80053434774" target="_blank" aria-label="Open Scopus in new tab">Scopus (57)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21832081/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M111.275107&amp;pmid=21832081" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">25.</a></div><div>Fitzgerald, D.J. ∙ Roy, L. ∙ Catella, F. ...</div><div><strong>Platelet activation in unstable coronary disease</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 1986; <strong>315</strong>:983-989</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJM198610163151602" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0022457212" target="_blank" aria-label="Open Scopus in new tab">Scopus (1051)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3531859/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJM198610163151602&amp;pmid=3531859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26-1" title="View in article">26.</a></div><div>Frelinger, A.L. ∙ Cohen, I. ∙ Plow, E.F. ...</div><div><strong>Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1990; <strong>265</strong>:6346-6352</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2819%2939332-9&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2819%2939332-9&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2318856/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2819%2939332-9&amp;pmid=2318856" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27-1" title="View in article">27.</a></div><div>Frelinger, A.L. ∙ Lam, S.C.T. ∙ Plow, E.F. ...</div><div><strong>Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1988; <strong>263</strong>:12397-12402</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2818%2937769-X&amp;cf=abstract&amp;site=jbc-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0021-9258%2818%2937769-X&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2457583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0021-9258%2818%2937769-X&amp;pmid=2457583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28-1" title="View in article">28.</a></div><div>Gante, J. ∙ Juraszyk, H. ∙ Raddatz, P. ...</div><div><strong>New peptidomimetics in the chemistry of fibrinogen receptor antagonists</strong></div><div><em>Lett. Pept. Sci.</em> 1995; <strong>2</strong>:135-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/BF00119139" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0000574181" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2FBF00119139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">29.</a></div><div>Gante, J. ∙ Juraszyk, H. ∙ Raddatz, P. ...</div><div><strong>New antithrombotic RGD-mimetics with high bioavailability</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 1996; <strong>6</strong>:2425-2430</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0960-894X(96)00445-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0030598191" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0960-894X%2896%2900445-3" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref89" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref89" title="View in article">30.</a></div>Himmelsbach, F., Volkhard, A., Pieper, H., Linz, G., Weisenberger, J., and Mueller, T. (1996). Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds. US patent US5576444 published Nov. 19 1996.</div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Himmelsbach%2C+F.%2C+Volkhard%2C+A.%2C+Pieper%2C+H.%2C+Linz%2C+G.%2C+Weisenberger%2C+J.%2C+and+Mueller%2C+T.+%281996%29.+Cyclic+imino+derivatives%2C+processes+for+preparing+them+and+pharmaceutical+compositions+containing+these+compounds.+US+patent+US5576444+published+Nov.+19+1996." target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">31.</a></div><div>Jansen, E.E. ∙ Hartmann, M.</div><div><strong>Clot retraction: cellular mechanisms and inhibitors, measuring methods, and clinical implications</strong></div><div><em>Biomedicines.</em> 2021; <strong>9</strong>:1064</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3390/biomedicines9081064" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85113687594" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34440268/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3390%2Fbiomedicines9081064&amp;pmid=34440268" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Kabsch, W.</div><div><em>XDS. Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909047337" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-76449099287" target="_blank" aria-label="Open Scopus in new tab">Scopus (12932)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124692/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909047337&amp;pmid=20124692" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33-1" title="View in article">33.</a></div><div>Kekomaki, R. ∙ Dawson, B. ∙ McFarland, J. ...</div><div><strong>Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1991; <strong>88</strong>:847-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI115386" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0025938109" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1715887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI115386&amp;pmid=1715887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34-1" title="View in article">34.</a></div><div>Kereiakes, D.J. ∙ Henry, T.D. ∙ DeMaria, A.N. ...</div><div><strong>First human use of RUC-4: A nonactivating second-generation small-molecule platelet glycoprotein IIb/IIIa (integrin αiibβ3) inhibitor designed for subcutaneous point-of-care treatment of ST-segment-elevation myocardial infarction</strong></div><div><em>J.&nbsp;Am. Heart Assoc.</em> 2020; <strong>9</strong>:e016552</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/JAHA.120.016552" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85090174407" target="_blank" aria-label="Open Scopus in new tab">Scopus (20)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32844723/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FJAHA.120.016552&amp;pmid=32844723" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35-1" title="View in article">35.</a></div><div>Lenter, M. ∙ Uhlig, H. ∙ Hamann, A. ...</div><div><strong>A monoclonal antibody against an activation epitope on mouse integrin chain β1 blocks adhesion of lymphocytes to the endothelial integrin α6β1</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1993; <strong>90</strong>:9051-9055</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.90.19.9051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0027421094" target="_blank" aria-label="Open Scopus in new tab">Scopus (240)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7692444/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.90.19.9051&amp;pmid=7692444" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36-1" title="View in article">36.</a></div><div>Ley, K. ∙ Rivera-Nieves, J. ∙ Sandborn, W.J. ...</div><div><strong>Integrin-based therapeutics: biological basis, clinical use and new drugs</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2016; <strong>15</strong>:173-183</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd.2015.10" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84959369497" target="_blank" aria-label="Open Scopus in new tab">Scopus (321)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26822833/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd.2015.10&amp;pmid=26822833" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37-1" title="View in article">37.</a></div><div>Li, J. ∙ Fukase, Y. ∙ Shang, Y. ...</div><div><strong>Novel pure αVβ3 integrin antagonists that do not induce receptor extension, prime the receptor, or enhance angiogenesis at low concentrations</strong></div><div><em>ACS Pharmacol. Transl. Sci.</em> 2019; <strong>2</strong>:387-401</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acsptsci.9b00041" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85087732052" target="_blank" aria-label="Open Scopus in new tab">Scopus (23)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32259072/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facsptsci.9b00041&amp;pmid=32259072" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">38.</a></div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Integrin extension enables ultrasensitive regulation by cytoskeletal force</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2017; <strong>114</strong>:4685-4690</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1704171114" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85018292985" target="_blank" aria-label="Open Scopus in new tab">Scopus (111)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28416675/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1704171114&amp;pmid=28416675" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">39.</a></div><div>Li, J. ∙ Springer, T.A.</div><div><strong>Energy landscape differences among integrins establish the framework for understanding activation</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2018; <strong>217</strong>:397-412</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201701169" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85039868951" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29122968/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201701169&amp;pmid=29122968" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40-1" title="View in article">40.</a></div><div>Li, J. ∙ Su, Y. ∙ Xia, W. ...</div><div><strong>Conformational equilibria and intrinsic affinities define integrin activation</strong></div><div><em>EMBO J.</em> 2017; <strong>36</strong>:629-645</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.15252/embj.201695803" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85016558478" target="_blank" aria-label="Open Scopus in new tab">Scopus (105)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28122868/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.15252%2Fembj.201695803&amp;pmid=28122868" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41-1" title="View in article">41.</a></div><div>Li, J. ∙ Vootukuri, S. ∙ Shang, Y. ...</div><div><strong>RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction</strong></div><div><em>Arterioscler. Thromb. Vasc. Biol.</em> 2014; <strong>34</strong>:2321-2329</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/ATVBAHA.114.303724" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84913554789" target="_blank" aria-label="Open Scopus in new tab">Scopus (67)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25147334/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2FATVBAHA.114.303724&amp;pmid=25147334" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">42.</a></div><div>Luo, B.H. ∙ Springer, T.A. ∙ Takagi, J.</div><div><strong>Stabilizing the open conformation of the integrin headpiece with a glycan wedge increases affinity for ligand</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2003; <strong>100</strong>:2403-2408</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0438060100" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0037418254" target="_blank" aria-label="Open Scopus in new tab">Scopus (126)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12604783/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0438060100&amp;pmid=12604783" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">43.</a></div><div>Luo, B.H. ∙ Springer, T.A. ∙ Takagi, J.</div><div><strong>A specific interface between integrin transmembrane helices and affinity for ligand</strong></div><div><em>PLoS Biol.</em> 2004; <strong>2</strong>:e153</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pbio.0020153" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-16644396938" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15208712/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pbio.0020153&amp;pmid=15208712" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44-1" title="View in article">44.</a></div><div>Luque, A. ∙ Gómez, M. ∙ Puzon, W. ...</div><div><strong>Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355–425) of the common β1 chain</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 1996; <strong>271</strong>:11067-11075</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.271.19.11067&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-15844363687" target="_blank" aria-label="Open Scopus in new tab">Scopus (273)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8626649/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.271.19.11067&amp;pmid=8626649" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45" title="View in article">45.</a></div><div>Ma, D. ∙ Xia, C.</div><div><strong>CuI-catalyzed coupling reaction of beta-amino acids or esters with aryl halides at temperature lower than that employed in the normal Ullmann reaction. Facile synthesis of SB-214857</strong></div><div><em>Org. Lett.</em> 2001; <strong>3</strong>:2583-2586</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ol016258r" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035833707" target="_blank" aria-label="Open Scopus in new tab">Scopus (262)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11483066/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fol016258r&amp;pmid=11483066" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Matsuno, H. ∙ Kozawa, O. ∙ Niwa, M. ...</div><div><strong>Effect of GR144053, a fibrinogen-receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tPA in the injured carotid artery of the hamster</strong></div><div><em>J.&nbsp;Cardiovasc. Pharmacol.</em> 1998; <strong>32</strong>:191-197</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/00005344-199808000-00004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0031828205" target="_blank" aria-label="Open Scopus in new tab">Scopus (14)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9700979/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2F00005344-199808000-00004&amp;pmid=9700979" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">47.</a></div><div>Matsuno, H. ∙ Kozawa, O. ∙ Niwa, M. ...</div><div><strong>GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster</strong></div><div><em>Br. J. Pharmacol.</em> 1997; <strong>122</strong>:1099-1104</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/sj.bjp.0701500" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0030781335" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9480031/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsj.bjp.0701500&amp;pmid=9480031" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48-1" title="View in article">48.</a></div><div>Miller, D.H. ∙ Weber, T. ∙ Grove, R. ...</div><div><strong>Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial</strong></div><div><em>Lancet Neurol.</em> 2012; <strong>11</strong>:131-139</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS1474-4422%2811%2970299-X&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84856015884" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22226929/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1474-4422%2811%2970299-X&amp;pmid=22226929" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49-1" title="View in article">49.</a></div><div>Mitjans, F. ∙ Sander, D. ∙ Adán, J. ...</div><div><strong>An anti-α v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice</strong></div><div><em>J.&nbsp;Cell Sci.</em> 1995; <strong>108</strong>:2825-2838</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.108.8.2825" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7593323/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.108.8.2825&amp;pmid=7593323" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50-1" title="View in article">50.</a></div><div>Miyake, K. ∙ Hasunuma, Y. ∙ Yagita, H. ...</div><div><strong>Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>119</strong>:653-662</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.119.3.653" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0026730043" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1400595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.119.3.653&amp;pmid=1400595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51-1" title="View in article">51.</a></div><div>Mould, A.P. ∙ Garratt, A.N. ∙ Askari, J.A. ...</div><div><strong>Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit</strong></div><div><em>FEBS Lett.</em> 1995; <strong>363</strong>:118-122</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0014-5793(95)00301-O" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0028944308" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7537221/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0014-5793%2895%2900301-O&amp;pmid=7537221" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">52.</a></div><div>Mould, D. ∙ Chapelsky, M. ∙ Aluri, J. ...</div><div><strong>A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients</strong></div><div><em>Clin. Pharmacol. Ther.</em> 2001; <strong>69</strong>:210-222</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1067/mcp.2001.114925" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035035790" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11309549/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1067%2Fmcp.2001.114925&amp;pmid=11309549" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53-1" title="View in article">53.</a></div><div>Müller, T.H. ∙ Weisenberger, H. ∙ Brickl, R. ...</div><div><strong>Profound and sustained inhibition of platelet aggregation by fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, lefradafiban, in men</strong></div><div><em>Circulation.</em> 1997; <strong>96</strong>:1130-1138</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.96.4.1130" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0342872079" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9286940/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.96.4.1130&amp;pmid=9286940" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">54.</a></div><div>Muro, F. ∙ Iimura, S. ∙ Sugimoto, Y. ...</div><div><strong>Discovery of trans-4-[1-[[2, 5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2009; <strong>52</strong>:7974-7992</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm901154c" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-73249123942" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19891440/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm901154c&amp;pmid=19891440" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">55.</a></div><div>Murphy, N.P. ∙ Pratico, D. ∙ Fitzgerald, D.J.</div><div><strong>Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in&nbsp;vivo</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 1998; <strong>286</strong>:945-951</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=fulltext&amp;site=jpet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0022-3565%2824%2937673-6&amp;cf=pdf&amp;site=jpet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9694954/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0022-3565%2824%2937673-6&amp;pmid=9694954" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56" title="View in article">56.</a></div><div>Nagae, M. ∙ Re, S. ∙ Mihara, E. ...</div><div><strong>Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2012; <strong>197</strong>:131-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201111077" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84860273145" target="_blank" aria-label="Open Scopus in new tab">Scopus (181)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22451694/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201111077&amp;pmid=22451694" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">57.</a></div><div>Newman, P.J. ∙ Allen, R.W. ∙ Kahn, R.A. ...</div><div><strong>Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3</strong></div><div><em>Blood.</em> 1985; <strong>65</strong>:227-232</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood.V65.1.227.227" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3155488/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood.V65.1.227.227&amp;pmid=3155488" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">58.</a></div><div>Nomoto, M. ∙ Tatebayashi, T. ∙ Morita, J. ...</div><div><strong>Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in&nbsp;vitro intestinal parameters</strong></div><div><em>J.&nbsp;Pharm. Sci.</em> 2009; <strong>98</strong>:1532-1544</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1002%2Fjps.21510&amp;cf=fulltext&amp;site=xphs-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1002%2Fjps.21510&amp;cf=pdf&amp;site=xphs-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-67449149636" target="_blank" aria-label="Open Scopus in new tab">Scopus (3)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18683862/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fjps.21510&amp;pmid=18683862" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59" title="View in article">59.</a></div><div>Onitilo, A.A.</div><div><strong>Delayed profound thrombocytopenia associated with eptifibatide</strong></div><div><em>Am. J. Hematol.</em> 2006; <strong>81</strong>:984</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/ajh.20609" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-33845243141" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16804935/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fajh.20609&amp;pmid=16804935" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">60.</a></div><div>Peter, K. ∙ Schwarz, M. ∙ Nordt, T. ...</div><div><strong>Intrinsic activating properties of GP IIb/IIIa blockers</strong></div><div><em>Thromb. Res.</em> 2001; <strong>103</strong>:S21-S27</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2801%2900300-0&amp;cf=fulltext&amp;site=tr-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0049-3848%2801%2900300-0&amp;cf=pdf&amp;site=tr-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035975625" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11567665/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0049-3848%2801%2900300-0&amp;pmid=11567665" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">61.</a></div><div>Pieniaszek, Jr., H.J. ∙ Sy, S.K. ∙ Ebling, W. ...</div><div><strong>Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of Roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers</strong></div><div><em>J.&nbsp;Clin. Pharmacol.</em> 2002; <strong>42</strong>:738-753</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/009127002401102687" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0035998752" target="_blank" aria-label="Open Scopus in new tab">Scopus (15)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12092741/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F009127002401102687&amp;pmid=12092741" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-1" title="View in article">62.</a></div><div>Ran, F.A. ∙ Hsu, P.D. ∙ Wright, J. ...</div><div><strong>Genome engineering using the CRISPR-Cas9 system</strong></div><div><em>Nat. Protoc.</em> 2013; <strong>8</strong>:2281-2308</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2013.143" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84887010498" target="_blank" aria-label="Open Scopus in new tab">Scopus (7783)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24157548/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2013.143&amp;pmid=24157548" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">63.</a></div><div>Reynolds, A.R. ∙ Hart, I.R. ∙ Watson, A.R. ...</div><div><strong>Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors</strong></div><div><em>Nat. Med.</em> 2009; <strong>15</strong>:392-400</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.1941" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-64149106522" target="_blank" aria-label="Open Scopus in new tab">Scopus (405)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19305413/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.1941&amp;pmid=19305413" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-1" title="View in article">64.</a></div><div>Scarborough, R.M. ∙ Gretler, D.D.</div><div><strong>Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2000; <strong>43</strong>:3453-3473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm000022w" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0034699501" target="_blank" aria-label="Open Scopus in new tab">Scopus (110)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10999999/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm000022w&amp;pmid=10999999" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">65.</a></div><div>Schumacher, S. ∙ Dedden, D. ∙ Nunez, R.V. ...</div><div><strong>Structural insights into integrin α5β1 opening by fibronectin ligand</strong></div><div><em>Sci. Adv.</em> 2021; <strong>7</strong>:eabe9716</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/sciadv.abe9716" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85105706612" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33962943/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fsciadv.abe9716&amp;pmid=33962943" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">66.</a></div><div>Sen, M. ∙ Yuki, K. ∙ Springer, T.A.</div><div><strong>An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>203</strong>:629-642</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201308083" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890230123" target="_blank" aria-label="Open Scopus in new tab">Scopus (76)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24385486/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201308083&amp;pmid=24385486" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">67.</a></div><div>Shimaoka, M. ∙ Springer, T.A.</div><div><strong>Therapeutic antagonists and the conformational regulation of integrin structure and function</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2003; <strong>2</strong>:703-716</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd1174" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0142026204" target="_blank" aria-label="Open Scopus in new tab">Scopus (311)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12951577/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd1174&amp;pmid=12951577" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref90" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref90" title="View in article">68.</a></div>Smallheer, J.M., Wang, S., and Jadhav, P.K. (2001). Isoxazoline fibrinogen receptor antagonists. US patent US6303609 B1. published October 16, 2001.</div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=Smallheer%2C+J.M.%2C+Wang%2C+S.%2C+and+Jadhav%2C+P.K.+%282001%29.+Isoxazoline+fibrinogen+receptor+antagonists.+US+patent+US6303609+B1.+published+October+16%2C+2001." target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">69.</a></div><div>Takagi, J. ∙ Petre, B.M. ∙ Walz, T. ...</div><div><strong>Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling</strong></div><div><em>Cell.</em> 2002; <strong>110</strong></div><div>599-511</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0092-8674%2802%2900935-2&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0092-8674%2802%2900935-2&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0037031906" target="_blank" aria-label="Open Scopus in new tab">Scopus (981)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12230977/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0092-8674%2802%2900935-2&amp;pmid=12230977" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">70.</a></div><div>Théroux, P. ∙ Catella-Lawson, F. ∙ Armstrong, P. ...</div><div><strong>Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 1998; <strong>338</strong>:1488-1497</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJM199805213382102" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-2642599026" target="_blank" aria-label="Open Scopus in new tab">Scopus (1677)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9599103/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJM199805213382102&amp;pmid=9599103" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">71.</a></div><div>Tilley, J.W. ∙ Sidduri, A. ∙ Lou, J. ...</div><div><strong>Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists</strong></div><div><em>Bioorg. Med. Chem. Lett.</em> 2013; <strong>23</strong>:1036-1040</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bmcl.2012.12.019" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84872914454" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23312471/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bmcl.2012.12.019&amp;pmid=23312471" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72-1" title="View in article">72.</a></div><div>Topol, E.J. ∙ Byzova, T.V. ∙ Plow, E.F.</div><div><strong>Platelet GPIIb-IIIa blockers</strong></div><div><em>Lancet.</em> 1999; <strong>353</strong>:227-231</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0140-6736%2898%2911086-3&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1016%2FS0140-6736%2898%2911086-3&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0033573790" target="_blank" aria-label="Open Scopus in new tab">Scopus (521)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9923894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2898%2911086-3&amp;pmid=9923894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73-1" title="View in article">73.</a></div><div>Topol, E.J. ∙ Easton, D. ∙ Harrington, R.A. ...</div><div><strong>Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease</strong></div><div><em>Circulation.</em> 2003; <strong>108</strong>:399-406</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1161/01.CIR.0000084501.48570.F6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0043166526" target="_blank" aria-label="Open Scopus in new tab">Scopus (199)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12874182/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1161%2F01.CIR.0000084501.48570.F6&amp;pmid=12874182" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74" title="View in article">74.</a></div><div>Trip, M.D. ∙ Cats, V.M. ∙ van Capelle, F.J. ...</div><div><strong>Platelet hyperreactivity and prognosis in survivors of myocardial infarction</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 1990; <strong>322</strong>:1549-1554</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJM199005313222201" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0025280866" target="_blank" aria-label="Open Scopus in new tab">Scopus (562)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/2336086/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJM199005313222201&amp;pmid=2336086" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75" title="View in article">75.</a></div><div>Wang, J. ∙ Su, Y. ∙ Iacob, R.E. ...</div><div><strong>General structural features that regulate integrin affinity revealed by atypical αVβ8</strong></div><div><em>Nat. Commun.</em> 2019; <strong>10</strong>:5481</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-019-13248-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-85075945737" target="_blank" aria-label="Open Scopus in new tab">Scopus (27)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31792290/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-019-13248-5&amp;pmid=31792290" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76-1" title="View in article">76.</a></div><div>Weller, T. ∙ Alig, L. ∙ Beresini, M. ...</div><div><strong>Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines</strong></div><div><em>J.&nbsp;Med. Chem.</em> 1996; <strong>39</strong>:3139-3147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jm9509298" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-9344236530" target="_blank" aria-label="Open Scopus in new tab">Scopus (132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/8759635/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjm9509298&amp;pmid=8759635" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77" title="View in article">77.</a></div><div>Wittke, B. ∙ Mackie, I.J. ∙ Machin, S.J. ...</div><div><strong>Pharmacokinetics and pharmacodynamics of RO 44–3888 after single ascending oral doses of sibrafiban, an oral platelet aggregation inhibitor, in healthy male volunteers</strong></div><div><em>Br. J. Clin. Pharmacol.</em> 1999; <strong>47</strong>:521-530</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1046/j.1365-2125.1999.00931.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0032932924" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10336576/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1046%2Fj.1365-2125.1999.00931.x&amp;pmid=10336576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">78.</a></div><div>Wysocki, L.J. ∙ Sato, V.L.</div><div><strong>"Panning" for lymphocytes: A method for cell selection</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1978; <strong>75</strong>:2844-2848</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.75.6.2844" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0018140454" target="_blank" aria-label="Open Scopus in new tab">Scopus (1253)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/351618/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.75.6.2844&amp;pmid=351618" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">79.</a></div><div>Xia, W. ∙ Springer, T.A.</div><div><strong>Metal ion and ligand binding of integrin α5β1</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2014; <strong>111</strong>:17863-17868</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1420645111" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84919363205" target="_blank" aria-label="Open Scopus in new tab">Scopus (76)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25475857/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1420645111&amp;pmid=25475857" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80-1" title="View in article">80.</a></div><div>Xiao, T. ∙ Takagi, J. ∙ Coller, B.S. ...</div><div><strong>Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics</strong></div><div><em>Nature.</em> 2004; <strong>432</strong>:59-67</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature02976" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-8544259562" target="_blank" aria-label="Open Scopus in new tab">Scopus (718)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15378069/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature02976&amp;pmid=15378069" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81" title="View in article">81.</a></div><div>Xiong, J.P. ∙ Stehle, T. ∙ Zhang, R. ...</div><div><strong>Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand</strong></div><div><em>Science.</em> 2002; <strong>296</strong>:151-155</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1069040" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0037023363" target="_blank" aria-label="Open Scopus in new tab">Scopus (1461)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11884718/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1069040&amp;pmid=11884718" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82" title="View in article">82.</a></div><div>Yu, Y. ∙ Schürpf, T. ∙ Springer, T.A.</div><div><strong>How natalizumab binds and antagonizes α4 integrins</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2013; <strong>288</strong>:32314-32325</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M113.501668&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=10.1074%2Fjbc.M113.501668&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84887434165" target="_blank" aria-label="Open Scopus in new tab">Scopus (66)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24047894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M113.501668&amp;pmid=24047894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib83" class="citations"><div id="sref83" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref83-1" title="View in article">83.</a></div><div>Yu, Y. ∙ Zhu, J. ∙ Mi, L.Z. ...</div><div><strong>Structural specializations of α4β7 an integrin that mediates rolling adhesion</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2012; <strong>196</strong>:131-146</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201110023" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_83_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863012638" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22232704/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201110023&amp;pmid=22232704" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib84" class="citations"><div id="sref84" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref84" title="View in article">84.</a></div><div>Zhang, Lh ∙ Chung, J.C. ∙ Costello, T.D. ...</div><div><strong>The enantiospecific synthesis of an isoxazoline. A RGD mimic platelet GPIIb/IIIa antagonist</strong></div><div><em>J.&nbsp;Org. Chem.</em> 1997; <strong>62</strong>:2466-2470</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/jo9612537" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_84_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-0030962376" target="_blank" aria-label="Open Scopus in new tab">Scopus (85)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11671583/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fjo9612537&amp;pmid=11671583" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib85" class="citations"><div id="sref85" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref85-1" title="View in article">85.</a></div><div>Zhang, C. ∙ Liu, J. ∙ Jiang, X. ...</div><div><strong>Modulation of integrin activation and signaling by α1/α1'-helix unbending at the junction</strong></div><div><em>J.&nbsp;Cell Sci.</em> 2013; <strong>126</strong>:5735-5747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1242/jcs.137828" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_85_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84890487402" target="_blank" aria-label="Open Scopus in new tab">Scopus (25)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24144695/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1242%2Fjcs.137828&amp;pmid=24144695" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib86" class="citations"><div id="sref86" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref86-1" title="View in article">86.</a></div><div>Zhu, J. ∙ Choi, W.-S. ∙ McCoy, J.G. ...</div><div><strong>Structure-guided design of a high affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg2+ binding to the MIDAS</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003576" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_86_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84863375270" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003576" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib87" class="citations"><div id="sref87" class="citation"><div class="citation-content"><div class="label"><a href="#fig1" title="View in article">87.</a></div><div>Zhu, J. ∙ Zhu, J. ∙ Springer, T.A.</div><div><strong>Complete integrin headpiece opening in eight steps</strong></div><div><em>J.&nbsp;Cell Biol.</em> 2013; <strong>201</strong>:1053-1068</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.201212037" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_87_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-84880008208" target="_blank" aria-label="Open Scopus in new tab">Scopus (186)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23798730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.201212037&amp;pmid=23798730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib88" class="citations"><div id="sref88" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref88-1" title="View in article">88.</a></div><div>Zhu, J. ∙ Zhu, J. ∙ Negri, A. ...</div><div><strong>Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening</strong></div><div><em>Blood.</em> 2010; <strong>116</strong>:5050-5059</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2010-04-281154" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_88_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2022.08.008&amp;key=2-s2.0-78649747986" target="_blank" aria-label="Open Scopus in new tab">Scopus (99)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20679525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2010-04-281154&amp;pmid=20679525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none linkback-ad widget-" id="684c6365-474d-4ce7-932a-ddffa4f64d88">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <h2>CHORUS Manuscript</h2>
<p style="margin-bottom:5px;">
<a target="_blank" href="/action/clickThrough?id=2959&amp;url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fam%2Fpii%2FS0092867422009953&amp;loc=%2Fcell%2Ffulltext%2FS0092-8674%2822%2900995-3&amp;pubId=61681494&amp;placeholderId=1346&amp;productId=1822"> View Open Manuscript</a>
</p>
        </div></div>
                </div>
                </div>

        
</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (33)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/fd8ef6f0-53fc-4b92-93a2-989a64a488ca/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/93cf154d-56fb-41b5-ab23-ff00facae63c/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/3cb1e0ab-4608-4649-b918-ab5ae641496c/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/b7a5aeb8-7acd-4c51-9a62-30bed9ce9b8d/main.assets/figs1.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/f745bea8-70d7-43ee-883f-5ea4dc3b4d8c/main.assets/figs2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/78579e06-b4da-4bbf-addf-c484895a02cb/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/f374fd5f-eae3-4cad-8f42-04007aad8c1c/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/e33c973d-6410-48c2-ace1-8f0aacd17a8a/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/bc35dcae-da90-4f9c-9fe8-a0dcb6b2b5b0/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/5cd3bad9-12b0-4f9f-b09e-a82d2e962343/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/744fc549-7135-4946-9013-550856449705/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/2a5e664d-386e-49eb-830b-4e6b8101e500/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/f480ba12-6096-4ec7-9aa6-ac48f556bc1f/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/57704890-f2c0-4336-ab2c-8208b04b01ff/main.assets/figs7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig2" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/c03269bf-c7d5-4525-8b82-c33db3479c96/main.assets/fx2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig3" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/e50676e5-7461-4504-bc5f-7ef6d5a60163/main.assets/fx3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig4" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/c5c1978e-bd06-4bde-8899-fda8842ec9c1/main.assets/fx4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig5" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/fd92947d-83f1-4392-bbd9-ad18d0876c40/main.assets/fx5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig6" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/089a6a98-bd54-4282-bc89-c77cc8fbcebb/main.assets/fx6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig7" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/57c3f814-2aa1-4c45-8adb-33f89defaac9/main.assets/fx7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig8" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/995e2a22-ac2b-4113-ab9e-ae2b98e309ed/main.assets/fx8.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig9" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/45f10f2b-3db7-4429-a76f-f0c23a90a629/main.assets/fx9.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig10" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/80a22bd2-d91d-4db4-927e-b7c962c6e35e/main.assets/fx10.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig19" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/05f0117a-2878-4f46-be49-907749b39e4b/main.assets/sc1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig20" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/e09b0f58-2da5-49f2-9ee6-34b2f1a625d5/main.assets/sc2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig11" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/7337d909-3e75-4205-a45f-cc7e176366b7/main.assets/fx11.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig12" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/4ffde0af-a762-434f-bdf5-31c717144d38/main.assets/fx12.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig13" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/2a60371d-58c4-4960-853c-70036cd394d9/main.assets/fx13.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig14" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/8236bf1e-2cfa-469f-a4ad-5e3dc0a7ff8b/main.assets/fx14.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig15" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/e532f359-ba6d-4eea-b052-d936be3250c9/main.assets/fx15.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig16" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/af49f849-08ad-4eab-804c-33b2683a28ff/main.assets/fx16.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig17" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/cd86ca33-e62d-496b-bb32-de2fc0a58edd/main.assets/fx17.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig18" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/asset/5582fc37-5340-41bf-9ee2-10ff17a05952/main.assets/fx18.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867421X00207%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Apii%5C%3AS0092867422009953%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (2)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/attachment/f528529c-6e82-4df5-b46e-3c756b3ad72d/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (192.32 KB)</span></a><div class="core-description">Table&nbsp;S1. X-ray diffraction and structure refinement, related to Figures&nbsp;3, S1, and S2</div></div></div><div class="core-supplementary-material" data-category="archive"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2022.08.008/attachment/388c37fe-9bf3-45e6-8bac-4c17dbed95e7/mmc2.zip" download="mmc2.zip"><span id="mmc2-link">Archive (5.85 KB)</span></a><div class="core-description">Data S1. Equation 4, related to Figures&nbsp;6 and S3</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867422009953" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2022.08.008","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">A general chemical principle for creating closure-stabilizing integrin inhibitors</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2022.08.008/asset/fd8ef6f0-53fc-4b92-93a2-989a64a488ca/main.assets/gr1.jpg" height="867" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/529457c5-f126-45a3-b733-68c672d47048/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2022.08.008/asset/93cf154d-56fb-41b5-ab23-ff00facae63c/main.assets/gr2.jpg" height="794" width="659" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5980c0d3-fc71-4bd6-af8d-b489e8a73cb8/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2022.08.008/asset/3cb1e0ab-4608-4649-b918-ab5ae641496c/main.assets/gr3.jpg" height="853" width="761" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dd511fb4-7aa4-441d-8b6b-b16b0a1bf198/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2022.08.008/asset/b7a5aeb8-7acd-4c51-9a62-30bed9ce9b8d/main.assets/figs1.jpg" height="525" width="506" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/3d1f99e6-9790-47bd-888e-0ee546b9b5b7/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2022.08.008/asset/f745bea8-70d7-43ee-883f-5ea4dc3b4d8c/main.assets/figs2.jpg" height="297" width="772" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/f1c2efcd-7105-4f54-8b6c-fc3ea8e42357/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2022.08.008/asset/78579e06-b4da-4bbf-addf-c484895a02cb/main.assets/figs3.jpg" height="526" width="506" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/63ae75d9-98c1-4318-bd74-4cf69625a46b/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2022.08.008/asset/f374fd5f-eae3-4cad-8f42-04007aad8c1c/main.assets/gr4.jpg" height="445" width="497" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/0bb95bd9-4c8a-4ce5-8039-a5afb89e0c23/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2022.08.008/asset/e33c973d-6410-48c2-ace1-8f0aacd17a8a/main.assets/gr5.jpg" height="923" width="765" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/c875c7b0-dc35-45bf-b1cb-125d8b38ba7f/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2022.08.008/asset/bc35dcae-da90-4f9c-9fe8-a0dcb6b2b5b0/main.assets/gr6.jpg" height="484" width="761" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dc66897d-5472-412c-ae81-57710e544033/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2022.08.008/asset/5cd3bad9-12b0-4f9f-b09e-a82d2e962343/main.assets/figs4.jpg" height="304" width="663" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/c1d77444-483c-4879-b29d-95f22677e089/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2022.08.008/asset/744fc549-7135-4946-9013-550856449705/main.assets/gr7.jpg" height="709" width="770" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2f92393d-7055-4739-bd6b-ef413ff11ebd/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2022.08.008/asset/2a5e664d-386e-49eb-830b-4e6b8101e500/main.assets/figs5.jpg" height="774" width="657" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/9d80281c-f134-4907-9000-f9cb72334b77/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2022.08.008/asset/f480ba12-6096-4ec7-9aa6-ac48f556bc1f/main.assets/figs6.jpg" height="575" width="657" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dc64037e-e5e2-4bec-9f7f-82bbf37a2bcf/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2022.08.008/asset/57704890-f2c0-4336-ab2c-8208b04b01ff/main.assets/figs7.jpg" height="425" width="506" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/8f7391f7-853b-4562-8c25-1b10852a71e7/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx2" alt="Figure undfig2" src="/cms/10.1016/j.cell.2022.08.008/asset/c03269bf-c7d5-4525-8b82-c33db3479c96/main.assets/fx2.jpg" height="234" width="604" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/174bb340-7755-48f4-a469-64edc80a01f9/main.assets/fx2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx3" alt="Figure undfig3" src="/cms/10.1016/j.cell.2022.08.008/asset/e50676e5-7461-4504-bc5f-7ef6d5a60163/main.assets/fx3.jpg" height="40" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5e47632e-baff-4ae9-bbd8-f6c8a3669a89/main.assets/fx3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx4" alt="Figure undfig4" src="/cms/10.1016/j.cell.2022.08.008/asset/c5c1978e-bd06-4bde-8899-fda8842ec9c1/main.assets/fx4.jpg" height="216" width="577" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/62550a95-1b51-4d74-985b-041ce5c8ec61/main.assets/fx4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx5" alt="Figure undfig5" src="/cms/10.1016/j.cell.2022.08.008/asset/fd92947d-83f1-4392-bbd9-ad18d0876c40/main.assets/fx5.jpg" height="185" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/a81c3073-b71e-425f-bc39-f4b3993e236c/main.assets/fx5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx6" alt="Figure undfig6" src="/cms/10.1016/j.cell.2022.08.008/asset/089a6a98-bd54-4282-bc89-c77cc8fbcebb/main.assets/fx6.jpg" height="209" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/0cdca29d-b6de-4aeb-b446-2fdc331d109f/main.assets/fx6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx7" alt="Figure undfig7" src="/cms/10.1016/j.cell.2022.08.008/asset/57c3f814-2aa1-4c45-8adb-33f89defaac9/main.assets/fx7.jpg" height="173" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2a90c30c-b57b-4afd-b721-645b70e15dcd/main.assets/fx7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx8" alt="Figure undfig8" src="/cms/10.1016/j.cell.2022.08.008/asset/995e2a22-ac2b-4113-ab9e-ae2b98e309ed/main.assets/fx8.jpg" height="211" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/35a3a600-947d-4e44-a4e8-96d8fabdb95c/main.assets/fx8_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx9" alt="Figure undfig9" src="/cms/10.1016/j.cell.2022.08.008/asset/45f10f2b-3db7-4429-a76f-f0c23a90a629/main.assets/fx9.jpg" height="248" width="539" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2b47bc2a-d02f-4403-8ebe-c60402a21c00/main.assets/fx9_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx10" alt="Figure undfig10" src="/cms/10.1016/j.cell.2022.08.008/asset/80a22bd2-d91d-4db4-927e-b7c962c6e35e/main.assets/fx10.jpg" height="212" width="606" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/266b2567-dfec-4697-ba78-cc54221fe8f2/main.assets/fx10_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="sc1" alt="Figure undfig19" src="/cms/10.1016/j.cell.2022.08.008/asset/05f0117a-2878-4f46-be49-907749b39e4b/main.assets/sc1.jpg" height="615" width="761" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5c510958-1912-4108-b3eb-002b9a6d4f3e/main.assets/sc1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="sc2" alt="Figure undfig20" src="/cms/10.1016/j.cell.2022.08.008/asset/e09b0f58-2da5-49f2-9ee6-34b2f1a625d5/main.assets/sc2.jpg" height="443" width="761" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/4af31048-0970-48e4-bf12-3e0daefab39c/main.assets/sc2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx11" alt="Figure undfig11" src="/cms/10.1016/j.cell.2022.08.008/asset/7337d909-3e75-4205-a45f-cc7e176366b7/main.assets/fx11.jpg" height="84" width="356" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/9a540885-366f-43a9-afd0-ede39e6ebaae/main.assets/fx11_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx12" alt="Figure undfig12" src="/cms/10.1016/j.cell.2022.08.008/asset/4ffde0af-a762-434f-bdf5-31c717144d38/main.assets/fx12.jpg" height="68" width="273" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/8d7d498f-d730-4dfe-b094-c7a5eed3b682/main.assets/fx12_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx13" alt="Figure undfig13" src="/cms/10.1016/j.cell.2022.08.008/asset/2a60371d-58c4-4960-853c-70036cd394d9/main.assets/fx13.jpg" height="130" width="367" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5b1eee4c-f4a7-4ab0-ab7c-992c643e6000/main.assets/fx13_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx14" alt="Figure undfig14" src="/cms/10.1016/j.cell.2022.08.008/asset/8236bf1e-2cfa-469f-a4ad-5e3dc0a7ff8b/main.assets/fx14.jpg" height="108" width="414" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/fdd64923-8056-4a27-93f7-ab521294c0d7/main.assets/fx14_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx15" alt="Figure undfig15" src="/cms/10.1016/j.cell.2022.08.008/asset/e532f359-ba6d-4eea-b052-d936be3250c9/main.assets/fx15.jpg" height="96" width="444" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/4f6fd470-3d18-4fef-a548-ed34aa93b8e5/main.assets/fx15_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx16" alt="Figure undfig16" src="/cms/10.1016/j.cell.2022.08.008/asset/af49f849-08ad-4eab-804c-33b2683a28ff/main.assets/fx16.jpg" height="101" width="567" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/a246cce0-d59b-4e11-83bf-7f3572709714/main.assets/fx16_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx17" alt="Figure undfig17" src="/cms/10.1016/j.cell.2022.08.008/asset/cd86ca33-e62d-496b-bb32-de2fc0a58edd/main.assets/fx17.jpg" height="120" width="463" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/6b9fd090-1496-4b07-99b4-d79ec44b2b6e/main.assets/fx17_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx18" alt="Figure undfig18" src="/cms/10.1016/j.cell.2022.08.008/asset/5582fc37-5340-41bf-9ee2-10ff17a05952/main.assets/fx18.jpg" height="113" width="456" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/20354254-3a1d-4d32-af76-79259df3d3f1/main.assets/fx18_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2022.08.008/asset/fd8ef6f0-53fc-4b92-93a2-989a64a488ca/main.assets/gr1.jpg" height="867" width="762" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/529457c5-f126-45a3-b733-68c672d47048/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2022.08.008/asset/93cf154d-56fb-41b5-ab23-ff00facae63c/main.assets/gr2.jpg" height="794" width="659" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5980c0d3-fc71-4bd6-af8d-b489e8a73cb8/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2022.08.008/asset/3cb1e0ab-4608-4649-b918-ab5ae641496c/main.assets/gr3.jpg" height="853" width="761" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dd511fb4-7aa4-441d-8b6b-b16b0a1bf198/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2022.08.008/asset/b7a5aeb8-7acd-4c51-9a62-30bed9ce9b8d/main.assets/figs1.jpg" height="525" width="506" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/3d1f99e6-9790-47bd-888e-0ee546b9b5b7/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2022.08.008/asset/f745bea8-70d7-43ee-883f-5ea4dc3b4d8c/main.assets/figs2.jpg" height="297" width="772" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/f1c2efcd-7105-4f54-8b6c-fc3ea8e42357/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2022.08.008/asset/78579e06-b4da-4bbf-addf-c484895a02cb/main.assets/figs3.jpg" height="526" width="506" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/63ae75d9-98c1-4318-bd74-4cf69625a46b/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2022.08.008/asset/f374fd5f-eae3-4cad-8f42-04007aad8c1c/main.assets/gr4.jpg" height="445" width="497" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/0bb95bd9-4c8a-4ce5-8039-a5afb89e0c23/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2022.08.008/asset/e33c973d-6410-48c2-ace1-8f0aacd17a8a/main.assets/gr5.jpg" height="923" width="765" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/c875c7b0-dc35-45bf-b1cb-125d8b38ba7f/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2022.08.008/asset/bc35dcae-da90-4f9c-9fe8-a0dcb6b2b5b0/main.assets/gr6.jpg" height="484" width="761" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dc66897d-5472-412c-ae81-57710e544033/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2022.08.008/asset/5cd3bad9-12b0-4f9f-b09e-a82d2e962343/main.assets/figs4.jpg" height="304" width="663" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/c1d77444-483c-4879-b29d-95f22677e089/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2022.08.008/asset/744fc549-7135-4946-9013-550856449705/main.assets/gr7.jpg" height="709" width="770" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2f92393d-7055-4739-bd6b-ef413ff11ebd/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2022.08.008/asset/2a5e664d-386e-49eb-830b-4e6b8101e500/main.assets/figs5.jpg" height="774" width="657" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/9d80281c-f134-4907-9000-f9cb72334b77/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2022.08.008/asset/f480ba12-6096-4ec7-9aa6-ac48f556bc1f/main.assets/figs6.jpg" height="575" width="657" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/dc64037e-e5e2-4bec-9f7f-82bbf37a2bcf/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2022.08.008/asset/57704890-f2c0-4336-ab2c-8208b04b01ff/main.assets/figs7.jpg" height="425" width="506" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/8f7391f7-853b-4562-8c25-1b10852a71e7/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx2" alt="Figure undfig2" src="/cms/10.1016/j.cell.2022.08.008/asset/c03269bf-c7d5-4525-8b82-c33db3479c96/main.assets/fx2.jpg" height="234" width="604" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/174bb340-7755-48f4-a469-64edc80a01f9/main.assets/fx2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx3" alt="Figure undfig3" src="/cms/10.1016/j.cell.2022.08.008/asset/e50676e5-7461-4504-bc5f-7ef6d5a60163/main.assets/fx3.jpg" height="40" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5e47632e-baff-4ae9-bbd8-f6c8a3669a89/main.assets/fx3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx4" alt="Figure undfig4" src="/cms/10.1016/j.cell.2022.08.008/asset/c5c1978e-bd06-4bde-8899-fda8842ec9c1/main.assets/fx4.jpg" height="216" width="577" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/62550a95-1b51-4d74-985b-041ce5c8ec61/main.assets/fx4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx5" alt="Figure undfig5" src="/cms/10.1016/j.cell.2022.08.008/asset/fd92947d-83f1-4392-bbd9-ad18d0876c40/main.assets/fx5.jpg" height="185" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/a81c3073-b71e-425f-bc39-f4b3993e236c/main.assets/fx5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx6" alt="Figure undfig6" src="/cms/10.1016/j.cell.2022.08.008/asset/089a6a98-bd54-4282-bc89-c77cc8fbcebb/main.assets/fx6.jpg" height="209" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/0cdca29d-b6de-4aeb-b446-2fdc331d109f/main.assets/fx6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx7" alt="Figure undfig7" src="/cms/10.1016/j.cell.2022.08.008/asset/57c3f814-2aa1-4c45-8adb-33f89defaac9/main.assets/fx7.jpg" height="173" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2a90c30c-b57b-4afd-b721-645b70e15dcd/main.assets/fx7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx8" alt="Figure undfig8" src="/cms/10.1016/j.cell.2022.08.008/asset/995e2a22-ac2b-4113-ab9e-ae2b98e309ed/main.assets/fx8.jpg" height="211" width="605" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/35a3a600-947d-4e44-a4e8-96d8fabdb95c/main.assets/fx8_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx9" alt="Figure undfig9" src="/cms/10.1016/j.cell.2022.08.008/asset/45f10f2b-3db7-4429-a76f-f0c23a90a629/main.assets/fx9.jpg" height="248" width="539" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/2b47bc2a-d02f-4403-8ebe-c60402a21c00/main.assets/fx9_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx10" alt="Figure undfig10" src="/cms/10.1016/j.cell.2022.08.008/asset/80a22bd2-d91d-4db4-927e-b7c962c6e35e/main.assets/fx10.jpg" height="212" width="606" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/266b2567-dfec-4697-ba78-cc54221fe8f2/main.assets/fx10_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="sc1" alt="Figure undfig19" src="/cms/10.1016/j.cell.2022.08.008/asset/05f0117a-2878-4f46-be49-907749b39e4b/main.assets/sc1.jpg" height="615" width="761" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5c510958-1912-4108-b3eb-002b9a6d4f3e/main.assets/sc1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="sc2" alt="Figure undfig20" src="/cms/10.1016/j.cell.2022.08.008/asset/e09b0f58-2da5-49f2-9ee6-34b2f1a625d5/main.assets/sc2.jpg" height="443" width="761" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/4af31048-0970-48e4-bf12-3e0daefab39c/main.assets/sc2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx11" alt="Figure undfig11" src="/cms/10.1016/j.cell.2022.08.008/asset/7337d909-3e75-4205-a45f-cc7e176366b7/main.assets/fx11.jpg" height="84" width="356" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/9a540885-366f-43a9-afd0-ede39e6ebaae/main.assets/fx11_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx12" alt="Figure undfig12" src="/cms/10.1016/j.cell.2022.08.008/asset/4ffde0af-a762-434f-bdf5-31c717144d38/main.assets/fx12.jpg" height="68" width="273" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/8d7d498f-d730-4dfe-b094-c7a5eed3b682/main.assets/fx12_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx13" alt="Figure undfig13" src="/cms/10.1016/j.cell.2022.08.008/asset/2a60371d-58c4-4960-853c-70036cd394d9/main.assets/fx13.jpg" height="130" width="367" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/5b1eee4c-f4a7-4ab0-ab7c-992c643e6000/main.assets/fx13_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx14" alt="Figure undfig14" src="/cms/10.1016/j.cell.2022.08.008/asset/8236bf1e-2cfa-469f-a4ad-5e3dc0a7ff8b/main.assets/fx14.jpg" height="108" width="414" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/fdd64923-8056-4a27-93f7-ab521294c0d7/main.assets/fx14_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx15" alt="Figure undfig15" src="/cms/10.1016/j.cell.2022.08.008/asset/e532f359-ba6d-4eea-b052-d936be3250c9/main.assets/fx15.jpg" height="96" width="444" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/4f6fd470-3d18-4fef-a548-ed34aa93b8e5/main.assets/fx15_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx16" alt="Figure undfig16" src="/cms/10.1016/j.cell.2022.08.008/asset/af49f849-08ad-4eab-804c-33b2683a28ff/main.assets/fx16.jpg" height="101" width="567" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/a246cce0-d59b-4e11-83bf-7f3572709714/main.assets/fx16_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx17" alt="Figure undfig17" src="/cms/10.1016/j.cell.2022.08.008/asset/cd86ca33-e62d-496b-bb32-de2fc0a58edd/main.assets/fx17.jpg" height="120" width="463" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/6b9fd090-1496-4b07-99b4-d79ec44b2b6e/main.assets/fx17_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx18" alt="Figure undfig18" src="/cms/10.1016/j.cell.2022.08.008/asset/5582fc37-5340-41bf-9ee2-10ff17a05952/main.assets/fx18.jpg" height="113" width="456" data-viewer-src="/cms/10.1016/j.cell.2022.08.008/asset/20354254-3a1d-4d32-af76-79259df3d3f1/main.assets/fx18_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(22)00995-3';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(22)00995-3';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749594466721","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"185","issueNumber":"19","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867422009953","coverDate":"202209","type":"XOCS-JOURNAL:SCOPE-FULL","title":"A general chemical principle for creating closurestabilizing integrin inhibitors","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc4c4169bf428c',t:'MTc0OTU5NDQ2Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dc4c4169bf428c&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2022.08.008&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>